10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

ý      ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended September 30, 2018 

or 

o         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For the transition period from                 to             

Commission File Number: 001-36477 

NEXEO SOLUTIONS, INC.

(Exact name of registrant as specified in its charter) 

Delaware	46-5188282
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
3 Waterway Square Place, Suite 1000 The Woodlands, Texas	77380
(Address of principal executive offices)	(Zip Code)

 

(281) 297-0700

(Registrant’s telephone number, including area code) 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Name of each exchange on which registered
Units, each consisting of one share of Common Stock,	NASDAQ Capital Market
$0.0001 par value, and one Warrant to purchase Common Stock
Common Stock, $0.0001 par value	NASDAQ Capital Market
Warrants to purchase Common Stock	NASDAQ Capital Market

 

Securities registered pursuant to Section 12(g) of the Act:

None.

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  o Yes  ý No 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.   o Yes ý  No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  ý Yes  o No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this Chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  ý Yes  o No

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 299.405 of this Chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  o	Accelerated filer  x
Non-accelerated filer  o	Smaller reporting company  o
	Emerging growth company  o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o No  ý

The aggregate market value of the voting stock held by non-affiliates of Nexeo Solutions, Inc. was $350,498,787 as of March 31, 2018, using the definition of beneficial ownership contained in Rule 13d-3 promulgated pursuant to the Securities Exchange Act of 1934, as amended, and excluding shares held by directors and executive officers. As of November 30, 2018, there were 89,698,331 shares of the Company's common stock outstanding, par value $0.0001 per share.

DOCUMENTS INCORPORATED BY REFERENCE:

Portions of the definitive proxy statement relating to the 2019 Annual Meeting of Stockholders of Nexeo Solutions, Inc., which will be filed with the Securities and Exchange Commission within 120 days of September 30, 2018, are incorporated by reference in Item 10, Item 11, Item 12, Item 13 and Item 14 of Part III of this Form 10-K.

TABLE OF CONTENTS

Glossary	ii
PART I
Item 1. Business	1
Item 1A. Risk Factors	16
Item 1B. Unresolved Staff Comments	36
Item 2. Properties	36
Item 3. Legal Proceedings	36
Item 4. Mine Safety Disclosures	37
PART II
Item 5. Market for the Company’s Common Equity, Related Stockholder Matters and Issue Purchases of Equity Securities	38
Item 6. Selected Financial Data	39
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations	41
Item 7A. Quantitative and Qualitative Disclosures About Market Risk	66
Item 8. Financial Statements and Supplementary Data	69
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosures	104
Item 9A. Controls and Procedures	104
Item 9B. Other Information	132
PART III
Item 10. Directors, Executive Officers and Corporate Governance	133
Item 11. Executive Compensation	133
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	133
Item 13. Certain Relationships and Related Transactions, and Director Independence	133
Item 14. Principal Accounting Fees and Services	133
PART IV
Item 15. Exhibits, Financial Statement Schedules	134
Item 16. Form 10-K Summary	139
SIGNATURES	140

i

GLOSSARY

The following terms and abbreviations appearing in the text of this Annual Report on Form 10-K have the meanings indicated below.

2016 LTIP	The Nexeo Solutions, Inc. 2016 Long Term Incentive Plan
ABL Borrowers	Holdings, Sub Holding and Solutions together with Nexeo Solutions Canada Corporation
ABL Facility	The asset-based credit facility pursuant to that certain asset-based credit agreement by and among the ABL Borrowers, Bank of America, N.A., as administrative agent and the lenders party thereto and the other parties thereto
ADA Purchase Agreement	The Ashland Distribution Acquisition purchase agreement
ASC	The FASB Accounting Standards Codification
Ashland	Ashland Inc. and its subsidiaries
ASU	Accounting Standards Update issued by the FASB
Blocker	TPG Accolade Delaware, L.P.
Blocker Merger	The merger of Blocker Merger Sub into Blocker on June 9, 2016, immediately following the Company Merger, with Blocker continuing as the surviving entity
Blocker Merger Sub	Neon Acquisition Company LLC, which was a wholly-owned subsidiary of WLRH at the time of the Blocker Merger
Business Combination	The business combination between WLRH and Holdings pursuant to the Merger Agreement, which was consummated on the Closing Date
CAA	U.S. Federal Clean Air Act
CAD	Canadian dollar
Canadian Tranche	Canadian tranche of the ABL Facility
CERCLA	U.S. Comprehensive Environmental Response, Compensation and Liability Act
CFATS	U.S. Chemical-Facility Anti-Terrorism Standards
Closing Date	June 9, 2016
Company / Successor / Nexeo	Nexeo Solutions, Inc. (f/k/a WL Ross Holding Corp.) and its consolidated subsidiaries
Company Merger	The merger of Company Merger Sub with and into Holdings consummated on June 9, 2016, with Holdings continuing as the surviving entity
Company Merger Sub	Neon Holding Company LLC, which was a wholly-owned subsidiary of WLRH at the time of the Company Merger
Credit Facilities	The ABL Facility and the Term Loan Facility, collectively
CWA	U.S. Clean Water Act
Deferred Cash Consideration	The deferred payment to be made in cash to the Selling Equityholders pursuant to the Merger Agreement, where such deferred cash payments will generally be in an amount equal to the Company’s prevailing stock price at the time that the Company pays such deferred cash payments multiplied by the number of Excess Shares or as otherwise set forth in the Merger Agreement
DHS	U.S. Department of Homeland Security
Director Founder Shares	The 30,000 original Founders Shares transferred to the Company’s prior independent directors
Distribution Business	The global distribution business purchased by the Predecessor from Ashland
DTSC	California Department of Toxic Substances Control
EBITDA	Earnings before interest, tax, depreciation and amortization
EMEA	Europe, Middle East and Africa
EPA	U. S. Environmental Protection Agency
EPCRA	U.S. Emergency Planning and Community Right-To-Know Act
EPS	Earnings or loss per share
ERP	Enterprise resource planning

ii

Excess Shares	The 5,178,642 shares of Company common stock used to calculate the Deferred Cash Consideration payable to the Selling Equityholders pursuant to the Merger Agreement
Exchange Act	U.S. Securities Exchange Act of 1934, as amended
FASB	Financial Accounting Standards Board
FCPA	U.S. Foreign Corrupt Practices Act
FHMTL	U.S. Federal Hazardous Material Transportation Law
FILO Tranche	$30.0 million tranche within the ABL Facility for non-Canadian foreign subsidiaries to issue loans and letters of credit
FPA	First Pacific Advisors, LLC
Founder Shares	The 12,506,250 shares of Company common stock issued to the Sponsor at the time of the IPO
GDP	Gross domestic product
Holdings	Nexeo Solutions Holdings, LLC
HMR	U.S. Hazardous Materials Regulations
HSR Act	Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended
IPO	The initial public offering of WLRH, consummated on June 11, 2014
Merger Agreement	Agreement and Plan of Merger, as amended, by and among WLRH, Blocker Merger Sub, Company Merger Sub, Holdings, Blocker, and Nexeo Holdco, LLC dated as of March 21, 2016
Mergers	The Company Merger and the Blocker Merger, collectively
Merger Sub I	Pilates Merger Sub I Corp, a Delaware corporation and direct wholly owned Subsidiary of Univar
Merger Sub II	Pilates Merger Sub II Corp, a Delaware corporation and direct wholly owned Subsidiary of Univar
Montgomery Lease	The Company’s leased facility in Montgomery, Illinois that commenced in the first fiscal quarter of 2017
NASDAQ	NASDAQ Stock Market
Notes	8.375% Senior Subordinated Notes of the Predecessor due 2018
NYSE	New York Stock Exchange
OSH Act	U.S. Occupational Safety and Health Act of 1970
OSHA	U.S. Occupational Safety and Health Administration which administers the OSH Act
Other Retained Remediation Liabilities	Under the ADA Purchase Agreement, Ashland agreed to retain environmental remediation liabilities unknown at the closing of the Ashland Distribution Acquisition related to the Distribution Business for which Ashland receives notice prior to the fifth anniversary of the closing of the ADA Purchase Agreement
Peso	Mexican peso
Predecessor	Holdings and its subsidiaries for the periods prior to the Closing Date
Predecessor ABL Facility	Holdings asset-based credit facility which was terminated in connection with the Business Combination
Predecessor Credit Facilities	Predecessor ABL Facility and Predecessor Term Loan Facility, collectively
Predecessor Term Loan Facility	Holdings’ senior secured term loan credit facility which was terminated in connection with the Business Combination
PSLRA	U.S. Private Securities Litigation Reform Act of 1995
PSU	Performance share unit issued under the 2016 LTIP
RCRA	U.S. Resource Conservation and Recovery Act
Retained Remediation Liabilities	Under the ADA Purchase Agreement, collectively, the Retained Specified Remediation Liabilities and the Other Retained Remediation Liabilities
Retained Specified Remediation Liabilities	Under the ADA Purchase Agreement, Ashland agreed to retain all known environmental remediation liabilities as of the date of closing of the ADA Purchase Agreement

iii

RMB	Chinese renminbi
RSU	Restricted stock unit issued under the 2016 LTIP
Ryder	Ryder Truck Rental, Inc.
Ryder Lease	Lease Agreement entered into by and between the Predecessor and Ryder in May 2015 for certain transportation equipment with payments of approximately $35.0 million over seven year term.
SAFE	People’s Republic of China State Administration of Foreign Exchange
SEC	U.S. Securities and Exchange Commission
Secured Net Leverage Ratio	The ratio of Consolidated Total Indebtedness divided by EBITDA (terms as defined in the Term Loan Facility agreement)
Securities Act	U.S. Securities Act of 1933, as amended
Selling Equityholders	The holders of equity interests in Holdings (other than Blocker) and the holders of equity interests in Blocker, in each case, as of the time immediately prior to the Business Combination
Solutions	Nexeo Solutions, LLC
Sponsor	WL Ross Sponsor LLC, the sponsor entity of WLRH prior to the Business Combination.
Sub Holding	Nexeo Solutions Sub Holding Corp.
Tax Act	The comprehensive tax legislation enacted by the U.S. government on December 22, 2017, commonly referred to as the Tax Cuts and Jobs Act.
Term Loan Facility	Term loan credit facility pursuant to that certain credit agreement by and among Holdings, Solutions, Sub Holding, Bank of America, N.A., as administrative and collateral agent, the other agents party thereto and the lenders party thereto
TLB Amendment No. 1	The amendment to the Term Loan Facility dated March 22, 2017
TLB Amendment No. 2	The amendment to the Term Loan Facility dated December 19, 2017
TPG	TPG Capital, L.P. together with its affiliates, including TPG Accolade
TPG Accolade	TPG Accolade, L.P.
TPG Restricted Stock Grants	Restricted stock agreements entered into between TPG and certain of the Company’s officers and employees
TRA	The Tax Receivable Agreement entered into in connection with the Business Combination, by and between the Company and the Selling Equityholders, dated as of June 9, 2016
TRA Holders	Nexeo Holdco, LLC, TPG VI, Nexeo I, LP., TPG VI Nexeo II, L.P. and TPG VI FOF Nexeo L.P.
TRA Termination Agreement	The TRA Termination Agreement included as Exhibit 10.1 to the Form 8-K filed with the SEC on September 18, 2018.
TSCA	U.S. Toxic Substances Control Act
Ultra Chem Acquisition	The April 3, 2017 acquisition of the equity interests of the Mexico City, Mexico based chemicals distribution business of the Ultra Chem Group pursuant to the Ultra Chem Stock Purchase Agreement
Ultra Chem Closing Date	April 3, 2017
Ultra Chem Group	The Mexico City, Mexico based chemicals distribution business of Ultra Chem, S. de R.L. de C.V. and its related entities
Ultra Chem Stock Purchase Agreement	The Stock Purchase Agreement dated March 9, 2017 related to the purchase of the equity interests of Ultra Chem Group
Univar	Univar, Inc.
Univar Merger Agreement	Agreement and Plan of Merger by and among Nexeo, Univar, Merger Sub I and Merger Sub II dated as of September 17, 2018 providing for the acquisition of Nexeo by Univar.
U.S.	United States of America
USD	U.S. Dollar
U.S. GAAP	U.S. Generally accepted accounting principles
U.S. Tranche	U.S. Tranche of the ABL Facility

iv

WLRH WL Ross Holding Corp.

Unless the context otherwise requires, the financial information presented in this Annual Report on Form 10-K (this "Form 10-K") is the financial information of the Company on a consolidated basis together with its subsidiaries.

The terms "the Company," "us," "our" and "we" and similar terms in this Annual Report on Form 10-K refer to Nexeo Solutions, Inc. and its consolidated subsidiaries.

TRADEMARKS AND TRADE NAMES

We own or have rights to various trademarks, service marks, and trade names that we use in connection with the operation of our business. This Form 10-K may also contain trademarks, service marks and trade names of third parties, which are the property of their respective owners. Third party trademarks, services marks, trade names or products used or displayed in this Form 10-K belong to the holders and are not intended to, and do not imply a relationship with, or endorsement or sponsorship by us. Solely for convenience, the trademarks, service marks and trade names referred to in this Form 10-K may appear without the ®, TM or SM symbols, but omission of these references is not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our right or the right of the applicable licensor to these trademarks, service marks and trade names.

v

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain information and statements contained in this Annual Report on Form 10-K are forward-looking statements within the meaning of the PSLRA codified in Section 27A of the Securities Act, and Section 21E of the Exchange Act. This statement is included for purposes of complying with the safe harbor provisions of the PSLRA. Forward-looking statements include statements regarding our expectations, beliefs, intentions, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical facts. These statements may be identified, without limitation, by the use of forward-looking terminology such as "anticipate," "assume," "believe," "estimate," "expect," "intend," "plan," "project," "may," "will," "could," "would" and similar expressions. Certain forward-looking statements are included in this Annual Report on Form 10-K, principally in the sections captioned "Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations."

These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting us will be those that we anticipate. Unless otherwise indicated or the context otherwise requires, comments concerning our expectations for future revenues and operating results are based on our forecasts for our existing operations and do not include the potential impact of any future acquisitions. Our forward-looking statements involve significant risks and uncertainties (some of which are beyond our control) and assumptions that could cause actual results to differ materially from our and our Predecessor’s historical experience and our present expectations or projections.

Our future results will depend upon various other risks and uncertainties, including those described in "Item 1A. Risk Factors." Readers are cautioned not to place undue reliance on forward-looking statements, which reflect management's current expectations and assumptions about future events, and speak only as of the date of this Annual Report on Form 10-K. We undertake no obligation to update or revise any forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise. All forward-looking statements attributable to us are qualified in their entirety by this cautionary statement.

vi

PART I

Item 1. Business

Company Overview

We are a global materials distributor for chemicals products in North America and Asia and for plastics products in North America, EMEA and Asia. In connection with the distribution of chemicals products, we provide value-added services such as custom blending, packaging and re-packaging, private-label manufacturing and product testing in the form of chemical analysis, product performance analysis and product development. We also provide on-site and off-site hazardous and non-hazardous environmental services, including waste collection, transportation, recovery, disposal arrangement and recycling services in North America, primarily the U.S. During fiscal year 2018, we distributed nearly 24,000 products in more than 80 countries for approximately 1,400 suppliers to approximately 27,300 customers.

We have long-standing relationships with major chemicals and plastics producers and suppliers, a strong geographic presence and supply chain network and a balanced customer base that benefits from the service and distribution value we provide. The products we distribute are used in various end markets and customer segments within a broad cross section of manufacturing industries, including household, industrial and institutional, lubricants, performance coatings (including architectural coatings, adhesives, sealants and elastomers), automotive, healthcare, personal care, oil and gas and construction end markets.

The depth and diversity of our product line and service offerings allows us to provide many of our customers with a one-stop-shop resource for their chemicals and plastics needs. For customers with multiple locations, our centralized business model helps ensure consistency of product offerings and a single point of contact. Our services and broad product offerings allow for product customization, cost savings to customers on transaction and transportation costs and reliance on a single supplier to source all of a customer's diverse product requirements.

We believe we provide a compelling value proposition to suppliers as a single bulk buyer of their products and acting as an extension of their sales force by representing their brands and providing technical support to customers. Our deep understanding of key end markets presents suppliers with additional market reach and penetration opportunities, while our operating platform supports supplier visibility into the marketing and distribution of their products. We also believe we provide value to suppliers by distributing to larger customers through dedicated strategic accounts sales and marketing programs designed to solidify key relationships through enhanced customer service, efficient delivery and specialized value-added solutions. In addition to the value-added services mentioned above, we also provide dedicated stocking programs, vendor-managed inventory, quarterly customer demand forecasting, technical support and supply chain services.

We have an experienced management team with deep knowledge of the industry. We continue to implement strategies and invest to build upon our strengths by creating industry-leading marketing capabilities, including our focus on specific end markets, sales force effectiveness tools, market-based pricing and geographic expansion.

We distribute our product portfolio through a global supply chain consisting of approximately 170 owned, leased or third party warehouses, rail terminals and tank terminals with a private fleet of 1,110 units, including tractors and trailers, primarily in North America. We currently employ approximately 2,760 employees globally. At September 30, 2018, we had approximately 510 sales professionals in North America, EMEA and Asia, including technical support, field managers and strategic account managers who assist our customers in the selection and application of commodity and specialty products for their end products and processes.

1

Company History

We were formed as a Delaware corporation on March 24, 2014, under the name WL Ross Holding Corp., as a special purpose acquisition company for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We completed our IPO in June 2014, raising approximately $500.0 million in cash proceeds. We neither engaged in any operations nor generated any revenue prior to the Business Combination.

We acquired the business of Nexeo Solutions Holdings, LLC on June 9, 2016 through the Business Combination. In connection with the closing of the Business Combination, we changed our name from "WL Ross Holding Corp." to "Nexeo Solutions, Inc." and changed our ticker symbol for our common stock on NASDAQ from "WLRH" to "NXEO".

On September 17, 2018, Nexeo and Univar entered into the Univar Merger Agreement providing for the acquisition of Nexeo by Univar. The Univar Merger Agreement and the proposed transaction were approved unanimously by the Board of Directors of both Nexeo and Univar and are subject to review by the SEC and regulatory agencies in the U.S. and other jurisdictions. The Univar Merger Agreement is also subject to a number of conditions, including, among other things and as further described in the Univar Merger Agreement: (i) the adoption by Nexeo’s stockholders of the Univar Merger Agreement, (ii) the approval by Univar’s stockholders of the issuance of the shares of Univar common stock in connection with the proposed transaction contemplated by the Univar Merger Agreement, (iii) the receipt of other required regulatory approvals, (iv) the absence of any law or governmental order prohibiting the proposed transaction, (v) the effectiveness of Univar's registration statement and the approval for listing on the NYSE of the shares of Univar common stock in connection with the proposed transaction contemplated by the Univar Merger Agreement, (vi) no material adverse effect on Nexeo's and Univar's operations having occurred since the signing of the Univar Merger Agreement and (vii) the termination of the TRA. There can be no assurance that the conditions to the completion of the proposed transaction will be satisfied or waived or that the proposed transaction will be completed. On November 16, 2018, Univar and Nexeo announced that the waiting period under the HSR Act expired.

See Note 3 to our consolidated financial statements for further discussion of the Univar Merger Agreement.

Industry Overview

The global market for industrial materials encompasses the products we offer. This market contains both products distributed directly to customers by suppliers and indirectly by distribution channel partners. Indirect distribution channel partners, like us, serve as intermediaries between suppliers and customers representing an additional step in the distribution supply chain. Suppliers leverage their distribution partners to administer the complexity of servicing the small and mid-size customer base while providing needed technical product expertise. The total available market of distribution is driven by macroeconomic factors, as well as suppliers’ decisions to either serve markets or customers directly or use a distribution partner. By creating and executing superior distribution services and related capabilities, we strive to encourage suppliers to increase the magnitude of business being served by us as a distribution partner in the global market.

The chemicals and plastics materials distribution industry is characterized by increasingly complex regulatory, environmental and safety landscapes, the need for market intelligence that requires time and effort to develop and, in some cases, significant capital investments for transportation and storage infrastructure. Adding to the complexity of this business environment is the increasing demand by end customers for individualized solutions. These solutions are generally comprised of essential products and value-added services including blending, packaging and other special handling and special logistics requirements such as 24/7 delivery. We believe our ability to serve these complex needs as a result of our capabilities and scale will encourage suppliers to further leverage distributors like us as their preferred channel to market.

2

Company Operations

Business Strategy

We strive to become a brand extension partner for key suppliers, provide best-in-class service, and align our sales force expertise with our customers' needs. Our value proposition focuses on supplier needs and direct customer activities. We have established four main strategies that drive our formula for success.

Go-To-Market Strategy. We aspire to use our technical capabilities, expertise and experience to commercially align with supplier strategies to operate as a brand extension while leveraging tools and systems to drive long-term loyalty through trust and transparency. Our sales force drives our customer-focused growth by utilizing technical expertise. The customer's journey is enhanced with a customized interface tailored for each customer's individual needs.

Profitability Growth & Margin Expansion. We seek to form strategic partnerships by leveraging foundational capabilities to demonstrate value propositions. We plan to optimize our portfolio by eliminating low profit business, expanding specialty product mix and executing ongoing productivity initiatives. To supplement growth, we have been actively pursuing accretive bolt-on acquisitions of product lines and businesses complementary to our current offerings.

Operational Excellence. We are committed to continued operational excellence by broadening our value-added service capabilities and delivering best-in-class service through a culture of continuous improvement. We focus on pricing strategies to optimize profit and efficient cash utilization through fully integrated purchasing and global enterprise cash management. Our commitment to high quality service is demonstrated by dedicated customer service representatives, company-owned warehouses, a private fleet having an on-time delivery percentage of 98.8% and sophisticated inventory management practices.

Driving Scale & Fostering Innovation.  We benefit from data-driven decision making and focus on scalable, long-term growth drivers. We continuously drive synergies by leveraging our centralized platform.

Competitive Strengths

We operate in a competitive industry and strive to differentiate ourselves from our competition by providing true end-to-end solutions, which requires using the right combination of integrated services that have the capacity and sophistication to serve larger customers while maintaining enough versatility to serve smaller customers. We believe our strengths include the following:

• Centralized, scalable technology platform that allows us to efficiently manage the inherent complexity of our business and supports value creation by unlocking scale and scope efficiencies from both organic growth and strategic acquisitions;

• Exceptional distribution network with strategically located facilities optimizing route density; and

• Extensive product knowledge and end market expertise allowing us to act as an extension of our suppliers while providing application-based, value-added services to our customers.

Segment Overview

We operate through three lines of business, or operating segments: Chemicals, Plastics and Environmental Services. Our lines of business market to different sets of customers operating in an array of different industries, with various end markets and customer segments within those industries. For segment presentation and disclosure purposes, our Chemicals and Plastics lines of business constitute separate reportable segments, while our Environmental Services line of business, which does not meet the materiality threshold for separate disclosure, is included in an "Other" segment.

3

Chemicals. Our Chemicals line of business distributes specialty and industrial chemicals, additives and solvents to industrial users via railcars, barges and bulk tanker trucks and as packaged goods in trucks. Our chemicals products are distributed in approximately 50 countries worldwide, primarily in North America and Asia. In connection with the distribution of chemicals products, we provide value-added services such as custom blending, packaging and re-packaging, private-label manufacturing and product testing in the form of chemical analysis, product performance analysis and product development. While our Chemicals line of business serves multiple end markets, the key end markets within the industrial space are household, industrial and institutional, performance coatings (including architectural coatings, adhesives, sealants and elastomers), lubricants, oil and gas and personal care.

Plastics. Our Plastics line of business distributes a broad product line consisting of commodity polymer products and prime engineering resins to plastics processors engaged in blow molding, extrusion, injection molding and rotation molding via railcars, bulk trucks, truckload boxes and mixed truckloads, or less-than-truckload quantities. We distribute plastics products in more than 60 countries worldwide, primarily in North America, EMEA and Asia. Our Plastics line of business serves a broad cross section of industrial segments, including key automotive and healthcare end markets.

Other. Our Environmental Services line of business, in connection with certain waste disposal service companies, provides customers with comprehensive on-site and off-site hazardous and non-hazardous waste collection, transportation, recovery, disposal arrangement and recycling services in North America, primarily in the U.S. These environmental services are offered through our network of distribution facilities used as transfer facilities and through a staff of dedicated on-site waste professionals. Our Environmental Services line of business serves multiple end markets such as aerospace and defense, automotive, chemical manufacturing, industrial manufacturing and oil and gas.

The table below provides a summary by line of business of the approximate number of customers served and key product offerings as of September 30, 2018:

	Chemicals	Plastics	Environmental Services
	Approximate Customers: 14,000(1)	Approximate Customers: 11,100(1)	Approximate Customers: 2,200(1)
Key Products	ž Alcohols ž Blends ž Esters ž Glycols ž Hydrocarbons ž Ketones ž Methanol ž Polyurethanes ž Resins ž Silicones ž Surfactants	ž Engineered Thermoplastics ž Polyolefins (including Polypropylene) ž Styrenics	ž On-Site Services ž Non-Hazardous and Hazardous Waste Disposal ž Non-Hazardous Waste Treatment/Recycling
(1) Customer duplication between lines of business is immaterial

In each of the past three fiscal years, polypropylene was the only product that accounted for over 10.0% of our consolidated net revenue. During the fiscal years ended September 30, 2018, 2017, and 2016 polypropylene accounted for 15.9%, 15.5%, and 17.6%, respectively, of total consolidated net revenue. For the period from October 1, 2015 through June 8, 2016, polypropylene accounted for 17.7% of the Predecessor total consolidated net revenue.

4

The charts below provide a summary of the proportional revenue contributions from our lines of business and primary geographic markets during the fiscal year ended September 30, 2018, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale. It was not practical to provide a summary of the revenue contributions of our primary geographic markets based on external customer location. The substantial majority of our sales to customers in the geographic markets described below are made by entities located within the applicable geographic market.

Our lines of business generally leverage the same infrastructure, distribution networks, information technology and operational processes, but are differentiated by the products they distribute, their geographic footprints and their distinct customer and supplier relationships. See Note 16 to our consolidated financial statements for additional financial information with respect to our reportable segments.

5

Supplier Relationships

We source chemicals and plastics from a wide array of suppliers, including many leading global chemicals and plastics producers. We generally purchase and take possession of these products and then resell and deliver them to our customers. While our top ten suppliers generally fulfill approximately 55% of total product procured by value on an annual basis, we source products from approximately 1,400 suppliers. Two suppliers accounted for 11.6% and 9.6%, respectively, of consolidated purchases during the fiscal year ended September 30, 2018, 12.1% and 9.9%, respectively, for the fiscal year ended September 30, 2017 and 11.9% and 10.4%, respectively, for the fiscal year ended September 30, 2016. Two suppliers accounted for 12.0% and 9.8%, respectively, for the period from October 1, 2015 through June 8, 2016 for the Predecessor consolidated purchases.

We maintain multiple sourcing options for most key products that we distribute to help ensure supply continuity and competitive pricing for our customers. We believe the depth of our supplier base ensures that we are able to satisfy the needs of all of our customers in all of our key geographic regions.

Our Chemicals and Plastics lines of business generally source products from distinct sets of suppliers.

• Chemicals. We source chemicals from many suppliers, including several of the largest global chemical companies such as DowDuPont, Eastman Chemical, LyondellBasell, Methanex and Solvay. Our ten largest suppliers generally account for approximately 55% by value of the chemical products procured on an annual basis.

• Plastics. Our plastics suppliers include several of the largest global chemical companies and plastics producers, such as BASF, Borealis, ExxonMobil Chemical Co., LyondellBasell and SABIC. Our ten largest suppliers generally account for approximately 85% by value of the plastics products procured on an annual basis.

In developing our supplier relationships, we evaluate prospective suppliers to determine the value they offer to the supply chain. We focus on suppliers that manufacture products utilized within the end markets we serve and provide opportunities that maintain healthy demand. Our key suppliers must also demonstrate a proven track record of reliability and commitment to invest in their businesses, as well as product price leadership.

We believe we provide value to suppliers in numerous ways, including the following:

• We serve as an aggregator of customer demand, enabling us to act as a single bulk buyer of our suppliers’ products;

• We act as an extension of suppliers’ sales force by representing their brands and providing technical support to customers, particularly those that are small and mid-sized, as well as larger customers through our strategic accounts program;

• We develop compelling value propositions in various end markets by providing core commodity products, core specialty products and value-added services to target certain customer segments we believe can generate sustainable and profitable revenue growth;

• We provide quarterly customer demand forecasting and visibility into the marketing and distribution of the suppliers’ products; and

• We have leading pricing technology to capture maximum value for our suppliers' brands in the marketplace.

Product Line Management and Purchasing

Our supplier relationships are managed by separate product management teams within our Chemicals and Plastics lines of business. These teams focus on developing and maintaining supplier relationships, monitoring existing product lines and trends, and analyzing potential new products. Product management teams work in close coordination with our sales and marketing teams, allowing them to quickly and effectively identify customer buying and demand trends.

6

Our purchasing department is generally responsible for executing purchase orders to suppliers through our ERP system. For the majority of our operations, this system provides a centralized control platform throughout the entire supply chain, enabling the purchasing department to optimize procurement decisions. See "—Proprietary Operating Systems" below.

Contracts

Our supply agreements allow flexibility, to help ensure product availability and our ability to set the specific terms of any purchase in accordance with prevailing market conditions. The agreements include commonly expected general terms and conditions such as volume expectations, pricing, price change mechanisms and guidelines for conflict resolution. Many of the agreements with key suppliers also provide for rebates upon achievement of specified volume purchase levels. Purchase prices are generally market-based and fluctuate in accordance with the costs of the relevant raw materials. We do not usually enter into contracts that are non-terminable, are "take or pay" or have other similar requirements.

Global Distribution Channels

We are organized around the philosophy that key operating processes, such as demand forecasting, purchasing and supplier selection, can be optimized for cost and efficiency when concentrated in a centralized business model. Accordingly, we operate our distribution network under a "hub-and-spoke" model by processing large volumes of inventory at our main regional hubs and shipping them to smaller local warehouses on a demand-driven basis from where they are delivered to customers. Products are transported to smaller customers in mixed truckloads or less-than-truckload quantities.

Facilities

Our facilities are strategically placed to optimize route density in an effort to balance high-quality customer service with execution costs. In North America, we operate several "hub-and-spoke" models as described above. We believe this model is beneficial, as it enables us to efficiently aggregate customer demand, and allows us to match a large number of suppliers and customers at a lower cost. This system also supports economies of scale, a key driver of our profitability, as the aggregation of inventory at the "hubs" reduces inventory procurement costs and permits fleet optimization and efficient route planning through shipment consolidation and frequent deliveries to the "spokes." During fiscal year 2018, these facilities served approximately 21,200 customers.

In EMEA, our international plastics business operates through 23 third party operated warehouses and eight sales offices. These warehouses are located across EMEA, and during fiscal year 2018 they served approximately 4,400 customers. 

In Asia, our international chemicals and plastics businesses operate through 16 third party operated warehouses and eight sales offices. These warehouses are located in China and served approximately 1,700 customers during fiscal year 2018.

The following table lists each of the active distribution facilities we own or lease and does not include third party operated facilities. We classify a facility as a "bulk facility" if it is engaged in delivering goods in bulk to our customers.

Distribution Facilities as of September 30, 2018

North American Facilities	Facility Type	Owned/Leased	Line(s) of Business
Birmingham, Alabama	Bulk/Warehouse	Owned	All
Mobile, Alabama	Bulk/Warehouse	Owned	All
Edmonton, Alberta	Bulk/Warehouse	Owned	All
Chandler, Arizona	Bulk/Warehouse	Owned	All
Richmond, British Columbia	Bulk/Warehouse	Leased	All
Carson, California (1)	Bulk/Warehouse	Leased	All
Fairfield, California	Bulk/Warehouse	Owned/Leased	All
Denver, Colorado	Bulk/Warehouse	Owned	All

7

Miami, Florida	Bulk/Warehouse	Owned	Chemicals and Plastics
Tampa, Florida	Bulk/Warehouse	Owned	Chemicals and Plastics
Doraville, Georgia	Bulk/Warehouse	Owned	Chemicals and Plastics
Montgomery, Illinois	Bulk/Warehouse	Leased	Chemicals and Plastics
Willow Springs, Illinois	Bulk/Warehouse	Owned	All
Kansas City, Kansas	Bulk/Warehouse	Owned	All
Kansas City, Kansas	Bulk/Warehouse	Leased	Plastics
Baton Rouge, Louisiana	Bulk/Warehouse	Owned	Chemicals and Plastics
Baton Rouge, Louisiana	Bulk/Warehouse	Owned	Chemicals and Plastics
Winnipeg, Manitoba	Bulk/Warehouse	Owned	All
Tewksbury, Massachusetts	Bulk/Warehouse	Owned	Chemicals and Plastics
Guadalajara, Mexico	Warehouse	Leased	Chemicals
Nuevo Leon, Mexico	Warehouse	Leased	Chemicals
Tepotzotlán, Mexico	Bulk/Warehouse	Leased	Chemicals and Plastics
Tepotzotlán, Mexico	Bulk/Warehouse	Leased	Chemicals
Querétaro, Mexico	Warehouse	Leased	Chemicals
Lansing, Michigan	Bulk/Warehouse	Owned	All
Warren, Michigan	Bulk/Warehouse	Owned	Chemicals and Plastics
Saint Paul, Minnesota	Bulk/Warehouse	Owned	Chemicals and Plastics
Shakopee, Minnesota	Bulk/Warehouse	Owned	All
St. Louis, Missouri	Bulk/Warehouse	Owned	All
Carteret, New Jersey	Bulk/Warehouse	Owned	Chemicals and Plastics
Charlotte, North Carolina	Bulk/Warehouse	Owned	All
Binghamton, New York	Warehouse	Owned	Plastics and Environmental Services
Tonawanda, New York	Bulk/Warehouse	Owned	Chemicals and Plastics
Columbus, Ohio	Bulk/Warehouse	Owned	Chemicals and Plastics
Dayton, Ohio	Warehouse	Owned	Plastics and Environmental Services
Evendale, Ohio	Bulk/Warehouse	Owned	Chemicals and Plastics
Grove City, Ohio	Bulk/Warehouse	Owned	Plastics
Twinsburg, Ohio	Bulk/Warehouse	Owned	Chemicals
Twinsburg, Ohio	Bulk/Warehouse	Leased	Chemicals and Plastics
Whipple, Ohio	Bulk/Warehouse	Leased	Chemicals
Tulsa, Oklahoma	Bulk/Warehouse	Owned	Chemicals and Plastics
Mississauga, Ontario	Bulk/Warehouse	Leased	All
Morrisville, Pennsylvania	Bulk/Warehouse	Owned	All
Catano, Puerto Rico	Warehouse	Owned	All
Anderson, South Carolina	Bulk/Warehouse	Owned	Plastics
Columbia, South Carolina	Bulk/Warehouse	Owned	All
Knoxville, Tennessee	Bulk/Warehouse	Owned	All
Memphis, Tennessee	Bulk/Warehouse	Owned	All
Nashville, Tennessee	Bulk/Warehouse	Owned	Chemicals and Plastics
Conroe, Texas	Bulk/Warehouse	Owned	Chemicals and Plastics
Garland, Texas	Bulk/Warehouse	Owned	All
Houston, Texas	Bulk/Warehouse	Owned	All
Midland, Texas	Bulk/Warehouse	Owned	All
Clearfield, Utah	Bulk/Warehouse	Leased	All

⁽¹⁾ During the first half of fiscal year 2019, we plan to acquire the land currently being leased.

8

Our principal executive offices are located in The Woodlands, Texas. We believe that our facilities are adequate for our current operations.

Private Fleet

Transportation of products to and from customers and suppliers is a fundamental component of our business. During fiscal year 2018, our North American distribution service relied on our private fleet of trucks, tankers and trailers for 69.4% of volume delivered from our warehouses to our customers. We relied on common carriers for the remainder of our deliveries.

At September 30, 2018, our private fleet consisted of 1,110 owned and leased units that carry solid, bulk and liquid materials.

Private Fleet Characteristics as of September 30, 2018

Vehicle Type	Number of Vehicles	Average Age (years)	Average Transport Capacity (lbs.)
Tractors	352	4	45,000
Bulk Liquid Tankers	400	16	42,000
Van Trailers	345	12	45,000
Dry Bulk Trailers	13	9	45,000

In addition, we currently lease approximately 400 railcars, which are primarily used for supplier shipments to our locations, stock transfers between our locations and occasional shipments to customers.

Our private fleet characteristics change constantly based on our market needs. We believe that we maintain an advantage over many of our competitors with our private fleet enterprise wide on-time delivery percentage of 98.8%. Our private fleet permits us to meet our customers’ demand and reduces their inventory risk through "just-in-time" delivery. Moreover, our ability to service our customers is less encumbered by the commercial transportation market providing reliability of service to customers, especially during periods of undersupply.

Direct Supply

In certain circumstances, we deliver full truckloads or large quantities of commodity products directly from a supplier to a customer, primarily via common carrier, and provide sourcing and supply chain support in connection with the delivery. Although the products move directly from supplier to customer, we remain the sole point of contact for both the customer and the supplier and generally take ownership of the products while in transit, bearing the risk of loss during transportation. Direct supply sales accounted for 18.1% of sales for the fiscal year ended September 30, 2018.

Sales and Marketing

For the fiscal year ended September 30, 2018, we served approximately 27,300 customers from a broad range of end markets resulting in approximately 480,000 orders for nearly 24,000 products. We have developed a sales and marketing organization with a broad scope of sales coverage to ensure we can service a diverse customer base.

As of September 30, 2018, our sales team consisted of approximately 510 sales professionals situated throughout North America, EMEA and Asia, including customer-facing personnel, such as technical support and corporate account managers, located in local markets. There are approximately 400 sales professionals based in North America, while approximately 60 sales professionals are based in EMEA and 50 sales professionals are based in Asia.

Our sales force compensation and incentive structure is designed to ensure alignment between the goals of the sales representatives and those of our overall business. All sales representatives earn a fixed base salary and variable rewards based on performance. We believe sales force compensation alignment is a key driver for the success of our business.

9

Customer Pricing Processes

We use data-driven pricing strategies, which enable our product managers to determine product pricing through the use of systems and tools that provide insight on relative market pricing across a number of factors including end markets, geography, packaging type and volume. Product managers, whose main responsibility is to cultivate and build supplier relationships, also develop a broad understanding of suppliers’ product offerings and the market’s needs. We have empowered these managers to make pricing decisions, working closely with our sales team to structure pricing for an optimal balance of price and volume to maximize profitability. The following is a description of our customers by line of business:

• Chemicals. Our Chemicals customer base ranges from some of the largest global companies to smaller regional, private companies. Generally, no single Chemicals customer accounts for more than 5.0% of Chemicals sales, annually, while the five largest customers by value represent less than 10.0% of Chemicals sales on an annual basis.

• Plastics. Our Plastics customer base is diverse and serves a variety of end markets. Generally, no single Plastics customer accounts for more than 5.0% of Plastics sales, annually, while the five largest customers by value represent less than 5.0% of Plastics sales on an annual basis.

• Environmental Services. Our Environmental Services line of business includes customers who generate hazardous and non-hazardous waste in North America. One Environmental Services customer accounts for more than 5.0% but less than 10.0% of Environmental Services sales, annually, while the five largest customers generally account for less than 25.0% of Environmental Services sales on an annual basis.

Contracts

Our customer contracts for the sale of chemicals and plastics products are generally framework agreements that do not contain an obligation to buy or sell. We use the agreements to define the general terms and conditions of sale and set volume expectations, pricing and price change mechanisms. The final terms of sale for each purchase are negotiated at the time of sale unless otherwise established by the terms of the contract. Consistent with industry standards, we may offer volume-based incentives to large customers if the customer purchases a specified volume with us over a specified time period. Our customer contracts for the provision of environmental services are generally framework agreements pursuant to which we provide environmental services from time to time, with fees agreed at the time the service is provided. These contracts are generally terminable by either party with or without cause upon 30 days’ notice. Additionally, our on-site environmental services contracts are typically term-based arrangements, with fee structures negotiated at the time of execution.

Value-Added Services

In addition to our products, we provide a range of value-added services, including mixing and blending to specific customer requirements, lab testing and analysis, formulating, repackaging from large to small quantities, vendor inventory management and technical support. We continue to seek opportunities to profitably expand our value-added services to differentiate our value proposition and create competitive advantages.

Three key services we offer are repackaging, custom blending and lab services. Our hub facilities handle large quantities of materials, usually receiving shipments by railcar or tank truck. Bulk deliveries are often repackaged into smaller containers, such as gaylords, totes and drums, which are in turn delivered to customers by truck. Our custom blending capabilities include buying in bulk from our large base of suppliers, lab testing for product customization and blending of numerous products to meet customer specifications. Our labs provide product testing services to our customers in the form of chemical analysis and product performance analysis. We employ a team of scientists and experienced formulation experts to help customers with product development, failure analysis and other technical support in a broad range of chemical and product applications.  

10

Proprietary Operating Systems

We have developed a highly scalable technology platform with a centralized system and robust data analytics. These highly sophisticated systems enhance operational flexibility and facilitate the volume of customer orders, global sourcing, customer relations, distribution-related logistics, regulatory compliance, risk management controls and financial reporting. The operating platform consists of our transportation management system, pricing system, digital marketing, customer portal and ERP system. Our ERP system is used across the Company, with the exception of our subsidiary in China. The advanced data gathering and analysis capabilities of our ERP system, and the efficiencies it provides, enable us to operate flexibly and create significant advantages across the supply chain. Our ERP system also provides advanced volume forecasting, enabling us to forecast rolling weekly volumes, anticipate demand shift fluctuations and quickly respond to rapidly changing customer needs. This capability helps our suppliers by providing reliable and accurate demand forecasts that result in improved efficiency, flexibility and faster execution. These daily forecasts also translate into better pricing as they allow for optimization of production schedules. We believe that continuous automation implementation drives operational excellence and productivity.

Seasonality

Seasonal changes may affect our business and results of operations. We serve a large number of customers in a broad range of end markets and our business trends follow the seasonality patterns exhibited by these end markets and customers. For example, we generally tend to realize lower sales across all of our lines of business in the fourth calendar quarter of each year (which is our first fiscal quarter) because industrial production tends to be seasonally lower during that period. Our business may also be affected by our suppliers’ decisions regarding seasonal capacity and production.

Competition

The chemicals and plastics distribution markets in which we operate are highly fragmented. The primary competitive factors affecting each of our lines of business are the diversity and quality of the product portfolio, service offerings, reliability of services and supply, technical support and price and delivery capabilities. In addition, producers represent another source of competition, as many elect to distribute products through direct sales as opposed to indirect distributors. For some of the markets in which we operate, if large chemical producers elect to limit or consolidate their outsourcing of distribution, partner with other distributors, or distribute their products directly to end-user customers, competition would increase. Additionally, competition could increase from producers reducing their level of distribution outsourcing to maintain profit margin during periods of poor macroeconomic factors and pricing weakness, particularly for commodity products that require nominal service complexity to the end-user customer. We believe that our reputation, our broad range of product offerings and our speed and responsiveness, coupled with our valued-added services and the breadth of our distribution network, allow us to compete effectively and achieve scale benefits.

Chemicals

Our principal Chemicals distribution competitors include Azelis, Brenntag AG, Helm, ICC Chemicals, IMCD and Univar Inc. Additionally, our Chemicals line of business competes with many regional and local companies throughout North America as well as a number of smaller companies in certain niche markets.

Plastics

Our primary Plastics distribution competitors in North America are Channel Prime Alliance, Entec Polymers, M. Holland Company and PolyOne Distribution. Our primary Plastics competitors in EMEA are Albis, Biesterfeld, Distrupol and two divisions of Ravago: Resinex and Ultrapolymers. Our primary Plastics competitors in Asia are KDF, Nagase and Sinochem.

Environmental Services

The primary competitors of our Environmental Services line of business are Clean Harbors, Heritage, Univar Inc. and Veolia.

11

Employees

At September 30, 2018, we had approximately 2,760 employees worldwide, with approximately 2,190 employees in the U.S., 100 employees in Canada, 180 employees in EMEA, 120 employees in Asia, and 170 employees in Latin America. In the U.S., approximately 150 of our employees are represented by unions in six locations representing seven bargaining units, five of which are affiliated with the International Brotherhood of Teamsters and two of which are affiliated with the United Steelworkers.

Regulatory Matters

We are subject to extensive regulation by federal, state and local governments and similar international agencies relating to the sale and distribution of our products. These regulations govern the use, labeling, packaging, transportation, storage and distribution of chemicals and hazardous substances. We are also subject to domestic and international import, export and customs regulations, and statutes and regulations relating to government contracting. In addition, we are subject to extensive environmental laws and other regulations concerning, among other things, emissions to the air, discharges to land, and water and the generation, handling, storage, transportation and disposal of non-hazardous and hazardous waste in various federal, state, local and foreign jurisdictions, including EMEA and Asia. We are also subject to other federal, state, local and foreign laws and regulations regarding health and safety matters. Below is a summary of certain of these regulations.

Environmental

We operate in a number of domestic and foreign jurisdictions and are subject to various types of governmental regulation relating to the protection of the environment. Such regulation comes in the form of federal, state, local and foreign laws and regulations concerning such issues as the handling, storage and transportation of chemicals, release of pollutants into the air, soil and water, disposal of hazardous and non-hazardous wastes, remediation of contaminated sites, protection of workers from exposure to hazardous substances and the public disclosure of information regarding environmental hazards. Some aspects of our businesses also require us to maintain various environmental permits and licenses. We believe that we are in substantial compliance with all applicable environmental laws, regulations and permits; however, environmental compliance costs in the form of compliance with regulations, remediation obligations, capital improvements, operating expenses and/or limitations on operations can be substantial.

Many of the environmental laws and regulations affecting our operations relate to the prevention and remediation of impacts to air, soil or water resulting from the release of regulated materials. Past operations at some of our facilities have resulted in the contamination of soil and groundwater, some of which require remediation. Under the ADA Purchase Agreement, Ashland retained liability for remediation obligations known prior to March 31, 2011 related to Ashland's ownership and operation of the Distribution Business. In addition, Ashland retained liability for all other environmental remediation liabilities arising prior to March 31, 2011 for which Ashland received notice on or before March 31, 2016. After March 31, 2016, we assumed responsibility for all newly reported contamination and are required to indemnify Ashland should Ashland incur any expense related to such newly reported contamination. In situations where Ashland does not fulfill its indemnification obligations to us, we may be responsible for substantial remediation costs at or associated with our facilities or with the Distribution Business.

Comprehensive Environmental Response, Compensation, and Liability Act

In the U.S., CERCLA and analogous state laws regulate the remediation of certain contaminated sites and establish liability for the release of hazardous substances and related damages to natural resources from such sites. Under CERCLA, potentially responsible parties (including waste generators, waste transporters, and parties arranging for waste disposal) are subject to strict and, in certain circumstances, joint and several liability, for the cost of remediating contaminated sites. Our Chemicals and Environmental Services lines of business conduct waste disposal activities and handle products which could subject us to CERCLA liability.

In addition, we currently indemnify some of our Environmental Services customers for liabilities related to waste disposal activities that such customers may incur under certain environmental laws, including CERCLA.

12

Resource Conservation and Recovery Act

RCRA and analogous state laws regulate the generation, transportation, treatment, storage and disposal of hazardous waste. RCRA also establishes the regulatory framework for the management of certain non-hazardous wastes. RCRA requires owners and operators of hazardous waste treatment, storage and disposal facilities to obtain a RCRA permit. These permits may include both remedial actions and operational conditions. RCRA requires owners and operators of regulated facilities to investigate and remediate hazardous waste releases and to demonstrate compliance with financial assurance requirements. The financial assurance requirements are designed to ensure that adequate financial resources exist to respond to any releases of hazardous wastes at a permitted site and to perform any necessary corrective action and permanent site closure activities. Several of our facilities are subject to RCRA permits and some are undergoing corrective action to address previous releases of regulated materials as required under their permits. While we were required to assume responsibility for corrective action at a few sites in connection with the transfer of the business from Ashland to the Predecessor, Ashland, pursuant to the ADA Purchase Agreement, agreed to continue to perform certain known ongoing corrective actions at these sites until they are completed and to indemnify the Predecessor for any costs necessary to complete these actions. However, we retain responsibility for any RCRA violations resulting from our own operations.

Clean Air Act

CAA and analogous state laws establish a variety of programs designed to regulate the discharge of pollutants into the air. Under these laws, permits may be required before construction can commence on any new or modified source that has the potential to emit a significant amount of any regulated pollutant, such as nitrogen oxides and volatile organic compounds. Additionally, we may be required to register with state environmental agencies, monitor and report emissions, and install new or improved emission control equipment in certain situations, including for existing sources of air emissions. Furthermore, CAA may require that we obtain federal operating permits for any major sources of air pollution, which incorporate applicable pollution control requirements and require reporting and certification obligations. CAA also requires owners and operators of facilities that produce, handle, process, distribute, or store threshold quantities of chemicals to implement and update detailed risk management plans, which must be filed with and approved by the EPA. We could be required to incur additional expenditures to comply with CAA, including costs to install and operate emissions control equipment at our facilities.

Clean Water Act

The EPA regulates discharges of pollutants into waters of the U.S. through the CWA. Pursuant to the CWA, the EPA establishes wastewater standards and water quality standards for contaminants discharged into surface waters such as streams, rivers and lakes. The discharge of any regulated pollutant from point sources (such as pipes and manmade ditches) into the waters of the U.S. is prohibited without a state or federally issued discharge permit. Several of our facilities are currently subject to and must comply with CWA permit limitations on the discharge of industrial wastewater and storm water.

Toxic Substances Control Act

The TSCA authorizes the EPA to require chemical manufacturers, importers, and exporters to comply with reporting, record keeping, testing, and other requirements relating to chemical substances or mixtures. The TSCA is primarily designed to ensure that certain chemicals do not pose an unreasonable risk to human health or the environment. The TSCA Chemical Substances Inventory, which is maintained by the EPA, lists approximately 85,000 covered chemical substances. Before a chemical substance can enter interstate commerce (either through manufacture or importation), the EPA must review and approve the substance’s pre-manufacture notice. As part of that review process, the EPA may identify conditions—up to and including a ban on production—limiting the use of a chemical substance before it enters commerce. The TSCA also requires the testing of chemicals by manufacturers, importers and processors and requires those importing or exporting chemicals to comply with certification reporting and recordkeeping requirements. The TSCA also requires that any chemical distributor having information reasonably suggesting a substantial risk of injury to health or the environment notify the EPA immediately. The TSCA reform legislation enacted in June 2016 expanded the EPA's authority to review and regulate new and existing chemicals. In addition, when we import chemicals into the U.S. or export chemicals out of the U.S., we must comply with the TSCA’s import certification and export notice requirements. We must also comply with the TSCA’s various recordkeeping requirements.

13

Emergency Planning and Community Right-To-Know Act

The EPCRA requires facilities manufacturing, processing, or storing designated hazardous chemicals to report certain information about their products to state and local officials and fire departments. These reporting obligations are intended to assist state and local governments in developing emergency response plans in the case of a chemical release and to provide information to the public regarding the type and amount of toxic or hazardous chemicals stored at a particular facility. In addition, facilities releasing toxic chemicals into the environment above certain thresholds must report such releases to the EPA as part of the facilities’ "Toxics Release Inventory." Because many of our chemical distribution facilities handle hazardous chemicals, we are subject to the reporting requirements under the EPCRA.

Chemical Facility Anti-Terrorism Standards

DHS regulates the security of certain high-risk chemicals facilities through CFATS. CFATS utilizes a Chemical Security Assessment Tool to identify those chemical facilities potentially deemed "high risk." The first step is user registration, followed by the completion of a top-screen evaluation. The top-screen evaluation analyzes whether a facility stores regulated chemicals above specified thresholds. If it does, the facility must complete a Security Vulnerability Assessment, which examines the likelihood that a threat against a facility will be successful. From there, the facility must develop a Site Security Plan to respond to any identified security vulnerabilities. The Site Security Plan must address such matters as access control, personnel credentialing, recordkeeping, employee training, emergency response, testing of security equipment, reporting of security incidents and suspicious activity, and deterring, detecting and delaying potential attacks. DHS must review and approve or deny all Security Vulnerability Assessments and Site Security Plans. CFATS also requires regulated facilities to keep detailed security records and allow DHS the right to enter, inspect, and audit the property, equipment, operations and records of such facilities. Our facilities handle a number of chemical substances subject to CFATS security requirements, and thus, some of our facilities must comply with its site security requirements. Other legislative and regulatory initiatives designed to minimize the vulnerability of chemical storage and transportation assets could result in increased regulation of our industry, potentially imposing additional limitations on our operations and causing us to incur higher operating and compliance costs.

Regulation of the Transportation of Hazardous Materials

The transportation of hazardous materials is a significant part of our business and is regulated by the Department of Transportation under the FHMTL and its implementing regulations, the HMR. The HMR regulate the handling of hazardous materials, hazardous wastes, hazardous substances, and marine pollutants, and establish rules applicable to myriad aspects of the transportation process, including employee training, incident notification, labeling and placarding of shipments, shipment preparation, carriage of hazardous materials, emergency response and the development of safety and security plans. Several Department of Transportation agencies, including the Pipeline and Hazardous Materials Safety Administration, the Federal Aviation Administration, the Federal Railroad Administration, the Federal Motor Carrier Safety Administration and the U.S. Coast Guard share responsibility for enforcing the FHMTL.

Certain international standards and regulations also govern the transportation of hazardous materials shipments within, to, and from the U.S. Such regulations include the International Civil Aviation Organization’s 132 Technical Instructions for the Safe Transport of Dangerous Goods by Air, the International Maritime Dangerous Goods Code, Transport Canada’s Transportation of Dangerous Goods Regulations and the International Atomic Energy Agency Regulations for the Safe Transport of Radioactive Materials. These standards and regulations prescribe, among other things, requirements for packaging, maximum weight and handling of hazardous materials. U.S. agencies have sought to harmonize their rules with international standards and regulations, but when hazardous materials are transported to, from, and within the U.S. in accordance with one or more of these international standards or regulations, U.S. HMR requirements must still be followed.

The majority of our logistics services, including transport of hazardous materials, involve highway transportation. The Transportation Security Administration requires any driver seeking to obtain, renew, or transfer a hazardous materials endorsement on a state-issued commercial driver’s license to undergo a security threat assessment. Additionally, under the Transportation Worker Identification Credential program, workers, including truckers, requiring unescorted access to maritime facilities must be issued tamper-resistant biometric credentials to access such facilities.

14

Like environmental regulations, the regulations governing the transportation of hazardous materials are often subject to modification. Compliance with new regulations on the transportation of hazardous materials could adversely affect our business by raising our compliance and operational costs.

Occupational Safety and Health Regulations

We are subject to the OSH Act, which addresses safety and health in workplace environments. In addition to the OSH Act, we are subject to applicable state occupational safety and health regulations as well as the safety and health rules of applicable jurisdictions outside of the U.S, such as the Workplace Hazardous Materials Information System in Canada.

The OSH Act is administered by OSHA, which has established maximum workplace chemical exposure levels. Manufacturers and distributors of chemicals must employ a hazard communication program utilizing labels and other forms of warnings, as well as safety data sheets, setting forth safety and hazardous materials information to employees and customers. OSHA’s Hazard Communication Standard covers both physical hazards (such as flammability or the potential for explosions) and health hazards. Employers are required to provide a certain level of training to ensure that relevant employees are equipped to properly handle chemicals. OSHA has modified its Hazard Communication Standard to make it consistent with the United Nation’s Globally Harmonized System of Classification and Labeling of Chemicals. The new standards include more specific requirements for hazard classification, as well as standardized label components that provide consistent information and definitions for hazardous chemicals and a standard approach to conveying information on safety data sheets. Our Chemicals line of business has already completed its transition to the revised Hazard Communication Standard.

Our Chemicals line of business in Canada has completed the transition to Health Canada's Globally Harmonized System - aligned Hazardous Products Regulations standard.

Both the U.S. and Canada Hazard Communication Standards remain subject to periodic updates and revisions, and those changes, as well as other regulatory initiatives in occupational health and safety, could result in increased operation and compliance costs.

Product Control

We operate in a number of domestic and foreign jurisdictions and are subject to various types of governmental regulation relating to use, labeling, packaging, storage and distribution of chemicals and hazardous substances. Statutes and regulations governing the import, export and control of our products are enforced by government agencies such as the U.S. Customs and Border Protection, the Drug Enforcement Administration, the Department of Homeland Security, the Department of Commerce, the Department of Transportation, the Food and Drug Administration, the Department of Agriculture and similar international agencies.

We believe that we are in compliance in all material respects with federal, state and local regulations relating to the sale, distribution, import and export of our products. We have automated systems, processes and procedures in place to support compliance with these regulations, and because we have these automated systems, processes and procedures in place, we believe we conduct our global business in compliance in all material respects with applicable statutes and regulations as promulgated in the countries into which we sell our products. Although we believe we are in compliance in all material respects with such laws and regulations, any non-compliance could result in substantial fines or otherwise restrict our ability to conduct our business.

Intellectual Property

We are not substantially dependent upon patents, trademarks or licenses.

15

Insurance

Our operations are subject to significant hazards and risks inherent in the transportation, storage and disposal of chemicals and other potentially hazardous materials. We seek to mitigate these risks with effective industry-specific risk management techniques that include continuing and improving upon current loss prevention, claims management and training programs as well as a comprehensive insurance program. We have insurance coverage at levels that we consider adequate for our worldwide facilities and activities. Our insurance policies cover, among others, the following categories of risk: property damage and business interruption; marine cargo throughput, product and general liability; environmental liability; directors’ and officers’ liability and fraud and crime/theft.

Available Information

We electronically file reports with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to such reports. The SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at www.sec.gov. Additionally, information about us, including our reports filed with the SEC, is available through our website at www.nexeosolutions.com. Such reports are accessible at no charge through our website and are made available as soon as reasonably practicable after such reports are filed with or furnished to the SEC. Our website and the information contained on that site, or connected to that site, are not incorporated by reference into this Annual Report on Form 10-K.

Item 1A. Risk Factors

We are subject to certain risks and hazards due to the nature of our business activities. Although it is not possible to identify all of the risks we encounter, we have identified the following significant risk factors that could materially adversely affect our business, financial condition, cash flows or results of operations.

Risks Related to the Proposed Transaction with Univar

On September 17, 2018, Univar and Nexeo entered into the Univar Merger Agreement. The Univar Merger Agreement has increased our exposure to non-business related risks associated with the potential loss of stockholder value due to increased market speculation in connection with the proposed transaction. Additionally, there is increased risk of loss of key employees and talent during the pre-close and post transition periods.

The proposed transaction is subject to certain conditions, including conditions that may not be satisfied or completed on a timely basis, if at all.

The Univar Merger Agreement and the proposed transaction were approved unanimously by the Board of Directors of both Nexeo and Univar and are subject to review by the SEC and regulatory agencies in the U.S. and other jurisdictions. The Univar Merger Agreement is also subject to a number of conditions, including, among other things and as further described in the Univar Merger Agreement: (i) the adoption by Nexeo’s stockholders of the Univar Merger Agreement, (ii) the approval by Univar’s stockholders of the issuance of the shares of Univar common stock in connection with the proposed transaction contemplated by the Univar Merger Agreement, (iii) the receipt of other required regulatory approvals, (iv) the absence of any law or governmental order prohibiting the proposed transaction, (v) the effectiveness of Univar's registration statement and the approval for listing on the NYSE of the shares of Univar common stock in connection with the proposed transaction contemplated by the Univar Merger Agreement, (vi) no material adverse effect on Nexeo's and Univar's operations having occurred since the signing of the Univar Merger Agreement and (vii) the termination of the TRA. There can be no assurance that the conditions to the completion of the proposed transaction will be satisfied or waived or that the proposed transaction will be completed.

16

In order to complete the proposed transaction, Univar and Nexeo must obtain certain governmental approvals, and if such approvals are not granted or are granted with conditions, completion of the proposed transaction may be jeopardized or the anticipated benefits of the proposed transaction could be reduced.

Completion of the proposed transaction is conditioned upon the receipt of other required regulatory approvals.

Although Nexeo and Univar have agreed in the Univar Merger Agreement to use their reasonable best efforts, subject to certain limitations, to make certain governmental filings and obtain the required governmental approvals, as the case may be, there can be no assurance that the relevant approvals will be obtained. In addition, the governmental entities that provide these approvals have broad discretion in administering the governing regulations. As a condition of approving the proposed transaction, these governmental entities may require divestitures, impose conditions, terms, obligations, or place restrictions on the conduct of Univar’s business after completion of the proposed transaction. Under the terms of the Univar Merger Agreement, Univar and Nexeo are required to use their respective reasonable best efforts to obtain the consents, approvals, permits and authorizations of any governmental entity required to consummate the proposed transaction.

Nexeo and Univar cannot be certain when, if, or under what conditions these approvals will be obtained. Failure to obtain such approvals may result in the delay or abandonment of the proposed transaction. There can be no assurance that regulators will not require divestitures, impose conditions, terms, obligations or place restrictions on the conduct of business, and that such divestitures, conditions, terms, obligations or restrictions will not have the effect of delaying the completion of the proposed transaction or imposing additional material costs on or materially limiting the revenues of the combined company following the proposed transaction, or otherwise adversely affecting Univar’s businesses and results of operations after the completion of the proposed transaction. In addition, Nexeo and Univar can provide no assurance that these divestitures, conditions, terms, obligations or restrictions will not result in the delay or abandonment of the proposed transaction.

Even after the remaining regulatory approvals that are a condition to the completion of the proposed transaction have been obtained, Nexeo and Univar can provide no assurances that the proposed transaction will not be challenged. Governmental authorities could seek to block or challenge the proposed transaction, including after the completion of the proposed transaction. In addition, private parties and individual states may bring legal actions under the antitrust laws in certain circumstances. Nexeo and Univar may not prevail and may incur significant costs in settling or defending any action under the antitrust laws. There can be no assurances that a challenge to the proposed transaction on antitrust grounds will not be made or, if a challenge is made, what the result will be.

Failure to complete the proposed transaction may negatively impact our share price and our future business and financial results.

If the proposed transaction is not completed for any reason, our ongoing businesses may be adversely affected and, without realizing any of the benefits of having completed the proposed transaction, we would be subject to a number of risks, including the following:

• We may experience adverse reactions from the financial markets, including negative impacts on our stock prices;

• We may experience negative reactions from our customers, regulators and employees;

• We will be required to pay certain costs relating to the proposed transaction, whether or not the proposed transaction is completed; and

• Matters relating to the proposed transaction (including integration planning) will require substantial commitments of time and resources by our management, which would otherwise have been devoted to day-to-day operations and other opportunities that may have been beneficial to us as an independent company.

17

If the proposed transaction is not completed, the risks described above may materialize and may adversely affect our businesses, financial condition, financial results and stock price.

In addition, we could be subject to litigation related to any failure to complete the proposed transaction or related to any enforcement proceeding commenced against us to perform our respective obligations under the Univar Merger Agreement. If the proposed transaction is not completed, these risks may materialize and may adversely affect our businesses, financial condition, financial results and stock prices.

While the proposed transaction is pending, we will be subject to contractual restrictions under the Univar Merger Agreement that may have an adverse effect on our businesses.

The Univar Merger Agreement contains customary covenants which restrict us, without Univar’s consent, from taking certain specified actions until the proposed transaction closes or the Univar Merger Agreement terminates. These restrictions may prevent us from pursuing otherwise attractive business opportunities that may arise prior to the completion of the proposed transaction or termination of the Univar Merger Agreement.

We will incur significant transaction and integration costs in connection with the proposed transaction.

We expect to pay significant transaction costs in connection with the proposed transaction. These transaction costs include legal, accounting, tax and financial advisory expenses, printing expenses, mailing costs and other related charges. A portion of the transaction costs will be incurred regardless of whether the proposed transaction is completed.

In accordance with the Univar Merger Agreement, we will generally pay our own costs and expenses in connection with the proposed transaction, whether or not the transaction is completed. Additionally, we have the right to terminate the Univar Merger Agreement under certain circumstances.

Uncertainty regarding the proposed transaction could cause suppliers, customers and other counterparties to delay or defer decisions concerning our Company that could adversely affect us.  

The proposed transaction will occur only if stated conditions are met, many of which are outside our control. In addition, both parties to the Univar Merger Agreement have rights to terminate the Univar Merger Agreement under specified circumstances. Accordingly, there may be uncertainty regarding the completion of the proposed transaction. This uncertainty may cause suppliers, customers and other counterparties to delay or defer decisions concerning our businesses, which could negatively affect our respective businesses, results of operations and financial conditions. Suppliers, customers and other counterparties may also seek to change existing agreements with us as a result of the proposed transaction. Any delay or deferral of those decisions or changes in agreements with us could adversely affect our businesses, results of operations and financial conditions, regardless of whether the proposed transaction is ultimately completed.

Uncertainty regarding the proposed transaction could affect our ability to retain key employees or attract new key employees that could adversely affect our business.

Uncertainty about the effect of the proposed transaction on employees and customers may have an adverse effect on us, regardless of whether the Univar Merger Agreement is eventually completed. These uncertainties may impair our ability to attract, retain and motivate key personnel until the Univar Merger Agreement is completed, or the Univar Merger Agreement is terminated, and for a period of time thereafter. Employee retention and recruitment may be particularly challenging for us during the pendency of the Univar Merger Agreement, as employees and prospective employees may experience uncertainty about their future roles with Univar. The departure of existing key employees or the failure of potential key employees to accept employment with us, despite our retention and recruiting efforts, could have a material adverse impact on our business, financial condition and operating results, regardless of whether the Univar Merger Agreement is eventually completed. Additionally, the loss of employees who manage key customer and supplier relationships or key products could negatively affect our ability to sell and support our business effectively, which could negatively impact our results of operations.

18

Risks Related to Our Business and Industry

We face competition from other companies, which places downward pressure on prices and profitability.

We operate in highly competitive markets and compete against a large number of domestic and foreign companies. Competitiveness is based on several key criteria, including product performance and quality, product price, product availability, product handling and storage capabilities, the ability to understand customer product development processes and respond to their needs, delivery capabilities and customer service, including technical support. In addition, competitors’ pricing decisions could compel us to decrease our prices, which could negatively affect our profitability. Furthermore, producers sometimes elect to distribute their products directly to end-user customers, rather than rely on indirect distributors like us. While we do not believe that our results depend materially on access to any individual supplier's products, a significant increase in the number of suppliers electing to serve customers directly could result in less revenue and gross profit for us either due to competitive pressure from suppliers or products becoming unavailable to us or both.

Certain competitors are significantly larger than we are and may have greater financial resources. As a result, these competitors may be better able to withstand changes in market and industry conditions, including changes in the prices of raw materials and general economic conditions.

The prices of the products we purchase and sell are volatile.

Rising or otherwise volatile raw material prices for our suppliers, especially those of hydrocarbon derivatives, may cause costs to increase or may result in volatility in our profitability. Also, costs associated with the distribution of our products fluctuate in the same direction as fuel and other transport-related costs. Our ability to pass on increases in our costs to our customers is dependent upon market conditions, such as the presence of competitors in particular geographic and product markets and of the prevailing pricing mechanisms in customer contracts.

Many of our products are commodities or include significant commodity content; however, we have no control over the changing market value of the commodities. For example, excess supplies or changes in demand of crude oil-based and/or natural gas-based feedstocks may cause base commodity chemical product prices to fall. This could subsequently result in a drop in prices for propylene and ethylene-based plastics products. We also typically maintain significant inventories of the products we sell in order to meet our customers’ service level requirements. Declining prices, particularly rapid declines like those that occurred at times during fiscal year 2015 and 2016, typically cause customers to reduce inventories and wait for lower prices in anticipation of continued falling prices. Additionally, rapidly declining prices can cause our inventory value to be higher than market and subject us to impairment charges. As a result of these factors, we are subject to price risk with respect to our product inventories. Significant unanticipated changes in market conditions can affect future product demand, which could materially and adversely affect the value of our inventory. If we overestimate demand and purchase too much of a particular product when customers are reducing/minimizing their purchases, we face a risk that the price of that product will fall, leaving us with inventory that we cannot profitably sell. As a result, our sales volumes and gross profit may decline.

If we underestimate demand and do not purchase sufficient quantities of a particular product and prices of that product rise, we could be forced to purchase that product at a higher price in order to satisfy customer demand for that product, but we may not be able to increase pricing to our customers resulting in reduced profitability.

Volatility in product prices also affects our borrowing base under the ABL Facility. A decline in prices of our products reduces the value of our product inventory collateral, which, in turn, may reduce the amount available for us to borrow under the ABL Facility.

19

Many of our contracts with suppliers and customers are terminable upon notice.

Our revenue stream is variable because it is primarily generated as customers place orders and customers may change their requirements or cancel their orders. We generally enter into framework agreements with customers and suppliers that set out volume and other performance expectations over the term of the contract, but purchases and sales of products are usually made by placing individual purchase orders based on customer demand or forecasts. Since many of our contracts with both suppliers and customers do not include firm obligations to buy or sell products or are otherwise terminable upon notice, we might, in certain instances, be unable to meet our customers’ orders, which could harm our business relationships and reputation and result in reduced profitability. In circumstances where customers terminate contracts or cancel orders, we may be unable to find alternative buyers for the materials we purchased and may be forced to hold such materials in inventory. Our gross profit could be negatively affected if suppliers or customers renegotiate contractual terms to our disadvantage. Additionally, while some of our relationships for the distribution and sale of specialty chemicals have exclusivity or preference provisions, we may be unable to enforce these provisions effectively for legal or business reasons.

We are affected by demand fluctuations and other developments in the broader economy, including any prolonged economic crisis.

Our businesses mainly service clients in North America, EMEA and Asia, specifically China, making us vulnerable to downturns in those economies. Our sales and gross profits could decline as a result of economic recessions, changes in industrial production processes or consumer preferences, significant episodes of inflation, fluctuations in interest and currency exchange rates, and changes in the fiscal or monetary policies of governments in North America, EMEA and Asia, specifically China. See also "—We are exposed to fluctuations in foreign exchange rates" and "—Our substantial international operations subject us to risks of doing business in foreign countries."

General economic conditions and macroeconomic trends could also negatively affect the creditworthiness of our customers, which could increase our credit risk with respect to our trade receivables. Similarly, volatility and disruption in financial markets could limit our customers’ ability to obtain financing necessary to maintain or expand their own operations, thereby reducing demand for our products.

Disruptions in the supply of or an inability to supply the products that we distribute could result in a loss of customers or damage to our reputation.

Our business depends on access to adequate supplies of the products that our customers purchase from us. From time to time, we may be unable to access adequate quantities of certain products because of supply disruptions due to natural disasters, extreme weather, industrial accidents, scheduled and unscheduled production outages, high demand leading to allocation, port closures and other transportation disruptions and other circumstances beyond our control. These types of events could negatively affect our results of operations.

We purchase certain products and raw materials from suppliers, often pursuant to written supply contracts. If those suppliers are unable to fulfill our orders timely or choose to terminate or otherwise avoid contractual arrangements, we may not be able to obtain the products from alternate sources. The loss of one or more significant suppliers or a supplier of certain key products, or a significant change in the business strategies of our suppliers could disrupt our supply of the products our customers purchase from us. If we are unable to obtain and retain qualified suppliers under commercially acceptable terms, our ability to deliver products in a timely, competitive and profitable manner could be adversely affected.

Further, if our forecasts are below actual market demand, or if market demand increases significantly beyond our forecasts, then we may not be able to satisfy customer product needs, which may cause our customers to purchase their products from our competitors and could result in a loss of market share.

Additionally, domestic and global government regulations related to the manufacture or transport of certain products may impede our ability to obtain those products on commercially reasonable terms.

20

If for any reason we experience widespread, systemic difficulties in filling our customers’ orders, we face the risk of customer dissatisfaction, possible loss of customers, damage to our reputation, or paying a supplier a higher price in order to obtain the needed products on short notice, any of which could result in loss of revenues and lower profitability.

We are exposed to fluctuations in foreign exchange rates.

A portion of our sales and costs of sales are denominated in currencies other than the functional currency of our subsidiaries, exposing us to currency transaction risk.  Additionally, because we report our consolidated results in USD, the results of operations and the financial position of our international operations, which are generally reported in the relevant local currencies, are then translated into USD at the applicable exchange rates for inclusion in our consolidated financial statements, exposing us to currency translation risk.  Further, we have exposure to foreign exchange fluctuations arising from the remeasurement of certain foreign operations where the USD is the functional currency but accounting records are kept in local currency. Consequently, any change in exchange rates between our foreign subsidiaries' functional currencies and the USD will affect our consolidated statements of operations and balance sheets when the results of those operating companies are translated/remeasured into USD for reporting purposes. During fiscal year 2018, our most significant currency exposures were to the RMB, the CAD and the Peso and our results of operations were negatively impacted due to these exposures. The exchange rates between these and other foreign currencies and the USD may fluctuate substantially, and these fluctuations may have an adverse effect on our results of operations in future periods. See "Item 7A. Quantitative and Qualitative Disclosures about Market Risk."

We require significant working capital.

We have significant working capital needs, as the nature of our business requires us to purchase and maintain inventories that enable us to fulfill customer demand. In addition, we extend a significant amount of trade credit to our customers to purchase our products. Increases in the price of the products we purchase from suppliers or our selling prices to customers could result in increased working capital needs, as it is more expensive to maintain inventories and extend trade credit, which could adversely affect our liquidity and cash flows. We generally finance our working capital needs through cash flows from operations and borrowings under our ABL Facility. If we are unable to finance our working capital needs on the same or more favorable terms going forward, or if our working capital requirements increase and we are unable to finance the increase, we may not be able to purchase the products required by our customers or extend them the credit they require to purchase our products, which could result in a loss of sales.

The amount of borrowings permitted under the ABL Facility may fluctuate significantly, which may adversely affect our liquidity, results of operations and financial condition.

The amount of borrowings permitted at any time under the ABL Facility is limited by a borrowing base that is comprised of the value of our and certain of our subsidiaries' eligible inventories and accounts receivable. As a result, our access to credit under the ABL Facility is potentially subject to significant fluctuations depending on the value of the eligible assets in the borrowing base as of any valuation date. The inability to borrow under the ABL Facility may adversely affect our liquidity, results of operations and financial condition.

21

We may not be able to generate sufficient cash flows to service all of our indebtedness and may be forced to take other actions in order to satisfy our obligations under our indebtedness, which may not be successful.

Our ability to make scheduled payments on, or to refinance, our debt obligations will depend on our financial and operating performance, which is subject to prevailing economic and competitive conditions and certain financial, business and other factors beyond our control. There can be no assurance that our business will generate sufficient cash flows from operating activities or that future sources of capital will be available to us in an amount sufficient to permit us to service our indebtedness or to fund our other liquidity needs. If we are unable to generate sufficient cash flows to satisfy our debt obligations, we may have to undertake alternative financing plans, such as refinancing or restructuring some or all of our indebtedness, selling assets, reducing or delaying capital investments or seeking to raise additional capital. We cannot assure you that any refinancing would be possible, that any assets could be sold or, if sold, of the timing of the sales and the amount of proceeds that may be realized from these sales, or that additional financing could be obtained on acceptable terms, if at all. Our inability to generate sufficient cash flows to satisfy our debt obligations, or to refinance our indebtedness on commercially reasonable terms, would materially and adversely affect our financial condition and results of operations and our ability to satisfy our obligations under the Credit Facilities.

In addition, if we cannot make scheduled payments on our indebtedness, we will be in default and, as a result:

• our debt holders could declare all outstanding principal and interest to be due and payable;

• the lenders under the ABL Facility could terminate their commitments to lend us money and foreclose against the assets securing their borrowings;

• the lenders under the Term Loan Facility and our other secured lenders could foreclose against the assets securing their borrowings; and

• we could be forced into bankruptcy or liquidation.

Despite our current level of indebtedness, we may incur substantially more indebtedness in the future, which could further exacerbate the risks described above. At September 30, 2018, we had $817.1 million of principal amount of debt outstanding. In addition, we have $344.2 million of borrowings available under the ABL Facility, and under the terms of the Credit Facilities and subject to our continued compliance with specified ratios, we have the option:

• under the ABL Facility, to raise up to $175.0 million of incremental or increased revolving credit commitments; and

• under the Term Loan Facility, to raise incremental term loans.

If borrowed, these incremental commitments and loans would be senior secured indebtedness. Furthermore, we and our subsidiary guarantors are permitted to incur additional unsecured indebtedness under the Credit Facilities, which could intensify the related risks that we and our subsidiaries now face.

Our substantial indebtedness could adversely affect our results of operations and financial condition and prevent us from fulfilling our obligations under our indebtedness.

Our substantial indebtedness could have important consequences with respect to our business, including the following:

• increasing our vulnerability to general adverse economic and industry conditions and limiting our ability to adjust rapidly to changing market conditions;

• requiring us to dedicate a substantial portion of our cash flows from operations to pay principal and interest on our indebtedness, which would reduce the availability of cash to fund working capital, capital expenditures, acquisitions or other future business opportunities that could affect the execution of our growth strategy;

22

• negatively impacting the terms on which customers or suppliers do business with us or alternatively requiring us to provide such customers or suppliers with credit support;

• placing us at a competitive disadvantage as compared to our competitors that have less debt; and

• exposing us to risks associated with interest rate fluctuations, which could result in increased interest expense if interest rates rise and we have to borrow additional funds under our variable interest rate Credit Facilities.

In addition, there can be no assurance that our business will generate sufficient cash flows from our operations in the future to service our indebtedness and to meet our other cash needs.

Restrictive covenants in our financing documents may adversely affect our operations.

Our Credit Facilities contain a number of restrictive covenants that impose operating and financial restrictions on us and may limit our ability to engage in acts that may be in our long-term best interest, including our ability to:

• incur or assume additional debt or provide guarantees in respect of obligations of other persons;

• issue redeemable stock and preferred stock;

• pay dividends or distributions or redeem or repurchase capital stock;

• prepay, redeem or repurchase debt;

• make loans, investments and capital expenditures;

• incur liens;

• engage in sale/leaseback transactions;

• restrict distributions from our subsidiaries;

• sell assets and capital stock of our subsidiaries;

• consolidate or merge with or into another entity, or sell substantially all of our assets; and

• enter into new lines of business.

A breach of the covenants under the Credit Facilities could result in an event of default under the Credit Facilities and our other indebtedness. An event of default under the Credit Facilities would permit the lenders under the facilities to declare all amounts outstanding under the facilities to be immediately due and payable and terminate all commitments to extend further credit. If we were unable to repay those amounts, the lenders under the Credit Facilities could proceed against the collateral granted to them to secure the borrowings under the facilities.

We depend on transportation and storage assets, some of which we do not own, in order to store and deliver products to our customers.

Although we maintain a significant portfolio of owned and leased transportation assets in North America, including trucks, tankers, railcars, barges and trailers, we also rely on transportation provided by third parties, such as common carriers, to deliver products to our customers. For the fiscal year ended September 30, 2018, common carriers accounted for approximately 31% of deliveries from our North American warehouses. For the fiscal year ended September 30, 2018, we leased 14 of our 55 distribution facilities and operated through more than 100 third party operated warehouses. In addition, in EMEA and Asia, we operated through third party operated transportation assets and warehouses for the fiscal year ended September 30, 2018.

23

Our access to third party transportation and storage is not guaranteed, and we may be unable to transport or store products at economically attractive rates or at all in certain circumstances, particularly in cases of adverse market conditions, such as shortages in transportation or storage capacity or disruptions to transportation infrastructure. We could also be subject to increased costs associated with transportation and storage that we may not always be able to recover from our customers, including fluctuating fuel prices, labor shortages, regulatory changes and unexpected increases in the charges imposed by common carriers and other third parties involved in transportation. Strikes or other service interruptions by third party transporters could also cause our operating expenses to rise and adversely affect our ability to deliver products on a timely basis. Any condition which results in our inability to store and deliver products to our customers for a prolonged period of time or our failure to deliver products in a timely manner, could harm our business relationships, reputation and brand and render portions of our business unprofitable.

We rely on the proper functioning of our computer and data processing systems and a large-scale malfunction could result in disruptions to our business.

We use an integrated ERP system to manage complexity across our supply chain by processing transactions and financial data in real-time, including ordering, purchasing, inventory management and delivery information. The proper functioning of our ERP platform and related IT systems is critical to the successful operation of our business and the implementation of our business strategies. Computer and data processing systems are susceptible to malfunctions and disruptions, including due to equipment damage, power outages, computer viruses and a range of other hardware, software and network problems. We cannot guarantee that we will not experience any malfunctions or disruptions in the future. A significant or large-scale malfunction or interruption of our computer or data processing systems could adversely affect our ability to keep our operations running effectively, including our ability to process orders, properly forecast customer demand, receive and ship products, maintain inventories, collect account receivables and pay expenses, which could materially adversely affect our business, financial condition, cash flows or results of operations. Any of these risks, if they materialize could significantly harm our reputation, expose us to substantial liabilities and have a material adverse effect on our business, financial condition and results of operations.

We may be unable to identify, purchase or integrate desirable acquisition targets. Future acquisitions may not be successful and we may not realize the anticipated cost savings, revenue enhancements or other synergies from any such acquisition.

We may investigate and acquire strategic businesses with the potential to be accretive to earnings, increase our market penetration, strengthen our market position or enhance our existing product offerings. There can be no assurance that we will identify or successfully complete transactions with suitable acquisition candidates in the future. A failure to identify and acquire desirable acquisition targets may slow our growth.

Additionally, if we were to undertake a substantial acquisition, the acquisition would likely need to be financed in part through additional financing from banks, through public offerings or private placements of debt or equity securities or through other arrangements. There can be no assurance that the necessary acquisition financing would be available to us on acceptable terms if and when required.

There also can be no assurance that any already completed acquisitions will be successful. We could have difficulty integrating the operations, systems, management and other personnel, technology and internal controls of a new acquisition with our own. These difficulties could disrupt our ongoing business, distract our management and employees, increase our expenses and adversely affect our results of operations. Matters related to integration may also delay and/or jeopardize strategic initiatives in place to enhance profitability. We may also experience an adverse impact on our operations and revenues if acquisition or integration activities disrupt key customer and supplier relationships or if we fail to retain, motivate and integrate key management and other employees of acquired businesses. Even if we are able to integrate successfully, we may not be able to realize the potential cost savings, synergies and revenue enhancements that were anticipated from any acquisition, either in the amount or within the time frame that we expected, and the costs of achieving these benefits may be higher than, and the timing may differ from, what we expected. Furthermore, the entities that we acquire in the future may not maintain effective systems of internal controls, or we may encounter difficulties integrating our system of internal controls with those of any acquired entities, which could prevent us from meeting our reporting obligations.

24

In connection with any acquisitions, we may acquire liabilities that may not adequately be covered by insurance or an enforceable indemnity or similar agreement from a creditworthy counterparty. As a result, we may be responsible for significant out-of-pocket expenditures and these liabilities, if they materialize, could have a material adverse effect on our business, financial condition, cash flows and results of operations.

The service of key employees or our inability to attract new key employees could adversely affect our business.

We may have difficulty locating, hiring and retaining qualified and experienced employees, including managerial, sales, sourcing and technical support personnel. This could have an adverse effect on our ability to operate and grow our business. Additionally, the loss of employees who manage key customer and supplier relationships or key products could negatively affect our ability to sell and support our business effectively, which could negatively impact our results of operations. This could be particularly true in certain foreign jurisdictions or with recent acquisitions where legacy relationships are important to the viability of the business.

We may fail to extend or renegotiate our collective bargaining agreements with our labor unions as they expire from time to time, and disputes with our labor unions may arise or our unionized employees may engage in a strike or other work stoppage.

As of September 30, 2018, approximately 150 of our 2,190 employees in the U.S. were represented by unions in six locations and seven separate bargaining units. Five of the local unions are affiliated with the International Brotherhood of Teamsters and two are affiliated with the United Steelworkers.

If we fail to extend or renegotiate our collective bargaining agreements, if disputes with our unions arise or if our unionized workers engage in a strike or other work stoppage, we could incur higher operation and labor costs or experience a significant disruption of operations.

Our employees in EMEA are represented by works councils or other labor organizations appointed pursuant to local law consisting of employee representatives who have rights to negotiate working terms and to receive notice of significant actions. These arrangements grant protections to employees and subject us to employment terms that are similar to collective bargaining agreements which may limit operational flexibility and increase operational expenses and labor costs.

Our substantial international operations subject us to risks related to doing business in foreign countries.

For the fiscal year ended September 30, 2018, we sold products to customers located in over 80 countries and generated 26.6% of total sales outside the U.S. These sales may represent an even larger portion of our net sales in the future. Also, we currently operate through approximately 70 third party warehouses located outside the U.S. Accordingly, our business is subject to risks related to the differing legal, political, social and regulatory requirements and economic conditions of many jurisdictions.

Legal and political risks are inherent in the operation of a company with our global scope. For example, it may be more difficult for us to enforce our agreements or collect receivables through foreign legal systems. In addition, the global nature of our business presents difficulties in hiring and maintaining a workforce in some countries and managing and administering an internationally dispersed business. In particular, the management of our personnel across several countries can present logistical challenges, including difficulties related to operating under different business cultures and languages.

Foreign countries may also impose additional withholding taxes or otherwise tax our foreign income, or adopt other restrictions on foreign trade or investment, including currency exchange controls. The imposition of tariffs is also a risk that could impair our financial performance.

There is a risk that foreign governments may nationalize private enterprises in countries where we operate. In some countries or regions, terrorist activities and the response to these activities may threaten our operations more than those in the U.S. and may result in limited operations, especially in the event of activities which may threaten the health and safety of our employees. Also, changes in general economic and political conditions in countries where we operate, particularly in emerging markets, are a risk to our financial performance.

25

There can be no assurance that the consequences of these and other factors relating to our multinational operations will not have an adverse effect on us.

As a multinational corporation doing business in the United States and various foreign jurisdictions, changes in tax laws could have an adverse impact on our earnings.

Changes to tax laws, rules and regulations, including changes in the interpretation or implementation of tax laws, rules and regulations by the Internal Revenue Service or other domestic or foreign governmental bodies, could affect us in substantial and unpredictable ways. Such changes could result in changes in our global structure, international operations or intercompany agreements, which could materially reduce our net income in future periods or result in restructuring costs, increased effective tax rates and other expenses.

We have significant operations in China and the laws and regulations applicable to our operations there are sometimes vague and uncertain. Any changes in such laws and regulations could materially adversely affect our business, financial condition, operating results and cash flows.

Our operations in China contributed, in aggregate across all lines of business, $211.9 million, $214.2 million, and $58.8 million in revenue for the fiscal years ended September 30, 2018, 2017, and 2016, respectively. China’s legal system is a civil law system based on written statutes, where decided legal cases have little value as precedents, unlike the common law system prevalent in the U.S. There are substantial uncertainties regarding the interpretation and application of China’s laws and regulations, including among others, the laws and regulations governing the conduct of business in China, or the enforcement and performance of arrangements with customers and suppliers in the event of death, bankruptcy or the imposition of statutory liens or criminal proceedings. The Chinese government has been developing a comprehensive system of commercial laws, and considerable progress has been made in introducing laws and regulations dealing with economic matters such as foreign investment, corporate organization and governance, commerce, taxation and trade. However, because the laws and regulations are relatively new, and because of the limited volume of published cases and judicial interpretation and their lack of force as precedents, interpretation and enforcement of these laws and regulations involve significant uncertainties. New laws and regulations that affect existing and proposed future businesses may also be applied retroactively. We cannot predict what effect the interpretation or enforcement of existing or new laws or regulations may have on our business in China. If the relevant authorities find that we are in violation of China’s laws or regulations, they would have broad discretion in dealing with such a violation, including levying fines or requiring that we discontinue any portion or all of our business in China.

The promulgation of new laws, changes to existing laws and the pre-emption of local regulations by national laws may adversely affect our business in China. There can be no assurance that a change in leadership, social or political disruption, or unforeseen circumstances affecting China’s political, economic or social life, will not affect China’s government’s ability to continue to support and pursue the promulgation of new laws and changes to existing laws, as described above. Such a shift in leadership, social or political disruption or unforeseen circumstances could have a material adverse effect on our business and prospects.

26

Changes in legislation, regulation and government policy may have a material adverse effect on our business in the future.

Elections in the United States and other democracies in which we conduct business could result in significant changes in, and uncertainty with respect to, legislation, regulation and government policy directly affecting our business or indirectly affecting us because of impacts on our customers and producers.  Legislative and regulatory proposals that could have a material direct or indirect impact on us include, but are not limited to, disallowances of income tax deductions, taxes or other restrictions repatriating foreign earnings, restrictions on imports and exports, modifications to international trade policy, including withdrawal from trade agreements, environmental regulation, changes to immigration policy, changes to health insurance legislation and the imposition of tariffs and other taxes on imports. We are currently unable to predict whether such changes will occur and, if so, the ultimate impact on our business. To the extent that such changes have a negative impact on us, our producers or our customers, including as a result of related uncertainty, these changes may materially and adversely impact our business, financial condition, results of operations and cash flows.

Our business could be negatively affected by security threats, including cybersecurity threats, and other disruptions.

We face various security threats, including cybersecurity threats to gain unauthorized access to sensitive, confidential or personal information or to render data or systems unusable, threats to our facilities, threats from disgruntled employees and terrorist acts. The potential for such security threats subjects our operations to increased risks that could have a material adverse effect on our business. In particular, our implementation of various procedures and controls to monitor and mitigate security threats and to increase security for our, and our customer's and supplier's information, facilities and infrastructure may result in increased capital and operating costs. Moreover, there can be no assurance that such procedures and controls will be sufficient to prevent security breaches from occurring. If any of these security breaches were to occur, they could lead to losses of sensitive information, critical infrastructure or capabilities essential to our operations and could have a material adverse effect on our reputation, financial position, results of operations or cash flows and could result in claims being brought against us. Cybersecurity attacks in particular are becoming more sophisticated and include, but are not limited to, malicious software, attempts to gain unauthorized access to data (either directly or through our vendors) and other electronic security breaches that could lead to disruptions in critical systems, unauthorized release of confidential or otherwise protected information and corruption of data. If any information about our customers and suppliers retained by us were the subject of a successful cybersecurity attack against us, we could be subject to litigation or other claims by the affected customers or suppliers. All events as described in this risk factor could damage our reputation and lead to financial losses from expenses related to remediation actions, loss of business or potential liability.

Attempts to expand our distribution services into new geographic markets may not achieve profitability for a period of time or at all.

We plan to expand our distribution services into new geographic markets, which will require us to make capital investments to extend and develop our distribution infrastructure. If we do not successfully add new distribution centers and routes, if we experience unanticipated costs or delays or if we experience competition in such markets that is greater than we expect, we may not achieve profitability in new regions for a period of time or at all.

Consolidation of our competitors in the markets in which we operate could place us at a competitive disadvantage and reduce our profitability.

We operate in an industry which is highly fragmented on a global scale, but in which there has been a trend toward consolidation in recent years. Consolidation of our competitors may jeopardize the strength of our position in one or more of the markets in which we operate and any advantages we currently have due to the comparative scale of our operations. Losing some of those advantages could adversely affect our business, financial condition, cash flows and results of operations, as well as our growth potential.

27

Our business is subject to many operational risks that can result in injury or loss of life, environmental damage, exposure to hazardous materials and other events that could potentially lead to the interruption of our business operations and/or the incurrence of significant costs.

The operations in our Chemicals and Environmental Services lines of business inherently involve the risk that chemical products or hazardous substances could be released into the environment from our facilities or equipment, either through spills or other accidents. Many of the chemical products and waste we handle, or have handled in the past, are potentially dangerous, and could present the risk of fires, explosions, exposure to hazardous materials and other hazards that could cause property or environmental damage or personal injury to our employees and third parties. Responding to the occurrence of any such incidents could cause us to incur potentially material expenditures related to response actions, government penalties, natural resource damages, business interruption and third party injury or property damage claims.

While we utilize extensive safety procedures and protocols in the operation of our businesses, there are risks inherent to the chemical distribution and environmental services industries. These relate primarily to the storage, handling, transportation and disposal of chemicals, wastes and other hazardous substances, which are subject to operational hazards and unforeseen interruptions caused by events beyond our control. These risks include, but are not limited to, accidents, explosions, fires, breakdowns in equipment or processes, acts of terrorism and severe weather. These events can result in injury or loss of life, environmental damage, exposure to hazardous materials and other events that could potentially lead to the interruption of our business operations and/or the incurrence of significant costs. In addition, the handling of chemicals has the potential for serious impacts on human health and the environment from such events as chemical spills, exposures and unintentional discharges or releases of toxic or hazardous substances or gases.

Our insurance policies may not cover all losses, costs or liabilities that we may experience.

Although we cover our operational risks with insurance policies in certain instances and to the extent our management deems appropriate, these policies are subject to customary exclusions, deductibles and coverage limits that we believe are in accordance with industry standards and practices. We are not insured against all risks, however, and we cannot guarantee that we will not incur losses beyond the policy limits or outside the coverage of our insurance policies. Moreover, from time to time, various types of insurance for companies involved in chemical distribution and environmental services have not been available on commercially acceptable terms or, in some cases, available at all. There can be no assurance that we will be able to maintain adequate insurance coverage in the future, that premiums, which have increased significantly in the last several years, will not continue to increase in the future, or that we will not be subject to liabilities in excess of available insurance.

Although we maintain liability insurance, there can be no assurance that this type or the level of coverage is adequate or that we will be able to continue to maintain our existing insurance or obtain comparable insurance at a reasonable cost, if at all. A product recall or a partially or completely uninsured judgment against us could have a material adverse effect on our business, financial condition, cash flows or results of operations.

Accidents, environmental damage, misuse of our products, adverse health effects or other harm related to hazardous materials that we carry or store could result in damage to our reputation and substantial remediation obligations.

Our business depends to a significant extent on our customers’ and suppliers’ trust in our reputation for quality, safety, reliability and environmental responsibility. Actual or alleged instances of safety deficiencies, inferior product quality, exposure to hazardous materials resulting in illness, injury or other harm to persons or property, environmental damage caused by us or our products, as well as misuse or misappropriation of our products, such as for terrorist activities or in the processing of illegal drugs, could damage our reputation and result in the loss of customers or suppliers. There can be no assurance that we will not incur such problems in the course of our operations. Also, there may be safety, personal injury or other environmental risks related to our products which are not known today. Any of the foregoing events, outcomes or allegations could also subject us to legal claims, and we could incur substantial legal fees and other costs in defending such claims.

28

Accidents or other incidents alleged to have taken place at our facilities, while a product is in transit, in a product’s end use application or otherwise involving our personnel or operations could also expose us to substantial liabilities and have a material adverse effect on our business, financial condition, cash flows and results of operations. Because many of the products we handle are potentially dangerous, we face the ongoing risk of explosions, fires, unintended releases and other hazards that may cause property damage, physical injury, illness or death.  

There can be no assurance that these types of events will not occur in the future. If these events occur, whether through our own fault, the fault of a third party, pre-existing conditions at our facilities or among our fleet, natural disaster or other event outside our control, our reputation could be significantly damaged. We could also become responsible, through the application of environmental or other laws or by court order, for substantial monetary damages, costly investigation or remediation obligations and various fines or penalties, which may include liabilities arising from third party lawsuits or environmental clean-up obligations. The amount of any costs we may incur under such circumstances could substantially exceed any insurance we have to cover those losses.

Our business exposes us to potential product liability claims and recalls, which could adversely affect our financial condition and performance.

We are a distributor of products that third party manufacturers produce. We also sell a limited number of products directly to retail stores. Accordingly, our business involves an inherent risk of exposure to product liability claims, product recalls, product seizures and related adverse publicity. A product liability claim or judgment against us could also result in substantial and unexpected expenditures, affect consumer or customer confidence in our products, and divert management’s attention from other responsibilities. We generally extend to our customers the warranties provided to us by our suppliers and, accordingly, the majority of our warranty obligations to customers are intended to be covered by corresponding supplier warranties. However, there can be no assurance that our suppliers will continue to provide such warranties to us in the future, that warranty obligations to our customers will be covered by corresponding warranties from our suppliers or that our suppliers will be able to financially provide protection.

We are relying upon the creditworthiness of Ashland, which is indemnifying Holdings for certain liabilities associated with the Distribution Business. To the extent Ashland is unable (or unwilling) to satisfy its obligations to us, we may have no recourse under the ADA Purchase Agreement and will bear the risk of the liabilities associated with the Distribution Business.

Under the ADA Purchase Agreement, Ashland agreed to retain the Retained Remediation Liabilities. Ashland’s obligation for these liabilities is not subject to any claim thresholds or deductibles. However, Ashland’s indemnification obligations under the ADA Purchase Agreement as described above terminated as of March 31, 2016, other than for the Retained Remediation Liabilities. As a result, any environmental remediation liabilities reported to Ashland after March 31, 2016 and not arising out of a Retained Remediation Liability will be liabilities of the Company. In addition, the Company is obligated to indemnify Ashland for any remediation liabilities other than the Retained Remediation Liabilities.

Based on the indemnification discussed above, we do not currently have any environmental or remediation reserves for matters that are covered by the ADA Purchase Agreement. If any Retained Specified Remediation Liability ultimately exceeds the liability ceilings described above, we would be responsible for such excess amounts. In addition, we are responsible for liabilities associated with our operation of the business, we would be required to take appropriate environmental or remediation reserves.

Several of our facilities are currently undergoing active remediation for previous impacts to soil and groundwater. Under the ADA Purchase Agreement, Ashland retained liability for all known remediation obligations related to its ownership and operation of the Distribution Business before March 31, 2011 and agreed to indemnify us for any losses associated with these liabilities, subject to some limitations. To date, we have not incurred any such costs. We may also discover new or previously unknown contamination which may not be indemnified by Ashland. In those cases and in situations where Ashland is unable or unwilling to fulfill its indemnification obligations, we may be responsible for substantial remediation costs.

To the extent Ashland is unable or unwilling to satisfy its indemnification obligations, we may have no recourse under the ADA Purchase Agreement and will bear the risk of the pre-closing liabilities associated with the Distribution Business, including certain known environmental liabilities.

29

We may be subject to personal injury claims related to exposure to hazardous materials and asbestos.

Our Chemicals and Environmental Services lines of business involve the storage, transportation and handling of hazardous materials, including chemicals and wastes. The nature of these operations could subject us to personal injury claims from individuals or classes of individuals related to exposure to such materials. We may also be subject to personal injury claims related to exposure to asbestos. Although we do not manufacture or distribute any products containing asbestos, asbestos-containing building materials have been identified at some of our facilities; these materials could present an exposure risk if improperly handled. Under the ADA Purchase Agreement, Ashland retained liability for all personal injury claims related to its ownership and operation of the Distribution Business before the closing date of the Ashland Distribution Acquisition filed on or before March 31, 2016, and will indemnify us for certain losses associated with these liabilities, subject to some limitations. Ashland will not indemnify us, however, for any personal injury claims filed after March 31, 2016 and for any personal injury claims arising from our own ownership and operation of the Distribution Business assets after the closing date of the Ashland Distribution Acquisition, nor will Ashland indemnify Holdings for any claims related to the removal or abatement of asbestos-containing materials. There can be no assurance that we will not incur any of these claims that could result in a material impact on our business, financial condition, cash flows or results of operations in the future.

We are exposed to ongoing litigation and other legal and regulatory actions and risks in the course of our business, and we could incur significant liabilities and substantial legal fees.

We are subject to the risk of litigation, other legal claims and proceedings and regulatory enforcement actions in the ordinary course of our business. The outcomes of these proceedings cannot be predicted with certainty. In addition, we cannot guarantee that the results of current and future legal proceedings will not materially harm our business, reputation or brand, nor can we guarantee that we will not incur losses in connection with current or future legal proceedings that exceed any provisions we may have set aside in respect of such proceedings. Many of the products we sell can cause liabilities to arise many years after their sale and use. Insurance purchased at the time of sale may not be available when costs arise in the future, and suppliers may no longer be available to provide indemnification or stand behind their warranties. There can be no assurance that we will not incur legal or regulatory cost that could result in a material impact on our business, financial condition, cash flows or results of operations in the future.

Our international sales and operations require access to international markets and are subject to applicable laws relating to trade, export and import controls and economic sanctions, the violation of which could adversely affect our operations.

We must comply with foreign laws relating to trade, export and import controls and economic sanctions. We may not be aware of all of such laws for the markets in which we do business, which subjects us to the risk of potential violations. Non-compliance could result in the loss of authorizations and licenses to conduct business in these countries or civil or criminal penalties. We must also comply with all applicable export and import laws and regulations of the U.S. and other countries. Such laws and regulations include, but are not limited to, the Export Administration Act, the Export Administration Regulations, the Arms Export Control Act and the International Traffic in Arms Regulations. The applicability of such laws and regulations generally is limited to "U.S. persons" (i.e., U.S. companies organized or registered to do business in the U.S. and to U.S. citizens, U.S. lawful permanent residents and other protected classes of individuals). However, these laws and regulations have certain extraterritorial effect in some instances, particularly with respect to the reexport of U.S.-origin equipment. We must comply with U.S. sanctions laws and regulations, which are primarily administered by the U.S. Department of Treasury’s Office of Foreign Assets Controls, as well as other U.S. government agencies. Transactions involving sanctioned countries, entities and persons are prohibited without U.S. government authorization (which will rarely be granted). The applicability of such sanctions laws and regulations generally is limited to U.S. persons. However, these sanctions laws and regulations have certain extraterritorial effect in some instances, particularly with respect to the reexport of U.S.-origin equipment. Moreover, U.S. sanctions against Cuba are specifically designed to cover foreign companies owned and controlled by U.S. companies and certain U.S. sanctions against Iran are designed to target foreign companies.

30

There can be no assurance that compliance with these laws and regulations will not have a material impact on our results of operations or cash flows in the future. Furthermore, while we have not experienced penalties from the violation of these laws that have materially impacted our results of operations or cash flows in any of the periods presented in this Annual Report on Form 10-K, violations of U.S. laws and regulations relating to trade, export and import controls and economic sanctions could result in significant civil and/or criminal penalties for our U.S. and foreign operations, including fines, onerous compliance requirements, prohibitions on exporting and importing, prohibitions on receiving government contracts or other government assistance and other trade-related restrictions. It should be noted that U.S. enforcement of such laws and regulations continues to increase, along with penalties for violations.

If we do not comply with the U.S. Foreign Corrupt Practices Act, we may become subject to monetary or criminal penalties.

The FCPA generally prohibits companies and their intermediaries from bribing foreign officials for the purpose of obtaining or keeping business. We currently take precautions to comply with this law. However, these precautions may not protect us against liability, particularly as a result of actions that may be taken in the future by agents and other intermediaries through whom we have exposure under the FCPA even though we may have limited or no ability to control such persons. Additionally, we have operations in certain countries, including Mexico, Russia and China, where strict compliance with the FCPA may conflict with local customs and practices. There can be no assurance that we will not be subject to penalties that might materially impact our business, financial condition, cash flows or results of operations in the future. Our competitors include foreign entities not subject to the FCPA, and hence compliance with this law may put us at a competitive disadvantage.

Regulatory compliance may divert our management's attention from day-to-day management of our business, which could have a material adverse effect on our business.

Our management team may not successfully or efficiently manage our continued transition to a public company that is subject to significant regulatory oversight and reporting obligations under the federal securities laws and the regulations imposed by NASDAQ. These regulations continue to evolve with the ongoing implementation of requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act and other new SEC regulations. In particular, these new obligations will require substantial attention from our senior management and could divert their attention away from the day-to-day management of our business, which could materially and adversely impact our business operations.    

Our balance sheet includes significant intangible assets, which could become impaired.

At September 30, 2018, our intangible assets totaled $911.5 million, including $699.9 million in goodwill resulting from the Business Combination and the Ultra Chem Acquisition. We may also recognize additional goodwill and intangible assets in connection with any future business or asset acquisitions. Under U.S. GAAP, we are required to evaluate goodwill for impairment at least annually. Although we have not had an impairment on these intangible assets, we cannot guarantee that no material impairment will occur, particularly in the event of a substantial deterioration in our future profitability prospects, either in our business as a whole or in a particular segment. If we determine that the carrying value of our long-lived assets, goodwill or intangible assets is less than their fair value, we may be required to record impairment charges in the future which may significantly impact our profitability. The determination of fair value is highly subjective and can produce significantly different results based on the assumptions used and methodologies employed.  

Changes in accounting standards issued by the FASB or other standard-setting bodies may adversely affect our financial statements.

Our financial statements are subject to the application of U.S. GAAP, which is periodically revised and/or expanded. Accordingly, from time-to-time we are required to adopt new or revised accounting standards issued by recognized authoritative bodies, including the FASB and the SEC. It is possible that future accounting standards we are required to adopt could change the current accounting treatment that we apply to our consolidated financial statements and that such changes could have a material adverse effect on our results of operations and financial condition.

31

If we fail to maintain an effective system of internal controls, we may not be able to accurately report our financial results and risk our ability to have such controls attested to by our independent auditors.

We are required to comply with Section 404 of the Sarbanes Oxley Act, which requires, among other things, that companies maintain disclosure controls and procedures to ensure timely disclosure of material information, and that management review the effectiveness of those controls on a quarterly basis. Effective internal controls are necessary for us to provide reliable financial reports and to help prevent fraud, and our management and other personnel devote a substantial amount of time to these compliance requirements. Moreover, these rules and regulations increased our legal and financial compliance costs and make some activities more time-consuming and costly. We cannot be certain that we will be able to maintain adequate controls over our financial processes and reporting in the future or that we will be able to comply with our obligations under Section 404 of the Sarbanes Oxley Act. Section 404 of the Sarbanes-Oxley Act also requires us to evaluate annually the effectiveness of our internal controls over financial reporting as of the end of each fiscal year and to include a management report assessing the effectiveness of our internal controls over financial reporting in our Annual Report on Form 10-K. If we fail to maintain the adequacy of our internal controls, we cannot assure you that we will be able to conclude in the future that we have effective internal controls over financial reporting and/or we may encounter difficulties in implementing or improving our internal controls, which could harm our operating results or cause us to fail to meet our reporting obligations. We cannot assure that we will receive a positive attestation from our independent auditors with respect to our internal controls. In the event we identify significant deficiencies or material weaknesses in our internal control that we cannot remediate in a timely manner or if we are unable to receive a positive attestation from our independent auditors with respect to internal controls, we might be subject to additional scrutiny by regulatory authorities, such as the SEC. Any such action could adversely affect our financial results and may also result in delayed filings with the SEC which could cause investors and others to lose confidence in the reliability of our financial statements.

We may incur significant costs and liabilities in the future resulting from new or existing environmental or safety laws or regulations or an accidental release of wastes or other materials into the environment.

Our Chemicals line of business, as well as the Predecessor's Composites line of business, involve the storage and distribution of various chemicals, solvents, additives, resins and catalysts to various end markets. Our Environmental Services line of business involves the collection, recovery, recycling and disposal of hazardous and non-hazardous materials. All of these lines of business, and to a lesser extent our Plastics line of business, are subject to increasingly stringent federal, state, local and foreign laws and regulations associated with protection of the environment. These laws and regulations govern such matters as the handling, storage and transportation of chemicals and composites, releases of pollutants into the air, soil, and water disposal of hazardous and non-hazardous wastes, remediation of contaminated sites, protection of workers from exposure to hazardous substances, and public disclosure of information regarding environmental and safety hazards. Our failure to comply with any environmental and safety laws or regulations could result in the assessment of administrative, civil or criminal penalties the imposition of investigatory or remediation liabilities and the issuance of injunctive relief, which could subject us to additional operational costs and constraints. Each of these outcomes could have an adverse effect on our business, financial condition, cash flows or results of operations.

Environmental and safety laws and regulations are subject to frequent modification, and recent trends indicate a movement towards increasingly stringent environmental and safety requirements. As a result, we may be required to make substantial expenditures to comply with future environmental and safety laws and regulations, and such expenditures could have an adverse effect on our business, financial condition, cash flows or results of operations. For example, the EPA has recently increased its regulation of toxic substances under TSCA. New or increased governmental restrictions on the transportation, use or disposal of certain chemicals, both domestically and abroad, could also reduce demand for our products, adversely affecting our operations.

32

Growing concerns about climate change may result in the imposition of additional regulations or restrictions to which we may become subject. Climate changes include changes in rainfall and in storm patterns and intensities, water shortages, significantly changing sea levels and increasing atmospheric and water temperatures, among others. A number of governments or governmental bodies have introduced or are contemplating regulatory changes in response to climate change, including regulating greenhouse gas emissions. Potentially, additional U.S. federal regulation may be forthcoming with respect to greenhouse gas emissions (including carbon dioxide) and/or “cap and trade” legislation that could impact our operations. The outcome of new legislation or regulation in the U.S. and other jurisdictions in which we operate may result in new or additional requirements, additional charges to fund energy efficiency activities, and fees or restrictions on certain activities. Furthermore, the potential impact of climate change and related regulation on our customers is highly uncertain and there can be no assurance that it will not have an adverse effect on our business, financial condition, cash flows or results of operations.

Risks Related to Our Securities

TPG and FPA, collectively, have significant influence over us, which could limit your ability to influence the outcome of key transactions, including a change of control.

TPG and FPA (and their affiliates), collectively, owned approximately 63.2% of our outstanding common stock as of September 30, 2018. Because of the degree of concentration of voting power, the ability to elect members of and representation on our board of directors (the "Board") and influence our business and affairs, including any determinations with respect to mergers or other business combinations, the acquisition or disposition of assets, the incurrence of indebtedness, the issuance of any additional shares of our common stock or other equity securities, the repurchase or redemption of shares of our common stock and the payment of dividends, may be diminished.

Our stock price could be extremely volatile, and, as a result, you may not be able to resell your shares at or above the price you paid for them.

In recent years the stock market in general has been highly volatile. As a result, the market price and trading volume of our common stock is likely to be similarly volatile, and investors in our common stock may experience a decrease, which could be substantial, in the value of their stock, including decreases unrelated to our results of operations or prospects, and could lose part or all of their investment. The price of our common stock could be subject to wide fluctuations in response to a number of factors, including those described elsewhere in this Annual Report on Form 10-K and our other filings with the SEC such as:

• operating results could fluctuate on a quarterly basis as a result of a number of factors, including, among other things, the timing of contracts, orders, the delay or cancellation of a contract, and changes in government regulations;

• actual or anticipated fluctuations in our quarterly financial results or the quarterly financial results of companies perceived to be similar to us;

• changes in the market’s expectations about our operating results;

•  our operating results failing to meet the expectation of securities analysts or investors in a particular period;

• changes in financial estimates and recommendations by securities analysts concerning us or the specialty chemicals industry in general;

• operating and stock price performance of other companies that investors deem comparable to us;

• low trading volume of our common stock may adversely affect its liquidity and reduce the number of market makers and/or large investors willing to trade in our common stock, making wider fluctuations in the quoted price of our common stock more likely to occur;

• our ability to market new and enhanced products on a timely basis;

• changes in laws and regulations affecting our business;

• our ability to meet compliance requirements;

33

• commencement of, or involvement in, litigation involving us;

• changes in our capital structure, such as future issuances of securities or the incurrence of additional debt;

• the volume of shares of our common stock available for public sale;

• any major change in the Board or management;

• sales of substantial amounts of common stock by our directors, executive officers or significant stockholders or the perception that such sales could occur; and

• general economic and political conditions such as recessions, interest rates, fuel prices, international currency fluctuations and acts of war or terrorism.

Securities class action litigation has often been initiated against companies following periods of volatility in their stock price. This type of litigation could result in substantial costs and divert our management’s attention and resources, and could also require us to make substantial payments to satisfy judgments or to settle litigation.

There may be sales of a substantial amount of our common stock by our current stockholders, and these sales could cause the price of our common stock to fall.

As of November 30, 2018, there were 89,755,231 shares of common stock issued and 89,698,331 shares outstanding.  Of our issued and outstanding shares that were issued prior to the Business Combination, all are freely transferable, except for any shares held by our "affiliates," as that term is defined in Rule 144 under the Securities Act. Future sales of our common stock may cause the market price of our common stock to drop significantly, even if our business is doing well.

We and certain of our current stockholders may sell large amounts of our common stock in the open market or in privately negotiated transactions, which could have the effect of increasing the volatility in our stock price or putting significant downward pressure on the price of our common stock.

Sales of substantial amounts of our common stock in the public market, or the perception that such sales will occur, could adversely affect the market price of our common stock and make it difficult for us to raise funds through securities offerings in the future.

Future issuances of capital stock could reduce your influence over matters on which stockholders vote.

The Board has the authority, without action or vote of our stockholders, to issue all or any part of our authorized but unissued shares of common stock, including shares issuable upon the exercise of options, or shares of our authorized but unissued preferred stock. Issuances of common stock or voting preferred stock would reduce your influence over matters on which our stockholders vote and, in the case of issuances of preferred stock, would likely result in your interest in us being subject to the prior rights of holders of that preferred stock. However, as previously noted, the Univar Merger Agreement contains customary covenants which restrict us, without Univar's consent, from taking certain specified actions until the proposed transaction closes or the Univar Merger Agreement terminates. Such restrictions preclude us from issuing any shares of our capital stock, subject to customary exceptions.

Warrants are exercisable for our common stock, which, if exercised, would increase the number of shares eligible for future resale in the public market and result in dilution to our stockholders.

As of November 30, 2018, outstanding warrants to purchase an aggregate of 25,012,500 shares of our common stock were exercisable in accordance with the terms of the warrant agreement governing those securities. These warrants will expire at 5:00 p.m., New York time, on June 9, 2021 or earlier upon redemption or liquidation. The exercise price of these warrants is $5.75 per half share, or $11.50 per one full share, subject to certain adjustments. To the extent such warrants are exercised, additional shares of our common stock will be issued, which will result in dilution to the holders of our common stock and increase the number of shares eligible for resale in the public market. Sales of substantial numbers of such shares in the public market or the fact that such warrants may be exercised could adversely affect the market price of our common stock.

34

If securities or industry analysts do not publish or cease publishing research or reports about us, our business, or our market, or if they change their recommendations regarding our common stock adversely, the price and trading volume of our common stock could decline.

The trading market for our common stock will likely be influenced by the research and reports that industry or securities analysts may publish about us, our business, our market, or our competitors. Securities and industry analysts do not currently, and may never, publish research on us. If no securities or industry analysts commence coverage of us, our stock price and trading volume would likely be negatively impacted. If any of the analysts who may cover us change their recommendation regarding our stock adversely, or provide more favorable relative recommendations about our competitors, the price of our common stock would likely decline. If any analyst who may cover us were to cease coverage of us or fail to regularly publish reports on it, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline.

Anti-takeover provisions contained in our certificate of incorporation and bylaws could impair a takeover attempt.

Our second amended and restated certificate of incorporation, or charter, and bylaws contain provisions that could have the effect of delaying or preventing changes in control or changes in our management without the consent of the Board. These provisions include:

• a staggered board providing for three classes of directors, which limits the ability of a stockholder or group to gain control of the Board;

• no cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director candidates;

• the right of the Board to elect a director to fill a vacancy created by the expansion of the Board or the resignation, death, or removal of a director in certain circumstances, which prevents stockholders from being able to fill vacancies on the Board;

• the ability of the Board to determine whether to issue shares of our preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer;

• a prohibition on stockholder action by written consent upon and following the date when TPG and the Sponsor cease to own more than 30% of the outstanding shares of stock (the "Trigger Date"), which forces stockholder action to be taken at an annual or special meeting of our stockholders;

• a prohibition on stockholders calling a special meeting upon and following the Trigger Date, which forces stockholder action to be taken at an annual or special meeting of our stockholders;

• the requirement that a meeting of stockholders may be called only by the Board after the Trigger Date, which may delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors;

• providing that after the Trigger Date directors may be removed prior to the expiration of their terms by stockholders only for cause or upon the affirmative vote of 75% of the voting power of all of our outstanding shares of capital stock;

• a requirement that changes or amendments to the charter or the bylaws must be approved (i) before the Trigger Date, by a majority of the voting power of our outstanding common stock, which such majority shall include at least 65% of the shares then held by the Sponsor and TPG, and (ii) thereafter, certain changes or amendments must be approved by at least 75% of the voting power of our outstanding common stock; and

• advance notice procedures that stockholders must comply with in order to nominate candidates to the Board or to propose matters to be acted upon at a stockholders’ meeting, which may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of the Company.

35

These provisions, alone or together, could delay hostile takeovers and changes in control of us or changes in our management. Any provision of the charter or bylaws that has the effect of delaying or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also affect the price that some investors are willing to pay for our common stock.

We have no current plans to pay cash dividends on our common stock for the foreseeable future.

We may retain future earnings, if any, for future operations, expansion and debt repayment and have no current plans to pay any cash dividends for the foreseeable future. Any decision to declare and pay dividends as a public company in the future will be made at the discretion of the Board and will depend on, among other things, our results of operations, financial condition, cash requirements, contractual restrictions and other factors that the Board may deem relevant. In addition, our ability to pay dividends may be limited by covenants of any existing and future outstanding indebtedness we or our subsidiaries incur, including the Credit Facilities. As a result, a stockholder may not receive any return on an investment in our common stock unless such stockholder sells our common stock for a price greater than that which it paid for it.

Our securities may be delisted from NASDAQ.

Our common stock and warrants are currently listed on NASDAQ. However, we cannot assure you that we will be able to comply with the continued listing standards of NASDAQ. If we fail to comply with the continued listing standards of NASDAQ, our securities may become subject to delisting. If NASDAQ delists our common stock or warrants from trading on its exchange for failure to meet the continued listing standards, we and our security holders could face significant material adverse consequences including:

• a limited availability of market quotations for our securities;

• a limited amount of analyst coverage; and

• a decreased ability for us to issue additional securities or obtain additional financing in the future.

Item 1B. Unresolved Staff Comments

Not applicable. 

Item 2. Properties

See "Item 1. Business—Global Distribution Channels —Facilities" for a description of our principal properties.

Item 3. Legal Proceedings

We are not currently a party to any legal proceedings that, if determined adversely against us, individually or in the aggregate, would have a material adverse effect on our financial position, results of operations or cash flows.

In July 2014, Ashland filed a lawsuit -- Ashland Inc. v. Nexeo Solutions, LLC, Case No. N14C-07-243 JTV CCLD, in the Superior Court for the State of Delaware in and for New Castle County. In the suit, Ashland sought a declaration that Holdings was obligated to indemnify Ashland for losses Ashland incurred pertaining to the Other Retained Remediation Liabilities, up to the amount of a $5.0 million deductible, which Ashland contended applied pursuant to the ADA Purchase Agreement. Ashland further alleged that Solutions breached duties related to that agreement by not having so indemnified Ashland for amounts Ashland incurred for the Other Retained Remediation Liabilities at sites where Ashland disposed of wastes prior to the Ashland Distribution Acquisition, and on that basis sought unspecified compensatory damages, costs and attorney’s fees. On June 21, 2017 the Company's Motion for Summary Judgment in this lawsuit was granted. Ashland appealed the ruling on July 20, 2017. On January 31, 2018, the Delaware Supreme Court affirmed the lower court's grant of the Company's Motion for Summary Judgment. Ashland did not request a rehearing of the ruling. Therefore, the judgment in the Company's favor is final and this matter is closed. The Company does not currently have any environmental or remediation reserves for matters covered under the ADA Purchase Agreement.

36

     In June 2014, we self-disclosed to the DTSC that an inventory of our Fairfield facility had revealed potential violations of RCRA and the California Health and Safety Code. Although no formal proceeding has been initiated, we expect the DTSC to seek payment of fines or other penalties for non-compliance. We do not expect the amount of any such fine or penalty to have a material adverse effect on our business, financial position or results of operations.

We expect that, from time to time, we may be involved in lawsuits, investigations and claims arising out of our operations in the ordinary course of business.

Item 4. Mine Safety Disclosures

Not applicable.

37

PART II

Item 5. Market for Company’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

The Company's common stock, warrants and units are currently quoted on NASDAQ under the symbols "NXEO", "NXEOW" and "NXEOU", respectively.

Common Stock, Warrants and Units Prices

    The following table sets forth, for the periods indicated, the reported high and low sales prices for our common stock, warrants and units.

	Common Stock				Warrants				Units
	Prices				Prices				Prices
Fiscal Year 2018:	High		Low		High		Low		High		Low
First	$	9.13	$	7.23	$	0.64	$	0.45	$	10.18	$	7.36
Second	10.70		8.87		0.81		0.61		13.00		9.21
Third	11.00		9.13		0.85		0.57		12.00		9.65
Fourth	12.42		8.70		1.05		0.50		13.25		8.78
Year	$	12.42	$	7.23	$	1.05	$	0.45	$	13.25	$	7.36
Fiscal Year 2017:
First	$	9.33	$	7.28	$	0.70	$	0.44	$	10.12	$	7.89
Second	9.79		8.78		0.78		0.62		10.44		9.05
Third	9.23		8.16		0.72		0.50		9.85		7.50
Fourth	8.45		7.02		0.57		0.44		8.94		6.76
Year	$	9.79	$	7.02	$	0.78	$	0.44	$	10.44	$	6.76

Holders

As of November 30, 2018, there were 96 holders of record of our common stock, one holder of record for our warrants and one holder of record of our units. Some of our securities are held in "street name" and held of record by banks, brokers and other financial institutions.

Dividends

We have not paid any cash dividends on shares of our common stock to date. The payment of cash dividends in the future will be dependent upon our revenues and earnings, capital requirements and general financial condition. In addition, our Credit Facilities currently limit our ability to pay dividends and our board of directors is not currently contemplating and does not anticipate declaring any dividends in the foreseeable future. Further, if we incur any additional indebtedness, our ability to declare dividends may be limited by restrictive covenants that we may agree to in connection therewith.

Issuer Purchases of Equity Securities

None.

38

Item 6. Selected Financial Data

The Company is the result of the Business Combination between WLRH and Holdings as of the Closing Date and referred to as the "Successor". The "Predecessor" financial information reflects the operations of Holdings prior to the Closing Date of the Business Combination.

This table should be read in conjunction with Item 1 "Business", Item 1A "Risk Factors", Item 7 "Management’s Discussion and Analysis of Financial Condition and Results of Operations" and our audited consolidated financial statements and the notes thereto included under Item 8 of this Annual Report on Form 10-K.

	Successor									Predecessor
	Fiscal Year Ended September 30,									October 1, 2015 Through June 8,			Fiscal Year Ended September 30,
	2018			2017			2016*			2016			2015			2014
Statement of Operations Data:
Sales and operating revenues	$	4,034.2		$	3,636.9		$	1,065.7		$	2,340.1		$	3,949.1		$	4,514.5
Gross profit	460.1			398.4			108.4			271.9			408.0			401.7
Net income (loss) from continuing operations	29.4			14.4			(8.4		)	(13.9		)	21.2			(12.2		)
Net income (loss) attributable to Nexeo Solutions, Inc.	29.4			14.4			(8.4		)	(13.8		)	20.4			4.9
Net income (loss) per share available to common stockholders
Basic	$	0.38		$	0.19		$	(0.24	)
Diluted	$	0.38		$	0.19		$	(0.24	)
Weighted average number of common shares outstanding
Basic	76,803,187			76,752,752			35,193,789
Diluted	76,909,547			76,839,810			35,193,789
Statement of Cash Flow Data (1):
Net cash provided by (used in):
Operating activities	$	88.7		$	78.6		$	3.2		$	69.6		$	154.1		$	57.5
Investing activities	(26.2		)	(84.2		)	133.0			(11.8		)	(31.5		)	(209.9		)
Financing activities	(57.4		)	11.8			(88.9		)	(121.5		)	(81.8		)	166.5
Other Financial Data(2):
Capital expenditures, excluding acquisitions (3)	$	18.6		$	27.6		$	12.7		$	14.2		$	35.6		$	49.9
Depreciation, amortization and impairment loss	74.9			74.6			20.6			37.7			52.6			53.4

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

⁽¹⁾  Statement of Cash Flow Data for all periods represents total cash flow amounts for each respective line item.

⁽²⁾  Other Financial Data for the Successor and Predecessor periods reflects amounts net of discontinued operations.

⁽³⁾  Excludes non-cash capital expenditures.

39

	Successor						Predecessor
	September 30,						September 30,
	2018		2017		2016		2015		2014
Balance Sheet Data (at period end):
Cash and cash equivalents	$	58.9	$	53.9	$	47.5	$	127.7	$	88.2
Working capital (1)	484.6		457.8		419.1		443.4		523.1
Total assets	2,243.6		2,253.5		2,078.9		1,708.9		1,906.1
Long term obligations(2)	762.0		804.3		774.9		891.9		925.2
Total liabilities	1,429.1		1,475.9		1,334.1		1,423.9		1,581.3

⁽¹⁾  Working capital is defined as accounts receivable plus inventory less accounts payable less accrued expenses and other liabilities less current due to related party pursuant to contingent consideration obligations.

⁽²⁾  Long term obligations represent debt, including current portion (net of discount and debt issuance costs) and capital leases. It excludes short-term borrowings under line of credit agreements available to the Company's operations in China and the Contingent Consideration Obligations. See Notes 3, 7 and 9.

40

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations is designed to provide information to better understand, and should be read together with, our consolidated financial statements and related notes included in Part II Item 8 in this Annual Report on Form 10-K. To the extent this discussion and analysis contains forward-looking statements, these statements involve risks and uncertainties. While management believes that these forward-looking statements are reasonable, there can be no assurance that future developments will be those that are anticipated. Actual results may differ materially from those anticipated in these forward-looking statements. See "Item 1A. Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements".

Overview

We are a global materials distributor for chemicals products in North America and Asia and for plastics products in North America, EMEA and Asia. In connection with the distribution of chemicals products, we provide value-added services such as custom blending, packaging and re-packaging, private-label manufacturing and product testing in the form of chemical analysis, product performance analysis and product development. We also provide on-site and off-site hazardous and non-hazardous environmental services, including waste collection, transportation, recovery, disposal arrangement and recycling services in North America, primarily the U.S. During fiscal year 2018, we distributed nearly 24,000 products in more than 80 countries for approximately 1,400 suppliers to approximately 27,300 customers. Based on revenues for calendar year 2017, we were ranked by the Independent Chemical Information Service (ICIS), one of the largest petrochemical market information providers, third in North America and fifth globally among the Top 100 Chemicals Distributors.

We distribute our product portfolio through a global supply chain consisting of approximately 170 owned, leased or third party warehouses, rail terminals and tank terminals with a private fleet of 1,110 units, including tractors and trailers, primarily in North America. We currently employ approximately 2,760 employees globally.

For a detailed overview of our business, refer to "Item 1. Business" of this Annual Report on Form 10-K.

Univar Merger Agreement

On September 17, 2018, Nexeo and Univar entered into the Univar Merger Agreement providing for the acquisition of Nexeo by Univar. The Univar Merger Agreement and the proposed transaction were approved unanimously by the Board of Directors of both Nexeo and Univar and are subject to review by the SEC and regulatory agencies in the U.S. and other jurisdictions. The Univar Merger Agreement is also subject to a number of conditions, including, among other things and as further described in the Univar Merger Agreement: (i) the adoption by Nexeo’s stockholders of the Univar Merger Agreement, (ii) the approval by Univar’s stockholders of the issuance of the shares of Univar common stock in connection with the proposed transaction contemplated by the Univar Merger Agreement, (iii) the receipt of other required regulatory approvals, (iv) the absence of any law or governmental order prohibiting the proposed transaction, (v) the effectiveness of Univar's registration statement and the approval for listing on the NYSE of the shares of Univar common stock in connection with the proposed transaction contemplated by the Univar Merger Agreement, (vi) no material adverse effect on Nexeo's and Univar's operations having occurred since the signing of the Univar Merger Agreement and (vii) the termination of the TRA. There can be no assurance that the conditions to the completion of the proposed transaction will be satisfied or waived or that the proposed transaction will be completed. On November 16, 2018, Univar and Nexeo announced that the waiting period under the HSR Act expired. For further information about the Univar Merger Agreement, see Note 3 to our consolidated financial statements.

41

Segment Overview

We operate through three lines of business, or operating segments: Chemicals, Plastics and Environmental Services. Each line of business represents unique products and suppliers focusing on specific end markets. Factors emphasized within each end market include supplier or customer opportunities, expected growth and prevailing economic conditions. Across our Chemicals and Plastics lines of business there are numerous industry segments, end markets and sub markets that we may choose to focus on. These end markets may change from year to year depending on the underlying market economics, supplier focus, expected profitability and our strategic agenda.

See Note 16 to our consolidated financial statements for detailed information on individual segments.

Key Factors Affecting our Results of Operations and Financial Condition

General and regional economic conditions. Consumption of chemicals and plastics in the industries and markets we serve are generally affected by the global economy and amplified by regional conditions. Although we manage our cost structure in line with general economic conditions, our volumes and profitability are ultimately correlated with the underlying demand for the end-products of the industries we serve. Throughout fiscal year 2018, we experienced improved industrial market demand.

Price fluctuations. Selling prices of the products we distribute within our Chemicals and Plastics lines of business fluctuate with changes in the prices we pay for products.  Product costs are largely driven by global and regional economic conditions affecting the prices of two primary raw materials of production: crude oil (primarily naphtha) and natural gas (primarily ethane).  These two raw materials are used in the production of propylene and ethylene, the key feedstocks used in over 90% of organic-based commodity and specialty chemicals, as well as in the subsequent production of the intermediate plastics products we distribute.  The prices of these feedstocks are also affected by other factors, including choices made by producers for uses of feedstocks (e.g., as an ingredient in gasoline versus a feedstock to the chemical industry) and the capacity devoted to production for market supply and other macroeconomic factors that impact the producers.  As a distributor, the prices of these feedstocks are not in our control.  We are generally able to adjust finished good prices in accordance with fluctuations of our product costs and transportation-related costs (e.g., fuel costs).  As a result, movements in our sales revenue and cost of sales tend to correspond with changes in our product prices.  Through fiscal year 2018, we continued to execute on effective pricing initiatives and managed supply constraints through efficient inventory management.

As supply or demand patterns change, there can be corresponding volatility in the selling prices of the products we distribute.  Gross profit margins generally decrease in deflationary price environments and increase during inflationary pricing environments, although the extent to which profitability increases or decreases depends on the rate at which selling prices adjust relative to inventory costs.  As a logistics provider, oil prices affect our transportation and delivery costs, along with changes in driver regulations, supply of drivers and common carrier rates.

Volume-based pricing. We generally procure chemicals and plastics raw materials through purchase orders rather than under long-term contracts with firm commitments.  Our arrangements with key producers and suppliers are typically embodied in agreements that we refer to as framework supply agreements.  We work to develop strong relationships with a select group of producers and suppliers that complement our strategy based on a number of factors, including price, breadth of product offering, quality, market recognition, delivery terms and schedules, continuity of supply and each producer’s strategic positioning.  Our framework supply agreements with producers and suppliers typically renew annually. They generally do not provide for specific product pricing, some, primarily those related to our Chemicals line of business, include volume-based financial incentives through supplier rebates, which we earn by meeting or exceeding target purchase volumes. Supplier rebates are recorded as a reduction of inventory costs and accrued as part of cost of sales for products sold based on its purchases to date and estimates of purchases for the remainder of the calendar year. For the fiscal year ended September 30, 2018, our supplier rebates were $8.9 million.

42

Inflation. Our average selling prices generally rise in inflationary environments as producers and suppliers raise the market prices of the products that we distribute.  During inflationary periods our customers typically maximize the amount of inventory they carry in anticipation of price increases.  Consequently, this environment of excess demand favorably impacts our volumes sold, revenues and gross profit due to the lag between rising prices and our cost of goods sold.  The reverse is true in deflationary price environments.  Deflationary forces create an environment of oversupply, driving market prices of products downward, and we must quickly adjust inventories and buying patterns to respond to price declines.  Our primary objective is to replace inventories at lower costs while maintaining or enhancing unit profitability. Fiscal year 2018 began in a deflationary environment causing lower sales prices and reduced volumes; however, the environment shifted to an inflationary environment through fiscal year end enabling higher prices.

Some of our assets and liabilities, primarily cash, receivables, inventories and accounts payable, are impacted by commodity price inflation because they are indirectly affected by market prices of the raw materials that are used to manufacture our products.  We manage our working capital during periods of changing prices, so the overall impact of inflation on our net working capital is generally not significant.

Currency exchange rate fluctuations. We conduct our business on an international basis, in multiple currencies.  A portion of our sales and costs of sales transactions are denominated in currencies other than the functional currency of our subsidiaries.  Further, we have exposure to foreign exchange fluctuations arising from the remeasurement of certain foreign operations where the USD is the functional currency but accounting records are maintained in local currency. Strengthening/weakening of our subsidiaries’ functional currency relative to the other currencies in which some transactions are denominated or recorded creates foreign currency gains/losses, which we include in Selling, general and administrative expenses. Additionally, we report our consolidated results in USD and the results of operations and the financial position of our local international operations are translated into USD at the applicable exchange rates for inclusion in our consolidated financial statements.  Strengthening of the USD relative to our subsidiaries’ functional currencies causes a negative impact on sales but a positive impact on costs. During fiscal year 2018, the weakening of the USD compared to the functional currencies where we operate caused a positive impact of $46.7 million on consolidated revenues and $3.8 million on consolidated gross profit when compared to fiscal year 2017.

For more information on how the above factors impact us see "Item 1A. Risk Factors" of this Annual Report on Form 10-K.

Outlook

General. We have operations in North America, EMEA and Asia and are subject to broad, global and regional macroeconomic factors. These factors include:

• the general state of the economy, specifically inflationary or deflationary trends, GDP growth rates and commodity/feedstock price movements;

• unemployment levels;

• government regulation and geopolitical changes;

• fiscal and monetary policies of governments, including import and export tariffs, duties and other taxes;

• general income growth and the consumption rates of products;

• increases in transportation related costs and changes in our relationship with common carriers; and

• technological change in the industries we serve.

We monitor these factors routinely for both strategic and operational impacts.

43

Our operations are most impacted by regional market price fluctuations of the primary feedstock materials, including crude oil and natural gas, and the downstream derivatives of these primary raw materials. Market price fluctuations of these primary raw materials directly impact the decisions of our suppliers, specifically the manufacturing capacity and market supply made available for production of the products we distribute. As supply or demand patterns change, we may experience a corresponding change in the average selling prices of the products we distribute.

The global markets showed growth through fiscal year 2018 reflected by increases in GDP, oil prices and U.S. Industrial Production Index.

The following is a summary of GDP, oil price and U.S. Industrial Production Index fluctuations in our various regions of operations by fiscal quarter.

	Year over Year Change
	Q4 18 v Q4 17		Q3 18 v Q3 17		Q2 18 v Q2 17		Q1 18 v Q1 17
North America
U.S. GDP Growth	3.0	%	2.9	%	2.6	%	2.5	%
U.S. Industrial Production Index	5.0	%	3.4	%	3.4	%	3.0	%
West Texas Intermediate Crude Oil Average Price Increase	44.1	%	41.0	%	21.5	%	12.2	%
EMEA
Euro Area GDP Growth	1.7	%	2.2	%	2.4	%	2.7	%
Brent Crude Oil Average Price Increase	45.4	%	47.6	%	23.1	%	20.3	%
Asia
China GDP Growth (1)	6.7	%	6.8	%	6.8	%	6.9	%

⁽¹⁾ As reported by the Chinese government.

Overall GDP growth has increased in many of the countries in which we operate. In terms of currency, the USD has weakened over the prior comparable period against most other currencies in which we transact. As a result of these factors, reported dollar revenues and gross profit have been positively impacted in many of our regional operations.

North America

The North American economic environment continued to improve during fiscal year 2018. U.S. GDP has increased in fiscal year 2018 as compared to fiscal year 2017, and the inflation rate rose 2.3% in fiscal year 2018 compared to the prior fiscal year due primarily to rising oil and gas prices.

In terms of currency, the CAD strengthened when compared against the USD for fiscal year 2018, which positively affected, among other items, the reported dollar revenues and gross profit from our operations in Canada. Additionally, the Peso strengthened in value against the USD through fiscal year 2018.

EMEA

In Europe, we conduct business primarily in the Western European countries. As evidenced by their increases in GDP through fiscal year 2018, the economic environment in the countries in which we operate in Europe has continued to improve.

In terms of currency, the euro and other European currencies strengthened versus the USD through fiscal year 2018, which positively affected, among other items, the reported dollar revenues and gross profit from our European operations. 

44

The market price for the products we sell in Europe typically correlate to the market price of Brent Crude as these operations are primarily based on the distribution of commodity plastics products which are sourced in Europe. Consistent with the increase in oil prices through fiscal year 2018, we have experienced an increase in average selling price for the products we distribute in Europe.

Asia

Our operations in Asia are concentrated mainly in China. GDP growth in China, as reported by the Chinese government, has remained steady through the past several quarters.

In terms of currency, the RMB strengthened against the USD through fiscal year 2018 following declines during fiscal year 2017, which positively affected, among other items, the reported dollar revenues and gross profit from our operations in China.

Certain Factors Affecting Comparability to Prior Fiscal Year Financial Results

• After the Business Combination (see Note 3 to our consolidated financial statements) our results of operations are not directly comparable to historical results of the operations for the periods presented, primarily due to:

◦ The fiscal year ended September 30, 2016 only includes 114 days of the acquired business' operating activities as a result of the consummation of the Business Combination. Our operations are referred to as the "Successor" during this period. The "Predecessor" financial information reflects the operations of Holdings prior to the Closing Date of the Business Combination.

• In April 2017, we completed the Ultra Chem Acquisition. Accordingly, the results of the acquired operations since the Ultra Chem Closing Date are included in our consolidated results of operations. The acquired operations are primarily included in our Chemicals line of business. See Note 3 to our consolidated financial statements.

45

Results of Operations

Fiscal Year Ended September 30, 2018 compared with Fiscal Year Ended September 30, 2017

												Percentage of Sales and Operating Revenues For the
	Fiscal Year Ended											Fiscal Year Ended
	September 30,						Difference					September 30,
(in millions)	2018			2017			$ Change			% Change		2018		2017
Sales and operating revenues
Chemicals	$	1,904.5		$	1,667.2		$	237.3		14.2	%	47.2	%	45.8	%
Plastics	1,980.0			1,841.7			138.3			7.5	%	49.1	%	50.7	%
Other	149.7			128.0			21.7			17.0	%	3.7	%	3.5	%
Total sales and operating revenues	$	4,034.2		$	3,636.9		$	397.3		10.9	%	100.0	%	100.0	%
Gross profit
Chemicals	$	248.0		$	205.6		$	42.4		20.6	%	13.0	%	12.3	%
Plastics	186.4			167.2			19.2			11.5	%	9.4	%	9.1	%
Other	25.7			25.6			0.1			0.4	%	17.2	%	20.0	%
Total gross profit	$	460.1		$	398.4		$	61.7		15.5	%	11.4	%	11.0	%
Selling, general and administrative expenses	352.6			312.9			39.7			12.7	%	8.7	%	8.6	%
Transaction related costs	2.8			1.9			0.9			47.4	%	0.1	%	0.1	%
Change in fair value of contingent consideration obligations	7.5			16.2			(8.7		)	(53.7	)%	0.2	%	0.4	%
Operating income	97.2			67.4			29.8			44.2	%	2.4	%	1.9	%
Other income, net	1.0			8.3			(7.3		)	(88.0	)%	—	%	0.2	%
Interest expense, net	(52.1		)	(50.8		)	(1.3		)	(2.6	)%	(1.3	)%	(1.4	)%
Net income before income taxes	46.1			24.9			21.2			85.1	%	1.1	%	0.7	%
Income tax expense	16.7			10.5			6.2			59.0	%	0.4	%	0.3	%
Net income	$	29.4		$	14.4		$	15.0		104.2	%	0.7	%	0.4	%

Sales and operating revenues

Sales and operating revenues for the fiscal year ended September 30, 2018 increased $397.3 million, or 10.9%, compared to the fiscal year ended September 30, 2017. The increase in revenues was attributable to an 8.1% increase in average selling prices across most product categories in all regions largely due to an inflationary pricing environment and increased specialty product mix. Volumes were down slightly for the period. Approximately $46.7 million of the increase was due to strengthening exchange rates of various currencies versus the USD as compared to the prior fiscal year.

Chemicals

Sales and operating revenues for the Chemicals line of business for the fiscal year ended September 30, 2018 increased $237.3 million, or 14.2%, compared to the fiscal year ended September 30, 2017. The revenue increase was attributable to a 13.3% increase in average selling prices as a result of an inflationary pricing environment and increased specialty product mix. Volumes were essentially flat for the period.

46

Plastics

Sales and operating revenues for the Plastics line of business for the fiscal year ended September 30, 2018 increased $138.3 million, or 7.5%, compared to the fiscal year ended September 30, 2017. The revenue increase was predominately attributable to an increase in average selling prices of 11.6% across all regions as a result of an inflationary pricing environment and increased specialty product mix. Volumes were down 3.7% resulting from the commercial decision to terminate low margin and unprofitable business. Approximately, $43.8 million of the increase was due to strengthening exchange rates of various currencies versus the USD compared to the prior fiscal year.

Other

Sales and operating revenues for the Other segment for the fiscal year ended September 30, 2018 increased $21.7 million, or 17.0%, compared to the fiscal year ended September 30, 2017. The increase in revenues was due to growth in the waste services business to both new and existing customers due to increased industrial production.

Gross profit

Gross profit increased $61.7 million, or 15.5%, for the fiscal year ended September 30, 2018 compared to the fiscal year ended September 30, 2017. Gross profit increased primarily due to the shift in product mix and continued specialty supplier growth. Additionally, our centralized platform allowed us to effectively manage supply chain logistics to mitigate supply constraints, freight cost increases and facilitate strong commercial execution. Approximately $3.8 million of the increase was attributable to strengthening exchange rates of various currencies versus the USD as compared to the prior fiscal year.

Chemicals

Gross profit increased $42.4 million, or 20.6%, for the fiscal year ended September 30, 2018 compared to the fiscal year ended September 30, 2017. The increase in gross profit was driven by improved specialty product mix compared to the prior fiscal year. Additionally, gross profit increased due to our strong commercial execution strengthened by leveraging our centralized technology platform to effectively manage supply shortages for certain specialty products globally as well as supply constraints in North America predominately caused by adverse weather conditions early in the current fiscal year.

Plastics

Gross profit increased $19.2 million, or 11.5%, for the fiscal year ended September 30, 2018 compared to the fiscal year ended September 30, 2017. The increase in gross profit was mainly attributable to a favorable shift in specialty product mix and strong commercial execution. Approximately $3.6 million of the increase was due to strengthening exchange rates of various currencies versus the USD compared to the prior fiscal year.

Other

Gross profit increased $0.1 million, or 0.4%, for the fiscal year ended September 30, 2018 compared to the fiscal year ended September 30, 2017. The increase was due to management cost savings initiatives and improved product mix.

47

Selling, general and administrative expenses

									Percentage of Sales and Operating Revenues For the
	Fiscal Year Ended								Fiscal Year Ended
	September 30,				Difference				September 30,
(in millions)	2018		2017		$ Change		% Change		2018		2017
Selling, general and administrative expenses	$	352.6	$	312.9	$	39.7	12.7	%	8.7	%	8.6	%

     Selling, general and administrative expenses for the fiscal year ended September 30, 2018 increased $39.7 million, or 12.7%, compared to the fiscal year ended September 30, 2017. This increase was driven by higher employee costs of $19.8 million reflecting variable incentives from our continued outperformance, increased professional services of $8.5 million directly a result of the Univar Merger Agreement, and additional depreciation and amortization expense of $3.8 million and assorted other variable expenses.

Transaction related costs

									Percentage of Sales and Operating Revenues For the
	Fiscal Year Ended								Fiscal Year Ended
	September 30,				Difference				September 30,
(in millions)	2018		2017		$ Change		% Change		2018		2017
Transaction related costs	$	2.8	$	1.9	$	0.9	47.4	%	0.1	%	0.1	%

      We incurred transaction related costs of $2.8 million and $1.9 million in the fiscal years ended September 30, 2018 and 2017, respectively. Current period transaction costs are related to the Univar Merger Agreement and the prior fiscal year was primarily related to the Ultra Chem Acquisition.

Changes in fair value of contingent consideration

										Percentage of Sales and Operating Revenues For the
	Fiscal Year Ended									Fiscal Year Ended
	September 30,				Difference					September 30,
(in millions)	2018		2017		$ Change			% Change		2018		2017
Change in fair value of contingent consideration obligations	$	7.5	$	16.2	$	(8.7	)	(53.7	)%	0.2	%	0.4	%

We incurred a loss of $7.5 million and $16.2 million in the fiscal years ended September 30, 2018 and 2017, respectively, related to the contingent consideration associated with the Deferred Cash Consideration and TRA. The loss in the current period was primarily due to the loss of $27.6 million in the Deferred Cash Consideration driven primarily by the increase in our stock price during the fiscal year ended September 30, 2018 offset by the TRA liability gain of $20.1 million which reflects the provisional impact of the Tax Act during the first fiscal quarter of 2018 and changes in various inputs to the calculation including the estimated discount rate, expected interest rates and assumptions surrounding certain tax benefits associated with the Business Combination (see Note 15 to our consolidated financial statements). The loss for the fiscal year ended September 30, 2017 was due to the loss in the fair value of both the TRA and Deferred Cash Consideration. See Notes 3 and 9 to our consolidated financial statements.

Other income, net

										Percentage of Sales and Operating Revenues For the
	Fiscal Year Ended									Fiscal Year Ended
	September 30,				Difference					September 30,
(in millions)	2018		2017		$ Change			% Change		2018		2017
Other income, net	$	1.0	$	8.3	$	(7.3	)	(88.0	)%	—	%	0.2	%

48

     Other income, net for the fiscal year ended September 30, 2018 was $1.0 million primarily related to proceeds from the sale of fleet vehicles. Other income, net for the fiscal year ended September 30, 2017 was $8.3 million primarily due to the gain related to reimbursements received for certain capital expenditures incurred in connection with the relocation of certain operations.

Interest expense, net

									Percentage of Sales and Operating Revenues For the
	Fiscal Year Ended								Fiscal Year Ended
	September 30,				Difference				September 30,
(in millions)	2018		2017		$ Change		% Change		2018		2017
Interest expense, net	$	52.1	$	50.8	$	1.3	2.6	%	1.3	%	1.4	%

     Interest expense, net was $52.1 million and $50.8 million for the fiscal year ended September 30, 2018 and 2017, respectively, related to the Credit Facilities, along with the amortization of debt issuance costs. Interest expense, net increased due to the increased weighted average interest rate on the ABL Facility.

Income tax expense

									Percentage of Sales and Operating Revenues For the
	Fiscal Year Ended								Fiscal Year Ended
	September 30,				Difference				September 30,
(in millions)	2018		2017		$ Change		% Change		2018		2017
Income tax expense	$	16.7	$	10.5	$	6.2	59.0	%	0.4	%	0.3	%

Income tax expense for the fiscal year ended September 30, 2018 was $16.7 million and was largely attributable to current year income on profitable U.S. and foreign operations. Additionally, the current period expense includes certain newly identified tax contingencies. The current period expense generated in the U.S. was partially offset by a benefit of $4.5 million on deferred tax liabilities as a result of the Tax Act. Income tax expense for the fiscal year ended September 30, 2017 was $10.5 million and largely attributable to foreign income tax expense on profitable foreign operations.

49

Fiscal Year Ended September 30, 2017 compared with Fiscal Year Ended September 30, 2016 and the period October 1 through June 8, 2016 (Predecessor)

Our fiscal year ended September 30, 2017 includes operating results for the full twelve months, and our fiscal year ended September 30, 2016 includes operating results from June 9, 2016 through September 30, 2016 for the "Successor". The "Predecessor" period includes the operating results from October 1, 2015 through June 8, 2016.

	Successor						Predecessor
(in millions)	Fiscal Year Ended September 30, 2017			Fiscal Year Ended September 30, 2016*			October 1, 2015 through June 8, 2016
Sales and operating revenues
Chemicals	$	1,667.2		$	478.1		$	1,066.4
Plastics	1,841.7			546.7			1,192.2
Other	128.0			40.9			81.5
Total sales and operating revenues	$	3,636.9		$	1,065.7		$	2,340.1
Gross profit
Chemicals	205.6			55.7			136.2
Plastics	167.2			43.6			117.6
Other	25.6			9.1			18.1
Total gross profit	398.4			108.4			271.9
Selling, general and administrative expenses	312.9			91.7			208.9
Transaction related costs	1.9			21.3			33.4
Change in fair value of contingent consideration obligations	16.2			(11.2		)	—
Operating income	67.4			6.6			29.6
Other income, net	8.3			0.5			2.9
Interest expense, net	(50.8		)	(14.3		)	(42.2		)
Income (loss) from continuing operations before income taxes	24.9			(7.2		)	(9.7		)
Income tax expense	10.5			1.2			4.2
Net income (loss) from continuing operations	14.4			(8.4		)	(13.9		)
Net income (loss) from discontinued operations, net of tax	—			—			0.1
Net Income (Loss)	$	14.4		$	(8.4	)	$	(13.8	)

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

50

Combined financial data:

	Successor					Predecessor		Combined
	Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*			October 1, 2015 through June 8, 2016		Fiscal Year Ended September 30, 2016			Difference			% Change
Sales and operating revenues
Chemicals	$	1,667.2	$	478.1		$	1,066.4	$	1,544.5		$	122.7		7.9	%
Plastics	1,841.7		546.7			1,192.2		1,738.9			102.8			5.9	%
Other	128.0		40.9			81.5		122.4			5.6			4.6	%
Total sales and operating revenues	$	3,636.9	$	1,065.7		$	2,340.1	$	3,405.8		$	231.1		6.8	%
Gross profit
Chemicals	205.6		55.7			136.2		191.9			13.7			7.1	%
Plastics	167.2		43.6			117.6		161.2			6.0			3.7	%
Other	25.6		9.1			18.1		27.2			(1.6		)	(5.9	)%
Total gross profit	398.4		108.4			271.9		380.3			18.1			4.8	%
Selling, general and administrative expenses	312.9		91.7			208.9		300.6			12.3			4.1	%
Transaction related costs	1.9		21.3			33.4		54.7			(52.8		)	(96.5	)%
Change in fair value of contingent consideration obligations	16.2		(11.2		)	—		(11.2		)	27.4			(244.6	)%
Operating income	67.4		6.6			29.6		36.2			31.2			86.2	%

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

Sales and operating revenues

Sales and operating revenues were $3,636.9 million for the fiscal year ended September 30, 2017, an increase of $231.1 million, or 6.8%, compared to the combined fiscal year ended September 30, 2016. Excluding the $37.2 million in revenues from Ultra Chem, the increase in revenues was driven by a 2.5% increase in average selling price resulting from leveraging our centralized pricing platform to manage a volatile market primarily in our Chemicals specialties businesses, and an increase in volume of 3.1% due to growth in our Plastics line of business in fiscal year 2017. The increase in revenues was partially offset by an approximately $11.8 million decline as a result of the weakening of the exchange rates of various currencies versus the USD as compared to the combined fiscal year ended September 30, 2016.

Chemicals

Sales and operating revenues for the Chemicals line of business were $1,667.2 million for the fiscal year ended September 30, 2017, an increase of $122.7 million, or 7.9%, compared to the combined fiscal year ended September 30, 2016. Excluding the $36.6 million in revenues from Ultra Chem, the increase in revenues was driven by a 5.0% increase in the average selling price due to the use of our centralized pricing platform to leverage price execution and order management in response to supply disruptions primarily in our specialties businesses, despite flat volume in fiscal year 2017 The increase in revenues was partially offset by a $0.7 million decline as a result of the weakening exchange rates of various currencies versus the USD as compared to the combined fiscal year ended September 30, 2016.

51

Plastics

Sales and operating revenues for the Plastics line of business were $1,841.7 million for the fiscal year ended September 30, 2017, an increase of $102.8 million or 5.9%, compared to the combined fiscal year ended September 30, 2016. The increase in revenue was driven by a 6.4% increase in volume driven by strong regional demand in EMEA and Asia. Average selling prices were flat for fiscal year 2017. The volume increase was partially offset by a decline of approximately $11.1 million as a result of the weakening exchange rates of various currencies versus the USD as compared to the combined fiscal year ended September 30, 2016. North America revenues were negatively impacted due to a supplier disruption which limited the availability to us of certain products we distribute on a regular basis.

Other

Sales and operating revenues for the Other segment were $128.0 million for the fiscal year ended September 30, 2017, an increase of $5.6 million, or 4.6%, compared to the combined fiscal year ended September 30, 2016. The increase in revenues was driven by a more effective pricing strategy.

Gross profit

Gross profit was $398.4 million for the fiscal year ended September 30, 2017, an increase from $380.3 million in the combined fiscal year ended September 30, 2016. The $18.1 million increase in gross profit was driven by the increase in average selling prices in our Chemicals line of business and Plastics volumes as discussed.

Gross profit was negatively affected in fiscal year 2017 by additional depreciation expense of approximately $6.8 million due to the step up in fair value of the property, plant and equipment as a result of the Business Combination, $1.0 million related to the inventory step up as a result of the Ultra Chem Acquisition and an impairment charge of $1.5 million recorded to Cost of sales and operating expenses in our consolidated income statement related to the three major hurricanes which adversely affected our facilities and inventory during the fourth quarter of fiscal year 2017. In addition, gross profit was negatively affected in fiscal year 2017 by the impact of weakening exchange rates of various currencies versus the USD of approximately $1.0 million and by an increase in common carrier transportation costs driven by driver shortages, and costs associated with recent federal mandates. Further, Plastics operations in North America were negatively impacted due to a supplier disruption which limited the availability to us during the fiscal year 2017 of certain products we distribute on a regular basis. In the prior period, gross profit included a one-time $13.8 million charge related to the inventory step up associated with the Business Combination

Chemicals

Gross profit was $205.6 million for the fiscal year ended September 30, 2017, an increase from $191.9 million in the combined fiscal year ended September 30, 2016. The $13.7 million increase in gross profit was due to the increase in average selling price as discussed and an increase in total Chemicals volume of 1.6%.

Gross profit was negatively affected in fiscal year 2017 by additional depreciation expense of approximately $4.9 million due to the step up in fair value of property, plant and equipment as a result of the Business Combination, $1.0 million related to the inventory step up as a result of the Ultra Chem Acquisition and an impairment charge of $1.3 million recorded to Cost of sales and operating expenses in our consolidated income statement related to the three major hurricanes which adversely affected our facilities in the fourth quarter of fiscal year 2017. Additionally, gross profit was negatively affected during fiscal year 2017 by an increase in common carrier transportation costs driven by driver shortages, and costs associated with recent federal mandates. In the prior period, gross profit included a one-time $6.0 million charge related to the inventory step up in basis associated with the Business Combination.

Plastics

Gross profit was $167.2 million for the fiscal year ended September 30, 2017, an increase from $161.2 million in the combined fiscal year ended September 30, 2016. The $6.0 million increase in gross profit was due to the increase in volumes as discussed.

52

Gross profit was negatively affected in fiscal year 2017 by additional depreciation expense of approximately $1.9 million due to the step up in fair value of the property, plant and equipment as a result of the Business Combination and by the impact of weakening exchange rates of various currencies versus the USD of approximately $0.8 million. Additionally, our North America revenues were negatively impacted in fiscal year 2017 due to a supplier disruption which limited the availability to us of certain products we distribute on a regular basis and by an increase in common carrier transportation costs driven by driver shortages, and costs associated with recent federal mandates. In the prior period, gross profit included a one-time $7.8 million charge related to the inventory step up associated with the Business Combination.

Other

Gross profit was $25.6 million for the fiscal year ended September 30, 2017, a decrease from $27.2 million compared to the combined fiscal year ended September 30, 2016. As compared to the combined fiscal year ended September 30, 2016, gross profit was negatively affected during fiscal year 2017 by an increase in common carrier transportation costs driven by driver shortages, and costs associated with recent federal mandates and a shift in service mix through the third quarter of fiscal year 2017 toward on-site services.

Selling, general and administrative expenses

     Selling, general and administrative expenses were $312.9 million for the fiscal year ended September 30, 2017, an increase of $12.3 million compared to the combined fiscal year ended September 30, 2016. The increase was attributable to higher depreciation and amortization expense of $8.1 million and higher employee costs of $10.5 million, partially offset by decreased foreign exchange losses of $2.1 million and a decrease in consulting costs of $3.2 million. The increase in depreciation and amortization expense was driven by the effect of the Business Combination of $5.2 million, as well as $2.0 million from the Ultra Chem Acquisition. The $10.5 million increase in employee costs was driven by an increase in stock compensation expense of $3.3 million, an increase in variable selling compensation of $3.0 million, certain reorganization expenses of approximately $1.7 million and additional employee cost of $1.6 million as a result of the Ultra Chem Acquisition, which were partially offset by cost management and productivity initiatives. Foreign exchange losses were primarily driven by fluctuations in the RMB to USD and Peso to USD.

Transaction related costs

We incurred transaction related costs of $1.9 million and $21.3 million for the fiscal years ended September 30, 2017 and 2016, respectively, and $33.4 million for the Predecessor period from October 1, 2015 through June 8, 2016. Transaction costs for the fiscal year ended September 30, 2017 were due to the Ultra Chem Acquisition. The combined fiscal year ended September 30, 2016 transaction costs were related to the Business Combination.

Changes in fair value of contingent consideration

The net loss of $16.2 million and a net gain of $11.2 million for the fiscal years ended September 30, 2017 and 2016, respectively, was related to the contingent consideration associated with the Deferred Cash Consideration and TRA from the Business Combination. See Notes 3 and 9 to our consolidated financial statements.

Other income, net

Other income, net for the fiscal year ended September 30, 2017 was $8.3 million due to the gain related to reimbursements of certain capital expenditures in connection with the relocation of certain operations. See Note 5 to our consolidated financial statements. Other income for the fiscal year ended September 30, 2016 was $0.5 million related to a $0.8 million reimbursement of certain capital expenditures in connection with the relocation of certain operations offset by a $0.2 million loss related to sale of property and equipment. Other income for the Predecessor period from October 1, 2015 through June 8, 2016 was $2.9 million, due to a gain of $2.0 million in the sale of old private fleet tractors under the Ryder Lease and a $0.6 million gain on the repurchase of $9.5 million of Notes.

53

Interest expense, net

Interest expense, net was $50.8 million and $14.3 million for the fiscal years ended September 30, 2017 and 2016, respectively, and $42.2 million for the Predecessor period from October 1, 2015 through June 8, 2016. Fiscal year 2017 interest expense is related to the Credit Facilities including the amortization of the costs associated with incurring the debt. Predecessor interest expense was related to the Predecessor Credit Facilities and the Notes, along with the amortization of the costs associated with issuing the debt. The decrease in the fiscal year ended September 30, 2017 compared to the combined fiscal year ended September 30, 2016 was due to the redemption of the Notes in connection with the Business Combination, which resulted in a decrease in debt balance and related weighted average interest rate.

Income tax expense

Income tax expense was $10.5 million and $1.2 million for the fiscal years ended September 30, 2017 and 2016, respectively. Fiscal year 2017 tax expense was largely attributable to profitable operations in Europe, Canada and the U.S as compared to profitable foreign operations in EMEA and Mexico in the combined fiscal year ended September 30, 2016. Income tax expense of $4.2 million for the Predecessor period from October 1, 2015 through June 8, 2016 was due to profitable foreign operations primarily in Canada, EMEA, Puerto Rico and Mexico. Income taxes for the Company are generally not comparable to the Predecessor as the Predecessor was organized as a limited liability company and taxed as a partnership for U.S. income tax purposes.

Liquidity and Capital Resources

Overview

Our primary sources of liquidity are cash flows generated from our operations and borrowing availability under the ABL Facility. Cash flows generated from operations are influenced by seasonal patterns of our business and other timing circumstances that can result in increases or decreases in working capital requirements for any given period during the course of our fiscal year. Our ability to generate sufficient cash flows from operating activities will continue to be primarily dependent on purchasing and distributing chemical and plastic materials. Additionally, our ability to generate cash flows in the normal course of business can be significantly influenced by changing global and regional macroeconomic conditions. Borrowing availability under the ABL Facility is subject to a borrowing base generally comprised of eligible inventory, accounts receivable and cash and cash equivalents held in certain accounts and certain subsidiaries. Our availability under the ABL Facility is, therefore, potentially subject to fluctuations, depending on the value of the eligible assets in the borrowing base on a given valuation date. An inability to borrow under the ABL Facility may adversely affect our liquidity, results of operations and financial condition.

Our operating cash requirements consist principally of inventory purchases, trade credit extended to customers, labor, occupancy costs and transportation and delivery costs. Non-operating cash requirements include debt service requirements, acquisition-related costs and capital expenditures.

 

Capital Expenditures

Cash capital expenditures were $18.6 million for fiscal year 2018, $27.6 million for fiscal year 2017, $12.7 million for fiscal year 2016 and $14.2 million for the Predecessor period October 1 through June 8, 2016 related primarily to facility improvements, equipment purchases and additional information technology investments. During the fiscal year ended September 30, 2017, we incurred capital expenditures in connection with the relocation of our leased facility in Montgomery, Illinois; however, reimbursements from the Illinois Tollway Authority resulted in net cash received of $8.4 million. We expect our aggregate capital expenditures for fiscal year 2019 (excluding acquisitions and any assets acquired via capital leases) to be approximately $39.5 million, including $10.8 million for a planned land acquisition at one of our facilities expected to close during the first half of fiscal year 2019. Capital expenditures are expected to be primarily related to fixed asset replacements, improvements to our information technology infrastructure and equipment.

54

We entered into the Montgomery Lease in the first quarter of fiscal year 2017 which is accounted for as a capital lease with an initial cost of $13.2 million. The Montgomery Lease has a term of 15 years, with annual payments beginning at $1.1 million per year. Our total capital lease obligations balance was $34.0 million as of September 30, 2018 and is primarily associated with the Ryder Lease and the Montgomery Lease. See Note 7 to our consolidated financial statements.

Credit Facilities

ABL Facility

The ABL Facility provides for committed revolving credit financing including a U.S. Tranche of up to $505.0 million, a Canadian Tranche of up to the USD equivalent of $40.0 million, and a FILO Tranche up to $30.0 million. The ABL Facility matures on June 9, 2021. Provided no default or event of default then exists or would arise therefrom, the ABL Borrowers have the option, at the beginning of each quarter, to request that the ABL Facility be increased by an aggregate amount, when included with any incremental borrowings issued under the Term Loan Facility, not to exceed $175.0 million.

The ABL Facility includes a letter of credit sub-facility, which permits up to $200.0 million of letters of credit under the U.S. Tranche (which may be denominated in USD, euros or other currencies approved by the administrative agent and the issuing bank) and up to the USD equivalent of $10.0 million of letters of credit under the Canadian Tranche (which may be denominated in CAD only). The ABL Facility also contains a FILO Tranche which can be used by any non-Canadian foreign subsidiary for loans or letters of credit up to an aggregate amount not to exceed $30.0 million.

Obligations under the ABL Facility are secured by a first priority lien on all ABL Facility first lien collateral, including eligible inventory and accounts receivable of the ABL Borrowers, and a second priority lien on all Term Loan Facility first lien collateral including outstanding equity interests of the Borrower and certain of the other subsidiaries of Holdings, in each case, subject to certain limitations; provided, that no ABL Facility first lien collateral or Term Loan Facility first lien collateral owned by the Canadian Borrower secure the obligations owing under the U.S. tranche of the ABL Facility.

At September 30, 2018, we had $104.6 million in borrowings outstanding under the ABL Facility. Interest expense related to the ABL Facility, excluding amortization of debt issuance costs, was $8.0 million and $6.7 million for the fiscal years ended September 30, 2018 and 2017, respectively.

As of September 30, 2018, we were in compliance with the covenants of the ABL Facility.

Term Loan Facility

The Term Loan Facility provides secured debt financing in an aggregate principal amount of up to $655.0 million and the right, at our option, to request additional tranches of term loans in an aggregate principal amount, when included with any incremental borrowings issued under the ABL Facility, amount up to $175.0 million, plus unlimited additional amounts such that the aggregate principal amount of indebtedness outstanding at the time of incurrence does not cause the consolidated Secured Net Leverage Ratio, calculated on a pro forma basis, to exceed 4.1 to 1.0. Availability of such additional tranches of term loans is subject to the absence of any default, and among other things, the receipt of commitments by existing or additional financial institutions. The Term Loan Facility matures on June 9, 2023.

On December 19, 2017, we completed TLB Amendment No. 2 amending the Term Loan Facility. TLB Amendment No. 2 reduced the interest rate margin applicable to outstanding term loans by 50 basis points from 3.75% to 3.25% for LIBOR loans and from 2.75% to 2.25% for base rate loans. TLB Amendment No. 2 also provides for a soft call premium equal to 1% of the amount of the term loans that are subject to certain repricing transactions occurring on or prior to twelve months from the effective date of TLB Amendment No. 2. As a result of TLB Amendment No. 2, we paid debt issuance costs of $0.8 million, which will be amortized throughout the remaining life of the Term Loan Facility. TLB Amendment No. 2 will result in an estimated $3.2 million reduction to our annual cash interest expense for each of the next five years, while all other terms of the Term Loan Facility remain unchanged.

55

Obligations under the Term Loan Facility are secured by a first priority lien on all Term Loan Facility first lien collateral, including outstanding equity interests of the Borrower and certain of the other subsidiaries of Holdings, and a second priority lien on all ABL Facility first lien collateral, including accounts receivable and inventory of the loan parties under the Term Loan Facility, subject to certain limitations.

At September 30, 2018, we had $640.4 million in borrowings outstanding under the Term Loan Facility. We are required to make mandatory principal payments on an annual basis, if cash flows for the year, as defined in the agreement, exceed certain levels specified in the agreement. We were not required to make such principal payment for fiscal year 2018. Interest expense related to the Term Loan Facility, excluding original issue discount amortization and amortization of debt issuance costs was $34.2 million and $33.6 million for the fiscal years ended September 30, 2018 and 2017, respectively.

At September 30, 2018, we were in compliance with the covenants of the Term Loan Facility.

Predecessor Credit Facilities

In addition to cash flows generated from its operations, the Predecessor’s sources of liquidity included borrowings under the Predecessor Credit Facilities. The Predecessor’s ABL Facility was scheduled to mature on July 11, 2017 and the Predecessor Term Loan Facility was scheduled to mature on September 9, 2017. As of the Closing Date, the Predecessor was in compliance with the covenants of the Predecessor Credit Facilities. In connection with the completion of the Business Combination, a principal payment of $617.5 million was made and all of the Predecessor’s outstanding indebtedness and other obligations under the Predecessor Credit Facilities were fully discharged.

Predecessor Senior Subordinated Notes due 2018

The Notes were scheduled to mature on March 1, 2018. Effective as of the Closing Date, the Issuers redeemed all of the approximately $149.7 million principal amount of the Notes outstanding at a redemption price equal to 100% of the principal amount (plus accrued and unpaid interest up to, but not including the Closing Date). The Issuers and the guarantors under the Notes have been released from their respective obligations under the Notes and the Indenture governing the Notes, effective as of the Closing Date. As of the Closing Date, the Predecessor was in compliance with the covenants of the indenture governing the Notes.

Working Capital

Our Chemicals and Plastics lines of business generally require significant working capital to purchase products from suppliers and sell those materials to our customers. The primary components of our working capital accounts are accounts receivable, inventories, accounts payable, accrued expenses and other liabilities and current portion due to related party pursuant to contingent consideration obligations. Working capital balances were $484.6 million and $457.8 million as of September 30, 2018 and 2017, respectively. The variance was primarily driven by higher inventory balances associated with the inflationary environment at the end of the current fiscal year 2018.

As discussed under "—Proprietary Operating Systems," we generally manage working capital by utilizing our ERP system, which enables us to forecast rolling weekly volumes, anticipate demand shift fluctuations and quickly respond to rapidly changing customer needs for the majority of our operations. This platform, combined with our product line management department as further described in "—Supplier Relationships—Product Line Management and Purchasing," enables us to efficiently manage working capital. We further manage working capital by focusing on terms of purchase and sale, evaluating the creditworthiness of customers when extending trade credit, utilizing systematic collection efforts and managing inventory to closely match demand and meet required customer service levels.

56

Liquidity

The following table summarizes our liquidity position as of September 30, 2018 and September 30, 2017:

	September 30, 2018		September 30, 2017
Cash and cash equivalents	$	58.9	$	53.9
ABL Facility availability	344.2		277.8
Total liquidity	$	403.1	$	331.7

Cash and Cash Equivalents

At September 30, 2018, we had $58.9 million in cash and cash equivalents of which $52.9 million was held by foreign subsidiaries, $48.8 million of which was denominated in currencies other than the USD, primarily in euros and CAD, and $6.5 million in China denominated in RMB. While the RMB is convertible into USD, foreign exchange transactions are subject to approvals from the SAFE. We do not anticipate any significant adverse impact to overall liquidity from potential limitations on the transfer or conversion of cash and cash equivalents.

ABL Facility

Under the ABL Facility, if as of any date of determination when Trigger Event Excess Availability (as defined in the ABL Facility) is below certain thresholds or upon certain defaults, we will be required to deposit cash on a daily basis from certain depository accounts in a collection account maintained with the administrative agent, which will be used to repay outstanding loans and cash collateralized letters of credit. Such requirement will be deemed continuing until the Trigger Event Excess Availability exceeds such threshold amount for 20 consecutive days. At September 30, 2018, Trigger Event Excess Availability under the ABL Facility was $344.2 million, which was $49.8 million in excess of the $294.4 million threshold that would trigger the foregoing requirements.

As previously described, the Univar Merger Agreement contains customary covenants which restrict us without Univar's consent, from taking certain specified actions until the proposed transaction closes or the Univar Merger Agreement terminates. One such restriction limits us from incurring any additional indebtedness (as defined in the Univar Merger Agreement) in excess of $150.0 million in aggregate principal amount over the amount outstanding under the Credit Facilities as in effect as of the date of execution of the Univar Merger Agreement.

Based on current and anticipated levels of operations, capital spending projections and conditions in our markets, we believe that cash on hand, together with cash flows from operations and borrowings available under the ABL Facility (after taking into account the limitation noted above), are adequate to meet our working capital and capital expenditure needs as well as any debt service and other cash requirements for at least twelve months.

In addition to operating and non-operating cash requirements previously described, our longer-term liquidity needs are primarily related to our final maturity debt payments due in 2021 and 2023. Depending on market conditions and other factors, we may also consider alternative financing options, including, but not limited to, issuance of equity, issuance of debt or refinancing of our existing debt obligations.

57

Cash Flows

The following table sets forth the major categories of our cash flows for the fiscal years ended September 30, 2018, 2017 and 2016 and of the Predecessor for the period October 1, 2015 through June 8, 2016.

Major Categories of Cash Flows	Successor									Predecessor
	Fiscal Year Ended September 30, 2018			Fiscal Year Ended September 30, 2017			Fiscal Year Ended September 30, 2016*			October 1, 2015 through June 8, 2016
(in millions)
Net cash provided by operating activities from continuing operations	$	88.7		$	78.6		$	3.2		$	69.5
Net cash provided by operating activities from discontinued operations	—			—			—			0.1
Net cash provided by operating activities	88.7			78.6			3.2			69.6
Net cash provided by (used in) investing activities	(26.2		)	(84.2		)	133.0			(11.8		)
Net cash provided by (used in) financing activities	(57.4		)	11.8			(88.9		)	(121.5		)
Effect of exchange rate changes on cash and cash equivalents	(0.1		)	0.2			—			0.3
Increase (decrease) in cash and cash equivalents	5.0			6.4			47.3			(63.4		)
Cash and cash equivalents at the beginning of the period	53.9			47.5			0.2			127.7
Cash and cash equivalents at the end of the period	$	58.9		$	53.9		$	47.5		$	64.3

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

Fiscal Year Ended September 30, 2018 Compared to Fiscal Year Ended September 30, 2017, Fiscal Year Ended September 30, 2016 and Period October 1, 2015 through June 8, 2016 (Predecessor)

Cash flows from operating activities

Net cash provided by operating activities for the fiscal year ended September 30, 2018 was $88.7 million. Net income of $29.4 million, adjusted for the gain from sales of property and equipment, and significant non-cash items such as depreciation and amortization expenses, amortization of debt issuance costs, provision for bad debt, deferred income taxes, equity-based compensation expense and changes relating to contingent consideration liabilities collectively totaling $88.5 million, resulted in cash inflows of $117.9 million during the fiscal year ended September 30, 2018. Net cash provided by operating activities was impacted by the items specified below:

• Accounts and notes receivable increased $16.8 million, primarily driven by higher average selling price due to an inflationary pricing environment in the current fiscal year. There were no significant changes in billing terms or collection processes during the current fiscal year.

• Inventories increased $25.8 million primarily due to the inflationary environment.

• Accounts payable decreased $2.0 million, primarily driven by the timing of payments during the current fiscal year.

• Accrued expenses and other liabilities increased $12.3 million, which included the accrual of our annual employee incentive compensation, which was partially offset by a decrease in other current assets of $2.0 million.

• Other assets and liabilities contributed $1.1 million.

58

Net cash provided by operating activities for the fiscal year ended September 30, 2017 was $78.6 million. Net income of $14.4 million, adjusted for the gain related to reimbursement for certain capital expenditures incurred in connection with the relocation of certain operations, and significant non-cash items such as depreciation and amortization expenses, amortization of debt issuance costs, impairment charge due to natural disasters, deferred income taxes, equity-based compensation expense, and changes relating to contingent consideration liabilities collectively totaling $94.5 million, resulted in $108.9 million of cash inflow during the fiscal year ended September 30, 2017. Net cash provided by operating activities was impacted by the items specified below:

• Accounts and notes receivable increased $101.9 million, primarily driven by higher sales volumes and rising average selling prices experienced during the current fiscal year, as well as timing of collections at period end. There were no significant changes in billing terms or collection processes during the current fiscal year.

• Inventories decreased $14.4 million due to higher sales volumes in the fourth quarter of fiscal year 2017.

• Accounts payable increased $43.7 million, primarily driven by higher volumes and purchase prices during the period.

• Accrued expenses and other liabilities increased $6.1 million, which included the accrual of our annual employee incentive compensation, which was partially offset by a decrease in other current assets of $5.6 million.

• Other assets and liabilities contributed $1.8 million to net cash provided by operating activities.

Net cash provided by operating activities for the fiscal year ended September 30, 2016 was $3.2 million, based on a 114 day operating period. Net loss of $8.4 million, adjusted for loss on sale of property and equipment and significant non-cash items such as depreciation and amortization expenses, debt issuance costs amortization, transaction costs paid in stock, equity-based compensation, and changes relating to contingent consideration liabilities, deferred income taxes, provision for bad debt and reimbursement for certain capital expenditures incurred in connection with eminent domain proceeding, collectively totaling $23.0 million, provided $14.6 million of cash inflow during the fiscal year ended September 30, 2016. Net cash provided by operating activities was impacted by the items specified below:

• Accounts and notes receivable increased $5.0 million, primarily driven by the timing of collections on accounts receivable during the fiscal year ended September 30, 2016. There were no significant changes in billing terms or collection processes during the fiscal year ended September 30, 2016.

• Accounts payable and accrued expenses decreased $19.4 million, driven primarily by payment of approximately $29.4 million of transaction costs accrued by the Predecessor at the time of the closing of the Business Combination, partially offset by the timing of payments.

• Inventories decreased $12.5 million primarily due to $13.8 million of fair value adjustment to inventory as result of the Business Combination, partially offset by a shift in inventory mix towards higher value plastics products.

Net cash provided by operating activities for the Predecessor period from October 1, 2015 through June 8, 2016 was $69.5 million, based on a 252 day operating period. Net loss of $13.9 million, adjusted for gain on sale of property and equipment and significant non-cash items such as depreciation and amortization expenses, debt issuance costs, bad debt, equity-based compensation, deferred income taxes and gain on debt extinguishment, collectively totaling $46.2 million, resulted in $32.3 million of cash inflow for the period from October 1, 2015 through June 8, 2016. Net cash provided by operating activities was impacted by the items specified below:

• Accounts and notes receivable decreased $34.4 million. The decrease in accounts and notes receivable was driven primarily by lower sales volumes and falling selling prices experienced during the period from October 1, 2015 through June 8, 2016 as well as timing of collections at period end. There were no significant changes in billing terms or collection processes during the period from October 1, 2015 through June 8, 2016.

59

• Accounts payable, accrued expenses and other liabilities increased $3.7 million driven primarily by transaction costs for the Business Combination.

• Inventories decreased $8.4 million which reflected the impact of lower prices for inventory purchases as well as improved inventory management.

• Other current assets and other operating assets and liabilities were impacted by $9.0 million.

Cash flows from investing activities

Investing activities used $26.2 million of cash during the fiscal year ended September 30, 2018, primarily due to the additions of property and equipment of $18.6 million primarily related to facility improvements, equipment purchases and additional information technology investments and the cash paid for asset acquisitions of $11.0 million, partially offset by $3.4 million of proceeds from the disposal of property and equipment.

Investing activities used $84.2 million of cash during the fiscal year ended September 30, 2017, primarily due to $65.6 million paid to effect asset and business acquisitions, and $27.6 million for additions of property and equipment primarily related to facility improvements and additional information technology investments, partially offset by $8.4 million of cash proceeds related to the reimbursement for certain capital expenditures incurred in connection with the relocation of certain operations.

Investing activities provided $133.0 million of cash during the fiscal year ended September 30, 2016, primarily due to $501.1 million withdrawn from the trust account offset by $360.6 million, net of cash acquired, and the addition of property and equipment of $12.7 million, primarily related to facility improvements and information technology investments. These expenditures were partially offset by net proceeds from the sale of assets of $4.7 million and the reimbursement of $0.5 million received for certain equipment under an eminent domain proceeding related to one of our facilities.

Investing activities used $11.8 million of cash for the Predecessor period from October 1, 2015 through June 8, 2016, primarily due to capital expenditures of $14.2 million, related primarily to facility improvements, additional information technology investments and vehicle additions. These expenditures were partially offset by net proceeds from the sale of assets of $2.4 million.

Cash flows from financing activities

Financing activities used $57.4 million of cash during the fiscal year ended September 30, 2018, primarily as a result of net payments on the ABL Facility of $34.7 million, net payments on short-term debt of $1.5 million, payments on the Term Loan Facility of $6.5 million, capital lease payments of $3.7 million, and the payment of debt issuance costs of $0.8 million related to TLB Amendment No. 2. In addition, $10.2 million was paid to TPG related to the TRA liability.

Financing activities provided $11.8 million of cash during the fiscal year ended September 30, 2017, primarily as a result of net borrowings on the ABL Facility of $21.1 million and net borrowings on short-term debt of $1.3 million, partially offset by payments on the Term Loan Facility of $6.5 million, capital lease payments of $2.8 million, and the payment of debt issuance costs of $1.3 million related to TLB Amendment No. 1. Net borrowings on the ABL Facility included approximately $58.0 million drawn for the closing of the Ultra Chem Acquisition at the Ultra Chem Closing Date.

Financing activities used $88.9 million of cash during the fiscal year ended September 30, 2016, primarily as a result of repaying Predecessor long-term debt of $767.3 million, repayment of long-term debt of $205.4 million and the payment of debt issuance costs of $25.3 million. These were offset by the issuance of long-term debt of $972.5 million and proceeds of short-term debt of $13.3 million. The Company also issued common stock as consideration for the Business Combination of $234.9 million and redeemed stock of $298.5 million.

Financing activities used $121.5 million of cash for the Predecessor period from October 1, 2015 through June 8, 2016, primarily as a result of repaying long-term debt and capital leases of $417.3 million and the repayment of short-term debt of $17.1 million. These were offset by the issuance of long-term debt of $292.1 million and proceeds of short-term debt of $20.9 million.

60

Contractual Obligations and Commitments

At September 30, 2018, amounts due under our contractual commitments were as follows:

	Payments Due by Period (in millions)
	Less than  1 Year		1-3 Years		4-5 Years		More  than 5  Years		Total
Short-term and long-term debt obligations (1)	$	44.5	$	117.5	$	621.0	$	—	$	783.0
Estimated interest payments on long-term debt obligations (2)	42.8		83.0		62.8		—		188.6
Capital lease obligations (3)	7.6		14.3		17.3		25.4		64.6
Operating lease obligations (4)	14.1		16.0		8.0		0.3		38.4
Employee benefit obligations	—		—		—		3.5		3.5
Contingent consideration (5)	16.3		94.5		17.5		66.4		194.7
Other obligations (6)	10.6		2.5		1.4		1.2		15.7
Total	$	135.9	$	327.8	$	728.0	$	96.8	$	1,288.5

⁽¹⁾  Short-term obligations primarily include the payment of $38.1 million outstanding under credit facilities available to our operations in China and $6.4 million in principal installment payments under our Term Loan Facility. Long-term debt obligations include (i) the payment of $104.6 million in outstanding principal (as of September 30, 2018) under our ABL Facility and (ii) the payment of $634.0 million in outstanding principal under our Term Loan Facility. See Note 7 to our consolidated financial statements.

⁽²⁾  Estimated interest payments include cash interest payments and estimated commitment fees on long-term debt obligations. Variable interest rate payments were estimated using interest rates as of September 30, 2018 held constant to maturity.

⁽³⁾  Capital lease obligations represent future payments on capital lease agreements, including lease payments on all tractors under the Ryder Lease and the Montgomery Lease. The amounts above include executory costs of approximately $2.4 million per year, for aggregate executory costs totaling $15.1 million. Additionally, the amounts include decreasing annual interest payments ranging from $2.0 million to $0.1 million, for aggregate interest payments totaling $15.5 million on all capital leases. We are permitted to terminate the lease of an individual tractor under the Ryder Lease on the anniversary of its delivery date, provided that certain conditions are met. In the event we terminate the lease of an individual tractor in accordance with the terms of the Ryder Lease, we may elect to purchase the individual tractor at a predetermined residual value or return the tractor to Ryder, subject to an adjustment based on the then-current market value of the individual tractor. See Note 7 to our consolidated financial statements.

⁽⁴⁾  Operating lease obligations represent payments for a variety of facilities and equipment under non-cancellable operating lease agreements, including office buildings, transportation equipment, warehouses and storage facilities and other equipment.

⁽⁵⁾  Liabilities for contingent consideration are related (i) to the TRA that we entered into in connection with the Business Combination and (ii) the Deferred Cash Consideration that will be paid to Selling Equityholders pursuant to the Merger Agreement. The amount included in the table above for the Deferred Cash Consideration is based on the undiscounted expected value of the payment and is currently included in the 1-3 Years column based on the final payment date of June 9, 2021 as defined in the Merger Agreement. However, as further defined in the Merger Agreement, payments could be required to be made by us prior to June 9, 2021. The timing of payments associated with the liability for the contingent consideration related to the TRA is based on expected undiscounted cash flows in future periods, and may change based on actual results. See Notes 3 and 9 to our consolidated financial statements.

⁽⁶⁾  Other obligations are related to (i) non-cancellable equipment orders, (ii) certain IT-related contracts and (iii) remaining payments related to the asset acquisitions. (See Note 3 to our consolidated financial statements).

Not included in the table above is $10.8 million for a planned land acquisition expected to be finalized during the first half of fiscal year 2019. The consummation of this purchase agreement is subject to customary closing conditions.

61

Off Balance Sheet Arrangements

We had no off balance sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K at September 30, 2018.

Critical Accounting Policies and Estimates

Our consolidated financial statements reflect a number of significant estimates that impact the carrying values of assets and liabilities and reported amounts of revenue and expenses. We make these estimates based on historical experience and on other judgments and assumptions that we believe are reasonable under the circumstances. The results of these estimates, judgments and assumptions form the basis for our determinations as to the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

We consider an accounting policy to be critical when it requires the most difficult, subjective and/or complex judgments by management regarding estimates about matters that are highly uncertain. We believe that the following critical accounting policies reflect our most significant estimates and assumptions used in the preparation of our consolidated financial statements.

Revenue Recognition

Revenues are recognized when persuasive evidence of an arrangement exists, products are shipped and title is transferred or services are provided to customers, the sales price is fixed or determinable and collectability is reasonably assured. Revenue for product sales is recognized at the time title and risk of loss transfer to the customer, based on the terms of the sale. For products delivered under our standard shipping terms, title and risk of loss transfer when the product is delivered to the customer’s delivery site. For sales transactions designated Freight on Board shipping point, the customer assumes risk of loss and title transfers at the time of shipment. Deferred revenues may result from (i) delivery delays for products delivered under our standard shipping terms or (ii) from bill and hold or other arrangements with our customers. Sales are reported net of tax assessed by qualifying governmental authorities. 

We are generally the primary obligor in sales transactions with our customers, retain inventory risk during transit and assume credit risk for amounts billed to our customers. Accordingly, we recognize revenue primarily based on the gross amount billed to our customers. In sales transactions where we are not the primary obligor and do not retain inventory risk, we recognize revenue on a net basis by recognizing only the commission we retain from such sales and including that commission in sales and operating revenues in our consolidated statements of operations. 

Consistent with industry standards, we may offer volume-based rebates to large customers if the customer purchases a specified volume with us over a specified time period. The determination of these rebates at interim dates involves management judgment. As a result, our revenues may be affected if a customer earns a rebate toward the end of a year that we had not expected or if our estimate of customer purchases are less than expected. We have the experience and the access to relevant information that we believe is necessary to reasonably estimate the amounts of such deductions from gross revenues. We regularly review information related to these estimates and adjust our reserves accordingly if and when actual experience differs from previous estimates. We recognize the rebate obligation as a reduction of revenue based on the estimate of the total volume of purchases from a given customer over the specified period of time.

62

Impairment of Long-lived Assets

Goodwill. Goodwill is tested for impairment annually as of March 31st and whenever events or circumstances indicate that it is more likely than not that an impairment may have occurred. Goodwill is reviewed for impairment at the reporting unit level, which is defined as operating segments or groupings of businesses one level below the operating segment level. Our operating segments are the same as the reporting units used in our goodwill impairment test. Relevant accounting guidance allows the consideration of qualitative factors to determine if it is more likely than not that an impairment of goodwill has occurred. In the absence of sufficient qualitative factors, goodwill is tested for impairment by comparing the fair value of a reporting unit (determined using a market approach if market prices are available, or alternatively, a discounted cash flow model) with its carrying value. If the fair value of the reporting unit exceeds its carrying value, the goodwill of the reporting unit is not considered impaired. If the fair value of the reporting unit is less than its carrying value, an impairment loss is recorded for the difference. The determination of the fair value of a reporting unit requires the use of key estimates about its future operating results, valuation multiples, discount rates and terminal growth rates. These key assumptions can change due to many factors and these changes can materially affect the fair value estimate and cause us to re-evaluate the carrying value of our goodwill. Once an impairment of goodwill has been recorded, it cannot be reversed.

Other Long-Lived Assets. Property, plant and equipment and other intangibles with definite lives are tested for impairment whenever events and circumstances indicate that the carrying value of an asset may not be recoverable. When an impairment test is performed and the undiscounted expected future cash flow is less than the carrying value, an impairment loss is recognized equal to an amount by which the carrying value exceeds the fair value of the asset. The factors considered by management in performing this assessment include current operating results, trends and prospects, as well as the effect of obsolescence, demand, competition and other economic factors.

Contingencies and Environmental Costs

Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of such liability can be reasonably estimated. Gain contingencies are not recorded until management determines it is certain that the future event will become or does become a reality.

Liabilities for environmental remediation costs are recognized when environmental assessments or remediation are probable and the associated costs can be reasonably estimated. Generally, the timing of these provisions coincides with the commitment to a formal plan of action or, if earlier, the divestment or closure of the relevant site. Environmental reserves are subject to numerous uncertainties that affect our ability to accurately estimate costs, or our share of costs if multiple parties are responsible. These uncertainties involve the legal, regulatory and enforcement parameters governing environmental assessment and remediation, the nature and extent of contamination at the site, the extent of required remediation efforts, the choice of remediation methodology, availability of insurance coverage and, in the case of a site with multiple responsible parties, the number and financial strength of other potentially responsible parties.

Under the ADA Purchase Agreement, Ashland agreed to retain the Retained Remediation Liabilities. Ashland’s obligation for these liabilities is not subject to any claim thresholds or deductibles. However, Ashland’s indemnification obligations under the ADA Purchase Agreement as described above terminated as of March 31, 2016, other than for the Retained Remediation Liabilities. As a result, any environmental remediation liabilities reported to Ashland after March 31, 2016 and not arising out of a Retained Remediation Liability will be liabilities of the Company. In addition, the Company is obligated to indemnify Ashland for any remediation liabilities other than the Retained Remediation Liabilities.

Based on the indemnification discussed above, we do not currently have any environmental or remediation reserves for matters that are covered by the ADA Purchase Agreement. If any Retained Specified Remediation Liability ultimately exceeds the liability ceilings described above, we would be responsible for such excess amounts. In addition, we are responsible for liabilities associated with our operation of the business, we would be required to take appropriate environmental or remediation reserves.

See Note 13 to our consolidated financial statements.

63

Business Combinations

In accounting for business combinations, the purchase price paid to acquire a business is allocated to its assets and liabilities based on the estimated fair values of the assets acquired and liabilities assumed as of the date of acquisition. These fair values are often estimated through the application of the income approach which requires us to estimate future cash inflows and outflows and apply an appropriate discount rate. The excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired is recorded as goodwill. A significant amount of judgment is involved in estimating the individual fair values of property, plant and equipment and identifiable intangible assets. The estimated fair values assigned to the net assets acquired could have a significant effect on our results of operations in the future. The estimates used in determining fair values are based on assumptions believed to be reasonable but which are inherently uncertain. Accordingly, while we use all available information to make these fair value determinations and generally engage third party consultants for assistance, actual results may differ from the projected results used to determine fair value. During fiscal year 2016, we completed the Business Combination and during fiscal year 2017 we completed the Ultra Chem Acquisition. See Note 3 to our consolidated financial statements.

Contingent Consideration Obligations

As described in Note 3, as part of the consideration for the Business Combination, we entered into the TRA and agreed to pay the Deferred Cash Consideration pursuant to the Merger Agreement.  Our obligation for these contingent consideration amounts was initially measured at fair value as of the Closing Date.  Our contingent consideration liabilities are required to be recorded at fair value as of the end of each reporting period with any changes in fair value recorded in operating income.

Changes in the estimates and inputs used in determining the fair value of the contingent consideration could have a material impact on the amounts recognized. The calculation of the liability for contingent consideration related to the TRA uses a discounted cash flow model which is sensitive to current interest rates and other market components incorporated in the discount rate. Additionally, this cash flow model is sensitive to changes in prevailing tax rates. The liability for the contingent consideration related to the Deferred Cash Consideration is highly sensitive to the price of our common stock at each valuation date. See "Item 7A. Quantitative and Qualitative Disclosures about Market Risk" and Note 9 to our consolidated financial statements.

Share-Based Compensation

We account for share-based compensation expense for equity instruments granted in exchange for employee and director services.  Share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as expense over the vesting period of the equity award grant.

Our PSU awards contain both market and performance-based conditions.  At the grant date, market conditions are incorporated into the fair value measurement using a Monte Carlo simulation model under the assumptions that performance-based conditions are met and not met.  We then determine the probability that performance-based conditions will be met and incorporate this into the grant date fair value of the award.

The compensation cost for the PSU awards is amortized over the vesting period on a straight-line basis, net of estimated forfeitures.  Forfeiture rates are estimated based on consideration of historical forfeitures of our and the Predecessor’s actual forfeitures of share-based compensation awards and a peer group of companies.

Supplier Rebates

Certain of our vendor arrangements provide for purchase incentives based on us achieving a specified volume or dollar value of purchases. We record the incentives as a reduction of inventory costs (and related cost of sales) based on our purchases to date and our estimates of purchases for the remainder of the calendar year. The determination of these rebates at interim dates involves management judgment. As a result, our cost of sales may be affected if we earn an incentive toward the end of a year that we had not expected to earn in earlier periods or if we fail to earn an incentive that we had expected to earn and had recorded the incentive based on our prior estimates.

64

Deferred Taxes

We recognize deferred tax assets and liabilities for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts using enacted tax rates in effect for the year differences are expected to reverse.

The recoverability of deferred tax assets and the recognition and measurement of uncertain tax positions are subject to various assumptions and judgment by us. If actual results differ from the estimates made by us in establishing or maintaining valuation allowances against deferred tax assets, the resulting change in the valuation allowance would generally impact earnings or other comprehensive income depending on the nature of the respective deferred tax asset. Additionally, the positions taken with regard to tax contingencies may be subject to audit and review by tax authorities, which may result in future taxes, interest and penalties.

In determining the recoverability of deferred tax assets, we give consideration to all available evidence on a jurisdiction by jurisdiction basis, and then increase or decrease our valuation allowance as appropriate.

Recent Accounting Pronouncements

See Note 2 to our consolidated financial statements.

65

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

Commodity and Product Price Risk

Our business model is to buy and sell products at current market prices in quantities approximately equal to estimated customer demand. Energy costs are a significant component of raw materials that are included in our product costs. Rising or volatile raw material prices for our suppliers, especially those of hydrocarbon derivatives, may cause our costs to increase or may result in volatility in our profitability. Although we do not speculate on changes in the prices of the products we sell, because we maintain inventories in order to serve the needs of our customers, we are subject to the risk of reductions in market prices for products we hold in inventory. We do not use derivatives to manage our commodity price risk because of the large number of products we sell and the large variety of raw materials used in the production of those products. Inventory management practices are focused on managing product price risk by generally purchasing our inventories via our ERP system which helps us forecast customer demand based on historical practices. Global inventory balances can fluctuate based on variations in regional customer demand forecasts. We collaborate directly with customers in all regions to enhance the ongoing accuracy of these forecasts in order to reduce the number of days sales held in inventories, as well as lower the amount of any slow moving and older inventories. In addition, we are generally able to pass on price increases to our customers, subject to market conditions, such as declining or otherwise volatile market prices for feedstocks, the presence of competitors in particular geographic and product markets and prevailing pricing mechanisms in customer contracts. We believe that these risk management practices reduce our exposure to changes in product selling prices or costs; however, significant unanticipated changes in market conditions or commodity prices could adversely affect our results of operations, financial condition and cash flows, as the prices of the products we purchase and sell are volatile.

Credit Risk

We are subject to the risk of loss arising from the credit risk related to the possible inability of our customers to pay for the products we resell and distribute to them. We attempt to limit our credit risk by monitoring the creditworthiness of our customers to whom we extend credit and establish credit limits in accordance with our credit policy. We perform credit evaluations on substantially all customers requesting credit and we will not extend credit to customers for whom we have substantial concerns and will deal with those customers on a cash basis. With the exception of our operations in China, we generally do not require collateral with respect to credit extended to customers. Our operations in China offer billing terms that allow certain customers to remit payment during a period of time ranging from 30 days to nine months. These notes receivable ($8.6 million at September 30, 2018) are supported by banknotes issued by large banks in China on behalf of these customers.

At September 30, 2018, no individual customer represented greater than 5.0% of the outstanding accounts receivable balance.

Interest Rate Risk

Interest rate risks can occur due to changes in market interest rates. This risk results from changes in the fair values of fixed-interest rate financial instruments or from changes in the cash flows of variable interest rate financial instruments. The optimal structure of variable and fixed interest rates is determined as part of interest rate risk management. It is not possible to simultaneously minimize both kinds of interest rate risk. We take steps to mitigate interest rate risk in part by entering into interest rate swap agreements as described under “Fair Value Measurements” below. Also, see Note 8 to our consolidated financial statements.

Borrowings under our ABL Facility bear a variable interest rate, which was a weighted average rate of 3.26% for the fiscal year ended September 30, 2018. For each $100.0 million drawn on the ABL Facility, a 100 basis point increase in the interest rate would result in a $1.0 million increase in annual interest expense.

On December 19, 2017, we completed TLB Amendment No. 2 amending the Term Loan Facility. TLB Amendment No. 2 reduced the interest rate margin applicable to outstanding term loans by 50 basis points from 3.75% to 3.25% for LIBOR loans and from 2.75% to 2.25% for base rate loans. TLB Amendment No. 2 also provides for a soft call premium equal to 1% of the amount of the term loans that are subject to certain repricing transactions occurring on or prior to twelve months from the effective date of TLB Amendment No. 2.

66

Changes in market interest rates will have an effect on the Term Loan Facility interest expense. A 100 basis point increase/decrease in the interest rate would result in an increase/decrease of $6.4 million in annual interest expense based on the Term Loan Facility balance.

See Note 7 to our consolidated financial statements for more information on the ABL Facility and Term Loan Facility.

Fair Value Measurements

Contingent Consideration

As a result of the Business Combination, we incurred liabilities related to contingent consideration payable to the Selling Equityholders, which are required to be adjusted to fair value at each reporting period. These measurements are considered Level 3 measurements within the fair value hierarchy. Projected taxable income, current interest rates, current tax rates and the market price of our common stock are key inputs used to estimate the fair value of these liabilities. As a result, any changes in these inputs will impact the fair value of these liabilities and could materially impact the amount of income or expense recorded each reporting period.

The fair value of the liability for the contingent consideration related to the TRA was $74.8 million as of September 30, 2018.  The calculation of the liability for the contingent consideration related to the TRA uses a cash flow model which incorporates current interest rates in the discount rate used to discount the obligation to present value.  A 100 basis point increase in the discount rate compared to the discount rate used at the September 30, 2018 valuation would have resulted in a decrease of approximately $0.6 million in the value of the liability for the contingent consideration related to the TRA. Additionally, this cash flow model is sensitive to changes in applicable tax rates. A 100 basis point decrease in the tax rate compared to the tax rate used at the September 30, 2018 valuation would have resulted in an increase of approximately $2.6 million in the value of the liability for the contingent consideration related to the TRA.

The fair value of the liability for the contingent consideration related to Deferred Cash Consideration was $62.7 million as of September 30, 2018. The liability for the contingent consideration related to the Deferred Cash Consideration is highly sensitive to the price of our common stock at each valuation date. A $1.00 increase/decrease in the price of our common stock from its September 30, 2018 price would have increased/decreased the fair value of the liability for the Deferred Cash Consideration by approximately $5.1 million.

Derivatives

During the three months ended March 31, 2018, we entered into three interest rate swap agreements with a combined notional amount of $300.0 million to help mitigate interest rate risk related to the variable rate Term Loan Facility. During the three months ended March 31, 2017, we entered into four interest rate swap agreements with a combined notional amount of $300.0 million to help mitigate interest rate risk related to the variable rate Term Loan Facility. The swap agreements expire at various dates from February 2020 through February 2023 and are accounted for as cash flow hedges. Gains or losses resulting from changes in the fair value of the swaps are recorded in other comprehensive income. Gains and losses recorded in other comprehensive income are reclassified into and recognized in income when the interest expense on the Term Loan Facility is recognized. The interest rate swaps continue to be accounted for as cash flow hedges and there was no material ineffectiveness related to the swaps after the modification of the terms described above. At September 30, 2018, we recorded a net asset of $10.2 million in the consolidated balance sheet related to these instruments.

During the fiscal year ended September 30, 2018, we reclassified into income and recognized a realized loss on the interest rate swaps of $1.2 million, which was recorded in interest expense. During the fiscal year ended September 30, 2018, we recorded an unrealized gain of $8.1 million on the interest rate swaps (net of taxes and reclassifications into income, including any ineffective portion), which was recorded in other comprehensive income. As of September 30, 2018, $2.8 million in unrealized gains were expected to be realized and recognized in income within the next twelve months.

Changes in market interest rates will impact the amount we ultimately pay or receive related to these swap agreements. A 100 basis point increase or decrease in market interest rates would result in a $6.0 million annual change in the amount we receive or pay, respectively, in connection with these swap agreements.

67

Foreign Currency Risk

We may be adversely affected by foreign exchange rate fluctuations since we conduct our business on an international basis in multiple currencies. A portion of our sales and costs of sales are denominated in currencies other than the functional currency of our subsidiaries, exposing us to currency transaction risk.  Additionally, because we report our consolidated results in USD, the results of operations and the financial position of our local international operations, which are generally reported in the relevant local currencies, are translated into USD at the applicable exchange rates for inclusion in our consolidated financial statements, exposing us to currency translation risk.  Further, we have exposure to foreign exchange fluctuations arising from the remeasurement of certain foreign operations where the USD is the functional currency but accounting records are kept in local currency. In this respect, we are vulnerable to currency remeasurement gains and losses to the extent that monetary assets and liabilities denominated in local currency do not offset each other when remeasured into USD.

We currently do not utilize financial derivatives to manage our foreign currency risk, but we continue to monitor our exposure to foreign currency risk, employ operational strategies where practical and may consider utilizing financial derivatives in the future to mitigate losses associated with these foreign currency risks.

Included in our consolidated statement of operations for the fiscal year ended September 30, 2018 is a $1.1 million net loss related to foreign exchange rate fluctuations. The most significant currency exposures during this period were to the RMB, CAD and Peso versus the USD. These currencies fluctuated to various degrees but such fluctuations did not exceed 5% from their respective values since September 30, 2017. Assuming the same directional fluctuations as occurred during the fiscal year ended September 30, 2018, a hypothetical 10.0% weakening/strengthening in the average exchange rates of these currencies from that date would have generated a net loss/gain of $0.3 million in our consolidated statement of operations for the fiscal year ended September 30, 2018.

68

Item 8. Financial Statements and Supplementary Data

Report of Independent Registered Public Accounting Firm	70
Consolidated Balance Sheets	73
Consolidated Statements of Operations	74
Consolidated Statements of Comprehensive Income (Loss)	75
Consolidated Statements of Equity	76
Consolidated Statements of Cash Flows	77
Notes to Consolidated Financial Statements	79
Schedule II Valuation and Qualifying Accounts	130

69

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Stockholders of Nexeo Solutions, Inc.:

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Nexeo Solutions, Inc. and its Subsidiaries (Successor) (the “Company”) as of September 30, 2018 and 2017, and the related consolidated statements of operations, comprehensive income (loss), equity and cash flows for each of the three years in the period ended September 30, 2018, including the related notes and financial statement schedule listed in the accompanying index for each of the three years in the period ended September 30, 2018 (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of September 30, 2018, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of September 30, 2018 and 2017, and the results of its operations and its cash flows for each of the three years in the period ended September 30, 2018, in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of September 30, 2018, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Annual Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

70

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/PricewaterhouseCoopers LLP

Houston, Texas

December 6, 2018

We have served as the Company’s auditor since 2011.  

71

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Members of Nexeo Solutions Holdings, LLC

In our opinion, the accompanying consolidated statements of operations, comprehensive income (loss) and cash flows present fairly, in all material respects, the results of operations and cash flows of Nexeo Solutions Holdings, LLC and its subsidiaries (Predecessor) for the period from October 1, 2015 through June 8, 2016, in conformity with accounting principles generally accepted in the United States of America. In addition, in our opinion, the accompanying financial statement schedule, Schedule II-Valuation and Qualifying Accounts, for the period from October 1, 2015 through June 8, 2016, presents fairly, in all material respects, the information set forth therein when read in conjunction with the related consolidated financial statements. These financial statements and financial statement schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and financial statement schedule based on our audits. We conducted our audits of these financial statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

/s/ PricewaterhouseCoopers LLP

Houston, Texas

December 8, 2016

72

Nexeo Solutions, Inc. and Subsidiaries

Consolidated Balance Sheets

(in millions, except share amounts and par value)

	September 30, 2018			September 30, 2017
Current Assets
Cash and cash equivalents	$	58.9		$	53.9
Accounts and notes receivable (net of allowance for doubtful accounts of $4.2 million and $2.2 million, respectively)	607.8			597.4
Inventories	338.8			315.5
Income taxes receivable	5.9			3.4
Other current assets	17.3			19.8
Total current assets	1,028.7			990.0
Non-Current Assets
Property, plant and equipment, net	284.9			316.1
Goodwill	699.9			703.0
Other intangible assets, net of amortization	211.6			231.5
Deferred income taxes	2.3			2.3
Other non-current assets	16.2			10.6
Total non-current assets	1,214.9			1,263.5
Total Assets	$	2,243.6		$	2,253.5
Current Liabilities
Short-term borrowings, current portion of long-term debt and capital lease obligations	$	47.7		$	51.1
Accounts payable	380.1			384.2
Accrued expenses and other liabilities	67.2			58.4
Due to related party pursuant to contingent consideration obligations	14.7			12.5
Income taxes payable	2.9			3.2
Total current liabilities	512.6			509.4
Non-Current Liabilities
Long-term debt and capital lease obligations, less current portion, net	752.4			794.0
Deferred income taxes	30.7			34.9
Due to related party pursuant to contingent consideration obligations	122.8			127.7
Other non-current liabilities	10.6			9.9
Total non-current liabilities	916.5			966.5
Total Liabilities	1,429.1			1,475.9
Commitments and Contingencies (see Note 13)
Equity
Preferred stock, $0.0001 par value (1,000,000 shares authorized, none issued and outstanding as of September 30, 2018 and September 30, 2017)	—			—
Common stock, $0.0001 par value (300,000,000 shares authorized, 89,747,062 shares issued and 89,727,546 shares outstanding as of September 30, 2018 and 89,353,641 shares issued and 89,344,065 shares outstanding as of September 30, 2017)	—			—
Additional paid-in capital	771.5			764.4
Retained earnings	34.2			4.8
Accumulated other comprehensive income	9.0			8.5
Treasury stock, at cost: 19,516 and 9,576 shares as of September 30, 2018 and September 30, 2017	(0.2		)	(0.1		)
Total equity	814.5			777.6
Total Liabilities and Equity	$	2,243.6		$	2,253.5

 

The accompanying notes are an integral part of these Consolidated Financial Statements.

73

Nexeo Solutions, Inc. and Subsidiaries

Consolidated Statements of Operations

(in millions, except share and per share data)

	Successor									Predecessor
	Fiscal Year Ended September 30, 2018			Fiscal Year Ended September 30, 2017			Fiscal Year Ended September 30, 2016*			October 1, 2015 Through June 8, 2016
Sales and operating revenues	$	4,034.2		$	3,636.9		$	1,065.7		$	2,340.1
Cost of sales and operating expenses	3,574.1			3,238.5			957.3			2,068.2
Gross profit	460.1			398.4			108.4			271.9
Selling, general and administrative expenses	352.6			312.9			91.7			208.9
Transaction related costs	2.8			1.9			21.3			33.4
Change in fair value of contingent consideration obligations	7.5			16.2			(11.2		)	—
Operating income	97.2			67.4			6.6			29.6
Other income, net	1.0			8.3			0.5			2.9
Interest income (expense)
Interest income	0.5			0.3			0.8			0.1
Interest expense	(52.6		)	(51.1		)	(15.1		)	(42.3		)
Net income (loss) from continuing operations before income taxes	46.1			24.9			(7.2		)	(9.7		)
Income tax expense	16.7			10.5			1.2			4.2
Net income (loss) from continuing operations	29.4			14.4			(8.4		)	(13.9		)
Net income from discontinued operations, net of tax	—			—			—			0.1
Net income (loss)	$	29.4		$	14.4		$	(8.4	)	$	(13.8	)
Net income (loss) per share available to common stockholders
Basic	$	0.38		$	0.19		$	(0.24	)
Diluted	$	0.38		$	0.19		$	(0.24	)
Weighted average number of common shares outstanding
Basic	76,803,187			76,752,752			35,193,789
Diluted	76,909,547			76,839,810			35,193,789

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

The accompanying notes are an integral part of these Consolidated Financial Statements.

74

Nexeo Solutions, Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income (Loss)

(in millions)

	Successor								Predecessor
	Fiscal Year Ended September 30, 2018			Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*			October 1, 2015 Through June 8, 2016
Net income (loss)	$	29.4		$	14.4	$	(8.4	)	$	(13.8	)
Unrealized foreign currency translation gain (loss), net of tax (1)	(7.6		)	13.0		(4.5		)	(4.0		)
Unrealized gain on interest rate hedges, net of tax (2)	8.1			—		—			0.3
Other comprehensive income (loss), net of tax	0.5			13.0		(4.5		)	(3.7		)
Total comprehensive income (loss), net of tax	$	29.9		$	27.4	$	(12.9	)	$	(17.5	)

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

^{(1)    Tax effects are not material.} 

^{(2) Tax impact of the unrealized gains related to the interest-rate swaps was $2.8 million for the fiscal year ended September 30, 2018 and immaterial for the} 

^{fiscal years ended September 30, 2017 and 2016 and for the period from October 1, 2015 through June 8, 2016, for the Predecessor.} 

The accompanying notes are an integral part of these Consolidated Financial Statements.

75

Nexeo Solutions, Inc. and Subsidiaries

Consolidated Statements of Equity

(in millions, except share amounts)

	Common Stock				Treasury Stock				Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)			Accumulated Other Comprehensive Income			Total
	Shares		Amount		Shares	Amount
Balance at September 30, 2016	89,286,936		$	—	—	$	—		$	758.9	$	(9.6	)	$	(4.5	)	$	744.8
Issuance of restricted stock	77,458		—		—	—			—		—			—			—
Forfeiture of restricted stock award	(10,753	)	—		—	—			—		—			—			—
Shares associated with employee tax withholding for vesting of certain equity awards	(9,576	)	—		9,576	(0.1		)	—		—			—			(0.1		)
Equity-based compensation	—		—		—	—			5.5		—			—			5.5
Comprehensive income:
Net income	—		—		—	—			—		14.4			—			14.4
Other comprehensive income	—		—		—	—			—		—			13.0			13.0
Balance at September 30, 2017	89,344,065		$	—	9,576	$	(0.1	)	$	764.4	$	4.8		$	8.5		$	777.6
Issuance of restricted stock	415,867		—		—	—			—		—			—			—
Vesting of restricted stock units	8,162		—		—	—			—		—			—			—
Forfeiture of restricted stock award	(30,608	)	—		—	—			—		—			—			—
Shares associated with employee tax withholding for vesting of certain equity awards	(9,940	)	—		9,940	(0.1		)	—		—			—			(0.1		)
Equity-based compensation	—		—		—	—			7.1		—			—			7.1
Comprehensive income:
Net income	—		—		—	—			—		29.4			—			29.4
Other comprehensive income	—		—		—	—			—		—			0.5			0.5
Balance at September 30, 2018	89,727,546		$	—	19,516	$	(0.2	)	$	771.5	$	34.2		$	9.0		$	814.5

The accompanying notes are an integral part of these Consolidated Financial Statements.

76

Nexeo Solutions, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(in millions)

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 through June 8, 2016
Cash flows from operations
Net income (loss) from continuing operations	29.4		14.4		(8.4	)	(13.9	)
Adjustments to reconcile to cash flows from operations:
Depreciation and amortization	74.9		73.1		20.6		37.7
Debt issuance costs amortization, debt issuance costs write-offs and original issue discount amortization	4.5		4.1		0.7		6.1
Non-cash transaction costs	—		—		12.8		—
Provision for bad debt	1.9		(0.2	)	0.3		1.2
Impairment charge due to natural disasters	—		1.5		—		—
Deferred income taxes	(6.9	)	2.2		(1.1	)	1.1
Equity-based compensation expense	7.1		5.5		1.5		2.7
Change in fair value of contingent consideration obligations	7.5		16.2		(11.2	)	—
(Gain) loss from sales of property and equipment	(0.5	)	0.2		0.2		(2.0	)
Gain related to reimbursements of certain capital expenditures incurred	—		(8.1	)	(0.8	)	—
Gain from debt extinguishment, net	—		—		—		(0.6	)
Changes in assets and liabilities:
Accounts and notes receivable	(16.8	)	(101.9	)	(5.0	)	34.4
Inventories	(25.8	)	14.4		12.5		8.4
Other current assets	2.0		5.6		0.1		(4.1	)
Accounts payable	(2.0	)	43.7		(14.5	)	13.4
Related party payable	—		—		(0.1	)	(0.3	)
Accrued expenses and other liabilities	12.3		6.1		(4.9	)	(9.7	)
Changes in other operating assets and liabilities, net	1.1		1.8		0.5		(4.9	)
Net cash provided by operating activities from continuing operations	88.7		78.6		3.2		69.5
Net cash provided by operating activities from discontinued operations	—		—		—		0.1
Net cash provided by operating activities	88.7		78.6		3.2		69.6
Cash flows from investing activities
Additions to property and equipment	(18.6	)	(27.6	)	(12.7	)	(14.2	)
Proceeds from the disposal of property and equipment	3.4		0.6		4.7		2.4
Proceeds from reimbursement for certain capital expenditures incurred	—		8.4		0.5		—
Proceeds withdrawn from trust account	—		—		501.1		—
Cash paid for asset and business acquisitions	(11.0	)	(65.6	)	(360.6	)	—
Net cash provided by (used in) investing activities	(26.2	)	(84.2	)	133.0		(11.8	)
Cash flows from financing activities
Proceeds from issuance of common stock	—		—		234.9		—
Redemption of common stock	—		—		(298.5	)	—
Proceeds from Sponsor convertible note and Sponsor promissory note	—		—		0.7		—
Repayment of Sponsor convertible note and Sponsor promissory note	—		—		(1.0	)	—
Repurchases of membership units	—		—		—		(0.1	)
Cash paid to TPG related to TRA	(10.2	)	—		—		—
Proceeds from short-term debt	54.6		40.6		13.3		20.9
Repayments of short-term debt	(56.1	)	(39.3	)	(12.8	)	(17.1	)
Proceeds from issuance of long-term debt	690.6		773.8		972.5		292.1
Repayments of long-term debt and capital lease obligations	(735.5	)	(762.0	)	(205.4	)	(417.3	)
Repayment of Predecessor long-term debt	—		—		(767.3	)	—
Payments of debt issuance costs	(0.8	)	(1.3	)	(25.3	)	—
Net cash provided by (used in) financing activities	(57.4	)	11.8		(88.9	)	(121.5	)

77

Effect of exchange rate changes on cash and cash equivalents	(0.1		)	0.2		—		0.3
Increase (decrease) in cash and cash equivalents	5.0			6.4		47.3		(63.4		)
Cash and cash equivalents at the beginning of the period	53.9			47.5		0.2		127.7
Cash and cash equivalents at the end of the period	$	58.9		$	53.9	$	47.5	$	64.3
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	$	48.2		$	46.1	$	16.9	$	32.9
Cash paid during the period for taxes (net of refunds)	$	20.9		$	6.9	$	2.9	$	3.4
Supplemental disclosure of non-cash operating activities:
Non-cash payment of deferred underwriting fees	$	—		$	—	$	18.3	$	—
Supplemental disclosure of non-cash investing activities:
Non-cash capital expenditures	$	1.8		$	17.3	$	3.2	$	16.5
Non-cash intangible assets acquired	$	—		$	3.7	$	—	$	—
Supplemental disclosure of non-cash financing activities:
Non-cash capital lease obligations, net	$	0.3		$	15.3	$	0.2	$	14.3

 

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

The accompanying notes are an integral part of these Consolidated Financial Statements.

78

Nexeo Solutions, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(in millions, except per share amounts)

1. Basis of Presentation and Nature of Operations

Basis of Presentation

Nexeo Solutions, Inc. (together with its subsidiaries, the "Company") is the result of the business combination between WL Ross Holding Corp.("WLRH") and Nexeo Solutions Holdings, LLC ("Holdings").  WLRH was incorporated in Delaware on March 24, 2014 and was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. WLRH completed its IPO in June 2014, raising approximately $500.0 million in cash proceeds. WLRH neither engaged in any operations nor generated any revenue prior to the Business Combination.

The Company’s financial statement presentation distinguishes a “Successor” for the periods after the Closing Date and a “Predecessor” for the periods prior to the Closing Date. In the Business Combination, WLRH was subsequently renamed "Nexeo Solutions, Inc.", was identified as the acquirer and Successor and Holdings was identified as the acquiree and Predecessor. As a result of the application of the acquisition method of accounting as of the Closing Date, the consolidated financial statements for the Successor and Predecessor periods are presented on a different basis and are, therefore, not comparable. See Note 3 for further discussion of the Business Combination.

           The Predecessor period in the consolidated financial statements represent the operating results of Holdings and its subsidiaries prior to the Business Combination.

The Company recorded out-of-period adjustments during the fiscal year ended September 30, 2018 to correct errors in the tax provision and accrued costs. The net impact of these adjustments for the fiscal year ended September 30, 2018 was an increase to revenue of $0.4 million, a decrease to gross profit of $0.9 million and a decrease to net income $2.0 million. The Company does not believe these adjustments are material, individually or in the aggregate, to its consolidated financial statements for the fiscal year ended September 30, 2018, nor does it believe such items are material to any of its previously issued annual or quarterly financial statements.

Nature of Operations

The Company is a global materials distributor for chemicals products in North America and Asia and for plastics products in North America, EMEA and Asia. In North America, primarily in the U.S., the Company provides on-site and off-site hazardous and non-hazardous environmental services, including waste collection, transportation, recovery, disposal arrangement and recycling services. The Company offers its customers products used in a broad cross-section of end markets including household, industrial and institutional, lubricants, performance coatings (including architectural coatings, adhesives, sealants and elastomers), automotive, healthcare, personal care, oil and gas and construction. In connection with the distribution of chemicals products, the Company provides value-added services such as custom blending, packaging and re-packaging, private-label manufacturing and product testing in the form of chemical analysis, product performance analysis and product development.

2. Significant Accounting Policies and Recent Accounting Pronouncements

Significant Accounting Policies

Principles of Consolidation

The accompanying consolidated financial statements include all the accounts of the Company and all wholly-owned subsidiaries in which it maintains control. Significant intercompany transactions and balances have been eliminated in consolidation.

79

Use of Estimates, Risks, and Uncertainties

The preparation of consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosures of contingent assets and liabilities. Significant items that are subject to such estimates and assumptions include:

•the fair value of assets acquired and liabilities assumed in a business combination;

•the assessment of recoverability of long lived assets, including property and equipment, goodwill

and intangible assets, income taxes, reserves and environmental remediation;

•the estimated useful lives of intangible and depreciable assets;

•the grant date fair value of equity-based awards;

•the recognition, measurement and valuation of current and deferred income taxes;

•the recognition and measurement of contingent consideration related to the TRA liability; and

•the recognition and measurement of contingent consideration related to the Deferred Cash Consideration.

Although management bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, actual results could differ significantly from the estimates under different assumptions or conditions.

The Company's financial instruments exposed to concentration of credit risk consist primarily of cash and cash equivalents. Although the Company deposits cash with multiple banks, these deposits, including those held in foreign branches of global banks, may exceed the amount of insurance provided on such deposits. These deposits may generally be redeemed upon demand and bear minimal risks.

No single customer accounted for more than 10% of revenues for any line of business, or on a consolidated basis, and no individual customer represented greater than 5.0% of the outstanding accounts receivable balance for each of the periods reported. The Company had two suppliers that each accounted for approximately 11.6% and 9.6% of consolidated purchases during the fiscal year ended September 30, 2018, 12.1% and 9.9% for the fiscal year ended September 30, 2017 and 11.9% and 10.4% for the fiscal year ended September 30, 2016. For the period from October 1, 2015 through June 8, 2016, these two suppliers accounted for approximately 12.0% and 9.8% of consolidated purchases for the Predecessor.

Cash and Cash Equivalents

All highly liquid temporary investments with original maturities of three months or less are considered to be cash equivalents. See Note 4.

Accounts and Notes Receivable and Allowance for Doubtful Accounts

Accounts receivable are recorded net of discounts and allowance for doubtful accounts. The Company performs ongoing credit evaluations of its customers and generally does not require collateral from its customers. The Company’s accounts receivable in the U.S. and Canada are collateral under the Credit Facilities.

80

The Company records an allowance for doubtful accounts as a best estimate of the amount of probable credit losses for accounts receivable. On a recurring basis, the Company reviews this allowance and considers factors such as customer credit, past transaction history with the customer and changes in customer payment terms when determining whether the collection of a receivable is reasonably assured. Past due balances over 90 days and over a specified amount are reviewed individually for collectability. Receivables are charged off against the allowance for doubtful accounts when it is probable a receivable will not be recovered. The allowance for doubtful accounts was $4.2 million and $2.2 million at September 30, 2018 and 2017, respectively. Bad debt expense, net of recoveries is a component of Selling, general and administrative expenses in the consolidated statements of operations. For the fiscal year ended September 30, 2018 net bad debt expense was $1.9 million and for the fiscal year ended September 30, 2017 net bad debt recovery was $0.2 million. For the fiscal year ended September 30, 2016 net bad debt expense was $0.3 million. Net bad debt expense for the Predecessor period from October 1, 2015 through June 8, 2016 was $1.2 million.

Certain customers of the Company's operations in China are allowed to remit payment during a period of time ranging from 30 days up to nine months. These notes receivables, which are supported by banknotes issued by large banks in China on behalf of these customers, are included in Accounts and Notes Receivable on the Company's consolidated balance sheets and totaled $8.6 million and $8.3 million at September 30, 2018 and 2017, respectively.

Inventories

Inventories are carried at the lower of cost or net realizable value using the weighted average cost method. The Company’s inventories in the U.S. and Canada are collateral under the Credit Facilities. See Note 4.

Goodwill and Intangibles

The Company had goodwill of $699.9 million and $703.0 million at September 30, 2018 and 2017, respectively, associated with the Business Combination and asset acquisitions. The purchase consideration of an acquisition is allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values at the date of acquisition. The estimated fair values are determined after review and consideration of relevant information including discounted cash flows, quoted market prices and estimates made by management. To the extent that the purchase consideration exceeds the fair value of the net identifiable tangible and intangible assets acquired, such excess is allocated to goodwill. See Notes 3 and 6.

The Company had other intangible assets, net of amortization, of $211.6 million and $231.5 million at September 30, 2018 and 2017, respectively. These intangible assets, which are amortized on a straight-line basis over their estimated useful lives, consist of customer relationships, supplier relationships, trade names, below-market leases and non-compete agreements. See Notes 3 and 6. The range of estimated useful lives used to amortize these intangible assets is as follows:

	Estimated Useful Lives (years)
Customer-related	5-13
Supplier-related	6-10
Trade name	2-10
Below-market leases	1-7
Non-compete agreements	3-10

81

Property, Plant and Equipment

Property, plant and equipment includes plants, buildings, machinery, equipment, software and computer equipment. Property, plant and equipment acquired or constructed in the normal course of business are initially recorded at cost. Property and equipment acquired in business combinations and asset acquisitions are initially recorded at their estimated fair value. Property, plant and equipment are depreciated by the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the shorter of their economic useful life or their lease term. The range of useful lives used to depreciate property, plant and equipment is as follows:

	Estimated Useful Lives (years)
Plants and buildings	5-35
Machinery and equipment	2-30
Software and computer equipment	3-10

Repairs and maintenance expenditures that do not extend the useful life of the asset are charged to expense as incurred. Major expenditures for replacements and significant improvements that increase asset values or extend useful lives are capitalized. The carrying amounts of assets that are sold or retired and the related accumulated depreciation are removed from the accounts in the year of disposal and any resulting gain or loss is reflected in the consolidated statements of operations. See Note 5.

Leases

The Company leases certain property, plant and equipment in the ordinary course of business. The leases are classified as either capital leases or operating leases. Assets under capital leases are included in Property, plant and equipment, net in the consolidated balance sheets and are depreciated over the lesser of the lease term or the useful life of the assets. Capital lease obligations are included in Short-term borrowings, current portion of long-term debt and capital lease obligations and Long-term debt and capital lease obligations, less current portion, net in the consolidated balance sheets. Generally, lease payments under capital leases are recognized as interest expense and a reduction of the capital lease obligations. Lease payments under operating leases are recognized as an expense in the consolidated statements of operations on a straight-line basis over the lease term.  See Note 13.

Impairment of Long-Lived Assets

Goodwill. Goodwill is tested for impairment annually as of March 31 and whenever events or circumstances make it more likely than not that an impairment may have occurred. Goodwill is reviewed for impairment at the reporting unit level, which is defined as operating segments or groupings of businesses one level below the operating segment level. The Company’s operating segments are the same as the reporting units used in its goodwill impairment test. Goodwill is tested for impairment by comparing the estimated fair value of a reporting unit, determined using a market approach, if market prices are available, or alternatively, a discounted cash flow model, with its carrying value. The annual evaluation of goodwill requires the use of estimates about future operating results, valuation multiples and discount rates of each reporting unit to determine their estimated fair value. Changes in these assumptions can materially affect these estimates. Once an impairment of goodwill has been recorded, it cannot be reversed. No goodwill impairment was recognized during any of the periods presented. See Note 6.

Other Long-Lived Assets. Property, plant and equipment and other intangible assets with definite lives are tested for impairment whenever events and circumstances indicate that the carrying value of an asset may not be recoverable. When an impairment test is performed and the undiscounted expected future cash flows are less than the carrying value, an impairment loss is recognized equal to an amount by which the carrying value exceeds the fair value of the asset. The factors considered by management in performing this assessment include current operating results, trends and prospects, as well as the effect of obsolescence, demand, competition and other economic factors.

82

Debt Issuance Costs

Costs associated with the ABL Facility are recorded as debt issuance costs, which are included in Other non-current assets in the consolidated balance sheets and are being amortized as interest expense over the contractual lives of the related agreements. Costs associated with non-revolving debt facilities are recorded as a reduction of the long-term debt, and are amortized as interest expense over the contractual lives of the related agreements. See Notes 4 and 7.

Commitments, Contingencies and Environmental Costs

Liabilities for loss contingencies arising from claims, assessments, litigation, fines, penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment and/or remediation can be reasonably estimated. Gain contingencies are not recorded until management determines it is certain that the future event will become or is realized.

Liabilities for environmental remediation costs are recognized when environmental assessments or remediation are probable and the associated costs can be reasonably estimated. Generally, the timing of these provisions coincides with the commitment to a formal plan of action or, if earlier, the divestment or closure of the relevant sites. The amount recognized reflects management’s best estimate of the expenditures expected to be required. Actual environmental expenditures that relate to current or future revenues are expensed or capitalized as appropriate. Actual expenditures that relate to an existing condition caused by past operations and that do not impact future earnings are expensed.

Ashland agreed to retain known environmental remediation liabilities and other environmental remediation liabilities for releases of hazardous materials occurring prior to March 31, 2011, and of which Ashland received notice prior to March 31, 2016. See Note 13.

Earnings or Loss per Share

Basic EPS, which excludes dilution, is computed by dividing income or loss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common shares and the proceeds from such activities, if any, were used to acquire shares of common stock at the average market price during the reporting period. During a net loss period, the assumed exercise of in-the-money stock options and unvested stock has an anti-dilutive effect and, therefore, such potential shares are excluded from the diluted EPS computation.

Per share information is based on the weighted average number of common shares outstanding during each period for the basic computation and, if dilutive, the weighted average number of potential common shares resulting from the assumed conversion of outstanding stock options, unvested stock and unvested stock units for the diluted computation. See Note 12.

Concentrations of Credit Risk

All of the Company’s financial instruments, consisting primarily of accounts and notes receivable and interest rate swaps, involve elements of credit and market risk. The most significant portion of this credit risk relates to non-performance by counterparties. To manage counterparty risk associated with financial instruments, the Company selects and monitors counterparties based on its assessment of their financial strength and on credit ratings, if available.

Foreign Currency

The reporting currency of the Company is the USD. With few exceptions, the local currency is the functional currency for the Company's foreign subsidiaries. In consolidating the results of operations, income and expense accounts are translated into USD at average exchange rates in effect during the period and asset and liability accounts are translated at period-end exchange rates. Translation gains or losses are recorded in the foreign currency translation component in Accumulated other comprehensive income (loss) in stockholders’ equity and are included in net earnings only upon sale or liquidation of the underlying foreign subsidiary or affiliated company.

83

Transactions undertaken in currencies other than the functional currency of the subsidiary are translated using the exchange rate in effect as of the transaction date and give rise to foreign currency transaction gains and losses, which the Company includes in Selling, general and administrative expenses in the consolidated statements of operations. Net foreign currency transaction losses from various currencies were $1.1 million, $0.6 million and $1.1 million for the fiscal years ended September 30, 2018, 2017 and 2016, respectively. Net foreign currency transaction losses were $1.6 million for the period from October 1, 2015 through June 8, 2016 for the Predecessor.

Revenue Recognition

Revenues are recognized when persuasive evidence of an arrangement exists, products are shipped and title is transferred or services are provided to customers, the sales price is fixed or determinable and collectability is reasonably assured. Revenue for product sales is recognized at the time title and risk of loss transfer to the customer, based on the terms of the sale. For products delivered under the Company’s standard shipping terms, title and risk of loss transfer when the product is delivered to the customer’s delivery site. For sales transactions designated Freight on Board shipping point, the customer assumes risk of loss and title transfers at the time of shipment. Deferred revenues may result from (i) delivery delays for products delivered under the Company’s standard shipping terms or (ii) from other arrangements with its customers. Sales are reported net of tax assessed by qualifying governmental authorities. 

The Company is generally the primary obligor in sales transactions with its customers, retains inventory risk during transit and assumes credit risk for amounts billed to its customers. Accordingly, the Company recognizes revenue primarily based on the gross amount billed to its customers. In sales transactions where the Company is not the primary obligor and does not retain inventory risk, the Company recognizes revenue on a net basis by recognizing only the commission the Company retains from such sales and including that commission in sales and operating revenues in the consolidated statements of operations. 

Consistent with industry standards, the Company may offer volume-based rebates to large customers if the customer purchases a specified volume with the Company over a specified time period. The determination of these rebates at an interim date involves management judgment. As a result, the Company’s revenues may be affected if a customer earns a rebate toward the end of a year that the Company had not expected or if its estimate of customer purchases are less than expected. The Company has the experience and access to relevant information that the Company believes are necessary to reasonably estimate the amounts of such deductions from gross revenues. The Company regularly reviews the information related to these estimates and adjusts its reserves accordingly if and when actual experience differs from previous estimates. The Company recognizes the rebate obligation as a reduction of revenue based on its estimate of the total volume of purchases from a given customer over the specified period of time. Customer rebates totaled $7.7 million, $7.8 million and $2.1 million for the fiscal years ended September 30, 2018, 2017 and 2016, respectively. Customer rebates totaled $4.0 million for the period from October 1, 2015 through June 8, 2016 for the Predecessor.  Rebates due to customers were $5.2 million and $4.8 million at September 30, 2018 and 2017, respectively.  These payables are included in Accrued expenses and other liabilities in the consolidated balance sheets. 

Supplier Rebates

Certain of the Company's vendor arrangements provide for purchase incentives based on the Company achieving a specified volume or dollar value of purchases. The Company records the incentives as a reduction of inventory costs (and related cost of sales) based on its purchases to date and its estimates of purchases for the remainder of the calendar year. The Company receives these incentives in the form of rebates that are payable only when the Company's purchases equal or exceed the relevant calendar year target. Supplier rebates totaled $8.9 million, $9.0 million and $3.1 million for the fiscal years ended September 30, 2018, 2017 and 2016, respectively. Supplier rebates totaled $6.5 million for the period from October 1, 2015 through June 8, 2016 for the Predecessor. Supplier rebates due to the Company were $4.4 million and $4.0 million at September 30, 2018 and 2017, respectively. These receivables are included in Accounts and notes receivable in the consolidated balance sheets.

Shipping and Handling

All shipping and handling amounts billed to customers are included in revenues. Costs incurred related to the shipping and handling of products are included in cost of sales.

84

Expense Recognition

Cost of sales include material and production costs, as well as the costs of inbound and outbound freight, purchasing and receiving, inspection, warehousing, internal transfers and all other distribution network costs. The Company's products and services are generally sold without any extended warranties. Selling, general and administrative expenses include sales and marketing costs, advertising, research and development, customer support, environmental remediation and administrative costs. Advertising and research and development costs are expensed as incurred. Advertising expenses totaled $2.3 million, $1.8 million and $0.3 million for the fiscal years ended September 30, 2018, 2017, and 2016 respectively. Advertising expenses totaled $1.3 million for the period from October 1, 2015 through June 8, 2016 for the Predecessor. There were no material research and development expenses incurred during any of the periods presented.

Income Taxes

The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the financial statements. Under this method, the Company determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. The provision for income taxes includes income taxes paid, currently payable or receivable and those deferred. 

The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of the net recorded amount, it would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.

The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) the Company determines whether it is more likely than not that the tax positions will be sustained and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount that is more than 50% likely to be realized upon ultimate settlement with the related tax authority.

The Predecessor was organized as a limited liability company and was taxed as a partnership for U.S. income tax purposes. As such, with the exception of a limited number of state and local jurisdictions, the Predecessor was not subject to U.S. income taxes. Accordingly, the members of the Predecessor reported their share of the Predecessor’s taxable income on their respective U.S. federal tax returns. The Predecessor’s sole active U.S. corporate subsidiary, Sub Holding, was subject to tax at the entity level in the U.S. The net earnings for financial statement purposes differed from taxable income reportable by the Predecessor to the members as a result of differences between the tax basis and financial reporting basis of certain assets and liabilities and other factors. The Predecessor was required to make quarterly distributions to its members to fund their tax obligations, if any, attributable to the Predecessor’s taxable income. In some jurisdictions, the Predecessor made such distributions in the form of tax payments paid directly to the taxing authority on behalf of its members. Controlled foreign corporations are subject to tax at the entity level in their respective jurisdictions. See Note 15.

Due to Related Party Pursuant to Contingent Consideration Obligations

As described in Note 3, as part of the consideration for the Business Combination, the Company entered into the TRA and agreed to pay the Deferred Cash Consideration pursuant to the Merger Agreement.  The Company’s obligation for these contingent consideration amounts was initially measured at fair value as of the Closing Date.  The Company’s contingent consideration liabilities are required to be recorded at fair value as of the end of each reporting period with any changes in fair value recorded in operating income. Changes in the estimates and inputs used in determining the fair value of the contingent consideration could have a material impact on the amounts recognized. See Note 9.

85

Share-Based Compensation

The Company accounts for share-based compensation expense for equity instruments granted in exchange for employee and director services.  Share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as expense over the vesting period of the equity award grant.

The Company’s PSU awards contain both market and performance-based conditions. At the grant date, market conditions are incorporated into the fair value measurement using a Monte Carlo simulation model under the assumptions that performance-based conditions are met and not met. The Company then determines the probability that performance-based conditions will be met and incorporates this into the grant date fair value of the award.

The compensation cost for the PSU awards is amortized over the vesting period on a straight-line basis, net of estimated forfeitures. Forfeiture rates are estimated based on consideration of historical forfeitures of the Company's and Predecessor’s actual forfeitures of its share-based compensation awards and a peer group of companies. See Note 10.

Recent Accounting Pronouncements Adopted as of September 30, 2018

In July 2015, the FASB issued ASU 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory. The amendments in this ASU require an entity to measure inventory at the lower of cost or net realizable value, whereas guidance previously required an assessment of market value of inventory, with different possibilities for determining market value. This ASU is effective for fiscal years beginning after December 15, 2016 and interim periods within those years and early adoption is permitted. The Company adopted this standard as of October 1, 2017, and it did not have a material effect on the Company’s financial position or results of operations.

In March 2016, the FASB issued ASU 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The updated guidance simplifies several aspects of accounting for certain aspects of share-based payment awards to employees, including the accounting for income taxes, forfeitures and statutory tax withholding requirements, as well as the classification of related matters in the statement of cash flows. This ASU is effective for annual reporting periods beginning after December 15, 2016 and interim periods within those annual periods. The Company adopted this standard as of October 1, 2017, and it did not have a material effect on the Company’s financial position or results of operations.

In May 2017, the FASB issued ASU 2017-09, Compensation - Stock Compensation (Topic 718). This ASU clarifies when changes to the terms or conditions of a share-based payment award must be accounted for as a modified award. The new guidance will reduce diversity in practice and result in fewer changes to the terms of an award being accounted for as modifications.  The amendments in this ASU will be applied prospectively to awards modified on or after the adoption date. The Company adopted this standard as of October 1, 2017, and it did not have a material effect on the Company’s financial position or results of operations.

New Accounting Pronouncements Not Yet Adopted as of September 30, 2018

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). The amendments in this ASU will supersede the revenue recognition requirements in Topic 605, Revenue Recognition and require that revenue be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB issued ASU 2015-14, which deferred the effective date of ASU 2014-09 for all entities by one year. These amendments will be effective in annual reporting periods beginning after December 15, 2017 including interim reporting periods within that reporting period. The Company has completed its assessment of the financial statement impact of the new standard, and does not expect it to have a material impact on the Company's financial position or results of operations. The Company adopted this standard on October 1, 2018 and will use the modified retrospective approach.

86

In January 2016, the FASB issued ASU 2016-01, Financial Instruments (Topic 825): Recognition and Measurement of Financial Assets and Financial Liabilities. This ASU (i) requires all equity investments in unconsolidated entities other than those measured using the equity method of accounting, to be measured at fair value through earnings; (ii) when the fair value option has been elected for financial liabilities, requires that changes in fair value due to instrument specific credit risk be recognized separately in other comprehensive income and accumulated gains and losses due to these changes and will be reclassified from accumulated other comprehensive income to earnings if the liability is settled before maturity; and (iii) amends certain fair value disclosure provisions related to financial instruments carried at amortized cost. This ASU is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years and early adoption is permitted. The Company is in the process of evaluating the provisions of the ASU and assessing the potential effect on the Company’s financial position or results of operations.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). This ASU requires all leases with terms greater than 12 months, whether finance or operating, to be recorded on the balance sheet, reflecting a liability to make lease payments and a right-to-use asset representing the right to use the underlying asset for the lease term. The recognition, measurement and presentation of expenses and cash flows arising from a lease by a lessee will not significantly change from current U.S. GAAP. These amendments are effective for the reporting periods beginning after December 15, 2018 with early adoption permitted. An entity will be required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. The Company is in the process of evaluating the potential effects of this standard and believes it may have a significant impact on its consolidated financial statements due, in part, to its substantial number of operating lease obligations that will be reflected on the consolidated balance sheet upon adoption of the new guidance.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.  This ASU requires an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts.  Forward-looking information will now be used to better inform credit loss estimates.  The amendments in this ASU are effective for fiscal years beginning December 15, 2020 including interim periods within those years with early adoption permitted.  The Company is currently in the process of evaluating the provisions of this ASU and assessing the potential effect on the Company’s financial position or results of operations.

In August 2016 the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments.  This ASU will make eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The new standard is effective for fiscal years beginning after December 15, 2017. Early adoption is permitted. The new standard will require adoption on a retrospective basis unless it is impracticable to apply, in which case the Company would be required to apply the amendments prospectively as of the earliest date practicable. The Company is in the process of evaluating the provisions of this ASU but does not expect it to have a material effect on the Company’s consolidated statements of cash flows.

In August 2018 the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. This ASU modified the disclosures related to recurring and nonrecurring fair value measurements. Disclosures related to the transfer of assets between Level 1 and Level 2 hierarchies have been eliminated and various additional disclosures related to Level 3 fair value measurements have been added, modified or removed. This ASU is effective for annual periods beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted upon issuance of the standard for disclosures modified or removed with a delay of adoption of the additional disclosures until their effective date. The Company is in the process of evaluating the provisions of the ASU but does not expect it to have a material effect on the Company’s consolidated financial statements.

87

3. Acquisitions

Merger Agreement with Univar

On September 17, 2018, Nexeo and Univar entered into the Univar Merger Agreement providing for the acquisition of Nexeo by Univar.

Subject to the terms and conditions set forth in the Univar Merger Agreement, holders of Nexeo’s common stock will receive (A) the Cash Consideration, described below, and (B) 0.305 of a share of Univar common stock (referred to as the "Stock Consideration").

The “Cash Consideration” will be $3.29 per share, subject to reduction by up to $0.41 per share based on the closing price of Univar common stock on the day prior to the closing of the proposed transaction. The Cash Consideration will be reduced on a linear basis between $3.29 per share and $2.88 per share to the extent that the closing price of Univar common stock is between $25.34 and $22.18. If the closing price of Univar common stock is $22.18 per share or lower, the Cash Consideration will be $2.88 per share. If the closing price of Univar common stock on is $25.34 per share or higher, the Cash Consideration will be $3.29 per share.

The Univar Merger Agreement and the proposed transaction were approved unanimously by the Board of Directors of both Nexeo and Univar and are subject to review by the SEC and regulatory agencies in the U.S. and other jurisdictions. The Univar Merger Agreement is also subject to a number of conditions, including, among other things and as further described in the Univar Merger Agreement: (i) the adoption by Nexeo’s stockholders of the Univar Merger Agreement, (ii) the approval by Univar’s stockholders of the issuance of the shares of Univar common stock in connection with the proposed transaction contemplated by the Univar Merger Agreement, (iii) the receipt of other required regulatory approvals, (iv) the absence of any law or governmental order prohibiting the proposed transaction, (v) the effectiveness of Univar's registration statement and the approval for listing on the NYSE of the shares of Univar common stock in connection with the proposed transaction contemplated by the Univar Merger Agreement, (vi) no material adverse effect on Nexeo's and Univar's operations having occurred since the signing of the Univar Merger Agreement and (vii) the termination of the TRA. There can be no assurance that the conditions to the completion of the proposed transaction will be satisfied or waived or that the proposed transaction will be completed. On November 16, 2018, Univar and Nexeo announced that the waiting period under the HSR Act expired.

The Univar Merger Agreement contains customary representations and warranties made by each of the Univar and Nexeo, and also contains customary pre-closing covenants, including covenants, among others, by each of Univar and Nexeo to operate its respective businesses in the ordinary course consistent with past practice and to refrain from taking certain actions without the other party’s consent during the period prior to closing.

The proposed transaction is expected to close in the first quarter of 2019. Transaction costs incurred by the Company associated with the Univar Merger Agreement were $11.3 million during the fiscal year ended September 30, 2018. Of this amount, approximately $2.8 million were recorded in Transaction Costs and $8.5 million were recorded in Selling, general and administrative expenses in the consolidated statement of operations.

Ultra Chem Acquisition

On April 3, 2017, the Company completed the Ultra Chem Acquisition for $56.7 million, net of cash acquired of $0.5 million, pursuant to the Ultra Chem Stock Purchase Agreement.  Of the purchase price, $10.7 million was initially placed in escrow. As of September 30, 2018, $9.3 million of the purchase price may remain in escrow for a period of up to five years from the closing of the Ultra Chem Acquisition and relates to indemnification obligations under the Ultra Chem Stock Purchase Agreement. The escrow amount will be released pursuant to the terms of the Ultra Chem Stock Purchase Agreement and related documentation. The Ultra Chem Acquisition was financed with approximately $58.0 million of borrowings under the ABL Facility. There is no contingent consideration related to the Ultra Chem Acquisition.

88

Purchase Price Allocation

The Ultra Chem Acquisition is accounted for under the acquisition method, which requires the Company to perform an allocation of the purchase consideration to the assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The excess of the purchase consideration over the estimated fair values is recorded as goodwill. The following table summarizes the Company’s allocation of the purchase consideration to assets acquired and liabilities assumed at the Ultra Chem Closing Date:

	Purchase Consideration Allocation
Accounts receivable	$	13.7
Inventory	9.1
Other current assets	2.4
Property and equipment	0.5
Customer-related intangible	24.0
Trade name	0.3
Non-compete agreements	3.9
Other non-current assets	2.5
Goodwill	28.0
Total assets acquired	84.4
Short-term borrowings	0.9
Accounts payable	12.1
Other current liabilities	4.1
Deferred tax liability — non-current	8.4
Other non-current liabilities	2.2
Total liabilities assumed	27.7
Net assets acquired	$	56.7

During the three months ended March 31, 2018, the Company completed its assessment of the fair values of the assets acquired and liabilities assumed in the Ultra Chem Acquisition. The Company recorded no material adjustments to the fair value estimates of assets and liabilities during the current period.

Transaction costs incurred by the Company associated with the Ultra Chem Acquisition were less than $0.1 million during the fiscal year ended September 30, 2018. Transaction costs incurred by the Company associated with the Ultra Chem Acquisition were $1.8 million during the fiscal year ended September 30, 2017. Of this amount, approximately $1.1 million were recorded in Transaction Costs and $0.7 million were recorded in Selling, general and administrative expenses in the consolidated statement of operations.

A summary and description of the acquired assets and assumed liabilities fair valued in conjunction with applying the acquisition method of accounting follows:

Accounts and Notes Receivable

Accounts and notes receivable consisted of receivables related to the customers of the acquired business, as well as various other miscellaneous receivables. The accounts receivable and other miscellaneous receivables were recorded at their approximate fair value based on expected collections of Ultra Chem Group. Accordingly, accounts receivable included an adjustment of $1.5 million to reduce gross receivables to their net value after consideration of expected uncollectable amounts at the Ultra Chem Closing Date.

89

Inventory

Inventory consisted primarily of finished products to be distributed to the acquired business’s customers. The fair value of inventory was established through application of the income approach, using estimates of selling prices and costs such as selling and marketing expenses to be incurred in order to dispose of the finished products and arriving at the future profitability expected to be generated once the inventory is sold (net realizable value). The inventory fair value step up of $1.0 million was recognized in Cost of sales and operating expenses during the fiscal year ended September 30, 2017.

Other Current Assets

Other current assets consisted primarily of prepaid expenses and did not have a fair value adjustment as part of acquisition accounting since their carrying value approximated fair value. Other current assets also include indemnification assets recorded in connection with the recognition of tax-related contingent liabilities assumed. The indemnification assets represented the reimbursement the Company would reasonably expect to receive from funds initially held in escrow pursuant to the purchase agreement if the liabilities were asserted by the relevant tax authority.

Property and Equipment

Property and equipment acquired consists primarily of leasehold improvements, computer and office equipment as well as furniture and fixtures. The purchase price allocation for property, plant and equipment was based on the carrying value of such assets as it was determined to approximate fair value.

Customer-Related Intangible

Customer relationships were valued through the application of the income approach. Under this approach, revenue, operating expenses and other costs associated with existing customers were estimated in order to derive cash flows attributable to the existing customer relationships. The resulting estimated cash flows were then discounted to present value to arrive at the fair value of existing customer relationships as of the valuation date. The value associated with customer relationships will be amortized on a straight-line basis over a ten-year period, which represents the approximate point in the projection period in which a majority of the asset’s cash flows are expected to be realized based on assumed attrition rates. The Company recognized $24.0 million for these intangible assets as part of the allocation of the purchase consideration.

Trade Name

The "Ultra Chem" trade name was valued through application of the income approach, involving the estimation of likely future sales and an estimated royalty rate reflective of the rate that a market participant would pay to use the "Ultra Chem" name. The fair value of this asset will be amortized on a straight-line basis over a two-year period, estimated based on the period in which the Company would expect a market participant to use the name prior to rebranding. The Company recognized $0.3 million for this intangible asset as part of the allocation of the purchase consideration.

Non-Compete Agreements

In connection with the Ultra Chem Acquisition, the former equityholders of the Ultra Chem Group agreed to non-compete agreements. The terms of the non-compete agreements prohibit the equityholders from competing in the chemical distribution space for three years after the Ultra Chem Closing Date. The income approach was used to value the non-compete agreements through a comparative discounted cash flow analysis based on the impact of competition absent these agreements. The Company recognized $3.9 million for this intangible asset as part of the allocation of the purchase consideration. This intangible is amortized on a straight-line basis over a three-year period.

90

Other Non-Current Assets

Other non-current assets acquired represented certain long-term deposits and other assets, which did not have a fair value adjustment as part of acquisition accounting since their carrying value approximated fair value. Other non-current assets also included indemnification assets recorded in connection with the recognition of tax-related contingent liabilities assumed, and the expected value of certain assets pledged as a guarantee to the Ultra Chem Group in connection with transactions with a particular customer. The indemnification assets represent the reimbursement the Company reasonably expects to receive from funds initially held in escrow pursuant to the purchase agreement if the related liabilities were asserted by the relevant tax authority.

Goodwill

Goodwill represents the excess of the total purchase price over the fair value of the underlying net assets, largely arising from synergies expected as a result of the Ultra Chem Acquisition. Goodwill is not amortized to earnings, but instead is reviewed for impairment at least annually, absent any indicators of impairment. The Company does not expect any goodwill from the Ultra Chem Acquisition to be deductible for tax purposes.

Short-Term Borrowings

Short-term borrowings included short-term borrowings of the Ultra Chem Group prior to the Ultra Chem Acquisition, which did not have a fair value adjustment as part of acquisition accounting as their carrying value approximated fair value. The balance was paid off immediately after the closing of the Ultra Chem Acquisition.

Accounts Payable

Accounts payable represented short-term obligations owed to the vendors of the acquired business, which were assumed in the Ultra Chem Acquisition. These obligations did not have a fair value adjustment as part of acquisition accounting as their carrying value approximated fair value.

Other Current Liabilities

Other current liabilities represented primarily accrued expenses, including accrued payroll, certain accrued taxes, the current portion of assumed tax-related contingent liabilities and various other liabilities arising out of the normal operations of the acquired business. The majority of these liabilities did not have a fair value adjustment as their carrying value approximated fair value.

Other Non-Current Liabilities

Other non-current liabilities represent assumed tax-related contingent liabilities, and the expected value of certain assets pledged as a guarantee to the Ultra Chem Group which would have to be returned to the third party under certain circumstances.

Deferred Taxes

Deferred tax assets and liabilities are attributable to the difference between the estimated fair values allocated to inventory, property and equipment and identified intangibles acquired for financial reporting purposes and the amounts determined for tax reporting purposes and give rise to temporary differences.  The deferred tax assets and liabilities will reverse in future periods or have reversed as the related tangible and intangible assets are amortized, acquired inventory is sold, or if goodwill is impaired.

Business Combination

On June 9, 2016, the Company consummated the Business Combination pursuant to the Merger Agreement, whereby WLRH acquired Holdings (including the portion of Holdings held by Blocker) through a series of two mergers. As a result of the transactions contemplated by the Merger Agreement, Holdings and Blocker became wholly-owned subsidiaries of WLRH.

91

The purchase consideration for the Business Combination was as follows:

Cash	$	424.9
Less: cash acquired	(64.3		)
Equity(1)	276.7
Founder Shares transferred to Selling Equityholders(1)	30.2
Contingent consideration - Fair value of Deferred Cash Consideration	45.4
Contingent consideration - Fair value of TRA (2)	89.8
Total purchase consideration(3)	$	802.7

⁽¹⁾ See Note 11.

⁽²⁾ During the fiscal year ended September 30, 2017, the Company recorded adjustments of $5.6 million. See below.

⁽³⁾ In addition to the total purchase consideration above, the Company assumed the outstanding indebtedness of the Predecessor, including related accrued interest through the Closing Date, totaling $774.3 million. The proceeds of the Credit Facilities were used to repay such indebtedness and accrued interest immediately following the consummation of the Business Combination.

Contingent Consideration - Deferred Cash Consideration

The contingent consideration associated with the Deferred Cash Consideration will be an amount in cash equal to the prevailing price of the Company’s common stock at the time that the Company pays such deferred cash payment multiplied by the number of Excess Shares (5,178,642 Excess Shares as of September 30, 2018).  Based on the terms of the Excess Shares, certain circumstances require the Company to pay all or a portion of the Deferred Cash Consideration to the Selling Equityholders, where such cash amount is calculated as set forth in the Merger Agreement, including (i) where the volume weighted average trading price of the Company’s common stock for any period of 20 trading days in any 30 trading day period exceeds $15.00 per share, and (ii) if any Excess Shares remain on June 30, 2021. If any Excess Shares remain on June 30, 2021, the Company must elect to either (i) within five business days of such date, pay the Selling Equityholders an amount in cash equal to the product of the number of remaining Excess Shares multiplied by the volume weighted-average trading price for the 20 trading day period immediately preceding such date or (ii) use reasonable best efforts to sell such shares to a third party in a primary offering and pay the gross proceeds thereof (less any underwriting discounts and commissions) to the Selling Equityholders. However, to the extent the number of shares issued in such offerings does not equal the full amount of Excess Shares remaining at the time of the offering, the Company’s obligations with respect to any remaining Excess Shares, including the obligation to continue to complete any necessary additional offerings, shall continue.

In order to estimate the fair value of the Deferred Cash Consideration, the Company estimates the value of the Excess Shares using a Monte Carlo simulation model. The estimated fair value of the Deferred Cash Consideration liability was $62.7 million and $35.1 million as of September 30, 2018 and September 30, 2017, respectively. See Note 9.

Upon consummation of the Univar Merger Agreement, the obligation to pay the Deferred Cash Consideration will be accelerated. The Deferred Cash Consideration will be calculated as an amount in cash equal to the Excess Shares multiplied by an amount equal to the Cash Consideration plus the implied value of the Stock Consideration based on the closing trading price of Univar's common stock on the day prior to the completion of the proposed transaction.

92

Contingent Consideration - TRA

Concurrent with the completion of the Business Combination, the Company incurred the liability for contingent consideration related to the TRA, which reflects amounts owed to the Selling Equityholders. This liability generally provides for the payment by the Company to the Selling Equityholders of 85% of the net cash savings, if any, in U.S. federal, state and local income taxes that the Company actually realizes (or is deemed to realize in certain circumstances) in periods after the Closing Date as a result of (i) certain increases in tax basis resulting from the Company Merger, (ii) certain tax attributes of Holdings existing prior to the Mergers, (iii) net operating losses and certain other tax attributes of Blocker available to the Company as a result of the Blocker Merger and (iv) imputed interest deemed to be paid by the Company as a result of, and additional tax basis arising from, payments the Company makes under the TRA. The Company will retain the benefit of the remaining 15% of the net cash savings, if any. The Company estimated the fair value of the TRA liability based on a discounted cash flow model which incorporates assumptions of projected taxable income, projected income tax liabilities and an estimate of tax benefits expected to be realized as a result of the Business Combination. The current undiscounted cash flows associated with the TRA liability were estimated to be approximately $131.3 million over the time period during which the tax benefits are expected to be realized, currently estimated at over 20 years. The estimated fair value of the TRA liability is $74.8 million and $105.1 million as of September 30, 2018 and September 30, 2017, respectively. See Note 9. The decrease in the liability is reflective of the provisional impact associated with the Tax Act enacted in December 2017 (see Note 15), which lowers the Company’s projected income tax liabilities, the estimate of tax benefits expected to be realized as a result of the Business Combination and the ultimate amount expected to be paid by the Company to the Selling Equityholders.

The amount and timing of any payments due under the TRA will vary depending upon a number of factors, including the amount and timing of the taxable income the Company generates in the future and the U.S. federal, state and local income tax rates then applicable. In addition, payments made under the TRA will give rise to additional tax benefits for the Company and therefore additional potential payments due under the TRA. The term of the TRA commenced upon the consummation of the Mergers and will continue until all tax benefits that are subject to the TRA have been utilized or expired, unless the Company exercises its right to terminate the TRA early. If the Company elects to terminate the TRA early, its obligations under the TRA would accelerate and it generally would be required to make an immediate payment equal to the present value of the anticipated future payments to be made by it under the TRA, calculated in accordance with certain valuation assumptions set forth in the TRA.

In connection with the Univar Merger Agreement, Nexeo and the TRA Holders entered into a TRA Termination Agreement under which the parties agreed to terminate the TRA, upon consummation of the proposed transaction. Upon termination of the TRA, a cash payment to the TRA Holders will be made in an amount equal to $60.0 million. In the event the Univar Merger Agreement is terminated, the TRA Termination Agreement will no longer be in force.

The liabilities related to the Deferred Cash Consideration and the TRA are included in Due to related party pursuant to contingent consideration obligations on the Company’s consolidated balance sheets.

Purchase Consideration Allocation

The Business Combination is accounted for under the acquisition method, with WLRH determined to be the accounting acquirer of Holdings, which requires the Company to perform an allocation of the purchase consideration to the assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The excess of the purchase consideration over the estimated fair values is recorded as goodwill. The following table summarizes the Company’s allocation of the purchase consideration to assets acquired and liabilities assumed at the Closing Date:

93

	Purchase Price Allocation
Accounts receivable	$	470.0
Inventory	327.9
Other current assets	26.0
Property, plant and equipment	328.2
Customer-related intangible	201.0
Trade name	21.0
Below-market leases	0.7
Other non-current assets	3.2
Deferred tax assets	1.2
Goodwill	673.4
Total assets acquired	2,052.6
Short-term borrowings and current portion of capital leases	40.6
Accounts payable	335.9
Other current liabilities	52.8
Long-term portion of capital leases	23.0
Long-term debt	767.3
Deferred tax liability	24.8
Other non-current liabilities	5.5
Total liabilities assumed	1,249.9
Net assets acquired	$	802.7

During the fiscal year ended September 30, 2017, the Company completed its assessment of the fair values of the assets acquired and liabilities assumed in the Business Combination. The Company recorded adjustments to decrease the fair value of inventory by $0.6 million, property, plant and equipment by $0.1 million, an adjustment to accounts payable of $2.1 million, an adjustment to increase the fair value of other current assets by $0.2 million, and adjustments to deferred tax liabilities of $0.4 million. Goodwill was impacted by these adjustments as well as by the $5.6 million adjustment to the fair value of the TRA described above which increased the purchase consideration.

Transaction costs incurred by the Company associated with the Business Combination were $0.9 million and $21.3 million during the fiscal years ended September 30, 2017 and 2016, respectively. The Company also incurred a total of $25.3 million of debt issuance costs related to the Credit Facilities in connection with the consummation of the Business Combination. Transaction costs incurred by the Predecessor associated with the Business Combination were $33.4 million for the period from October 1, 2015 through June 8, 2016.

A summary and description of the acquired assets and assumed liabilities fair valued in conjunction with applying the acquisition method of accounting follows:

Accounts Receivable

Accounts receivable consisted of receivables related to the customers of the acquired business, as well as various other miscellaneous receivables. The accounts receivable and other miscellaneous receivables were recorded at their approximate fair value based on expected collections of the Predecessor. Accordingly, accounts receivable included an adjustment of $4.1 million to reduce gross receivables to their net value after consideration of expected uncollectable amounts at the Closing Date.

94

Inventory

Inventory consisted primarily of finished products to be distributed to the acquired business’s customers. The fair value of inventory was established through application of the income approach, using estimates of selling prices and costs such as selling and marketing expenses to be incurred in order to dispose of the finished products and arriving at the future profitability that is expected to be generated once the inventory is sold (net realizable value). An inventory fair value step up of $13.8 million was recognized in income during the fiscal year ended September 30, 2016, which is included in Cost of sales and operating expenses in the consolidated statement of operations.

Other Current Assets

Other current assets consisted primarily of prepaid expenses, which did not have a fair value adjustment as part of acquisition accounting since their carrying value approximated fair value. Additionally, as a result of the Business Combination, the Company recognized $1.3 million for certain tax receivables.

Property, Plant and Equipment

Property, plant and equipment consisted primarily of: 42 owned distribution locations in the U.S., Puerto Rico and Canada; 11 leased locations in the U.S., Canada, Puerto Rico, Mexico, Europe and China (excluding third party operated warehouses); and office equipment and other similar assets used in the Predecessor's operations. The allocation of the purchase consideration for property, plant and equipment was based on the fair market value of such assets determined using the cost approach. The cost approach consisted of estimating the fixed assets’ replacement cost less all forms of depreciation. The fair value of land was determined using the comparable sales approach. The fair value adjustment to property, plant and equipment was $96.0 million.

Customer-Related Intangible

Customer relationships were valued through the application of the income approach. Under this approach, revenue, operating expenses and other costs associated with existing customers were estimated in order to derive cash flows attributable to the existing customer relationships. The resulting estimated cash flows were then discounted to present value to arrive at the fair value of existing customer relationships as of the valuation date. The value associated with customer relationships will be amortized on a straight-line basis over a 12-year period, which represents the approximate point in the projection period in which a majority of the asset’s cash flows are expected to be realized based on assumed attrition rates. The Company recognized $201.0 million for these intangible assets as part of the allocation of the purchase consideration.

Trade Name

The "Nexeo" trade name was valued through application of the income approach, involving the estimation of likely future sales and an estimated royalty rate reflective of the rate that a market participant would pay to use the Nexeo name. The fair value of this asset will be amortized on a straight-line basis over a four year period, estimated based on the period in which the Company expects a market participant would use the name prior to rebranding and the length of time the name would be expected to maintain recognition and value in the marketplace. The Company recognized $21.0 million for this intangible asset as part of the allocation of the purchase consideration.

Below-Market Leases

The Company recognized an intangible asset related to favorable lease terms of certain properties under operating leases where rental payments were determined to be less than current market rates. The intangible asset will be amortized over the remaining life of the operating leases, which ranges from one to seven years. The Company recognized $0.7 million for this intangible asset as part of the allocation of the purchase consideration.

Other Non-Current Assets

Other non-current assets acquired represented certain long-term deposits, which did not have a fair value adjustment as part of acquisition accounting since their carrying value approximated fair value.

95

Goodwill

Goodwill represents the excess of the total purchase consideration over the fair value of the underlying net assets acquired, largely arising from the workforce and extensive efficient distribution network that has been established by the acquired business. Of the total amount of goodwill recognized as part of the allocation of the purchase consideration above, the Company expects approximately $252.9 million to be deductible for tax purposes as of September 30, 2018.

Short-Term Borrowings and Current Portion of Capital Leases.

Short-term borrowings and current portion of capital leases includes short-term borrowings of the Company's operations in China and the current portion of capital leases, which did not have a fair value adjustment as part of acquisition accounting since their carrying value approximated fair value.

Accounts Payable

Accounts payable represented short-term obligations owed to the vendors of the acquired business, which were assumed in the Business Combination. These obligations did not have a fair value adjustment as part of acquisition accounting since their carrying value approximated fair value.

Other Current Liabilities

Other current liabilities represented primarily accrued expenses, including accrued payroll, accrued interest on long-term debt, certain accrued taxes and various other liabilities arising out of the normal operations of the acquired business. The majority of these liabilities did not have a fair value adjustment because their carrying value approximated fair value. However, no fair value was recognized for certain recorded liabilities that did not meet the definition of a liability under the acquisition method of accounting.

Long-Term Portion of Capital Leases

The long-term portion of capital leases included the non-current portion of capital leases for machinery and equipment, which did not have a fair value adjustment as part of acquisition accounting as their carrying value approximated fair value.

Long-term Debt

Long-term debt represented the outstanding principal balance at the Closing Date of the Predecessor Term Loan Facility and the Notes which did not have a fair value adjustment as part of acquisition accounting as the carrying value approximated fair value.

Deferred Taxes

Deferred tax assets and liabilities are attributable to the difference between the estimated fair values allocated to inventory, property, plant and equipment and identified intangibles acquired for financial reporting purposes and the amounts determined for tax reporting purposes and give rise to temporary differences.  The deferred tax assets and liabilities will reverse in future periods or have reversed as the related tangible and intangible assets are amortized, acquired inventory is sold, or if goodwill is impaired. Additionally, the Company’s entity structure includes several partnerships.  The amounts recorded for deferred taxes reflect the evaluation of the tax basis of each individual partner's interest in the partnerships.

96

Unaudited Consolidated Pro Forma Financial Information

The unaudited consolidated pro forma results presented below include the effects of the Business Combination as if it had occurred as of October 1, 2014, the beginning of the fiscal year the Business Combination was consummated, and the Ultra Chem Acquisition as if it had occurred as of October 1, 2015.  The unaudited consolidated pro forma results reflect certain adjustments related to these acquisitions, primarily reflecting a full period of Ultra Chem Group’s results of operations for each period presented, the estimated changes in fair value of the contingent consideration liability from the Business Combination, amortization expense associated with estimates for the acquired intangible assets, depreciation expense based on the new fair value of property, plant and equipment, the effects of inventory step ups from the acquisitions, transaction costs, interest expense and income taxes.

The unaudited consolidated pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the Business Combination been completed on October 1, 2014 or the Ultra Chem Acquisition on October 1, 2015.

	Fiscal Year Ended September 30,
	2018		2017		2016
Sales and operating revenues	$	4,034.2	$	3,672.2	$	3,466.3
Operating income	$	97.2	$	71.1	$	96.6
Net income from continuing operations	$	29.4	$	16.4	$	33.4
Net income	$	29.4	$	16.4	$	33.5
Basic and diluted net income per share	$	0.38	$	0.21	$	0.44
Pro forma weighted average number of common shares outstanding
Basic	76,803,187		76,752,752		76,746,168
Diluted	76,909,547		76,839,810		76,799,052

The unaudited consolidated pro forma information for the fiscal year ended September 30, 2016 above reflects the effect of recognizing the non-recurring inventory fair value step up of $1.0 million and the effect of transaction related costs of $1.8 million during that period from the Ultra Chem Acquisition.

There was no impact to the calculation of pro forma basic or diluted weighted average number of common shares outstanding as a result of the Ultra Chem Acquisition, as no shares were issued as consideration. For the fiscal year ended September 30, 2016 presented above, the pro forma weighted average number of common shares outstanding were computed assuming all shares issued as a result of the Business Combination would have been issued on October 1, 2014. There were 12,476,250 Founder Shares not included in the basic or diluted computations because market conditions are assumed to be not satisfied. Additionally, the outstanding PSU awards were not included in the computation of diluted shares outstanding because performance targets and/or market conditions are assumed not to have been met for these awards. Diluted shares outstanding also did not include 25,012,500 shares based on the exercise of 50,025,000 warrants because the warrants were out-of-the-money.

97

Asset Acquisitions

In December 2016, the Company acquired customer contracts and a customer list. Additionally, in connection with this transaction, the Company entered into a supply agreement and a licensing agreement granting the Company the non-exclusive use of a certain trademark. The total consideration associated with this transaction was $8.5 million, of which $5.1 million was paid at closing. Of the remaining consideration, the Company paid $1.7 million in January 2018 and the remaining $1.7 million will be paid in January 2019. The remaining consideration is included in Accrued expenses and other liabilities on the Company’s consolidated balance sheets. In connection with this transaction, the Company recognized intangible assets totaling $8.5 million which are included in Other intangible assets, net of amortization on the Company’s consolidated balance sheet. The acquired intangible assets will be fully amortized over estimated useful lives ranging between 10 and 13 years.

In April 2017, the Company acquired customer contracts, a customer list and inventory. The total consideration associated with this transaction was approximately $1.9 million, with $1.6 million paid at closing. The remaining consideration was paid in April 2018. In connection with this transaction, the Company recognized an intangible asset related to the customer list of approximately $1.1 million which is included in Other intangible assets, net of amortization on the Company’s consolidated balance sheet. The customer list will be amortized over an estimated useful life of five years.

In August 2017, the Company acquired customer contracts, a customer list and certain trademarks. As part of this transaction, the Company entered into a supply agreement. The total consideration associated with this transaction was $2.2 million, and the Company recognized intangible assets of the same amount which are included in Other intangible assets, net of amortization on the Company's consolidated balance sheet. The acquired intangible assets will be fully amortized over an estimated useful life of five years.

In February 2018, the Company acquired customer contracts and a customer list. As part of this transaction, the Company entered into a supply agreement and agreements granting the Company the non-exclusive use of certain trademarks and patents for the products covered by the supply agreement. The total consideration associated with this transaction was $9.0 million, and the Company recognized intangible assets of the same amount, which are included in Other intangible assets, net of amortization on the Company's consolidated balance sheet. The Company paid $6.0 million of the consideration during the three months ended March 31, 2018, and paid the remaining $3.0 million in April 2018. The acquired intangible assets will be fully amortized over estimated useful lives ranging between 5 and 13 years.

4. Certain Balance Sheet Information

Cash and Cash Equivalents 

Cash and cash equivalents were $58.9 million as of September 30, 2018 and $53.9 million as of September 30, 2017. These amounts included the following:

	September 30, 2018		September 30, 2017
Cash held by foreign subsidiaries	$	52.9	$	36.8
Non-USD denominated currency held by foreign subsidiaries	$	48.8	$	31.1
Currency denominated in RMB	$	6.5	$	8.5

Non-USD denominated currency held by foreign subsidiaries was primarily in euros and CAD. While the RMB is convertible into USD, foreign exchange transactions are subject to approvals from SAFE. The Company does not anticipate any significant adverse impact to overall liquidity from potential limitations on the transfer or conversion of cash and cash equivalents.

98

Inventories

Inventories at September 30, 2018 and 2017 consisted of the following:

	September 30, 2018		September 30, 2017
Finished products	$	334.0	$	310.6
Supplies	4.8		4.9
Total	$	338.8	$	315.5

The Company’s inventories in the U.S. and Canada are collateral under the Credit Facilities.

Other Non-Current Assets

Other non-current assets at September 30, 2018 and 2017 consisted of the following:

	September 30, 2018		September 30, 2017
Debt issuance costs of the ABL Facility	$	3.8	$	5.1
Deposits	2.5		2.8
Interest rate swap (1)	8.0		0.3
Other	1.9		2.4
Total	$	16.2	$	10.6

⁽¹⁾ See Note 8 for additional information.

Amortization of debt issuance costs related to the ABL Facility recorded in Interest expense in the consolidated statements of operations was $1.3 million, $1.3 million and $0.4 million for the fiscal years ended September 30, 2018, 2017 and 2016, respectively.

Amortization of debt issuance costs related to the Predecessor ABL Facility recorded in interest expense was $2.1 million for the period from October 1, 2015 through June 8, 2016.

Investments and Cash Previously Held in Trust

Prior to the Business Combination, the Company held in a trust account securities which the Company had the ability and intent to hold until maturity. Held-to-maturity treasury securities were recorded at amortized cost and adjusted for the amortization of the original discount. During the fiscal year ended September 30, 2016, the Company recognized $0.5 million of amortization related to the original discount, which was recorded in Interest income in the consolidated statement of operations. As part of the Business Combination, the Company withdrew all $501.1 million of proceeds from the trust account.

99

5. Property, Plant and Equipment

Property, plant and equipment at September 30, 2018 and 2017 consisted of the following:

	September 30, 2018			September 30, 2017
Land	$	50.8		$	51.0
Plants and buildings (1)	109.7			106.5
Machinery and equipment (2)	153.4			152.8
Software and computer equipment	70.5			63.3
Construction in progress	5.4			5.0
Total	389.8			378.6
Less accumulated depreciation (3)	(104.9		)	(62.5		)
Property, plant and equipment, net	$	284.9		$	316.1

⁽¹⁾ Includes $13.7 million related to facilities acquired under capital leases for the periods ended September 30, 2018 and September 30, 2017.

⁽²⁾ Includes $26.5 million and $27.2 million, respectively, related to equipment acquired under capital leases.

⁽³⁾ Includes $7.4 million and $4.9 million, respectively, related to facilities and equipment acquired under capital leases.

Depreciation expense recognized on the property, plant and equipment described above was as follows:

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 Through June 8, 2016
Depreciation expense	$	46.8	$	48.2	$	13.6	$	27.1

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

Included in the carrying value of property, plant and equipment in the Company's consolidated balance sheets are certain closed facilities located in the U.S., which collectively have a carrying value of $1.1 million as of September 30, 2018 and 2017, respectively. The facilities do not currently meet the criteria for held-for-sale classification; accordingly, they remain classified as held and used.  

During the fourth quarter of fiscal year 2017, the Company's facilities were adversely effected by three major hurricanes. Hurricane Harvey caused extensive flooding and costly physical damage along the Texas Gulf Coast, while Puerto Rico suffered a direct hit from Hurricanes Irma and Maria. The Company has recorded an impairment charge of $1.4 million to Cost of sales and operating expenses in the Company’s consolidated income statement related to these natural disasters.

During the fourth quarter of fiscal year 2017, the Company entered into a purchase agreement to buy land currently leased at one of the Company's distribution centers. The purchase is expected to be finalized during the first half of fiscal year 2019 for approximately $10.8 million.

Facility Lease

The Company's sale of its Franklin Park facility to the Illinois Tollway Authority under an eminent domain proceeding was completed in September 2016 for $4.6 million, net of costs incurred.

As a result of the sale of this facility, the Company relocated operations to a new leased facility in Montgomery, Illinois. The Montgomery Lease has a term of 15 years, with annual payments beginning at $1.1 million per year, excluding executory costs, and annual escalations of 2.5% per year. The lease agreement includes three, five year renewal options. The Montgomery Lease is accounted for as a capital lease and began in the first quarter of fiscal year 2017 at an initial cost of $13.2 million.

100

During the fiscal years ended September 30, 2017 and 2016, the Company recorded a gain of $8.1 million and $0.8 million, respectively, related to capital expenditures incurred in connection with the relocation and reimbursed by the Illinois Tollway Authority, which is included in Other Income on the consolidated statements of operations.

6. Goodwill and Other Intangibles

Goodwill

The following is a progression of goodwill by reportable segment: 

	Chemicals			Plastics			Other		Total
Balance at September 30, 2016	$	331.6		$	271.1		$	63.0	$	665.7
Measurement period adjustments	2.7			1.2			0.5		4.4
Ultra Chem Acquisition	28.0			—			—		28.0
Foreign currency translation	0.5			4.4			—		4.9
Balance at September 30, 2017	$	362.8		$	276.7		$	63.5	$	703.0
Foreign currency translation	(0.4		)	(2.7		)	—		(3.1		)
Balance at September 30, 2018	$	362.4		$	274.0		$	63.5	$	699.9

Goodwill amounts by reportable segment at September 30, 2018 are based on the allocation of the purchase consideration of the Business Combination as of the Closing Date and the allocation of the purchase consideration of the Ultra Chem Acquisition as of the Ultra Chem Closing Date. See Note 3.

Goodwill Impairment Test

Goodwill is tested for impairment annually as of March 31 and whenever events or circumstances make it more likely than not that an impairment may have occurred. Goodwill is reviewed for impairment at the reporting unit level, or operating segment, for the Company. The Company performed an impairment test as of March 31 2018 and concluded that goodwill was not impaired. For purposes of the impairment testing of the Company's recognized goodwill, fair value measurements are determined using the income approach, based largely on inputs that are not observable to active markets, which would be deemed Level 3 fair value measurements as defined in Note 9. These inputs include management’s expectations about future revenue growth and profitability, working capital needs and capital expenditures. Inputs also include estimates of a market participant’s expectations for 1) a discount rate at which the cash flows should be discounted in order to determine the fair value of such expected cash flows, and 2) an estimated income tax rate. The Company also considers a market approach using the comparable company method to verify if is comparable to the income approach.

The evaluation of goodwill requires the use of estimates about future operating results of each reporting unit to determine its estimated fair value. Changes in forecasted operations can materially affect these estimates, which could materially affect the Company’s results of operations. The estimate of fair value requires significant judgment and is based on management’s fair value estimates on assumptions that are believed to be reasonable but that are unpredictable and inherently uncertain, including: estimates of future growth rates, operating margins and assumptions about the overall economic climate as well as the competitive environment for the reporting units. There can be no assurance that these estimates and assumptions made for purposes of the goodwill testing as of the time of testing will prove to be accurate. If assumptions regarding business plans, competitive environments or anticipated growth rates are not correct, the Company may be required to record goodwill impairment charges in future periods, whether in connection with future annual impairment testing, or earlier, if an indicator of an impairment is present prior to the next annual evaluation.

101

Other Intangible Assets

Definite-lived intangible assets at September 30, 2018 and September 30, 2017 consisted of the following: 

	September 30, 2018							September 30, 2017
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Customer-related	$	239.6	$	(44.1	)	$	195.5	$	234.6	$	(23.7	)	$	210.9
Supplier-related	3.1		(0.4		)	2.7		1.5		(0.1		)	1.4
Trade name	23.3		(12.7		)	10.6		22.3		(7.0		)	15.3
Below-market leases	0.7		(0.5		)	0.2		0.7		(0.3		)	0.4
Non-compete agreements	4.6		(2.0		)	2.6		4.2		(0.7		)	3.5
Total	$	271.3	$	(59.7	)	$	211.6	$	263.3	$	(31.8	)	$	231.5

Amortization expense recognized on the intangible assets described above was as follows:

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 Through June 8, 2016
Amortization expense	$	28.1	$	24.9	$	7.0	$	10.6

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

Expected amortization expense for the next five years is as follows:

2019	$	28.3
2020	25.9
2021	21.6
2022	21.4
2023	20.9

7. Debt

Short-term borrowings outstanding and the current portion of long-term debt and capital lease obligations at September 30, 2018 and 2017 are summarized below:

	September 30, 2018		September 30, 2017
Short-term borrowings	$	38.1	$	40.8
Current portion of long-term debt and capital lease obligations	9.6		10.3
Total short-term borrowings and current portion of long term debt and capital lease obligations, net	$	47.7	$	51.1

102

Long-term debt outstanding at September 30, 2018 and 2017 is summarized below:

	September 30, 2018			September 30, 2017
ABL Facility	$	104.6		$	139.3
Term Loan Facility	640.4			646.9
Capital lease obligations (1)	34.0			37.5
Total long-term debt	779.0			823.7
Less: unamortized debt discount (2)	(2.3		)	(2.7		)
Less: debt issuance costs (3)	(14.7		)	(16.7		)
Less: current portion of long-term debt and capital lease obligations	(9.6		)	(10.3		)
Long-term debt and capital lease obligations, less current portion, net	$	752.4		$	794.0

⁽¹⁾  Capital lease obligations exclude executory costs and interest payments associated with the underlying leases. See “Capital Lease Obligations” below.

⁽²⁾  The unamortized debt discount is related to the Term Loan Facility and amortized to interest expense over the life of the instrument using the effective interest rate method.

⁽³⁾  See discussion below under Term Loan Facility and Debt Issuance Cost Amortization.

Short-Term Borrowings

The Company's short-term borrowings are associated with the Company's operations in China and are summarized below:    

	Facility Limit		Outstanding Borrowings Balance		Weighted Average Interest Rate on Borrowings		Outstanding LOC and Bankers' Acceptance Bills		Remaining Availability
September 30, 2018
Bank of America - China (1)	$	24.3	$	22.2	4.6	%	$	—	$	2.1
Bank of Communications - China (2)	21.8		15.9		5.4	%	5.1		0.8
Total	$	46.1	$	38.1			$	5.1	$	2.9
September 30, 2017
Bank of America - China (1)	$	24.3	$	23.8	4.3	%	$	—	$	0.5
Bank of Communications - China (2)	22.5		17.0		5.3	%	5.3		0.2
Total	$	46.8	$	40.8			$	5.3	$	0.7

⁽¹⁾  The borrowing limit of this facility is denominated in USD. This line of credit is secured by a standby letter of credit drawn on the ABL Facility covering at least 110% of the facility's borrowing limit amount. Borrowings under the line of credit are payable in full within 12 months of the date of the advance. The Company has the ability to provide additional capacity under these lines of credit, if needed.

⁽²⁾ The borrowing limit of this facility is denominated in RMB. This line of credit is secured by a standby letter of credit drawn on the ABL Facility covering at least 100% of the facility's borrowing limit amount. Borrowings under the line of credit are payable in full within 12 months of the date of the advance.

Long-Term Debt

ABL Facility

The ABL Facility provides for committed revolving credit financing including a U.S. Tranche of up to $505.0 million, a Canadian Tranche of up to the USD equivalent of $40.0 million, and a FILO Tranche up to $30.0 million. The ABL Facility matures on June 9, 2021. Provided no default or event of default, the ABL Borrowers have the option to request that the ABL Facility be increased by an aggregate amount, when included with any incremental borrowings issued under the Term Loan Facility, not to exceed $175.0 million.

103

The ABL Facility includes a letter of credit sub-facility, which permits up to $200.0 million of letters of credit under the U.S. Tranche (which may be denominated in USD, euros or other currencies approved by the administrative agent and the issuing bank) and up to the USD equivalent of $10.0 million of letters of credit under the Canadian Tranche (which may be denominated in CAD only). The ABL Facility also contains a FILO Tranche which can be used by any non-Canadian foreign subsidiary for loans or letters of credit up to an aggregate amount not to exceed $30.0 million.

The amount of available credit changes every month, depending on the amount of eligible receivables and inventory the ABL Borrowers have available to serve as collateral. In general, the facility is limited to the lesser of (i) the aggregate commitment or (ii) the sum of (a) 90.0% of eligible accounts receivable, as defined therein, and (b) 85.0% of the orderly liquidation value of the eligible inventory and (c) 100.0% of cash and cash equivalents held in blocked accounts, as defined, maintained by the ABL Agent, for each ABL Borrower. Available credit for the U.S. and Canadian Tranches are calculated separately, and the borrowing base components are subject to customary reserves and eligibility criteria.

Borrowings under the U.S. Tranche and the Canadian Tranche of the ABL Facility bear interest, at the ABL Borrowers’ option, at either an alternate base rate or Canadian prime rate, as applicable, plus an applicable margin (ranging from 0.25% to 0.75% pursuant to a grid based on average excess availability) or LIBOR or Canadian BA rate (as defined therein), as applicable, plus an applicable margin (ranging from 1.25% to 1.75% pursuant to a grid based on average excess availability). Loans under the FILO Tranche, within the ABL Facility, bear interest at an alternate base rate plus an applicable margin (ranging from 1.00% to 1.50% pursuant to a grid based on average excess availability) or LIBOR plus an applicable margin (ranging from 2.00% to 2.50% pursuant to a grid based on average excess availability). In addition to paying interest on outstanding principal amounts under the ABL Facility, the ABL Borrowers are required to pay a commitment fee in respect of the unutilized commitments, which commitment fee is 0.250% or 0.375% per annum and is determined based on average utilization of the ABL Facility (increasing when utilization is low and decreasing when utilization is high). The ABL Borrowers are required to pay customary letters of credit fees.

The ABL Facility requires that if the sum of (i) excess availability, as defined (for the ABL Borrowers) and (ii) the amount by which the then-current borrowing base exceeds the aggregate commitments under the ABL Facility (for the ABL Borrowers) is less than the greater of (a) $40.25 million and (b) 10.0% of the Line Cap (as defined in the ABL Facility), the ABL Borrowers shall comply with a minimum fixed charge coverage ratio of at least 1.0 to 1.0. In addition, the ABL Facility contains negative covenants that restrict Holdings and its subsidiaries, including the ABL Borrowers from, among other things, incurring additional debt, granting liens, entering into guarantees, entering into certain mergers, making certain loans and investments, disposing of assets, prepaying certain debt, declaring dividends, modifying certain material agreements or changing the business it conducts.

The ABL Facility also contains certain customary representations and warranties, affirmative covenants and events of default, including, among other things, payment defaults, breach of representations and warranties, covenant defaults, cross-defaults and cross-acceleration to certain indebtedness, certain events of bankruptcy, certain events under the Employee Retirement Income Security Act of 1974, as amended from time to time, material judgments, actual or asserted failure of any guaranty or security document supporting the ABL Facility to be in full force and effect, and change of control. If such an event of default occurs, the lenders under the ABL Facility are entitled to take various actions, including the acceleration of amounts due under the ABL Facility and all actions permitted to be taken by a secured creditor.

The weighted average interest rate on borrowings under the ABL Facility was 3.26% at September 30, 2018. The Company had the USD equivalent of $74.1 million in outstanding letters of credit under the ABL Facility at September 30, 2018. The collective credit availability under the U.S. and Canadian Tranches of the ABL Facility was the U.S. equivalent of $344.2 million at September 30, 2018. There was $5.0 million availability under the FILO Tranche at September 30, 2018.

Obligations under the ABL Facility are secured by a first priority lien on all ABL Facility first lien collateral, including eligible inventory and accounts receivable of the ABL Borrowers, and a second priority lien on all Term Loan Facility first lien collateral including outstanding equity interests of the Borrower and certain of the other subsidiaries of Holdings, in each case, subject to certain limitations; provided, that no ABL Facility first lien collateral or Term Loan Facility first lien collateral owned by the Canadian Borrower secure the obligations owing under the U.S. tranche of the ABL Facility. These accounts receivable and inventory totaled $709.4 million in the aggregate as of September 30, 2018.

104

As of September 30, 2018, the ABL Borrowers were in compliance with the covenants of the ABL Facility.

Term Loan Facility

The Term Loan Facility provides secured debt financing in an aggregate principal amount of up to $655.0 million and the right, at the Company's option, to request additional tranches of term loans in an aggregate principal amount, when included with any incremental borrowings issued under the ABL Facility, of up to $175.0 million, plus unlimited additional amounts such that the aggregate principal amount of indebtedness outstanding at the time of incurrence does not cause the Secured Net Leverage Ratio, calculated on a pro forma basis, to exceed 4.1 to 1.0. Availability of such additional tranches of term loans is subject to the absence of any default and, among other things, the receipt of commitments by existing or additional financial institutions. Borrowings under the Term Loan Facility bear interest at the borrower’s option at either (i) the LIBOR rate determined by reference to the costs of funds for USD deposits for the interest period relevant to such borrowing adjusted for certain additional costs, which shall be no less than 1.0%, plus an applicable margin of 4.25% or (ii) a base rate determined by reference to the highest of (a) the prime commercial lending rate published by Bank of America, N.A. as its "prime rate," (b) the federal funds effective rate plus 0.50% and (c) a one-month LIBOR rate plus 1.0%, plus an applicable margin of 3.25%. The Company is required to make scheduled quarterly payments in an aggregate annual amount equal to 1.0% of the aggregate principal amount of the initial term loans made on the Closing Date of the Mergers, with the balance due at maturity. The Term Loan Facility matures on June 9, 2023. The weighted average interest rate for the Term Loan Facility was 5.58% at September 30, 2018. The Company amortized $0.4 million and $0.5 million of debt discount to interest expense during the fiscal years ended September 30, 2018 and 2017, respectively.

On December 19, 2017, the Company completed TLB Amendment No. 2 amending the Term Loan Facility. TLB Amendment No. 2 reduced the interest rate margin applicable to outstanding term loans by 50 basis points from 3.75% to 3.25% for LIBOR loans and from 2.75% to 2.25% for base rate loans. TLB Amendment No. 2 also provides for a soft call premium equal to 1% of the amount of the term loans that are subject to certain repricing transactions occurring on or prior to twelve months from the effective date of TLB Amendment No. 2. As a result of TLB Amendment No. 2, the Company paid debt issuance costs of $0.8 million, which will be amortized throughout the remaining life of the Term Loan Facility.

Additionally, the Term Loan Facility requires the Company to make mandatory principal payments on an annual basis, if cash flows for the year, as defined in the Term Loan Facility, exceed certain levels specified in the Term Loan Facility. The Company was not required to make such mandatory principal payment for the fiscal year ended September 30, 2018. The Company generally has the right to prepay loans in whole or in-part, without incurring any penalties for early payment.

The Term Loan Facility contains a number of covenants that, among other things and subject to certain exceptions, restrict Holdings’ ability and the ability of its subsidiaries to incur additional indebtedness, pay dividends on its capital stock or redeem, repurchase or retire its capital stock or other indebtedness, make investments, loans and acquisitions, create restrictions on the payment of dividends or other amounts to the Company from its restricted subsidiaries, engage in transactions with its affiliates, sell assets, including capital stock of its subsidiaries, alter the business it conducts, consolidate or merge, incur liens. The Term Loan Facility does not require the Company to comply with any financial maintenance covenants and contains certain customary representations and warranties, affirmative covenants and provisions relating to events of default.

Obligations under the Term Loan Facility are secured by a first priority lien on all Term Loan Facility first lien collateral, including outstanding equity interests of the Borrower and certain of the other subsidiaries of Holdings, and a second priority lien on all ABL Facility first lien collateral, including accounts receivable and inventory of the loan parties under the Term Loan Facility, subject to certain limitations.

As of September 30, 2018, the Company was in compliance with the covenants of the Term Loan Facility.

105

Debt Issuance Cost Amortization

Amortization expense included in interest expense related to debt issuance costs of the Term Loan Facility was $2.8 million, $2.4 million and $0.7 million for the fiscal years ended September 30, 2018, 2017 and 2016, respectively.

Amortization expense included in interest expense related to debt issuance costs was $3.6 million for the period from October 1, 2015 through June 8, 2016 for the Predecessor.

Capital Lease Obligations

The capital lease obligation balance of $34.0 million as of September 30, 2018 is primarily associated with the Ryder Lease and the Montgomery Lease. The Ryder Lease obligation excludes decreasing annual interest payments ranging from $0.9 million to less than $0.1 million, for aggregate interest payments totaling $2.8 million. The Montgomery Lease obligation excludes decreasing annual interest payments ranging from $1.0 million to $0.1 million, for aggregate interest payments of $12.6 million.

Debt Obligations

The following table sets forth future principal payments on debt and capital lease obligations at September 30, 2018:

2019	$	47.7
2020	9.6
2021	114.1
2022	13.2
2023	619.7
Thereafter	12.8
Total	$	817.1

8. Derivatives

During the three months ended March 31, 2018, the Company entered into three additional interest rate swap agreements with a combined notional amount of $300.0 million to help mitigate interest rate risk related to the variable rate Term Loan Facility. During the three months ended March 31, 2017, the Company entered into four interest rate swap agreements with a combined notional amount of $300.0 million to help mitigate interest rate risk related to the variable rate Term Loan Facility. The swap agreements expire at various dates from February 2020 through February 2023 and are accounted for as cash flow hedges. Gains or losses resulting from changes in the fair value of the swaps are recorded in other comprehensive income. Gains and losses recorded in other comprehensive income are reclassified into and recognized in income when the interest expense on the Term Loan Facility is recognized.

On June 29, 2017, the Company removed the interest rate floor component of the interest-rate swaps to align the swaps with the Term Loan Facility terms after the modification of the Term Loan Facility in March 2017 with TLB Amendment No. 1. In connection with the modification of the swaps’ terms, the Company received cash proceeds of $0.5 million. During the fiscal year ended September 30, 2017, the Company recognized approximately $0.6 million of interest expense related to ineffectiveness of the interest-rate swaps prior to June 29, 2017. The interest rate swaps continue to be accounted for as cash flow hedges and there was no material ineffectiveness related to the swaps after the modification of the terms described above.

106

Derivative assets and liabilities at September 30, 2018 and September 30, 2017 consisted of the following:

	Recorded to	September 30, 2018		September 30, 2017
Short-term derivative asset	Other current assets	$	2.2	$	—
Long-term derivative asset	Other non-current assets	$	8.0	$	0.3
Short-term derivative liability(1)	Accrued expenses and other liabilities	$	—	$	1.1
Long-term derivative liability	Other non-current liabilities	$	—	$	0.2
Other Comprehensive Income(2)	Accumulated other comprehensive income	$	8.1	$	—

^{(1) Short-term derivative liability for the fiscal year ended September 30, 2018 was less than $0.1 million}  

^{(2) Other Comprehensive Income for the fiscal year ended September 30, 2017 was less than $0.1 million}  

Prior to the Business Combination, the Predecessor was a party to interest rate swap agreements of varying expiration dates through March 2017, to mitigate the exposure to interest rate risk related to the variable-rate Predecessor Term Loan Facility. As a result of the Business Combination, the Predecessor Term Loan Facility was extinguished, the related swap agreements were terminated and an early termination payment penalty of $0.3 million was paid and recorded in Transaction related costs in the consolidated statement of operations.

Gains and losses (net of reclassifications into income, including any ineffective portion) related to the interest rate swaps of the Company and the Predecessor were as follows:

		Successor				Predecessor
	Recorded to	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		October 1, 2015 through June 8, 2016
Realized loss	Interest expense	$	1.2	$	2.0	$	0.3
Unrealized gain, net of tax	Other comprehensive income	$	8.1	$	—	$	0.3

The tax impact of the unrealized gains related to the interest-rate swaps was $2.8 million and less than $0.1 million for the fiscal years ended September 30, 2018 and 2017, respectively. There was no material tax impact for the Predecessor periods presented. At September 30, 2018, $2.8 million in unrealized gains were expected to be realized and recognized in income within the next twelve months.

See Note 9 for additional information on the fair value of the Company and Predecessor’s derivative instruments.

9. Fair Value Measurements

The accounting standard for fair value measurements establishes a framework for measuring fair value that is based on the inputs market participants use to determine the fair value of an asset or liability and establishes a fair value hierarchy to prioritize those inputs. The fair value hierarchy is as follows:

• Level 1—Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

• Level 2—Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability.

• Level 3—Prices or valuation models that require inputs that are both significant to the fair value measurement and less observable for objective sources (i.e., supported by little or no market activity).

107

The fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs are obtained from independent sources and can be validated by a third party, whereas unobservable inputs reflect assumptions a third party would use in pricing an asset or liability based on the best information available under the circumstances. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment, which may affect the valuation of the assets and liabilities and their placement within the fair value hierarchy levels. The Company considers active markets as those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis.

Fair value of financial instruments

The carrying values of cash and cash equivalents, accounts and notes receivable, accounts payable and short-term borrowings approximate their fair value due to the short-term maturity of those instruments.

The carrying values of borrowings outstanding under the Credit Facilities approximate fair value at September 30, 2018 and 2017 primarily due to their variable interest rate. The estimated fair value of these instruments is classified by the Company as a Level 3 measurement within the fair value hierarchy due to the varying interest rate parameters as outlined in the respective loan agreements.

Assets and Liabilities Measured at Fair Value on a Non-recurring Basis

In addition to the financial instruments that are recorded at fair value on a recurring basis, the Company records assets and liabilities at fair value on a non-recurring basis as required by U.S. GAAP. Generally, assets are recorded at fair value on a non-recurring basis as a result of impairment charges or as part of a business combination. As discussed in Note 3, during the fiscal year ended September 30, 2017, the Company recorded non-recurring fair value measurements related to the Ultra Chem Acquisition and its asset acquisitions. These fair value measurements were classified as Level 3 within the fair value hierarchy.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Contingent Consideration

The fair value of the contingent consideration related to the Deferred Cash Consideration as discussed in Note 3 was $62.7 million and $35.1 million as of September 30, 2018 and 2017, respectively. The increase in the liability was largely driven by the increase in the Company’s stock price. The measurement of the contingent consideration related to the Deferred Cash Consideration is classified by the Company as a Level 3 measurement within the fair value hierarchy. In order to estimate the fair value of the Deferred Cash Consideration, the Company estimates the value of the Excess Shares using a Monte Carlo simulation model with the market price of the Company’s common stock at each valuation date being a significant input to this model. Unobservable inputs to the valuation are the expected volatility during the applicable period as well as a marketability discount to reflect the illiquidity of the Excess Shares given their terms. An increase in the market price of the Company’s common stock has the same directional effect on the value of the liability related to the Deferred Cash Consideration. An increase in the volatility and marketability discount will lower the value of the liability related to the Deferred Cash Consideration.

108

The fair value of the liability for the contingent consideration related to the TRA as discussed in Note 3 was $74.8 million and $105.1 million as of September 30, 2018 and 2017, respectively. The decrease in the liability includes the impact of the Tax Act enacted in December 2017 (see Note 15), which lowers the Company's projected income tax liabilities, the estimate of tax benefits expected to be realized as a result of the Business Combination and the ultimate amount expected to be paid by the Company to the Selling Equityholders and payments made to the Selling Equityholders. The liability for the contingent consideration related to the TRA is classified by the Company as a Level 3 measurement within the fair value hierarchy. The Company estimates the fair value of the liability for the contingent consideration related to the TRA based on a discounted cash flow model which incorporates assumptions of projected taxable income, projected income tax liabilities and an estimate of tax benefits expected to be realized as a result of the Business Combination. Key inputs to the valuation are prevailing tax rates and market interest rates impacting the discount rate. A 100 basis point increase in the discount rate compared to the discount rate used at the September 30, 2018 valuation would have resulted in a decrease of approximately $0.6 million in the value of the liability for the contingent consideration related to the TRA. Additionally, this cash flow model is sensitive to changes in applicable tax rates. A 100 basis point decrease in the tax rate compared to the tax rate used at the September 30, 2018 valuation would have resulted in an increase of approximately $2.6 million in the value of the liability for the contingent consideration related to the TRA.

During the fiscal year ended September 30, 2017, the Company recorded a $5.6 million measurement period adjustment to the estimated fair value of the TRA liability as of the Closing Date, related to the assessments of the tax attributes associated with certain entities.

Changes in the fair value of the contingent consideration obligations for the fiscal years ended September 30, 2018 and 2017 were as follows:

	TRA			Deferred Cash Consideration		Total Fair Value
Contingent consideration as of September 30, 2016	$	83.4		$	35.0	$	118.4
Measurement period adjustment	5.6			—		5.6
Change in fair value of contingent consideration(1)	16.1			0.1		16.2
Contingent consideration as of September 30, 2017	$	105.1		$	35.1	$	140.2
Cash Paid to TPG	(10.2		)	—		(10.2		)
Change in fair value of contingent consideration(1)	(20.1		)	27.6		7.5
Contingent consideration as of September 30, 2018	$	74.8		$	62.7	$	137.5

⁽¹⁾ Included in Operating income in the consolidated statements of operations.

Significant changes in the estimates and inputs used in determining the fair value of the contingent consideration could have a material impact on the amounts recognized as a component of Operating income (loss) in future periods. For additional information regarding the contingent consideration obligations, see Note 3.

Interest Rate Swaps

The Company classifies interest rate swaps within Level 2. During the three months ended March 31, 2017, the Company entered into four interest rate swap agreements to help mitigate interest rate risk related to the variable-rate Term Loan Facility. On June 29, 2017, the Company removed the interest rate floor component of the interest-rate swaps to align the swaps with the Term Loan Facility terms after the modification of the Term Loan Facility in March 2017 with TLB Amendment No. 1. During the three months ended March 31, 2018, the Company entered into three additional interest rate swap agreements to help mitigate interest rate risk related to the variable rate Term Loan Facility. The agreements expire at various dates through February 2023. At September 30, 2018, the Company recorded $2.2 million in Other current assets and $8.0 million in Other non-current assets in the consolidated balance sheet related to these instruments.

Prior to the Business Combination, the Predecessor was a party to interest rate swap agreements of varying expiration dates through March 2017 to mitigate the exposure to interest rate risk related to the variable-rate Predecessor Term Loan Facility. As a result of the Business Combination, the Predecessor Term Loan Facility was extinguished, the related swap agreements were terminated and an early termination payment of $0.3 million was made and recorded during the Predecessor period of October 1, 2015 through June 8, 2016 in Transaction related costs in the consolidated statement of operations.

109

During the fiscal years ended September 30, 2018 and 2017, the Company did not have any transfers between Level 1, Level 2 or Level 3 fair value measurements.

10. Share-Based Compensation and Employee Benefit Plans

On June 8, 2016, the Company’s stockholders approved the 2016 LTIP, with an effective date of March 30, 2016, covering approximately a ten-year period. No awards may be granted under the 2016 LTIP after March 20, 2026. The 2016 LTIP permits the grant of up to 9,000,000 shares of the Company's common stock for various types of awards to employees, directors and consultants of the Company or its subsidiaries, including incentive and non-incentive stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalents, stock awards, conversion awards and performance awards.

Vesting conditions of awards under the 2016 LTIP are determined by the Compensation Committee of the Board of Directors of the Company, including treatment upon the occurrence of a change of control of the Company. Upon a change of control, the Compensation Committee has the discretion to remove forfeiture restrictions, accelerate vesting, require recipients of awards to surrender the awards for cash consideration, cancel unvested awards without payment of consideration, cause any surviving entity to assume and continue any outstanding awards, or make other such adjustments as the Compensation Committee deems appropriate to reflect such change of control.

If any change is made to the Company’s capitalization, appropriate adjustments will be made by the Compensation Committee as to the number and price of shares awarded under the 2016 LTIP, the securities covered by such awards, the aggregate number of shares of common stock of the Company available for the issuance of awards under the 2016 LTIP and the maximum annual per person compensation limits on share-based awards under the 2016 LTIP.

Other than in connection with a change in capitalization or other transaction where an adjustment is permitted or required under the terms of the 2016 LTIP, the Compensation Committee is prohibited from making any adjustment or approving any amendment that reduces or would have the effect of reducing the exercise price of a stock option or stock appreciation right previously granted under the 2016 LTIP unless the Company’s stockholders have approved such adjustment or amendment.

In each calendar year during any part of which the 2016 LTIP is in effect, an employee may not receive awards under the plan in excess of 1,000,000 shares of common stock, or a value of greater than $12.0 million if an award is to be paid in cash or if settlement is not based on shares of common stock, in each case, multiplied by the number of full or partial calendar years in any performance period established with respect to an award, if applicable. A non-employee member of the Board may not be granted awards with a cumulative value of greater than $1.0 million during any calendar year for services rendered in their capacity as a director. This limit does not apply to grants made to a non-employee director for other reasons not related to their services as a director.

During the fiscal year ended September 30, 2018, the Company granted 193,667 PSUs to employees under the 2016 LTIP. These awards will vest on September 30, 2020, entitling the recipient to receive a certain number of shares of the Company’s common stock, based on the Company’s achievement of the performance goals included in the PSUs, which are based on a return on invested capital calculation over a three-year performance period. Depending on the calculation as of the vesting date, a recipient is entitled to receive between 0% and 200% of the initial award. The awards are accounted for as equity instruments, and the fair value of these awards was determined by the closing price of the Company's common stock on the date of grant.

110

During the fiscal years ended September 30, 2017 and 2016, the Company granted 212,000 and 1,557,500 PSU awards to employees, respectively, under the 2016 LTIP. The performance aspect of the PSUs vest on June 30, 2019, entitling the recipient to receive a certain number of shares of the Company's common stock, based on the Company’s achievement of the performance goals included in the PSUs. Depending on the performance of common stock during the approximate three-year performance period, a recipient of the award is entitled to receive a number of shares of common stock equal to a percentage, ranging from 0% to 200%, of the initial award granted, with a 35% total stockholder return entitling the recipient to receive 100% of the award granted. If the Company’s total stockholder return for the performance period is negative, then the number of units ultimately awarded is based on the Company’s achievement of its cumulative Adjusted EBITDA target, as defined by the PSU agreement, during the performance period. If total stockholder return is between negative 15% and 0%, a recipient is entitled to receive a number of shares of common stock between 50% and 70% of the number of PSUs granted. If the cumulative Adjusted EBITDA target is not met, or the total stockholder return is less than negative 15%, no shares of the Company’s common stock will be issued. The Company used the Monte Carlo simulation model to estimate the fair value of the PSU awards at the grant date, considering the probability of satisfying the various performance criteria. The resulting grant date fair value is recognized as expense on a straight-line basis from the grant date through the end of the performance period. The assumptions used in the Monte Carlo simulation model for PSUs included an expected stock price volatility between 35% and 40% based on a peer group of similar companies, an expected dividend yield of 0%, an expected term of two to three years, and a risk-free interest rate of between 0.9% and 1.3%.

The following table summarizes all PSU activity during the fiscal year ended September 30, 2018:

	Units		Average Grant Date Fair Value Per Unit
Unvested PSUs at September 30, 2017	1,524,000		$	8.92
Granted	193,667		7.50
Vested	—		—
Forfeited/Canceled	(22,500	)	9.13
Unvested PSUs at September 30, 2018	1,695,167		$	8.76

As of September 30, 2018, the Company may issue up to 3,390,334 shares of common stock related to the outstanding PSU awards described above under the 2016 LTIP.

In November 2017, the Company granted 415,867 shares of restricted stock to employees under the 2016 LTIP. The restricted stock awards vest equally on the anniversary of the grant date over a three-year period provided that the recipients of such grants continue their employment with the Company. The awards are accounted for as equity instruments, and the fair value of the restricted stock awards was determined by the closing price of the Company's common stock on the date of grant. During the fiscal years ended September 30, 2017 and 2016, the Company granted restricted stock awards to certain of the Company’s non-employee directors under the 2016 LTIP that vest one year from the date of grant.

During the fiscal years ended September 30, 2017 and 2016, the Company also granted 77,458 and 64,518 shares of restricted stock, respectively, to certain of the Company's non-employee directors under the 2016 LTIP. The restricted stock will vest on the anniversary of the grant date provided the director continues his services as a director of the Company. The fair value of the restricted stock was determined by the closing price of the Company's common stock on the date of grant.

The following table summarizes restricted stock activity during the fiscal year ended September 30, 2018:

	Shares of Restricted Stock		Average Grant Date Fair Value Per Unit
Restricted stock at September 30, 2017	77,458		$	8.26
Granted	415,867		7.50
Vested	(53,450	)	8.28
Forfeited/Canceled	(30,608	)	8.05
Restricted stock at September 30, 2018	409,267		$	7.50

111

During the fiscal year ended September 30, 2016, TPG Restricted Stock Grants were awarded with respect to 100,000 shares of Company common stock owned by TPG. These awards vest in equal amounts over a three-year period provided that the recipients of such grants continue their employment with the Company. During the fiscal year ended September 30, 2018, 27,471 shares of these awards vested and 7,163 shares were transferred to the Company (reflected as treasury stock) to satisfy the officers' and employees tax withholding obligations in connection with the vesting. During the fiscal year ended September 30, 2017, 33,297 shares of these awards vested and 9,576 shares were transferred to the Company (reflected as treasury stock) to satisfy the officers’ and employees’ tax withholding obligations in connection with the vesting, and 11,673 shares were transferred back to TPG due to forfeiture. There were 27,559 unvested shares of these awards at September 30, 2018. While these awards were not made pursuant to the 2016 LTIP, they constitute equity-based compensation and therefore will count against the 2016 LTIP's share reserve to the extent the awards vest.

During the fiscal year ended September 30, 2018, the Company granted 999,492 stock options to employees under the 2016 LTIP. The awards vest in equal amounts over a three-year period provided that the recipients of such grants continue their employment with the Company and have a ten-year contractual term. The awards are accounted for as equity instruments. The Company used the Black-Scholes Merton model to estimate the fair value of the option awards at the grant date. The resulting grant date fair value is recognized as expense on a straight-line basis over the vesting period. The assumptions used in the Black-Scholes Merton model for the options included an expected term of six years, an expected stock price volatility of 35.0% based on a peer group of similar companies, an expected dividend yield of 0% and a risk-free interest rate of 2.1%.

The following table summarizes stock option activity during the fiscal year ended September 30, 2018:

	Stock Options		Average Grant Date Fair Value Per Unit		Weighted Average Exercise Price
Stock options at September 30, 2017	—		$	—	$	—
Granted	999,492		2.84		7.42
Exercised	—		—		—
Forfeited/Canceled	(6,600	)	2.84		7.42
Stock options at September 30, 2018	992,892		$	2.84	$	7.42

The outstanding stock options as of September 30, 2018 had an aggregate intrinsic value of $4.8 million. No stock options were exercisable as of September 30, 2018.

During the fiscal year ended September 30, 2017, the Company granted certain employees a total of 28,000 RSUs that vest equally over a three-year period on the anniversary of the grant date provided the employee remains employed by the Company. The awards are accounted for as equity instruments. Upon vesting, the recipients will receive a share of common stock in the Company for each RSU awarded. The fair value of these RSUs was determined based on the closing price of the Company’s stock on the grant date.

The following table summarizes RSU award activity during the fiscal year ended September 30, 2018:

	RSUs		Average Grant Date Fair Value Per Unit
Unvested RSUs at September 30, 2017	24,500		$	7.28
Granted	—		—
Vested	(8,162	)	7.28
Forfeited/Canceled	—		—
Unvested RSUs at September 30, 2018	16,338		$	7.28

112

During the fiscal year ended September 30, 2017, the Company also awarded 10,500 phantom RSUs and 10,000 phantom PSUs to certain non-U.S. employees. The phantom RSUs vest equally over a three-year period on the anniversary of the grant date while the phantom PSUs vest under the same conditions as the PSU awards described above. During the fiscal year ended September 30, 2017, 3,500 of the phantom RSUs were forfeited and all of the phantom PSUs were forfeited. Upon vesting and provided the employee remains employed by the Company at that time, the awards will be settled in cash. In accordance with ASC 718, the remaining phantom RSU awards are accounted for as a liability, with the awards re-measured at the end of each reporting period based on the closing price of the Company’s common stock or using a Monte Carlo simulation model, as applicable. Compensation expense is recognized ratably on a straight-line basis over the requisite service period. An immaterial amount of compensation expense was recognized during the fiscal years ended September 30, 2018 and 2017 related to these awards.

The following table summarizes the amount of compensation expense recognized as a component of Selling, general and administrative expenses on the consolidated statements of operations by award type:

	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*
PSUs	$	4.7	$	4.5	$	1.3
Restricted Stock	$	1.2	$	0.6	$	0.1
TPG restricted stock grants	$	0.3	$	0.3	$	0.1
Stock options	$	0.8	$	—	$	—
RSUs	$	0.1	$	0.1	$	—

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

The following table summarizes unrecognized compensation expense and weighted average remaining life as of the fiscal year ended September 30, 2018 by award type:

	Unrecognized Compensation Expense		Weighted Average Remaining Life (in years)
PSUs	$	4.1	0.9
Restricted Stock	$	2.0	2.1
TPG restricted stock grants	$	0.4	0.7
Stock options	$	1.9	9.1
RSUs	$	0.1	1.1

113

As of September 30, 2018, there were 3,980,465 shares of the Company’s common stock available for issuance under the 2016 LTIP, assuming the PSU awards vest at their maximum target. Pursuant to the terms of the Univar Merger Agreement and upon the closing of the transactions contemplated by the Univar Merger Agreement, each outstanding award granted, including unvested awards, under the 2016 LTIP will be cancelled in exchange for the consideration set forth in the Univar Merger Agreement. Each outstanding stock option, including options out of the money, will be cancelled and converted into the right to receive the merger consideration received by the Company's stockholders in respect of each "net share" covered by such stock option. The number of "net shares" covered by each stock option is equivalent to the number of shares of the Company's common stock with a value equal to the intrinsic value of such stock option. Each outstanding share of restricted stock, including unvested shares, will be cancelled and converted into the right to receive the merger consideration received by the Company's stockholders. Each outstanding PSU award, including unvested PSU awards, will be cancelled and converted into the right to receive the merger consideration received by the Company's stockholders with respect to the number of shares of the Company's common stock subject to such PSU award (determined based on actual performance through the latest practicable date prior to the closing of the transactions contemplated by the Univar Merger Agreement). Each outstanding RSU award, including unvested RSU awards, will be cancelled and converted into the right to receive the merger consideration received by the Company's stockholders with respect to the number of shares of the Company's common stock subject to such RSU award. Each outstanding phantom RSU, including unvested phantom RSUs, will be cancelled and converted into the right to receive an amount in cash equal to the value of the merger consideration received by the Company's stockholders with respect to the number of shares of the Company's common stock subject to such phantom RSU award. The Company is restricted from granting any addition share-based compensation pursuant to a covenant contained in the Univar Merger Agreement.

Defined Contribution Plans

Qualifying employees of the Company are eligible to participate in the Company's 401(k) Plan. The 401(k) Plan is a defined contribution plan which allows employees to make tax deferred contributions as well as company contributions, designed to assist employees of the Company and its affiliates in providing for their retirement. The Company matches 100% of employee contributions up to 4.0%. The Company makes an additional contribution to the 401(k) Plan of 1.5%, 3.0%, or 4.5%, based upon years of service of one to ten years, eleven to twenty years, and over twenty-one years or more, respectively. A version of the 401(k) Plan is also available for qualifying employees of the Company in its foreign subsidiaries.

The following summarizes contributions to the plans described above:

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 through June 8, 2016
Contributions recorded as a component of cost of sales and operating expenses	$	4.2	$	4.0	$	1.3	$	2.7
Contributions recorded as a component of selling, general and administrative expenses	6.4		6.4		2.2		4.5
Total contributions	$	10.6	$	10.4	$	3.5	$	7.2

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

11. Equity

Common Stock

The authorized common stock of the Company consists of 300,000,000 shares. Holders of the Company’s common stock are entitled to one vote for each share of common stock. As of September 30, 2018, there were 89,747,062 shares of common stock issued and 89,727,546 shares of common stock outstanding and warrants to purchase 25,012,500 shares of common stock at a strike price of $11.50 per share. The Company has units outstanding which consist of one share of common stock and one warrant which are included in the totals above.

114

Prior to the completion of the Business Combination, the Company had 62,531,250 shares of common stock issued and outstanding, consisting of 50,025,000 shares originally sold as part of units issued in the Company’s IPO, consummated on June 11, 2014, and 12,506,250 shares of Founder Shares that were issued to the Sponsor prior to the IPO.

All of the 50,025,000 shares of common stock sold as part of the units in the IPO contained a redemption feature which allowed for the redemption of such shares. These redemption provisions generally required the Company to classify these shares outside of permanent equity, except for certain provisions related to ordinary liquidations involving the redemption and liquidation of all of the Company’s equity instruments that allowed the Company to classify a certain amount related to these shares as permanent equity at each reporting period. At March 31, 2016, 47,512,924 of the 50,025,000 public shares with a value of $475.2 million were classified outside of permanent equity at their redemption value.

On June 9, 2016, in connection with the completion of the Business Combination, 47,512,924 shares of common stock were reclassified into equity and 29,793,320 shares were redeemed at $10.02 per share. Additionally, the Company issued (i) 27,673,604 new shares of common stock at $10.00 per share to the Selling Equityholders as consideration, (ii) 23,492,306 new shares of common stock at a price of $10.00 per share in private placements with eligible purchasers, (iii) 3,078,578 new shares of common stock to settle the payment of an aggregate of $30.8 million in fees and disbursements outstanding and due to certain of WLRH’s advisors in connection with services and work performed by the advisors, including shares issued to pay the liability of $18.3 million for deferred underwriting fees due upon the completion of a Business Combination from the IPO and (iv) 2,240,000 new shares of common stock in exchange for 22,400,000 warrants to purchase shares of common stock privately placed to Sponsor at the time of the IPO. In connection with the completion of the Business Combination, the Sponsor (on behalf of the Company) transferred 30,000 original Founder Shares to the Company’s prior independent directors ("Director Founder Shares") in connection with services previously rendered to the Company reducing the total outstanding Founder Shares to 12,476,250. In addition, the Sponsor transferred 3,554,240 Founder Shares with a fair value of $30.2 million to the Selling Equityholders. The fair value of the Founder Shares transferred to the Company’s prior independent directors was recorded as an equity contribution and a transaction related cost in the third quarter of fiscal year 2016. The fair value of the Founder Shares transferred to the directors and the Selling Equityholders was estimated using a Monte Carlo simulation model. The 3,554,240 of Founder Shares that were transferred to the Selling Equityholders was a component of the Business Combination purchase consideration and was recorded by the Company as an equity contribution and included in the purchase consideration. See Note 3.

In connection with the consummation of the Business Combination, the Founder Shares, other than the Director Founder Shares, became subject to forfeiture on the tenth anniversary of the Closing Date unless:

• with respect to 50% of such Founder Shares, the last sale price of the Company’s common stock as quoted on NASDAQ equals or exceeds $12.50 per share (as adjusted for stock splits, dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 trading day period; and

• with respect to the remaining 50% of such Founder Shares, the last sale price of the Company’s common stock equals or exceeds $15.00 per share (as adjusted for stock splits, dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 trading day period; or

• the post-combination company completes a liquidation, merger, stock exchange or other similar transaction that results in all or substantially all of its stockholders having the right to exchange their shares of common stock for consideration in cash, securities or other property or any transaction involving a consolidation, merger, proxy contest, tender offer or similar transaction in which the post-combination company is the surviving entity which results in a change in the majority of the Company’s board of directors or management team or the Company’s post-combination stockholders immediately prior to such transaction ceasing to own a majority of the surviving entity immediately after such transaction.

The Founder Shares will not participate in dividends or other distributions with respect to the shares prior to these targets being met, whereupon the Founder Shares shall be entitled to all dividends and distributions paid on the common stock after the Business Combination as if they had been holders of record entitled to receive distributions on the applicable record date.

115

Warrants

As of September 30, 2018 there were 50,025,000 warrants outstanding to purchase 25,012,500 shares of common stock at an exercise price of $11.50 per share.

In the case of any reclassification, reorganization, merger or consolidation, or upon a dissolution following such sale or transfer, the holders of the warrants share thereafter have the right to purchase and receive the kind and amount of shares of stock or other securities or property (including cash) receivable upon reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holders of the warrants have received if such holders had exercised their warrants immediately prior to such event.

Preferred Stock

The authorized preferred stock of the Company consists of 1,000,000 shares. As of September 30, 2018, there were no shares of preferred stock issued and outstanding.

The Company’s second amended and restated certificate of incorporation provides that shares of preferred stock may be issued from time to time in one or more series. The Board is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The Board is able, without stockholder approval, to issue preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the Company's common stock and could have anti-takeover effects. The ability of the Board to issue preferred stock without stockholder approval could have the effect of delaying, deferring or preventing a change of control of the Company.

Treasury Stock

During the fiscal year ended September 30, 2018, 7,163 shares of common stock relating to the vesting of one third of the TPG Restricted Stock and 2,777 shares of common stock relating to RSUs were transferred to the Company to satisfy the employees' tax withholding obligations. Following the transfer, these shares were not canceled and are therefore classified as treasury stock. Total treasury stock as of September 30, 2018 is 19,516 shares.

12. Earnings Per Share

A reconciliation of the numerators and denominators of the basic and diluted per share computation follows.

	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*
Basic:
Net income (loss)	$	29.4	$	14.4	$	(8.4	)
Weighted average number of common shares outstanding during the period	76,803,187		76,752,752		35,193,789
Net income (loss) per common share - basic	$	0.38	$	0.19	$	(0.24	)
Diluted:
Net income (loss)	$	29.4	$	14.4	$	(8.4	)
Denominator for diluted earnings per share:
Weighted average number of common shares attributable to the period	76,803,187		76,752,752		35,193,789
Incremental common shares attributable to outstanding dilutive options and unvested restricted shares	106,360		87,058		—
Denominator for diluted earnings per common share	76,909,547		76,839,810		35,193,789
Net income (loss) per common share - diluted	$	0.38	$	0.19	$	(0.24	)

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

116

Dilutive computations during the current fiscal year contain additional incremental common shares which are attributable to the outstanding unvested restricted stock awards issued to directors and employees, restricted stock units awarded to employees and unvested outstanding stock options awarded to employees. For the fiscal years ended September 30, 2018, 2017 and 2016, there were 12,476,250 Founder Shares excluded from the basic and diluted computations because such shares were subject to forfeiture, and PSU awards, which were not included in the computation of diluted shares outstanding because performance targets and/or market conditions were not yet met for these awards. Diluted shares outstanding also did not include 25,012,500 shares of common stock issuable on the exercise of 50,025,000 warrants because the warrants were out-of-the-money for the fiscal years ended September 30, 2018, 2017 and 2016. There were no stock options outstanding as of September 30, 2017 and 2016. As of September 30, 2016, the shares of unvested restricted stock awards issued to directors were not included in the diluted share calculation as their impact on the Company's net loss would have been antidilutive. There were no restricted stock units outstanding as of September 30, 2016.

The calculation for weighted average number of common shares reflects shares outstanding over the reporting period based on the actual number of days the shares of common stock were outstanding. A large number of shares were issued in connection with the Business Combination on the Closing Date and the weighted average common shares outstanding only incorporates these shares from that date through September 30, 2016, or 114 days.

13. Commitments, Contingencies and Litigation

Operating Leases

The Company is a lessee of office buildings, transportation equipment, warehouses and storage facilities, other equipment, facilities and properties under operating lease agreements that expire at various dates. Rent expense (including rentals under short-term leases) was $25.9 million, $25.0 million and $6.9 million for the fiscal years ended September 30, 2018, 2017 and 2016, respectively, and $17.1 million for the period from October 1, 2015 through June 8, 2016 for the Predecessor.

Future minimum non-cancellable rental payments as of September 30, 2018 are as follows:

2019	$	14.1
2020	8.9
2021	7.1
2022	5.2
2023	2.8
Thereafter	0.3
Total	$	38.4

Capital Leases

The Company leases certain equipment and facilities under capital lease agreements. As of September 30, 2018, future minimum lease payments under capital leases were as follows:

2019	$	7.6
2020	7.2
2021	7.1
2022	10.4
2023	6.9
Thereafter	25.4
Total minimum capital lease payments	64.6
Less amount representing executory costs	(15.1		)
Less amount representing interest	(15.5		)
Present value of net minimum capital lease payments	$	34.0

117

Environmental Remediation

Due to the nature of its business, the Company is subject to various laws and regulations pertaining to the environment and to the sale, handling, transportation and disposal of chemicals and hazardous materials. These laws pertain to air and water, the management of solid and hazardous wastes, transportation and human health and safety.

On March 31, 2011, the Predecessor purchased certain assets of the global distribution business (the "Distribution Business") from Ashland (the "Ashland Distribution Acquisition"), evidenced by the ADA Purchase Agreement.  In the ADA Purchase Agreement, Ashland agreed to retain all known environmental remediation liabilities ("the Retained Specified Remediation Liabilities") and other environmental remediation liabilities unknown at the closing of the Ashland Distribution Acquisition related to the Distribution Business for which Ashland received notice prior to the fifth anniversary of the closing (the "Other Retained Remediation Liabilities") (collectively, the "Retained Remediation Liabilities").  Ashland’s liability for the Retained Remediation Liabilities is not subject to any claim thresholds or deductibles other than expenses the Predecessor incurs arising out of the Other Retained Remediation Liabilities. Had the Predecessor incurred expenses arising out of the Other Retained Remediation Liabilities, Ashland’s indemnification obligation would have been subject to an individual claim threshold of $0.2 million and an aggregate claim deductible of $5.0 million.  Ashland’s indemnification obligation under the ADA Purchase Agreement as described above terminated as of March 31, 2016, other than for Retained Remediation Liabilities.

In July 2014, Ashland filed a lawsuit numbered Ashland Inc. v. Nexeo Solutions, LLC, Case No. N14C-07-243 JTV CCLD, in the Superior Court for the State of Delaware in and for New Castle County.  In the suit, Ashland seeks a declaration that, pursuant to the ADA Purchase Agreement, Solutions was obligated to indemnify Ashland for losses Ashland incurred pertaining to the Other Retained Remediation Liabilities, up to the amount of the aggregate $5.0 million deductible applicable to expenses incurred by Solutions, whether or not Solutions incurred any expenses or obtained any indemnity from Ashland.  Ashland further alleged that Solutions breached duties related to the ADA Purchase Agreement by not having so indemnified Ashland for amounts Ashland incurred for Other Retained Remediation Liabilities, and on that basis sought unspecified compensatory damages, costs and attorney’s fees.  On June 21, 2017, the Company's Motion for Summary Judgment for this lawsuit was granted. Ashland appealed the ruling on July 20, 2017. On January 31, 2018, the Delaware Supreme Court affirmed the lower court's grant of the Company's Motion for Summary Judgment. Ashland did not request a rehearing of the ruling. Therefore, the judgment in the Company's favor is final and this matter is closed. The Company does not currently have any environmental or remediation reserves for matters covered under the ADA Purchase Agreement.

The Company’s reserves will be subject to numerous uncertainties that affect its ability to accurately estimate its costs, or its share of costs if multiple parties are responsible. These uncertainties involve the legal, regulatory and enforcement parameters governing environmental assessment and remediation, the nature and extent of contamination, the extent of required remediation efforts, the choice of remediation methodology, availability of insurance coverage and, in the case of sites with multiple responsible parties, the number and financial strength of other potentially responsible parties.

Other Legal Proceedings

The Company is subject to various claims and legal proceedings covering a wide range of matters that arise in the ordinary course of its business activities, including product liability claims.  Management believes that any liability that may ultimately result from the resolution of these matters will not have a material adverse effect on the financial condition or results of operations of the Company.

Other Contingencies

In June 2014, the Predecessor self-disclosed to the DTSC that an inventory of its Fairfield facility had revealed potential violations of the RCRA and the California Health and Safety Code. Although no formal proceeding has been initiated, the Company expects the DTSC to seek payment of fines or other penalties for non-compliance. The Company does not expect the amount of any such fine or other penalty to have a material adverse effect on its business, financial position or results of operations.

118

14. Related Party Transactions

On February 28, 2018, the Company entered into a Transportation Logistics Management Services Agreement with Transplace Texas, LP (“Transplace”), pursuant to which Transplace, a portfolio company of TPG and affiliate of the Company, agreed to provide certain transportation logistics management services to the Company over a minimum period of three years. The agreement was entered into on arms’ length terms following a competitive bid process. The Company subsequently signed an addendum to this agreement whereby Transplace will provide additional services for certain foreign operations. The estimated annual fee for services to be performed by Transplace is $1.4 million.

The table below summarizes activity recorded during the respective periods for related party transactions:

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 Through June 8, 2016
Sales to related entities:
TPG portfolio entities	$	4.5	$	3.1	$	1.7	$	3.1
Entities related to members of the Board of Directors	$	1.4	$	0.1	$	—	$	—
Purchases from related entities:
TPG portfolio entities	$	0.5	$	—	$	—	$	—
Entities related to members of the Board of Directors	$	13.1	$	1.7	$	—	$	—
Amounts included in Selling, general and administrative expenses
Management fees to TPG	$	—	$	—	$	—	$	2.1
Consulting fees to TPG	$	—	$	—	$	0.1	$	0.4
Amounts included in Transaction related costs
Fee paid in connection with the Business Combination	$	—	$	—	$	—	$	9.9

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

	September 30, 2018		September 30, 2017
Accounts receivable from related entities:
TPG portfolio entities	$	1.0	$	0.7
Entities related to members of the Board of Directors	$	0.2	$	—
Accounts payable to related entities:
TPG portfolio entities	$	0.5	$	—
Entities related to members of the Board of Directors	$	0.6	$	0.1

Contingent Consideration Obligations Pursuant to the TRA and the Merger Agreement

Subsequent to the Business Combination, TPG beneficially owns approximately 35% of the Company’s common stock, including Founder Shares, and is considered a related party of the Company. In connection with the Business Combination, TPG became a party to the TRA and obtained the right to receive the Deferred Cash Consideration pursuant to the Merger Agreement. The fair value of these contingent consideration liabilities was as follows:

	September 30, 2018		September 30, 2017
Due to related party pursuant to contingent consideration obligations:
Current liability	$	14.7	$	12.5
Non-current liability	122.8		127.7
Total fair value	$	137.5	$	140.2

119

During the fiscal year ended September 30, 2018 the Company paid $10.2 million to TPG related to the TRA. See Note 9.

Predecessor - Other Agreements with TPG

The Predecessor entered into agreements with TPG, including a management services agreement pursuant to which the Predecessor paid TPG management fees and also consulting fees for services provided. The fees incurred in connection with this agreement were recorded in Selling, general and administrative expenses in the consolidated statements of operations.

As a result of the Business Combination on the Closing Date, TPG and the Predecessor terminated the management services agreement and their rights and obligations thereunder. Pursuant to the management services agreement, the Predecessor paid TPG a success fee of $9.9 million relating to the closing of the Business Combination determined in accordance with the terms of the management services agreement.  This fee was recorded in Transaction related costs in the consolidated statement of operations.

FPA Subscription Agreement

On May 23, 2016, the Company entered into a Subscription Agreement (the "FPA Subscription Agreement") with Sponsor and First Pacific Advisors, LLC ("FPA"), on behalf of certain clients pursuant to which FPA agreed to purchase 18,260,000 shares of common stock on a private placement basis in connection with the Business Combination.

Sponsor Subscription Agreement

On June 6, 2016, the Company entered into a Subscription Agreement with Sponsor, pursuant to which Sponsor agreed to purchase 1,000,000 shares of common stock on a private placement basis for $10.00 per share in connection with the Business Combination. Wilbur L. Ross, Jr. was the manager of Sponsor and a former Chairman of the Board of Nexeo Solutions, Inc.

PWPI and PWIMF Commitment Agreements

On June 6, 2016, the Company entered into a Commitment Agreement with Sponsor and Park West Investors Master Fund, Ltd. ("PWIMF") and a second Commitment Agreement with Sponsor and Park West Partners International, Ltd. ("PWPI") (such agreements collectively, the "PW Commitment Agreements"), pursuant to which PWIMF and PWPI agreed to purchase from redeeming stockholders and withdraw from redemption an aggregate of 3,000,000 public shares of common stock.

FPA Commitment Agreement

On June 6, 2016, the Company entered into a Commitment Agreement (the "FPA Commitment Agreement") with Sponsor and FPA, pursuant to which FPA agreed not to redeem 2,094,727 public shares of common stock then owned by FPA in connection with the closing of the Business Combination.

Sponsor Convertible Notes and Promissory Note

On March 31, 2016, the Company issued the March 2016 promissory note to Sponsor pursuant to which the Company could borrow up to $0.75 million. The March 2016 promissory note was interest bearing at 5% per annum and was due and payable on the first to occur of (1) the consummation of Business Combination or (2) June 11, 2016 (or such later date as would have been approved by the Company’s stockholders by amendment of the Company’s charter to complete the Business Combination). Sponsor loaned the Company $0.2 million to cover expenses related to daily operations. In connection with the consummation of the Business Combination, the March 2016 promissory note balance of $0.2 million, including unpaid interest, was paid in full.

120

On January 5, 2016, the Company issued a convertible promissory note, referred to as the "January 2016 convertible note" to Sponsor pursuant to which the Company borrowed $0.4 million from Sponsor for operating expenses. The January 2016 convertible note was interest bearing at 5% per annum and was due and payable on June 11, 2016. At the option of Sponsor, any amounts outstanding under the January 2016 convertible note could have been converted into warrants to purchase shares of common stock at a conversion price of $0.50 per warrant. Each warrant would have entitled Sponsor to purchase one-half of one share of common stock at an exercise price of $5.75 per half share ($11.50 per whole share). Each warrant would have contained other terms identical to the terms contained in the private placement warrants previously issued to Sponsor. Through March 31, 2016, the Company incurred an insignificant amount of interest expense which, under the terms of the January 2016 convertible note, was added to the principal amount. In connection with the consummation of the Business Combination, the January 2016 convertible note balance of $0.4 million, including unpaid interest, was paid in full.

On March 26, 2015, the Company issued a convertible promissory note, referred to as the "March 2015 convertible note," to Sponsor pursuant to which, on April 16, 2015, the Company borrowed $0.3 million from Sponsor for operating expenses. The March 2015 convertible note was interest bearing at 5% per annum and was due and payable on June 11, 2016. At the option of Sponsor, any amounts outstanding under the March 2015 convertible note could have been converted into warrants to purchase shares of common stock at a conversion price of $0.60 per warrant. Each warrant would have entitled Sponsor to purchase one-half of one share of common stock at an exercise price of $5.75 per half share ($11.50 per whole share). Each such warrant would have contained other terms identical to the terms contained in the private placement warrants previously issued to Sponsor. Through March 31, 2016, the Company incurred $14,000 of interest expense which under the terms of the March 2015 convertible note was added to the principal amount. In connection with the consummation of the Business Combination, the March 2015 convertible note balance of $0.3 million, including unpaid interest, was paid in full.

Predecessor - Letter Agreement for Chairman’s Services

On January 16, 2012, the Predecessor and Dan F. Smith, a member of the Predecessor Board of Directors, entered into a Letter Agreement for Chairman’s Services (together with subsequent extensions, the "Letter Agreement"). In connection with the closing of the Business Combination, the parties agreed to terminate the Letter Agreement and their rights and obligations thereunder.  The termination of the Letter Agreement entitled Mr. Smith to a fee of $0.2 million in cash, which is included in Transaction related costs on the Company’s consolidated statement of operations.

Predecessor - Consulting Services Agreement

The Predecessor had a strategic consulting services agreement with Steven B. Schwarzwaelder, a member of the board of directors of the Predecessor, under which it paid an annual fee of $0.175 million. The Predecessor recorded $0.1 million from October 1, 2015 through June 8, 2016 related to this agreement. This fee was recorded in Selling, general and administrative expenses in the consolidated statements of operations. As a result of the Business Combination, the parties terminated the consulting services agreement and their rights and obligations thereunder.

15. Income Taxes

The Company provides for income taxes and the related accounts under the asset and liability method. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates expected to be in effect during the year in which the basis differences reverse. The Company has not recognized deferred taxes for temporary outside basis differences of $94.3 million as of September 30, 2018, related to investments in foreign subsidiaries that management considers to be permanent in duration. It is not practicable to estimate the amount of the unrecognized deferred income tax liabilities at this time due to the complexities associated with its hypothetical calculation.

The Company and its two active U.S. corporate subsidiaries, Blocker and Sub Holding, were both incorporated in the U.S. and as such are subject to U.S. income taxes. The Company and Blocker will file a consolidated U.S. Federal income tax return and both will file various state returns. Sub Holding will file a separate U.S. Federal income tax return and various state tax returns. The Company’s controlled foreign corporations are subject to taxation at the entity level in each of their respective jurisdictions.

121

Holdings is organized as a limited liability company and is taxed as a partnership for U.S. income tax purposes. With the exception of a limited number of state and local jurisdictions, Holdings is not subject to U.S. income taxes. Accordingly, Blocker and the Selling Equityholders (other than the holders of equity interests in Blocker) will report their share of Holdings’ taxable income earned prior to the Closing Date on their respective U.S. federal tax returns. Holdings and its subsidiaries made no tax distributions to, or on behalf of, the Selling Equityholders during the fiscal year ended September 30, 2016.

For all periods, the Company computed the provision for income taxes based on the actual year-to-date effective tax rate by applying the discrete method.  Use of the annual effective tax rate, which relies on accurate projections by legal entity of income earned and taxed in foreign jurisdictions, as well as accurate projections by legal entity of permanent and temporary differences, was not considered a reliable estimate for purposes of calculating year-to-date income tax expense.

The Tax Act significantly revises future U.S. corporate income taxes by, among other things, lowering U.S. corporate income tax rates and implementing a modified territorial tax system. Because the Company has a September 30 fiscal year end, the lower corporate income tax rate will be phased in, resulting in a U.S. statutory federal rate of approximately 24.5% for the Company's fiscal year ending September 30, 2018 and 21.0% for subsequent fiscal years. The Tax Act also provided for certain transition impacts. As part of the transition to the new modified territorial tax system, the Tax Act imposes a one-time repatriation tax on deemed repatriation of historical earnings of foreign subsidiaries. The Company did not have an impact from the repatriation tax charge.

For the twelve months ended September 30, 2018, the impact of the Tax Act resulted in a net benefit of approximately $4.5 million, related solely to the remeasurement of the Company's net deferred tax liabilities at the lower enacted corporate tax rates.

For financial reporting purposes, income (loss) before income taxes includes the following components:

	Successor							Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*			October 1, 2015 Through June 8, 2016
U.S.	$	24.8	$	7.9	$	(9.1	)	$	(19.6	)
Foreign	21.3		17.0		1.9			9.9
Income (loss) before income taxes	$	46.1	$	24.9	$	(7.2	)	$	(9.7	)

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

122

A summary of income tax expense (benefit) is as follows:

	Successor									Predecessor
	Fiscal Year Ended September 30, 2018			Fiscal Year Ended September 30, 2017			Fiscal Year Ended September 30, 2016*			October 1, 2015 Through June 8, 2016
Current tax expense (benefit):
U.S. - Federal	$	9.5		$	1.3		$	0.5		$	—
U.S. - State	2.8			0.5			(0.2		)	(0.1		)
Foreign	11.3			6.5			2.0			3.2
Total current tax expense	23.6			8.3			2.3			3.1
Deferred tax expense (benefit):
U.S. - Federal	(4.7		)	4.6			(0.8		)	0.4
U.S. - State	0.1			0.2			0.4			0.1
Foreign	(2.3		)	(2.6		)	(0.7		)	0.6
Total deferred tax expense (benefit)	(6.9		)	2.2			(1.1		)	1.1
Total income tax expense	$	16.7		$	10.5		$	1.2		$	4.2

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

Reconciliation of income taxes at the U.S. statutory rate and income tax expense (benefit):

	Successor									Predecessor
	Fiscal Year Ended September 30, 2018*			Fiscal Year Ended September 30, 2017**			Fiscal Year Ended September 30, 2016***			October 1, 2015 Through June 8, 2016
U.S. statutory rate	21.0		%	34.0		%	34.0		%	0.0		%
Pretax income (loss) at statutory rate	$	9.7		$	8.5		$	(2.5	)	$	—
State income taxes	2.1			0.9			0.2			—
Statutory rate differential	1.4			(1.4		)	(0.2		)	2.5
FIN 48 expense (benefit)	2.3			(0.5		)	—			0.1
Non-U.S. tax credit	(2.0		)	—			—			—
Withholding and other taxes	0.5			0.5			—			0.3
Tax impact of tax reform	(4.5		)	—			—			—
Transaction costs	0.9			—			5.0			—
Contingent liability	0.8			2.4			(1.6		)	—
Other permanent differences	0.3			0.3			0.3			0.6
Statutory tax rate changes and differences	0.9			—			(0.2		)	(0.1		)
True-up to prior year taxes	2.6			(0.3		)	—			0.2
Nondeductible stewardship costs	1.1			—			—			—
Valuation allowance	0.6			0.1			0.2			0.6
Income tax expense	$	16.7		$	10.5		$	1.2		$	4.2
Effective tax rate	36.2		%	42.2		%	(16.7		)%	(43.3		)%

^{*Due to the Company's fiscal year ending on September 30, 2018, the phased in rate of 24.5% was used in calculating the U.S. federal taxes presented in the reconciliation for the fiscal year ended September 30, 2018.} 

^{**For comparability, the presentation of balances at September 30, 2017 were adjusted to align to current year presentation.} 

^{***The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

123

The principal temporary differences included in deferred income taxes reported on the September 30, 2018 and 2017 balance sheets were:

	September 30, 2018			September 30, 2017
Deferred Tax Assets
Foreign operating losses	$	5.5		$	6.3
Federal and state operating losses	15.5			27.6
Non-U.S. tax credit (1)	1.9			—
Unrealized gains/losses	0.3			0.2
Fixed assets and intangibles	1.1			0.9
Compensation and other accruals	4.0			2.4
Other items	0.8			0.9
Valuation allowance	(3.6		)	(3.1		)
Total deferred tax assets	$	25.5		$	35.2
Deferred Tax Liabilities
Fixed assets and intangibles	$	23.2		$	23.8
Compensation and other accruals	0.2			0.2
Investment in partnerships	27.1			43.2
Other items	3.4			0.6
Total deferred tax liabilities	$	53.9		$	67.8

⁽¹⁾  Related to the European tax uncertainty recorded in the current period.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

At September 30, 2018, the Company had foreign loss carryforwards of $23.4 million and U.S. federal loss carryforwards of $59.5 million. In those countries in which net operating losses are subject to an expiration period, the Company's loss carryforwards, if not utilized, will expire at various dates from 2018 through 2038. Based on historical performance, the Company believes that it is more likely than not that taxable income in future years will allow the Company to utilize the carryforwards that have not had a valuation allowance placed against them.

At September 30, 2018 and September 30, 2017, the valuation allowance was $3.6 million and $3.1 million, respectively, primarily relating to operations in Asia. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based upon management’s expectations at September 30, 2018, management believes it is more likely than not that it will realize the majority of its deferred tax assets.

Uncertain Tax Positions

U.S. GAAP prescribes a recognition threshold and measurement attribute for the accounting and financial statement disclosure of tax positions taken or expected to be taken in a tax return. The evaluation of a tax position is a two-step process.  The first step requires the Company to determine whether it is more likely than not that a tax position will be sustained upon examination based on the technical merits of the position.  The second step requires the Company to recognize in the financial statements each tax position that meets the more likely than not criteria, measured as the amount of benefit that has a greater than 50% likelihood of being realized. Differences between the amount of tax benefits taken or expected to be taken in the income tax returns and the amount of tax benefits recognized in the financial statements represent the Company’s unrecognized income tax benefits, which are recorded as a liability, with the long-term portion included in Other non-current liabilities and the current portion included in Accrued expenses and other liabilities on the Company’s consolidated balance sheets.

During the fiscal year ended September 30, 2018, the Company added income tax related uncertainties primarily related to the Company's operations in Europe. The reserve of approximately $2.2 million is inclusive of interest and penalties.

124

During the fiscal year ended September 30, 2017, the Company added income tax-related uncertainties associated with the purchase of Ultra Chem. The initial reserve of $1.3 million, inclusive of interest and penalties, was added in connection with these uncertainties. Accordingly, the Company also recognized indemnification assets related to certain of these income tax-related uncertainties. The indemnification assets were initially included in Other current assets and other non-current assets in the consolidated balance sheets, representing the reimbursement the Company reasonably expected to receive from funds held in escrow pursuant to the purchase agreement.

A reconciliation of the beginning and ending amount of unrecognized tax benefits is shown below:

	September 30, 2018			September 30, 2017
Balance at beginning of period	$	1.2		$	0.9
Increases related to positions taken on items from prior years	2.3			0.1
Decreases related to positions taken on items from prior years	(0.2		)	—
Unrecognized tax benefits assumed related to acquisitions	—			0.8
Lapse of statute of limitations	(0.2		)	(0.6		)
Balance at end of period	$	3.1		$	1.2

The Company recognizes interest and penalties related to uncertain tax positions, if any, as a component of income tax expense in the consolidated statements of operations. The amount of interest and penalties recognized was $0.9 million during fiscal years ending September 30, 2018 and 2017 and $0.2 million during fiscal year ended September 30, 2016. At September 30, 2018, September 30, 2017 and September 30, 2016, there was $4.0 million, $1.8 million and $1.2 million, respectively, related to uncertain tax positions.

The total amount of the unrecognized tax benefits that would affect the Company's effective tax rate, if recognized, is $3.1 million as of September 30, 2018. The Company does not expect a significant change in the unrecognized tax benefits during the next twelve months.

The Company or one of its subsidiaries files income tax returns in the U.S. and various state and foreign jurisdictions. Within the U.S., the Company is subject to federal and state income tax examination by tax authorities for periods after December 2013. With respect to countries outside of the U.S., with certain exceptions, the Company’s foreign subsidiaries are subject to income tax audits for years after 2013.

16. Segment and Geographic Data

The Company operates through three lines of business, or operating segments: Chemicals, Plastics and Environmental Services, which market to different sets of customers operating in an array of industries, with various end markets and customer segments within those industries. For segment presentation and disclosure purposes, the Chemicals and Plastics lines of business constitute separate reportable segments, while the Environmental Services line of business, which does not meet the materiality threshold for separate disclosure, is included in an "Other" segment.

Each line of business represents unique products and suppliers, and each line of business focuses on specific end markets within its industry based on a variety of factors, including supplier or customer opportunities, expected growth and prevailing economic conditions. Across the Chemicals and Plastics lines of business there are numerous industry segments, end markets and sub markets that the Company may choose to focus on. These end markets may change from year to year depending on the underlying market economics, supplier focus, expected profitability and the Company’s strategic agenda.

The Chemicals, Plastics and Environmental Services lines of business compete with national, regional and local companies throughout North America. Additionally, the Chemicals and Plastics lines of business compete with other distribution companies in Asia. The Plastics line of business also competes with other distribution companies in EMEA. Competition within each line of business is based primarily on the diversity of the product portfolio, service offerings, reliability of services and supply, technical support, price and delivery capabilities. The accounting policies used to account for transactions in each of the lines of business are the same as those used to account for transactions at the corporate level.

125

The Chemicals and Plastics lines of business are distribution businesses, while the Environmental Services line of business provides hazardous and non-hazardous waste collection, recovery, recycling and disposal services.

A brief description of each segment follows:

Chemicals. The Chemicals line of business distributes specialty and industrial chemicals, additives and solvents to industrial users via railcars, barges, bulk tanker trucks and as packaged goods in trucks. The Company’s chemical products are distributed in approximately 50 countries worldwide, primarily in North America and Asia. In connection with the distribution of chemicals products, the Company provides value-added services such as custom blending, packaging and re-packaging, private-label manufacturing and product testing in the form of chemical analysis, product performance analysis and product development. While the Chemicals line of business serves multiple end markets, the key end markets within the industrial space are household, industrial and institutional, performance coatings (including architectural coatings, adhesives, sealants and elastomers), lubricants, oil and gas and personal care.

Plastics. The Plastics line of business distributes a broad product line consisting of commodity polymer products and prime engineering resins to plastics processors engaged in blow molding, extrusion, injection molding and rotation molding via railcars, bulk trucks, truckload boxes and mixed truckloads, or less-than-truckload quantities. The Company's plastics products are distributed in more than 60 countries worldwide, primarily in North America, EMEA and Asia. The Plastics line of business serves a broad cross section of industrial segments, including key automotive and healthcare end markets.

Other. The Environmental Services line of business, in connection with certain waste disposal service companies, provides customers with comprehensive on-site and off-site hazardous and non-hazardous waste collection, transportation, recovery, disposal arrangement and recycling services in North America, primarily in the U.S. These environmental services are offered through the Company’s network of distribution facilities used as transfer facilities and through a staff of dedicated on-site waste professionals. The Environmental Services line of business serves multiple end markets such as aerospace and defense, automotive, chemical manufacturing, industrial manufacturing and oil and gas.

The Chief Executive Officer is the Chief Operating Decision Maker. The Chief Operating Decision Maker reviews operating results in order to make decisions, assess performance and allocate resources to each line of business. In order to maintain the focus on line of business performance, certain expenses are excluded from the line of business results utilized by the Company’s Chief Operating Decision Maker in evaluating line of business performance. These expenses include depreciation and amortization, selling, general and administrative expense and corporate items including transaction related costs, interest and income tax expense. These items are separately delineated to reconcile to reported net income. Intersegment revenues were insignificant.

No single customer accounted for more than 10.0% of revenues for any line of business for each of the fiscal years reported. In each of the past three fiscal years, polypropylene, a product offering in the Company’s Plastics line of business, was the only product that accounted for over 10.0% of the Company's consolidated net revenue. Polypropylene accounted for 15.9%, 15.5% and 17.6% during the fiscal years ended September 30, 2018, 2017 and 2016, respectively, of total consolidated net revenue. Polypropylene accounted for 17.7% for the period from October 1, 2015 through June 8, 2016 of Predecessor total consolidated net revenue. Two suppliers accounted for 11.6% and 9.6%, respectively, of the consolidated purchases during the fiscal year ended September 30, 2018, 12.1% and 9.9%, respectively, for the fiscal year ended September 30, 2017, and 11.9% and 10.4%, respectively for the fiscal year ended September 30, 2016. Two suppliers accounted for 12.0% and 9.8%, respectively, for the period from October 1, 2015 through June 8, 2016 for the Predecessor consolidated purchases.

Certain assets are aggregated at the line of business level. The assets attributable to the Company’s lines of business, that are reviewed by the Chief Operating Decision Maker, consist of trade accounts receivable, inventories, goodwill and any specific assets that are otherwise directly associated with a line of business. The Company’s inventory of packaging materials and containers, as well as property, plant and equipment, are generally not allocated to a line of business and are included in unallocated assets.

126

Summarized financial information relating to the Company’s lines of business is as follows:

	Successor									Predecessor
	Fiscal Year Ended September 30, 2018			Fiscal Year Ended September 30, 2017			Fiscal Year Ended September 30, 2016*			October 1, 2015 through June 8, 2016
Sales and operating revenues
Chemicals	$	1,904.5		$	1,667.2		$	478.1		$	1,066.4
Plastics	1,980.0			1,841.7			546.7			1,192.2
Other	149.7			128.0			40.9			81.5
Total sales and operating revenues	$	4,034.2		$	3,636.9		$	1,065.7		$	2,340.1
Gross profit
Chemicals	248.0			205.6			55.7			136.2
Plastics	186.4			167.2			43.6			117.6
Other	25.7			25.6			9.1			18.1
Total gross profit	460.1			398.4			108.4			271.9
Selling, general and administrative expenses	352.6			312.9			91.7			208.9
Transaction related costs	2.8			1.9			21.3			33.4
Change in fair value of contingent consideration obligations	7.5			16.2			(11.2		)	—
Operating income	97.2			67.4			6.6			29.6
Other income, net	1.0			8.3			0.5			2.9
Interest income (expense)
Interest income	0.5			0.3			0.8			0.1
Interest expense	(52.6		)	(51.1		)	(15.1		)	(42.3		)
Net income (loss) from continuing operations before income taxes	$	46.1		$	24.9		$	(7.2	)	$	(9.7	)

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

	September 30, 2018		September 30, 2017
IDENTIFIABLE ASSETS
Chemicals	$	826.2	$	793.6
Plastics	758.2		762.7
Other	95.7		91.0
Total identifiable assets by reportable segment	1,680.1		1,647.3
Unallocated assets	563.5		606.2
Total assets	$	2,243.6	$	2,253.5

127

Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale, are presented below:

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 through June 8, 2016
U.S.	$	2,959.9	$	2,682.2	$	808.2	$	1,779.4
Canada	189.9		171.6		46.5		102.4
Other North America	132.8		87.2		18.4		35.4
Total North America Operations	3,282.6		2,941.0		873.1		1,917.2
EMEA	539.7		481.7		130.6		291.9
Asia	211.9		214.2		62.0		131.0
Total	$	4,034.2	$	3,636.9	$	1,065.7	$	2,340.1

 

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

17. Unaudited Quarterly Information

The following tables contain selected unaudited statement of operations information for each quarter of the fiscal years ended September 30, 2018 and 2017. All numbers are in millions except for per share amounts.

	Fiscal Year Ended September 30, 2018
	First Quarter		Second Quarter		Third Quarter		Fourth Quarter
Sales and operating revenues	$	929.6	$	1,041.0	$	1,046.4	$	1,017.2
Gross profit	$	106.9	$	115.7	$	120.2	$	117.3
Net income (loss)	$	26.5	$	0.4	$	17.5	$	(15.0	)
Income (loss) per share:(1)
Basic	$	0.35	$	0.01	$	0.23	$	(0.20	)
Diluted	$	0.34	$	0.01	$	0.23	$	(0.20	)
Weighted average number of common shares outstanding
Basic	76,793,518		76,795,742		76,797,414		76,825,850
Diluted	76,857,244		76,961,218		76,983,350		76,825,850

⁽¹⁾ Per share amounts for the quarter and full year have been computed separately. The sum of the quarterly amounts may not equal the annual amounts presented because of differences in the average shares outstanding during each period.

128

	Fiscal Year Ended September 30, 2017
	First Quarter			Second Quarter			Third Quarter		Fourth Quarter
Sales and operating revenues	$	794.8		$	917.7		$	942.7	$	981.7
Gross profit	$	84.4		$	102.2		$	102.7	$	109.1
Net income (loss)	$	(8.3	)	$	(1.1	)	$	10.2	$	13.6
Income (loss) per share:(1)
Basic	$	(0.11	)	$	(0.01	)	$	0.13	$	0.18
Diluted	$	(0.11	)	$	(0.01	)	$	0.13	$	0.18
Weighted average number of common shares outstanding
Basic	76,746,168			76,746,168			76,743,853		76,774,578
Diluted	76,746,168			76,746,168			76,828,868		76,852,267

⁽¹⁾ Per share amounts for the quarter and full year have been computed separately. The sum of the quarterly amounts may not equal the annual amounts presented because of differences in the average shares outstanding during each period.

129

Nexeo Solutions, Inc. and Subsidiaries

Schedule II—Valuation and Qualifying Accounts

(in millions)	Balance Beginning of Period		Charged to  Costs and  Expenses			Charged to Other Accounts				Deductions				Balance End of Period
Fiscal Year Ended September 30, 2018
Allowance for doubtful accounts	$	2.2	$	1.9		$	—			$	0.1		(1)	$	4.2
Reserve for sales returns and allowances	1.4		—			0.2			(2)	—				1.6
Fiscal Year Ended September 30, 2017
Allowance for doubtful accounts	$	1.4	$	(0.2	)	$	1.7			$	(0.7	)	(1)	$	2.2
Reserve for sales returns and allowances	1.5		—			(0.1		)	(2)	—				1.4
Fiscal Year Ended September 30, 2016
Allowance for doubtful accounts	$	—	$	0.3		$	1.3			$	(0.2	)	(1)	$	1.4
Reserve for sales returns and allowances	—		—			1.5			(2)	—				1.5
October 1, 2015 through June 8, 2016 (Predecessor)
Allowance for doubtful accounts	$	3.8	$	1.2		$	—			$	(0.9	)	(1)	$	4.1
Reserve for sales returns and allowances	1.6		—			(0.1		)	(2)	—				1.5

⁽¹⁾  Accounts written off during the year, net of recoveries and foreign exchange impact.

⁽²⁾  Amounts represent estimates for expected sales returns.

130

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15(b) under the Exchange Act, management, under the supervision and with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the fiscal year covered by this Annual Report on Form 10-K. Based on such evaluation, our principal executive officer and principal financial officer have concluded the Company's disclosure controls and procedures were effective at the reasonable assurance level as of September 30, 2018. Our disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed by us in reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure and is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC.

Management’s Annual Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management assessed the effectiveness of our internal control over financial reporting as of the end of the period covered by this Annual Report on Form 10-K. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control – Integrated Framework (2013). Based on management's assessment, management concluded that our internal control over financial reporting was effective as of September 30, 2018.

The effectiveness of the Company's internal control over financial reporting as of September 30, 2018 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which appears herein.

Changes in Internal Control over Financial Reporting

During the fourth quarter ended September 30, 2018, there were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

131

Item 9B. Other Information

None.

132

PART III

Item 10. Directors, Executive Officers and Corporate Governance

The information required by this Item is incorporated herein by reference to the Nexeo Solutions, Inc. proxy statement for our 2019 Annual Meeting of Stockholders.

Item 11. Executive Compensation

The information required by this Item is incorporated herein by reference to the Nexeo Solutions, Inc. proxy statement for our 2019 Annual Meeting of Stockholders.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information required by this Item is incorporated herein by reference to the Nexeo Solutions, Inc. proxy statement for our 2019 Annual Meeting of Stockholders.

Item 13. Certain Relationships and Related Transactions, and Director Independence

The information required by this Item is incorporated herein by reference to the Nexeo Solutions, Inc. proxy statement for our 2019 Annual Meeting of Stockholders.

Item 14. Principal Accounting Fees and Services

The information required by this Item is incorporated herein by reference to the Nexeo Solutions, Inc. proxy statement for our 2019 Annual Meeting of Stockholders.

133

PART IV

Item 15. Exhibits

 

Exhibit Number	Description
2.1**	Agreement and Plan of Merger, dated September 17, 2018, by and among Nexeo Solutions, Inc, Univar, Inc, Pilates Merger Sub I Corp and Pilates Merger Sub II (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K dated September 18, 2018)
2.2**	Agreement and Plan of Merger, dated March 21, 2016, by and among WL Ross Holding Corp., Neon Acquisition Company LLC, Neon Holding Company LLC, TPG Accolade Delaware, LP, Nexeo Solutions Holdings, LLC and Nexeo Holdco, LLC (incorporated by reference to Exhibit 2.2 to the Company's Current Report on Form 8-K dated March 21, 2016)
2.3**	Amendment No. 1 to the Agreement and Plan of Merger, dated June 6, 2016, by and among the WL Ross Holding Corp., Neon Acquisition Company, LLC, Neon Holding Company LLC, Nexeo Solutions Holdings, LLC, TPG Accolade Delaware, L.P. and Nexeo Holdco, LLC (incorporated by reference to Exhibit 2.2 to the Company's Current Report on Form 8-K dated June 6, 2016)
2.4	Stock Purchase Agreement, dated March 9, 2017, by and among Nexeo Solutions, LLC, Nexeo Solutions Mexico Holdings, LLC and the shareholders party thereto (incorporated by reference to Exhibit 2.2 to the Company's Current Report on Form 8-K dated April 3, 2017)
3.1	Second Amended and Restated Certificate of Incorporation of Nexeo Solutions, Inc. (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K dated June 9, 2016)
3.2	Amended and Restated Bylaws of Nexeo Solutions, Inc. (incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K dated June 9, 2016)
4.1	Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 to the Company's S-1 Registration Statement (Commission File No. 333-195854)
4.2	Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.2 to the Company's S-1 Registration Statement (Commission File No. 333-195854)
4.3	Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 to the Company's S-1 Registration Statement (Commission File No. 333-195854)
4.4	Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (incorporated by reference to Exhibit 4.4 to the Company's S-1 Registration Statement (Commission File No. 333-195854)
4.5	Shareholders' and Registration Rights Agreement, dated as of March 21, 2016, by and among TPG Capital LLC, WL Ross Sponsor LLC and WL Ross Holding Corp. (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated March 21, 2016)

134

Exhibit Number	Description
4.6	Amendment No. 1 to Shareholders' and Registration Rights Agreement, dated June 6, 2016, by and among WL Ross Holding Corp., WL Ross Sponsor LLC and Nexeo Holdco, LLC (incorporated by reference to Exhibit 10.5 to the Company's Current Report on Form 8-K dated June 6, 2016)
4.7	Form of Joinder to Shareholders' and Registration Rights Agreement (incorporated by reference to Exhibit 10.10 to the Company's Current Report on Form 8-K dated June 9, 2016)
4.8	Waiver and Consent Agreement made as of September 13, 2017 by and among Nexeo Solutions, Inc. and Nexeo Holdco, LLC (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated September 13, 2017)
10.1	Tax Receivable Termination and Settlement Agreement, dated September 17, 2018, by and among WL Ross Holding Corp., TPG VI Nexeo II, L.P., TPG VI FOF Nexeo, L.P., Nexeo Holdco, LLC, TPG VI AIV SLP SD, LP, and TPG VI DE BDH, LP. (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated September 18, 2018)
10.2	Tax Receivable Agreement, dated June 9, 2016, by and between WL Ross Holding Corp. and the Selling Equityholders (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated June 9, 2016)
10.3	Form of Joinder to Tax Receivable Agreement (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K dated June 9, 2016)
10.4t	Form of Indemnification Agreement (incorporated by reference to Exhibit 10.7 to the Company's Current Report on Form 8-K dated June 9, 2016)
10.5t	Form of TPG Restricted Stock Agreement (incorporated by reference to Exhibit 10.27 to the Company's Annual Report on Form 10-K for the year ended September 30, 2016)
10.6	Credit Agreement, dated as of June 9, 2016, by and Nexeo Solutions, LLC, the other U.S Borrowers referred to therein, Nexeo Solutions Canada Corp., Nexeo Solutions Holdings, LLC, Nexeo Solutions Sub Holding Corp., Bank of America, N.A. as agent, the other agents party thereto and the others lenders party thereto (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K dated June 9, 2016)
10.7	Credit Agreement, dated as of June 9, 2016, by and among Nexeo Solutions, LLC, Nexeo Solutions Holdings, LLC, Nexeo Solutions Sub Holding Corp., Bank of America, N.A., as administrative agent and collateral agent, the other agents party thereto and the other lenders party thereto (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K dated June 9, 2016)
10.8	Amendment No. 1 to the ABL Credit Facility agreement, dated as of December 6, 2016 by Nexeo Solutions, LLC, the other U.S. Borrowers referred to therein, Nexeo Solutions Canada Corp., Nexeo Solutions Holdings, LLC, Nexeo Solutions Sub Holding Corp., Bank of America N.A. as agent, the other agents party thereto and the other lenders party thereto (incorporated by reference to Exhibit 10.28 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2016)
10.9	Amendment No. 1, dated March 22, 2017, among Nexeo Solutions Holdings, LLC, Nexeo Solutions, LLC, Nexeo Solutions Sub Holdings Corp., the other Loan Parties identified therein, Bank of America, N.A., as administrative agent and collateral agent, and the lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K dated March 22, 2017)

135

Exhibit Number	Description
10.10	Amendment No. 2, dated December 19, 2017, among Nexeo Solutions Holdings, LLC, Nexeo Solutions, LLC, Nexeo Solutions Sub Holdings Corp., the other Loan Parties identified therein, Bank of America, N.A., as administrative agent and collateral agent, and the lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K dated December 19, 2017)
10.11t	Nexeo Solutions, Inc. Severance Plan for U.S. Officers and Executives, as Amended and Restated, Effective as of June 9, 2016 (incorporated by reference to Exhibit 10.6 to the Company’s Current Report on Form 8-K dated June 9, 2016)
10.12t	Nexeo Solutions, Inc. 2016 Long Term Incentive Plan (incorporated by reference to Exhibit 4.3 to the Company’s S-8 Registration Statement (Commission File No. 333-212199))
10.13t	Form of Performance Share Unit Award Agreement under the Nexeo Solutions, Inc. 2016 Long Term Incentive Plan (incorporated by reference to Exhibit 10.14 to the Company’s Current Report on Form 8-K dated June 9, 2016)
10.14† t	Nexeo Solutions, LLC Excess Benefit Plan
10.15t	Employment Agreement, dated June 9, 2016, by and between Nexeo Solutions, Inc., Nexeo Solutions, LLC and David Bradley (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K dated June 9, 2016)
10.16	Separation Agreement and Release of Claims dated effective April 11, 2016 by and among Nexeo Solutions, LLC, Nexeo Solutions Holdings, LLC and Henry E. Harrell (incorporated by reference to Exhibit 10.23 to the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2016)
10.17	Registration Rights Agreement, dated May 23, 2016, by and between WL Ross Holding Corp., WL Ross Sponsor LLC and First Pacific Advisors, LLC, on behalf of one or more clients (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K dated May 23, 2016)
10.18	Registration Rights Agreement, dated June 9, 2016, by and among Nexeo Solutions, Inc., Merrill Lynch Pierce, Fenner & Smith Incorporated, Credit Suisse Securities (USA) LLC and Deutsche Bank Securities Inc. (incorporated by reference to Exhibit 10.12 to the Company’s Current Report on Form 8-K dated June 9, 2016)
10.19	Founder Share Transfer Letter Agreement, dated March 21, 2016, by and among WL Ross Holding Corp, WL Ross Sponsor LLC and Nexeo Holdco, LLC (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K dated March 21, 2016)
10.20	Amendment No. 1 to Founder Share Transfer Letter Agreement, dated June 6, 2016, by and among WL Ross Holding Corp, WL Ross Sponsor LLC and Nexeo Holdco, LLC (incorporated by reference to Exhibit 10.6 to the Company’s Current Report on Form 8-K dated June 6, 2016)
10.21	Private Placement Warrant Exchange Letter Agreement, dated as of March 21, 2016, by and among WL Ross Holding Corp., WL Ross Sponsor LLC and Nexeo Solutions Holdings, LLC (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K dated March 21, 2016)

136

Exhibit Number	Description
10.22	Subscription Agreement, dated May 9, 2016, by and between WL Ross Holding Corp. and Fidelity Select Portfolios: Chemicals Portfolio, Fidelity Advisor Series I: Fidelity Advisor Value Fund, Fidelity Capital Trust: Fidelity Value Fund, Fidelity Select Portfolios: Materials Portfolio, Fidelity Central Investment Portfolios LLC: Fidelity Materials Central Fund and Variable Insurance Products Fund IV: Materials Portfolio (incorporated by reference to Exhibit 10.6 to the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2016)
10.23	Subscription Agreement, dated May 6, 2016, by and between WL Ross Holding Corp. and MFS Series Trust XV on behalf of MFS Global Alternative Strategy Fund, MFS Series Trust I on behalf of MFS New Discovery Fund and MFS Variable Insurance Trust on behalf of MFS New Discovery Series (incorporated by reference to Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2016)
10.24	Subscription Agreement, dated May 23, 2016, by and among WL Ross Holding Corp., WL Ross Sponsor LLC and First Pacific Advisors, LLC, on behalf of one or more clients (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K dated May 23, 2016)
10.25	Subscription Agreement, dated June 6, 2016, by and among WL Ross Holding Corp. and WL Ross Sponsor LLC (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K dated June 6, 2016)
10.26	Commitment Agreement, dated June 6, 2016, by and among WL Ross Holding Corp., WL Ross Sponsor LLC and First Pacific Advisors, LLC, on behalf of one or more clients (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K dated June 6, 2016)
10.27	Commitment Agreement, dated June 6, 2016, by and among WL Ross Holding Corp., WL Ross Sponsor LLC and Park West Investors Master Fund, Limited (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K dated June 6, 2016)
10.28	Commitment Agreement, dated June 6, 2016, by and among WL Ross Holding Corp., WL Ross Sponsor LLC and Park West Partners International, Limited (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K dated June 6, 2016)
10.29	Vehicle Operating and Service Agreement dated May 22, 2015 by and between Ryder Truck Rental, Inc. d/b/a Ryder Transportation Services, and Nexeo Solutions, LLC (incorporated by reference to Exhibit 10.21 to Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2016)
10.30	Amendment to Vehicle Operating and Service Agreement dated May 22, 2015 by and between Ryder Truck Rental, Inc., d/b/a Ryder Transportation Services, and Nexeo Solutions, LLC (incorporated by reference to Exhibit 10.22 to Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2016)
21.1†	List of Subsidiaries.
23.1†	Consent of PricewaterhouseCoopers LLP
31.1†	Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

137

Exhibit Number	Description
31.2†	Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1††	Certifications of Principal Executive Officer and Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101*	Interactive data files pursuant to Rule 405 of Regulation S-T.

†                          Filed herewith.

††                   Furnished herewith.

t                       Management contract or compensatory plan or arrangement.

*                          Pursuant to Rule 406T of Regulation S-T, the interactive data files included in Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act are deemed not filed for purposes of Section 18 of the Exchange Act and otherwise are not subject to liability under those sections.

**                   Schedules omitted pursuant to item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule to the SEC upon request, provided, however, that the Company may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any schedule or exhibit so furnished.

138

Item 16. Form 10-K Summary

Not applicable.

139

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the 6th day of December, 2018.

NEXEO SOLUTIONS, INC.
By:	/s/ David A. Bradley
	David A. Bradley
	President, Chief Executive Officer and Director

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities indicated on the 6th day of December, 2018.

Signature	Title
/s/ David A. Bradley	President, Chief Executive Officer and Director
David A. Bradley	(Principal Executive Officer)
/s/ Ross J. Crane	Executive Vice President, Chief Financial Officer
Ross J. Crane	(Principal Financial Officer)
/s/ Kristina A. Smith	Vice President, Controller and Chief Accounting Officer
Kristina A. Smith	(Principal Accounting Officer)
/s/ Dan F. Smith	Chairman
Dan F. Smith
/s/ Kenneth M. Burke	Director
Kenneth M. Burke
/s/ Brian A. Selmo	Director
Brian A. Selmo
/s/ Nathan H. Wright	Director
Nathan H. Wright
/s/ Christopher J. Yip	Director
Christopher J. Yip
/s/ Thomas E. Zacharias	Director
Thomas E. Zacharias
/s/ Robert J. Zatta	Director
Robert J. Zatta

140

EX-10.8

Exhibit 10.8

AMENDMENT NO. 1 TO CREDIT AGREEMENT

AMENDMENT NO. 1 TO CREDIT AGREEMENT, dated as of December 7, 2016 (this “Amendment”), among NEXEO SOLUTIONS, LLC, a Delaware limited liability company (as successor to Neon Finance Company LLC) (the “Company”), each domestic subsidiary of the Company party hereto as a U.S. Borrower (each a “U.S. Borrower” and together with the Company, Holdings (as defined below) and Sub Holdco (as defined below), the “U.S. Borrowers”), NEXEO SOLUTIONS CANADA CORP., a Canadian corporation (the “Canadian Borrower” and together with the U.S. Borrowers, collectively the “Borrowers”, and individually, each a “Borrower”), NEXEO SOLUTIONS HOLDINGS, LLC, a Delaware limited liability company (as successor to Neon Holding Company LLC) (“Holdings”), NEXEO SOLUTIONS SUB HOLDING CORP., a Delaware corporation (“Sub Holdco”), BANK OF AMERICA, N.A., as administrative agent (in such capacity, the “Administrative Agent”) and as collateral agent (in such capacity, the “Collateral Agent”), and the Lenders (as defined below) party hereto.

PRELIMINARY STATEMENTS

A.    The Borrowers, the Administrative Agent and each lender from time to time party thereto (the “Lenders”) have entered into a Credit Agreement, dated as of June 9, 2016 (the “Existing Credit Agreement”).

B.    The Borrowers have requested that, pursuant to Section 9.02 of the Existing Credit Agreement, the Required Lenders consent to the amendments described herein, and the Required Lenders are willing to agree to such amendments on the terms and subject to the conditions described herein.

NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, the sufficiency and receipt of all of which is hereby acknowledged, the parties hereto hereby agree as follows:

SECTION 1.Definitions. Capitalized terms used herein and not otherwise defined in this Amendment have the same meanings as specified in the Existing Credit Agreement, as amended by this Amendment (as so amended, the “Credit Agreement”).

SECTION 2.Amendments to Existing Credit Agreement. Effective as of the Amendment Effective Date (as defined below), the Existing Credit Agreement is hereby amended as follows:

(a)Clause (e) of the definition of “Collateral and Guarantee Requirement” in Section 1.01 of the Existing Credit Agreement is amended and restated in its entirety to read as follows: “the Agent shall have received each of the documents required to be delivered pursuant to Section 5.11 and 5.13, as applicable.”;

(b)The definition of “Collateral Documents”, in Section 1.01 of the Existing Credit Agreement is amended to delete the words “the Mortgages”.

(c)Clause (i) of the definition of “Excluded Property” in Section 1.01 of the Existing Credit Agreement is amended by deleting the words “that is not a Material Real Property”;

(d)Section 1.01 of the Existing Credit Agreement is further amended by deleting the definitions of “Material Real Property”, “Mortgage Policies”, “Mortgaged Properties” and “Mortgages” in their entirety;

(e)Clause (e)(ii) of Section 4.01 of the Existing Credit Agreement is amended to delete the words “(other than local counsel opinions relating to the Mortgages which shall be delivered as provided in Section 5.13(b)(v))”;

(f)Clause (b) of Section 5.07 of the Existing Credit Agreement is amended and restated in its entirety to read as follows: “[Reserved]”;

(g)Clause (a)(i)(A) of Section 5.11 of the Existing Credit Agreement is amended and restated in its entirety to read as follows: “[Reserved]”;

(h)Clause (a)(i)(B) in Section 5.11 of the Existing Credit Agreement is amended and restated in its entirety to read as follows: “within forty-five (45) days (or such longer period as agreed by the Agent in its reasonable discretion) after such formation, acquisition or designation, cause each such Material Domestic Subsidiary or Material Foreign Subsidiary that is required to become a Guarantor pursuant to the Collateral and Guarantee Requirement to duly execute and deliver to the Agent a Joinder Agreement in substantially the form set forth as Exhibit D hereto (the “Joinder Agreement”), a joinder to the guaranty, security agreement supplements, Intellectual Property Security Agreements and other security agreements and documents”;

(i)Clause (a)(i)(D) in Section 5.11 of the Existing Credit Agreement is amended by deleting the words (x) “(or within one hundred twenty (120) days in the case of documents listed in Section 5.13(b))” and (y) “the recording of Mortgages,”;

(j)Clause (a)(ii) of Section 5.11 of the Existing Credit Agreement is amended by deleting the words “(or within one hundred twenty (120) days in the case of documents listed in Section 5.13(b))”;

(k)Clause (a)(iii) of Section 5.11 of the Existing Credit Agreement is amended and restated in its entirety to read as follows: “[Reserved]”;

(l)Clause (c) of Section 5.11 of the Existing Credit Agreement is amended and restated in its entirety to read as follows: “[Reserved]”;

(m)Clause (b) of Section 5.13 of the Existing Credit Agreement is amended and restated in its entirety to read as follows: “[Reserved]”;

(n)Clause (E) of Section 6.04(d) of the Existing Credit Agreement is amended and restated in its entirety to read as follows: “[Reserved]”;

(o)Clause (m) of Section 7.01 of the Existing Credit Agreement is amended by deleting the words “and except as to Collateral consisting of real property to the extent that such losses are covered by a lender’s title insurance policy and such insurer has been notified and has not denied coverage”;

(p)The second paragraph of Section 9.08 of the Existing Credit Agreement is hereby deleted in its entirety; and

(q)Schedule 1.01(f) of the Existing Credit Agreement is hereby deleted in its entirety.

SECTION 3.Conditions of Effectiveness. This Amendment shall become effective as of the first date (such date being referred to as the “Amendment Effective Date”) when each of the following conditions shall have been satisfied:

(a)Execution of Documents. The Administrative Agent shall have received this Amendment, duly executed and delivered by (A) the Borrowers and (B) the Lenders constituting the Required Lenders.

(b)Expenses. The Administrative Agent shall have received all fees required to be paid, and all expenses required to be paid or reimbursed under Section 9.03(a) of the Credit Agreement for which invoices have been presented a reasonable period of time prior to the Amendment Effective Date, in each case on or before the Amendment Effective Date.

SECTION 4.Representations and Warranties. The Borrowers represent and warrant as follows as of the date hereof:

(a)The execution, delivery and performance by the Borrowers of this Amendment have been duly authorized by all necessary corporate and/or other organizational action. The execution, delivery and performance by the Borrowers of this Amendment will not (i) contravene the terms of any of the Borrowers’ Organization Documents; (ii) result in any breach or contravention of, or the creation of any Lien upon any of the property or assets of any Borrower or any of the Restricted Subsidiaries under (A) any Contractual Obligation to which any Borrower is a party or affecting any Borrower or the properties of any Borrower or any of the Restricted Subsidiaries or (B) any order, injunction, writ or decree of any Governmental Authority or any arbitral award to which any Borrower or its property is subject; or (iii) violate any applicable Law; except with respect to any breach, contravention or violation (but not creation of Liens) referred to in clauses (ii) and (iii), to the extent that such breach, contravention or violation would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

(b)This Amendment has been duly executed and delivered by each Borrower. Each of this Amendment and each other Loan Document to which any Borrower is a party, after giving effect to the amendments pursuant to this Amendment, constitutes a legal, valid and binding obligation of such Borrower, enforceable against such Borrower in accordance with its terms, except as such enforceability may be limited by Debtor Relief Laws and by general principles of equity and principles of good faith and fair dealing.

(c)No Default or Event of Default has occurred and is continuing.

(d)The representations and warranties of the Borrowers and each other Loan Party contained in Article III of the Credit Agreement or any other Loan Document are true and correct in all material respects on and as of the date hereof; provided that, to the extent that such representations and warranties specifically refer to an earlier date, they are true and correct in all material respects as of such earlier date; provided, further, that any representation and warranty that is qualified as to “materiality,” “Material Adverse Effect” or similar language is true and correct (after giving effect to any qualification therein) in all respects on such respective dates.

SECTION 5.Reference to and Effect on the Credit Agreement and the Loan Documents.

(a)Except as expressly set forth herein, this Amendment (i) shall not by implication or otherwise limit, impair, constitute a waiver of, or otherwise affect the rights and remedies of the Lenders, the Administrative Agent or the Borrowers under the Existing Credit Agreement or any other Loan Document, and (ii) shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Existing Credit Agreement or any other Loan Document, all of which are ratified and affirmed in all respects and shall continue in full force and effect. Without limiting the generality of the foregoing, the Collateral Documents and all of the Collateral described therein do and shall continue to secure the payment of all Obligations of the Loan Parties under the Loan Documents, in each case, as amended by this Amendment. Each Borrower hereby consents to this Amendment and confirms that all of its obligations under the Loan Documents to which it is a party shall continue to apply to the Credit Agreement. The parties hereto acknowledge and agree that the amendment of the Existing Credit Agreement pursuant to this Amendment shall not constitute a novation of the Existing Credit Agreement and the other Loan Documents as in effect prior to the Amendment Effective Date.

(b)On and after the effectiveness of this Amendment, this Amendment shall for all purposes constitute a Loan Document.

SECTION 6.Execution in Counterparts. This Amendment may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this Amendment by telecopy or other electronic imaging means shall be effective as delivery of a manually executed counterpart of this Amendment.

SECTION 7.Notices. All communications and notices hereunder shall be given as provided in the Credit Agreement.

SECTION 8.Severability. If any provision of this Amendment is held to be illegal, invalid or unenforceable, (a) the legality, validity and enforceability of the remaining provisions of this Amendment shall not be affected or impaired thereby and (b) the parties shall endeavor in good faith negotiations to replace the illegal, invalid or unenforceable provisions with valid provisions, the economic effect of which comes as close as possible to that of the illegal, invalid or unenforceable provisions. The invalidity of a provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

SECTION 9.Successors. The provisions of this Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and registered assigns permitted under Section 9.04 of the Credit Agreement.

SECTION 10.Governing Law; Jurisdiction; Consent to Service of Process; Waiver of Jury Trial. The provisions set forth in Sections 9.09 and 9.10 of the Credit Agreement are hereby incorporated mutatis mutandis, with all references to the “Agreement” therein being deemed references to this Amendment.

[The remainder of this page is intentionally left blank]

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the date first above written.

NEXEO SOLUTIONS, LLC

NEXEO SOLUTIONS HOLDINGS, LLC

NEXEO SOLUTIONS CANADA CORP.

NEXEO SOLUTIONS SUB HOLDING CORP.

ARCHWAYS SALES, LLC

CHEMICAL SPECIALISTS AND DEVELOPMENT, LLC

STARTEX CHEMICAL, LLC

STARTEX DISTRIBUTION WEST, LLC

NEXEO SOLUTIONS FINANCE CORPORATION

By:     /s/ Ross Crane        Name: Ross Crane    Title: Executive Vice President, Chief Financial

Officer and Treasurer

[Amendment No. 1 to Credit Agreement]

BANK OF AMERICA, N.A., as Administrative Agent and Collateral Agent

By: /s/ Robert Q. Mahoney   Name: Robert Q. Mahoney   Title: Senior Vice President

[Amendment No. 1 to Credit Agreement]

The undersigned hereby consents to the Amendment:

WELLS FARGO CAPITAL FINANCE

CORPORATION CANADA, as a lender    

By: /s/ David G. Phillips
Name: David G. Phillips
Title: Senior Vice President

Credit Officer, Canada

Wells Fargo Capital Finance

Corporation Canada

[Amendment No. 1 to Credit Agreement]

The undersigned hereby consents to the Amendment:

WELLS FARGO BANK N.A., as a lender    

By: /s/ Krista Mize
Name: Krista Mize
Title: Authorized Signatory

[Amendment No. 1 to Credit Agreement]

The undersigned hereby consents to the Amendment:

Sun Trust Bank    

By: /s/ Michael Dembski
Name: Michael Dembski
Title: Director

[Amendment No. 1 to Credit Agreement]

The undersigned hereby consents to the Amendment:

Capital One, National Association    

By: /s/ Drew Vinca
Name: Drew Vinca
Title: Director

[Amendment No. 1 to Credit Agreement]

The undersigned hereby consents to the Amendment:

U.S. BANK NATIONAL ASSOCIATION    

As a U.S. Lender

By: /s/ Deborah Saffie
Name: Deborah Saffie
Title: Vice President

[Amendment No. 1 to Credit Agreement]

The undersigned hereby consents to the Amendment:

Citibank, N.A.    

By: /s/ Christopher Marino
Name: Christopher Marino
Title: Director and Vice President

[Amendment No. 1 to Credit Agreement]

EX-10.14

Exhibit 10.14

NEXEO SOLUTIONS, LLC EXCESS BENEFIT PLAN

(as Amended and Restated Effective January 1, 2012)

Exhibit 10.14

Table of Contents

I. Purpose of the Excess Plan1

II. Incorporation of the Basic Plan1

III. Administration2

IV. Eligibility2

V. Amount of Benefit2

VI. Deemed Investment of Excess Plan Accounts and Adjustment for Net Income or Loss4

VII. Payment of Benefits4

VIII. Employee’s Rights4

IX. Amendment and Termination5

X. Restrictions on Assignment5

XI. Nature of Excess Plan5

XII. Nonguarantee of Employment6

XIII. Binding on Employer, Employees and Their Successors6

XIV. Employment with More than One Employer6

XV. Laws Governing6

APPENDIX A A-1

Exhibit 10.14

NEXEO SOLUTIONS, LLC EXCESS BENEFIT PLAN

WHEREAS, NEXEO SOLUTIONS, LLC, a Delaware limited liability company (the "Company" or collectively with any other participating employers as set forth on Appendix A the "Employer"), has heretofore adopted the NEXEO SOLUTIONS, LLC EMPLOYEE SAVINGS PLAN (the "Basic Plan") for the benefit of their employees;

WHEREAS, the Employer adopted the NEXEO SOLUTIONS, LLC EXCESS BENEFIT PLAN (the "Excess Plan") to provide additional benefits to certain of its employees who are participants in the Basic Plan on and after the effective date hereof whose benefits are limited under the Basic Plan; and

WHEREAS, the Employer desires to provide to certain individuals an additional annual contribution equal to three percent (3%) of the respective individual’s compensation.

NOW, THEREFORE, the Employer hereby adopts the Excess Plan as amended and restated effective as of January 1, 2012, as follows:

I.

Purpose of the Excess Plan

The Employer intends and desires by the adoption of this Excess Plan to recognize the value to the Employer of the past and present services of employees covered by the Excess Plan and to encourage and assure their continued service with the Employer by making more adequate provision for their future retirement security. The establishment of this Excess Plan is made necessary by certain benefit limitations which are imposed on the Basic Plan by the Employee Retirement Income Security Act of 1974, as amended, ("ERISA"), and by sections 401(a)(17) and 415 of the Internal Revenue Code of 1986, as amended (the "Code"). For purposes of the Code, the Company intends this Plan to be an unfunded, unsecured promise to pay on the part of the Company. For purposes of ERISA, the Company intends the Plan to be an unfunded plan solely for the benefit of a select group of management or highly compensated employees of the Employer for the purpose of qualifying the Plan for the "top hat" plan exception under sections 201(2), 301 (a)(3) and 401(a)(I) of ERISA.

II.

Incorporation of the Basic Plan

The Basic Plan, with any amendments thereto to the date of adoption of the Excess Plan, will be attached hereto as Exhibit I and is hereby incorporated by reference into and will form a part of this Excess Plan as if fully set forth herein verbatim. Any amendment made to the Basic Plan will also be incorporated by reference into and form a part of this Excess Plan, effective as of the effective date of such amendment. The Basic Plan, whenever referred to in this Excess Plan, will mean the Basic Plan, as amended, as it exists as of the date any determination is made of amounts credited or benefits payable under this Excess Plan. All terms used in this Excess Plan will

Exhibit 10.14

have the meanings assigned to them under the provisions of the Basic Plan unless otherwise qualified by the context.

III.

Administration

This Excess Plan will be administered by the plan administrator or administrative committee under the Basic Plan (the "Plan Administrator") which will administer it in a manner consistent with the administration of the Basic Plan, as from time to time amended and in effect, except that this Excess Plan will be administered as an unfunded plan which is not intended to meet the qualification requirements of section 401 of the Code. The Plan Administrator will have full power and authority to interpret, construe and administer this Excess Plan and the Plan Administrator’s interpretations and construction hereof, and actions hereunder, including the amount or recipient of any payment to be made hereunder, will be binding and conclusive on all persons for all purposes. The Plan Administrator will not participate in any action or determination regarding his or her own benefits hereunder. The Company will indemnify and hold harmless the Plan Administrator and each Employee who is a delegate of the Plan Administrator against any and all expenses and liabilities arising out of his administrative functions or fiduciary responsibilities, including any expenses and liabilities that are caused by or result from an act or omission constituting the negligence of such individual in the performance of such functions or responsibilities, but excluding expenses and liabilities that are caused by or result from such individual’s own gross negligence or willful misconduct. Expenses against which such individual will be indemnified hereunder will include, without limitation, the amounts of any settlement or judgment, costs, counsel fees, and related charges reasonably incurred in connection with a claim asserted or a proceeding brought or settlement thereof.

IV.

Eligibility

Those who are eligible to participate in the Excess Plan are those Employees (a) who are participating in the Basic Plan, (b) who are classified as compensation bands 21 and above, and (c) whose benefits under Sections 3.2 ("Matching Contributions") and 3.3 ("Nonelective Contributions") (i.e., collectively the "Employer Contributions") of the Basic Plan are limited pursuant to sections 401(a)(17) or 415 of the Code. In no event will an Employee who is not entitled to benefits under the Basic Plan be eligible for a benefit under this Excess Plan.

V.

Amount of Benefit

The Plan Administrator will establish a memorandum bookkeeping account (the "Excess Plan Account") for each Employee whose allocations of Employer Contributions under the Basic Plan have been limited pursuant to sections 401(a)(17) or 415 of the Code. As of the end of each

Exhibit 10.14

Plan Year, the Plan Administrator will credit such Employee’s Excess Plan Account in an amount equal to the sum of (a), (b), and (c) where:

(a) equals the excess, if any, of:

(1) the amount that would have been allocated to the Matching Contributions Account and Nonelective Contribution Account of such Employee under the Basic Plan as of the end of such Plan Year if the provisions of the Basic Plan were administered without regard to the maximum amount of retirement income limitations of section 415 of the Code, over

(2) the amount that was in fact allocated as of the end of such Plan Year to the Matching Contributions Account and Nonelective Contributions Account of such Employee under the Basic Plan; and

(b) equals the excess, if any, of:

(1) the amount that would have been allocated to the Matching Contributions Account and Nonelective Contribution Account of such Employee under the Basic Plan as of the end of such Plan Year if the provisions of the Basic Plan were administered without regard to the maximum compensation limitation under section 401(a)(17) of the Code, over

(2) the amount that was in fact allocated as of the end of such Plan Year to the Matching Contributions Account and Nonelective Contributions Account of such Employee under the Basic Plan.

(c) equals zero ($0.00), unless the Employee is a direct report to the Company’s Chief Executive Officer and receives an award letter addressing the following, then (c) shall be equal to three percent (3%) of such Employee's compensation, provided that for the 2012 Plan Year, it shall also include an additional catch-up contribution amount equal to three percent (3%) of such Employee's compensation for the prior year (i.e., the initial contribution shall reflect two (2) years of contributions).

In determining the excess benefits for Employees of the Employer in compensation bands 21 and above, the definition of Compensation will include bonuses. An Employee’s Vested Interest in his Excess Plan Account will be the same percentage as his Vested Interest in his Employer Contribution Accounts under the Basic Plan. Therefore, if any portion of an Employee’s Employer Contribution Accounts under the Basic Plan is forfeited for any reason, the Plan Administrator will debit such Employee’s Excess Plan Account by an amount equal to the percentage of such Excess Plan Account which corresponds to the percentage of his Employer Contribution Accounts under the Basic Plan that were forfeited. Benefits payable under this Excess Plan to any recipient will be computed in accordance with the foregoing and with the objective that such recipient should receive under this Excess Plan and the Basic Plan that total amount which would have been payable to that recipient solely under the Basic Plan had sections 401(a)(17) and 415 of the Code not been applicable thereto. This Excess Plan is intended to constitute an unfunded "excess benefit plan" within the meaning of sections 3(36) and 4(b)(5) of ERISA.

Exhibit 10.14

VI.

Deemed Investment of Excess Plan Accounts and Adjustment for Net Income or Loss

The amounts credited to each Employee’s Excess Plan Account will be deemed to be invested in the funds made available under the Basic Plan (the "Investment Funds") in the same manner as the Employee designates for amounts allocated to his Account under the Basic Plan. If an Employee changes his investment designation with respect to amounts allocated to his Account under the Basic Plan, such change will also apply to the amounts credited to such Employee’s Excess Plan Account. The Plan Administrator will ascertain the net income (or net loss) of the Investment Funds at such times and in such manner as it deems appropriate and will adjust the balance of each Employee’s Excess Plan Account as appropriate to reflect such net income (or net loss). An Employee’s Excess Plan Account will continue to be adjusted for the net income (or net loss) of the Investment Funds so long as there is any balance credited to such account.

VII.

Payment of Benefits

The vested portion of the amount credited to an Employee’s Excess Plan Account will be paid in a lump sum cash payment as soon as practicable following the Employee’s termination of employment with the Employer for any reason including death. If an Employee’s termination of employment is by reason of his death, the payment will be made to the Employee’s beneficiary under the Basic Plan. In the event the Employee is a "specified employee" of the Company, as such term is defined in Treasury Regulation Section 1.409A-1(i), as of the Employee’s date of termination of employment, payments made pursuant to this Article VII will not be paid until the first day of the seventh month following the Employee’s date of termination of employment. The Employer will have the right to deduct from all payments made under this Excess Plan any federal, state or local taxes required by law to be withheld with respect to such payments. The Employee’s Excess Plan Account will be debited for the amount paid pursuant to this Article VII.

VIII.

Employee’s Rights

Except as otherwise specifically provided, an Employee’s rights under this Excess Plan will be the same as his rights under the Basic Plan. Benefits payable under this Excess Plan will be a general, unsecured obligation of the Employer to be paid by the Employer from its general assets, and such payments will not (a) impose any obligation upon the Trust under the Basic Plan; (b) be paid from the Trust under the Basic Plan; or (c) have any effect whatsoever upon the Basic Plan or the payment of benefits from the Trust under the Basic Plan. No Employee or Beneficiary will have any title to or beneficial ownership in any assets which the Employer may set aside to pay benefits hereunder or any other assets of the Employer. Further, Employees will not be permitted to withdraw or borrow from their Excess Plan Accounts.

Exhibit 10.14

IX.

Amendment and Termination

The Employer expects to continue this Excess Plan indefinitely, but reserves the right to amend or terminate it if, in its sole judgment, such a change is deemed necessary or desirable. Any such amendment or termination will be by action of the Company’s Authorized Representative. However, if the Employer should amend or terminate this Excess Plan, the Employer will be liable for any benefits accrued including any nonvested benefits under this Excess Plan (determined on the basis of each Employee’s presumed termination of employment as of the date of such amendment or discontinuance) as of the date of such action.

X.

Restrictions on Assignment

The interest of an Employee or Beneficiary may not be sold, transferred, assigned, or encumbered in any manner, either voluntarily or involuntarily, and any attempt to anticipate, alienate, sell, transfer, assign, pledge, encumber, or charge the same will be null and void; neither will the benefits hereunder be liable for or subject to the debts, contracts, liabilities, engagements, or torts of any person to whom such benefits or funds are payable, nor will they be subject to garnishment, attachment, or other legal or equitable process nor will they be an asset in bankruptcy, except that no amount will be payable hereunder until and unless any and all amounts representing debts or other obligations owed to the Company or any affiliate of the Company by the Employee with respect to whom such amount would otherwise be payable will have been fully paid and satisfied. The preceding notwithstanding, the Plan Administrator will comply with the terms and provisions of an order that satisfies the requirements for a "qualified domestic relations order" as defined in section 206(d) of ERISA, including an order that requires distributions to an alternate payee prior to an Employee’s earliest retirement age as such term is defined in section 206(d)(3)(E)(ii) of ERISA.

XI.

Nature of Excess Plan

The Excess Plan is not intended to meet the qualification requirements of section 401 of the Code. Although the Employer is obligated to pay all amounts due under the Excess Plan out of its general assets, the Employer, in its sole discretion, may set aside such amounts for the payment of benefits as the Employer may from time to time determine. Neither the establishment of the Excess Plan, the operation thereof, nor the setting aside of any amounts will be deemed to create a funding arrangement. Any and all amounts set aside will remain subject to the claims of the general creditors of the Employer, present and future, and no payment will be made under the Excess Plan unless the Employer is then solvent. This Article will not require the Employer to set aside any funds, but the Employer may set aside such funds if it chooses to do so. The preceding paragraph to the contrary notwithstanding, the Employer may fund all or part of its obligations hereunder by transferring assets to a trust if the provisions of the trust agreement creating such trust require the use of such trust’s assets to satisfy claims of the Employer’s general unsecured creditors in the event of the

Exhibit 10.14

Employer’s insolvency or bankruptcy and provide that no Employee will at any time have a prior claim to such assets and that such trust will not cause the Plan to be other than "unfunded" for the purposes of ERISA. The assets of such trust will not be deemed to be assets of this Excess Plan.

XII.

Nonguarantee of Employment

Nothing contained in this Excess Plan will be construed as a contract of employment between the Employer and any Employee, or as a right to have benefits which are provided by the Employer maintained, or as a right of any Employee to be continued in the employment of the Employer, or as a limitation of the right of the Employer to discharge any of its Employee, with or without cause.

XIII.

Binding on Employer, Employees and Their Successors

This Excess Plan will be binding upon and inure to the benefit of the Employer, its successors and assigns and the Employee and his heirs, executors, administrators and legal representatives. The provisions of this Excess Plan will be applicable with respect to each Employer separately, and amounts payable hereunder will be paid by the Employer which employs the particular Employee.

XIV.

Employment with More than One Employer

If any Employee will be entitled to benefits under the Basic Plan on account of service with more than one Employer, the obligations under this Excess Plan will be apportioned among such Employers on the basis of time of service with each.

XV.

Laws Governing

This Excess Plan will be construed in accordance with and governed by the laws of the State of Delaware except to the extent preempted by federal law.

[SIGNATURE PAGE TO FOLLOW]

Exhibit 10.14

EXECUTED this 11th day of November, 2011.

NEXEO SOLUTIONS, LLC

By:/s/ Gene M. Gillock

Name:Gene M. Gillock

Title:VP Global Rewards

Exhibit 10.14

APPENDIX A

OTHER PARTICIPATING EMPLOYERS

None

EX-21.1

Exhibit 21.1

Subsidiaries of Nexeo Solutions, Inc.

Entity	Jurisdiction of Formation
Nexeo Solutions Canada Corp.	Canada
Nexeo Solutions Cayman Holding Co. Ltd.	Cayman Islands
Nexeo Solutions Chemicals Trading (Shanghai) Company Limited	China
Nexeo Solutions Trading (Shanghai) Company Limited	China
Nexeo Plaschem (Shanghai) Co., Ltd.	China
Nexeo Solutions Costa Rica, S. de R.L.	Costa Rica
Accolade Finland OY	Finland
Accolade France SAS	France
Nexeo Solutions Germany GmbH	Germany
Nexeo Solutions Guatemala, S.A.	Guatemala
Nexeo Solutions Asia Limited	Hong Kong
Nexeo Solutions Hong Kong Limited	Hong Kong
Pacific Sky (H.K.) Ltd.	Hong Kong
Nexeo Solutions Italy SRL	Italy
Nexeo Solutions Luxembourg Holding Co. S.a.r.l.	Luxembourg
Nexeo Solutions Mexico S. de R.L. de C.V.	Mexico
Nexeo Solutions Services Mexico S. de R.L. de C.V.	Mexico
Nexeo Solutions Europe B.V.	Netherlands
Nexeo Solutions Poland Sp. zo.o.	Poland
Accolade Portugal, Unipessoal Limitada	Portugal
Nexeo Solutions Puerto Rico, LLC	Puerto Rico
Nexeo Solutions RUS LLC	Russia
Nexeo Solutions Singapore Pte. Ltd.	Singapore
Nexeo Solutions Spain SLU	Spain
Nexeo Solutions Sweden AB	Sweden
Nexeo Solutions Plastics UK Limited	United Kingdom
Nexeo Solutions, LLC	Delaware
Nexeo Solutions Holdings, LLC	Delaware
Nexeo Solutions Mexico Holdings, LLC	Delaware
Nexeo Solutions Pico Holdings, LLC	Delaware
Nexeo Solutions Sub Holding Corp.	Delaware
Nexeo Solutions Finance Corporation	Delaware
Chemical Specialists and Development, LLC	Delaware
Startex Chemical, LLC	Delaware
Startex Distribution West, LLC	Delaware
Archway Sales, LLC	Delaware
TPG Accolade Delaware, LLC	Delaware

EX-23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-212199) and Form S-3 (No. 333-212200) of Nexeo Solutions, Inc. of our reports dated December 7, 2017 and December 8, 2016 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appear in this Form 10‑K.

/s/ PricewaterhouseCoopers LLP

Houston, Texas
December 7, 2017

EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A)

OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, David A. Bradley, certify that:

1. I have reviewed this Annual Report on Form 10-K for the fiscal year ended September 30, 2018 of Nexeo Solutions, Inc. (the “registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: December 6, 2018	By:	/s/ David A. Bradley
	Name:	David A. Bradley
	Title:	Chief Executive Officer (Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A)

OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Ross J. Crane, certify that:

1. I have reviewed this Annual Report on Form 10-K for the fiscal year ended September 30, 2018 of Nexeo Solutions, Inc. (the “registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: December 6, 2018	By:	/s/ Ross J. Crane
	Name:	Ross J. Crane
	Title:	Chief Financial Officer (Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION OF

CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

UNDER SECTION 906 OF THE

SARBANES OXLEY ACT OF 2001, 18 U.S.C. § 1350

In connection with the Annual Report of Nexeo Solutions, Inc. (the “Company”) on Form 10-K for the fiscal year ended September 30, 2018, as filed with the Securities and Exchange Commission on December 6, 2018 (the “Report”), the undersigned, David A. Bradley, Chief Executive Officer, Nexeo Solutions, Inc., and Ross J. Crane, Chief Financial Officer, Nexeo Solutions, Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

(a) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(b) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: December 6, 2018	By:	/s/ David A. Bradley
	Name:	David A. Bradley
	Title:	Chief Executive Officer (Principal Executive Officer)

Date: December 6, 2018	By:	/s/ Ross J. Crane
	Name:	Ross J. Crane
	Title:	Chief Financial Officer (Principal Financial Officer)

XML

Document and Entity Information - USD ($)	12 Months Ended
	Sep. 30, 2018	Nov. 30, 2018	Mar. 31, 2018
Document and Entity Information
Entity Registrant Name	NEXEO SOLUTIONS, INC.
Entity Central Index Key	0001604416
Current Fiscal Year End Date	--09-30
Entity Filer Category	Accelerated Filer
Document Type	10-K
Document Period End Date	Sep. 30, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Common Stock, Shares Outstanding		89,698,331
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 350,498,787
Membership Interest Description
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false

XML

Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2018	Sep. 30, 2017
Current Assets
Cash and cash equivalents	$ 58.9	$ 53.9
Accounts and notes receivable (net of allowance for doubtful accounts of $4.2 million and $2.2 million, respectively)	607.8	597.4
Inventories	338.8	315.5
Income taxes receivable	5.9	3.4
Other current assets	17.3	19.8
Total current assets	1,028.7	990.0
Non-Current Assets
Property, plant and equipment, net	284.9	316.1
Goodwill	699.9	703.0
Other intangible assets, net of amortization	211.6	231.5
Deferred income taxes	2.3	2.3
Other non-current assets	16.2	10.6
Total non-current assets	1,214.9	1,263.5
Total Assets	2,243.6	2,253.5
Current Liabilities
Short-term borrowings, current portion of long-term debt and capital lease obligations	47.7	51.1
Accounts payable	380.1	384.2
Accrued expenses and other liabilities	67.2	58.4
Due to related party pursuant to contingent consideration obligations	14.7	12.5
Income taxes payable	2.9	3.2
Total current liabilities	512.6	509.4
Non-Current Liabilities
Long-term debt and capital lease obligations, less current portion, net	752.4	794.0
Deferred income taxes	30.7	34.9
Due to related party pursuant to contingent consideration obligations	122.8	127.7
Other non-current liabilities	10.6	9.9
Total non-current liabilities	916.5	966.5
Total Liabilities	1,429.1	1,475.9
Commitments and Contingencies
Equity
Preferred stock, $0.0001 par value (1,000,000 shares authorized, none issued and outstanding as of September 30, 2018 and September 30, 2017)	0.0	0.0
Common stock, $0.0001 par value (300,000,000 shares authorized, 89,747,062 shares issued and 89,727,546 shares outstanding as of September 30, 2018 and 89,353,641 shares issued and 89,344,065 shares outstanding as of September 30, 2017)	0.0	0.0
Additional paid-in capital	771.5	764.4
Retained earnings	34.2	4.8
Accumulated other comprehensive income	9.0	8.5
Treasury stock, at cost: 19,516 and 9,576 shares as of September 30, 2018 and September 30, 2017	(0.2)	(0.1)
Total equity	814.5	777.6
Total Liabilities and Equity	$ 2,243.6	$ 2,253.5

XML

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2018	Sep. 30, 2017
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 4.2	$ 2.2
Preferred stock, par value (in USD per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	300,000,000	300,000,000
Common stock, shares issued (in shares)	89,747,062	89,353,641
Common stock, shares outstanding (in shares)	89,727,546	89,344,065
Treasury stock (in shares)	19,516	9,576

XML

Consolidated Statements of Operations - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017
Sales and operating revenues	$ 1,065.7		$ 4,034.2	$ 3,636.9
Cost of sales and operating expenses	957.3		3,574.1	3,238.5
Gross profit	108.4		460.1	398.4
Selling, general and administrative expenses	91.7		352.6	312.9
Transaction related costs	21.3		2.8	1.9
Change in fair value of contingent consideration obligations	(11.2)		7.5	16.2
Operating income	6.6		97.2	67.4
Other income, net	0.5		1.0	8.3
Interest income (expense)
Interest income	0.8		0.5	0.3
Interest expense	(15.1)		(52.6)	(51.1)
Net income (loss) from continuing operations before income taxes	(7.2)		46.1	24.9
Income tax expense	1.2		16.7	10.5
Net income (loss) from continuing operations	(8.4)		29.4	14.4
Net income from discontinued operations, net of tax	0.0		0.0	0.0
Net income (loss)	$ (8.4)		$ 29.4	$ 14.4
Net income (loss) per share available to common stockholders, basic (in USD per share)	$ (0.24)		$ 0.38	$ 0.19
Net income (loss) per share available to common stockholders - diluted (USD per share)	$ (0.24)		$ 0.38	$ 0.19
Weighted average number of common shares outstanding, basic (in shares)	35,193,789		76,803,187	76,752,752
Weighted average number of common shares outstanding, diluted (in shares)	35,193,789		76,909,547	76,839,810
Period acquiree is included in operations	114 days
Predecessor
Sales and operating revenues		$ 2,340.1
Cost of sales and operating expenses		2,068.2
Gross profit		271.9
Selling, general and administrative expenses		208.9
Transaction related costs		33.4
Change in fair value of contingent consideration obligations		0.0
Operating income		29.6
Other income, net		2.9
Interest income (expense)
Interest income		0.1
Interest expense		(42.3)
Net income (loss) from continuing operations before income taxes		(9.7)
Income tax expense		4.2
Net income (loss) from continuing operations		(13.9)
Net income from discontinued operations, net of tax		0.1
Net income (loss)		$ (13.8)

XML

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions		4 Months Ended	8 Months Ended	12 Months Ended
		Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017
Net income (loss)		$ (8.4)		$ 29.4	$ 14.4
Unrealized foreign currency translation gain (loss), net of tax	[1]	(4.5)		(7.6)	13.0
Unrealized gain on interest rate hedges, net of tax	[2]	0.0		8.1	0.0
Other comprehensive income (loss), net of tax		(4.5)		0.5	13.0
Total comprehensive income (loss), net of tax		$ (12.9)		29.9	$ 27.4
Period acquiree is included in operations		114 days
Tax impact of unrealized gains				$ 2.8
Predecessor
Net income (loss)			$ (13.8)
Unrealized foreign currency translation gain (loss), net of tax	[1]		(4.0)
Unrealized gain on interest rate hedges, net of tax	[2]		0.3
Other comprehensive income (loss), net of tax			(3.7)
Total comprehensive income (loss), net of tax			$ (17.5)

[1] Tax effects are not material.

[2] Tax impact of the unrealized gains related to the interest-rate swaps was ^{$2.8 million for the fiscal year ended September 30, 2018 and immaterial for the}  fiscal years ended September 30, 2017 and 2016 and for the period from October 1, 2015 through June 8, 2016, for the Predecessor.

XML

Consolidated Statements of Equity - USD ($) $ in Millions	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	$ 744.8	$ 0.0	$ 0.0	$ 758.9	$ (9.6)	$ (4.5)
Beginning balance (in shares) at Sep. 30, 2016		89,286,936	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	777.6	$ 0.0	$ (0.1)	764.4	4.8	8.5
Issuance of restricted stock		77,458
Forfeiture of restricted stock award		(10,753)
Shares associated with employee tax withholding for vesting of certain equity awards (in shares)		(9,576)	9,576
Shares associated with employee tax withholding for vesting of certain equity awards	(0.1)		$ (0.1)
Equity-based compensation	5.5			5.5
Comprehensive income:
Net income	14.4				14.4
Other comprehensive income	13.0					13.0
Ending balance (in shares) at Sep. 30, 2017		89,344,065	9,576
Ending balance at Sep. 30, 2017	777.6	$ 0.0	$ (0.1)	764.4	4.8	8.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	777.6	0.0	(0.1)	764.4	4.8	8.5
Beginning balance	814.5	$ 0.0	$ (0.2)	771.5	34.2	9.0
Issuance of restricted stock		415,867
Vesting of restricted stock units		8,162
Forfeiture of restricted stock award		(30,608)
Shares associated with employee tax withholding for vesting of certain equity awards (in shares)		(9,940)	9,940
Shares associated with employee tax withholding for vesting of certain equity awards	(0.1)		$ (0.1)
Equity-based compensation	7.1			7.1
Comprehensive income:
Net income	29.4				29.4
Other comprehensive income	0.5					0.5
Ending balance (in shares) at Sep. 30, 2018		89,727,546	19,516
Ending balance at Sep. 30, 2018	814.5	$ 0.0	$ (0.2)	771.5	34.2	9.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	$ 814.5	$ 0.0	$ (0.2)	$ 771.5	$ 34.2	$ 9.0

XML

Consolidated Statements of Cash Flows - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operations
Net income (loss) from continuing operations	$ (8.4)		$ 29.4	$ 14.4
Adjustments to reconcile to cash flows from operations:
Depreciation and amortization	20.6		74.9	73.1
Debt issuance costs amortization, debt issuance costs write-offs and original issue discount amortization	0.7		4.5	4.1
Non-cash transaction costs	12.8		0.0	0.0
Provision for bad debt	0.3		1.9	(0.2)
Impairment charge due to natural disasters	0.0		0.0	1.5
Deferred income taxes	(1.1)		(6.9)	2.2
Equity-based compensation expense	1.5		7.1	5.5
Change in fair value of contingent consideration obligations	(11.2)		7.5	16.2
(Gain) loss from sales of property and equipment	0.2		(0.5)	0.2
Gain related to reimbursements of certain capital expenditures incurred	(0.8)		0.0	(8.1)
Gain from debt extinguishment, net	0.0		0.0	0.0
Changes in assets and liabilities:
Accounts and notes receivable	(5.0)		(16.8)	(101.9)
Inventories	12.5		(25.8)	14.4
Other current assets	0.1		2.0	5.6
Accounts payable	(14.5)		(2.0)	43.7
Related party payable	(0.1)		0.0	0.0
Accrued expenses and other liabilities	(4.9)		12.3	6.1
Changes in other operating assets and liabilities, net	0.5		1.1	1.8
Net cash provided by operating activities from continuing operations	3.2		88.7	78.6
Net cash provided by operating activities from discontinued operations	0.0		0.0	0.0
Net cash provided by operating activities	3.2		88.7	78.6
Cash flows from investing activities
Additions to property and equipment	(12.7)		(18.6)	(27.6)
Proceeds from the disposal of property and equipment	4.7		3.4	0.6
Proceeds from reimbursement for certain capital expenditures incurred	0.5		0.0	8.4
Proceeds withdrawn from trust account	501.1		0.0	0.0
Cash paid for asset and business acquisitions	(360.6)		(11.0)	(65.6)
Net cash provided by (used in) investing activities	133.0		(26.2)	(84.2)
Cash flows from financing activities
Proceeds from issuance of common stock	234.9		0.0	0.0
Redemption of common stock	(298.5)		0.0	0.0
Proceeds from Sponsor convertible note and Sponsor promissory note	0.7		0.0	0.0
Repayment of Sponsor convertible note and Sponsor promissory note	(1.0)		0.0	0.0
Repurchases of membership units	0.0		0.0	0.0
Cash paid to TPG related to TRA	0.0		(10.2)	0.0
Proceeds from short-term debt	13.3		54.6	40.6
Repayments of short-term debt	(12.8)		(56.1)	(39.3)
Proceeds from issuance of long-term debt	972.5		690.6	773.8
Repayments of long-term debt and capital lease obligations	(205.4)		(735.5)	(762.0)
Repayment of Predecessor long-term debt	(767.3)		0.0	0.0
Payments of debt issuance costs	(25.3)		(0.8)	(1.3)
Net cash provided by (used in) financing activities	(88.9)		(57.4)	11.8
Effect of exchange rate changes on cash and cash equivalents	0.0		(0.1)	0.2
Increase (decrease) in cash and cash equivalents	47.3		5.0	6.4
Cash and cash equivalents at the beginning of the period	0.2		53.9	47.5
Cash and cash equivalents at the end of the period	47.5	$ 0.2	58.9	53.9
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	16.9		48.2	46.1
Cash paid during the period for taxes (net of refunds)	2.9		20.9	6.9
Supplemental disclosure of non-cash operating activities:
Non-cash payment of deferred underwriting fees	18.3		0.0	0.0
Supplemental disclosure of non-cash investing and non-cash financing activities:
Non-cash capital expenditures	3.2		1.8	17.3
Non-cash intangible assets acquired	0.0		0.0	3.7
Non-cash capital lease obligations, net	$ 0.2		$ 0.3	$ 15.3
Period acquiree is included in operations	114 days
Predecessor
Cash flows from operations
Net income (loss) from continuing operations		(13.9)
Adjustments to reconcile to cash flows from operations:
Depreciation and amortization		37.7
Debt issuance costs amortization, debt issuance costs write-offs and original issue discount amortization		6.1
Non-cash transaction costs		0.0
Provision for bad debt		1.2
Impairment charge due to natural disasters		0.0
Deferred income taxes		1.1
Equity-based compensation expense		2.7
Change in fair value of contingent consideration obligations		0.0
(Gain) loss from sales of property and equipment		(2.0)
Gain related to reimbursements of certain capital expenditures incurred		0.0
Gain from debt extinguishment, net		(0.6)
Changes in assets and liabilities:
Accounts and notes receivable		34.4
Inventories		8.4
Other current assets		(4.1)
Accounts payable		13.4
Related party payable		(0.3)
Accrued expenses and other liabilities		(9.7)
Changes in other operating assets and liabilities, net		(4.9)
Net cash provided by operating activities from continuing operations		69.5
Net cash provided by operating activities from discontinued operations		0.1
Net cash provided by operating activities		69.6
Cash flows from investing activities
Additions to property and equipment		(14.2)
Proceeds from the disposal of property and equipment		2.4
Proceeds from reimbursement for certain capital expenditures incurred		0.0
Proceeds withdrawn from trust account		0.0
Cash paid for asset and business acquisitions		0.0
Net cash provided by (used in) investing activities		(11.8)
Cash flows from financing activities
Proceeds from issuance of common stock		0.0
Redemption of common stock		0.0
Proceeds from Sponsor convertible note and Sponsor promissory note		0.0
Repayment of Sponsor convertible note and Sponsor promissory note		0.0
Repurchases of membership units		(0.1)
Cash paid to TPG related to TRA		0.0
Proceeds from short-term debt		20.9
Repayments of short-term debt		(17.1)
Proceeds from issuance of long-term debt		292.1
Repayments of long-term debt and capital lease obligations		(417.3)
Repayment of Predecessor long-term debt		0.0
Payments of debt issuance costs		0.0
Net cash provided by (used in) financing activities		(121.5)
Effect of exchange rate changes on cash and cash equivalents		0.3
Increase (decrease) in cash and cash equivalents		(63.4)
Cash and cash equivalents at the beginning of the period	$ 64.3	127.7
Cash and cash equivalents at the end of the period		64.3
Supplemental disclosure of cash flow information:
Cash paid during the period for interest		32.9
Cash paid during the period for taxes (net of refunds)		3.4
Supplemental disclosure of non-cash operating activities:
Non-cash payment of deferred underwriting fees		0.0
Supplemental disclosure of non-cash investing and non-cash financing activities:
Non-cash capital expenditures		16.5
Non-cash intangible assets acquired		0.0
Non-cash capital lease obligations, net		$ 14.3

XML

Basis of Presentation and Nature of Operations

12 Months Ended

Sep. 30, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation and Nature of Operations

Basis of Presentation and Nature of Operations

Basis of Presentation

Nexeo Solutions, Inc. (together with its subsidiaries, the "Company") is the result of the business combination between WL Ross Holding Corp.("WLRH") and Nexeo Solutions Holdings, LLC ("Holdings").  WLRH was incorporated in Delaware on March 24, 2014 and was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. WLRH completed its IPO in June 2014, raising approximately $500.0 million in cash proceeds. WLRH neither engaged in any operations nor generated any revenue prior to the Business Combination.

The Company’s financial statement presentation distinguishes a “Successor” for the periods after the Closing Date and a “Predecessor” for the periods prior to the Closing Date. In the Business Combination, WLRH was subsequently renamed "Nexeo Solutions, Inc.", was identified as the acquirer and Successor and Holdings was identified as the acquiree and Predecessor. As a result of the application of the acquisition method of accounting as of the Closing Date, the consolidated financial statements for the Successor and Predecessor periods are presented on a different basis and are, therefore, not comparable. See Note 3 for further discussion of the Business Combination.

           The Predecessor period in the consolidated financial statements represent the operating results of Holdings and its subsidiaries prior to the Business Combination.

The Company recorded out-of-period adjustments during the fiscal year ended September 30, 2018 to correct errors in the tax provision and accrued costs. The net impact of these adjustments for the fiscal year ended September 30, 2018 was an increase to revenue of $0.4 million, a decrease to gross profit of $0.9 million and a decrease to net income $2.0 million. The Company does not believe these adjustments are material, individually or in the aggregate, to its consolidated financial statements for the fiscal year ended September 30, 2018, nor does it believe such items are material to any of its previously issued annual or quarterly financial statements.

Nature of Operations

The Company is a global materials distributor for chemicals products in North America and Asia and for plastics products in North America, EMEA and Asia. In North America, primarily in the U.S., the Company provides on-site and off-site hazardous and non-hazardous environmental services, including waste collection, transportation, recovery, disposal arrangement and recycling services. The Company offers its customers products used in a broad cross-section of end markets including household, industrial and institutional, lubricants, performance coatings (including architectural coatings, adhesives, sealants and elastomers), automotive, healthcare, personal care, oil and gas and construction. In connection with the distribution of chemicals products, the Company provides value-added services such as custom blending, packaging and re-packaging, private-label manufacturing and product testing in the form of chemical analysis, product performance analysis and product development.

XML

Significant Accounting Policies and Recent Accounting Pronouncements

12 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Significant Accounting Policies and Recent Accounting Pronouncements

Significant Accounting Policies and Recent Accounting Pronouncements

Significant Accounting Policies

Principles of Consolidation

The accompanying consolidated financial statements include all the accounts of the Company and all wholly-owned subsidiaries in which it maintains control. Significant intercompany transactions and balances have been eliminated in consolidation.

Use of Estimates, Risks, and Uncertainties

The preparation of consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosures of contingent assets and liabilities. Significant items that are subject to such estimates and assumptions include:

•the fair value of assets acquired and liabilities assumed in a business combination;

•the assessment of recoverability of long lived assets, including property and equipment, goodwill

and intangible assets, income taxes, reserves and environmental remediation;

•the estimated useful lives of intangible and depreciable assets;

•the grant date fair value of equity-based awards;

•the recognition, measurement and valuation of current and deferred income taxes;

•the recognition and measurement of contingent consideration related to the TRA liability; and

•the recognition and measurement of contingent consideration related to the Deferred Cash Consideration.

Although management bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, actual results could differ significantly from the estimates under different assumptions or conditions.

The Company's financial instruments exposed to concentration of credit risk consist primarily of cash and cash equivalents. Although the Company deposits cash with multiple banks, these deposits, including those held in foreign branches of global banks, may exceed the amount of insurance provided on such deposits. These deposits may generally be redeemed upon demand and bear minimal risks.

No single customer accounted for more than 10% of revenues for any line of business, or on a consolidated basis, and no individual customer represented greater than 5.0% of the outstanding accounts receivable balance for each of the periods reported. The Company had two suppliers that each accounted for approximately 11.6% and 9.6% of consolidated purchases during the fiscal year ended September 30, 2018, 12.1% and 9.9% for the fiscal year ended September 30, 2017 and 11.9% and 10.4% for the fiscal year ended September 30, 2016. For the period from October 1, 2015 through June 8, 2016, these two suppliers accounted for approximately 12.0% and 9.8% of consolidated purchases for the Predecessor.

Cash and Cash Equivalents

All highly liquid temporary investments with original maturities of three months or less are considered to be cash equivalents. See Note 4.

Accounts and Notes Receivable and Allowance for Doubtful Accounts

Accounts receivable are recorded net of discounts and allowance for doubtful accounts. The Company performs ongoing credit evaluations of its customers and generally does not require collateral from its customers. The Company’s accounts receivable in the U.S. and Canada are collateral under the Credit Facilities.

The Company records an allowance for doubtful accounts as a best estimate of the amount of probable credit losses for accounts receivable. On a recurring basis, the Company reviews this allowance and considers factors such as customer credit, past transaction history with the customer and changes in customer payment terms when determining whether the collection of a receivable is reasonably assured. Past due balances over 90 days and over a specified amount are reviewed individually for collectability. Receivables are charged off against the allowance for doubtful accounts when it is probable a receivable will not be recovered. The allowance for doubtful accounts was $4.2 million and $2.2 million at September 30, 2018 and 2017, respectively. Bad debt expense, net of recoveries is a component of Selling, general and administrative expenses in the consolidated statements of operations. For the fiscal year ended September 30, 2018 net bad debt expense was $1.9 million and for the fiscal year ended September 30, 2017 net bad debt recovery was $0.2 million. For the fiscal year ended September 30, 2016 net bad debt expense was $0.3 million. Net bad debt expense for the Predecessor period from October 1, 2015 through June 8, 2016 was $1.2 million.

Certain customers of the Company's operations in China are allowed to remit payment during a period of time ranging from 30 days up to nine months. These notes receivables, which are supported by banknotes issued by large banks in China on behalf of these customers, are included in Accounts and Notes Receivable on the Company's consolidated balance sheets and totaled $8.6 million and $8.3 million at September 30, 2018 and 2017, respectively.

Inventories

Inventories are carried at the lower of cost or net realizable value using the weighted average cost method. The Company’s inventories in the U.S. and Canada are collateral under the Credit Facilities. See Note 4.

Goodwill and Intangibles

The Company had goodwill of $699.9 million and $703.0 million at September 30, 2018 and 2017, respectively, associated with the Business Combination and asset acquisitions. The purchase consideration of an acquisition is allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values at the date of acquisition. The estimated fair values are determined after review and consideration of relevant information including discounted cash flows, quoted market prices and estimates made by management. To the extent that the purchase consideration exceeds the fair value of the net identifiable tangible and intangible assets acquired, such excess is allocated to goodwill. See Notes 3 and 6.

The Company had other intangible assets, net of amortization, of $211.6 million and $231.5 million at September 30, 2018 and 2017, respectively. These intangible assets, which are amortized on a straight-line basis over their estimated useful lives, consist of customer relationships, supplier relationships, trade names, below-market leases and non-compete agreements. See Notes 3 and 6. The range of estimated useful lives used to amortize these intangible assets is as follows:

	Estimated Useful Lives (years)
Customer-related	5-13
Supplier-related	6-10
Trade name	2-10
Below-market leases	1-7
Non-compete agreements	3-10

Property, Plant and Equipment

Property, plant and equipment includes plants, buildings, machinery, equipment, software and computer equipment. Property, plant and equipment acquired or constructed in the normal course of business are initially recorded at cost. Property and equipment acquired in business combinations and asset acquisitions are initially recorded at their estimated fair value. Property, plant and equipment are depreciated by the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the shorter of their economic useful life or their lease term. The range of useful lives used to depreciate property, plant and equipment is as follows:

	Estimated Useful Lives (years)
Plants and buildings	5-35
Machinery and equipment	2-30
Software and computer equipment	3-10

Repairs and maintenance expenditures that do not extend the useful life of the asset are charged to expense as incurred. Major expenditures for replacements and significant improvements that increase asset values or extend useful lives are capitalized. The carrying amounts of assets that are sold or retired and the related accumulated depreciation are removed from the accounts in the year of disposal and any resulting gain or loss is reflected in the consolidated statements of operations. See Note 5.

Leases

The Company leases certain property, plant and equipment in the ordinary course of business. The leases are classified as either capital leases or operating leases. Assets under capital leases are included in Property, plant and equipment, net in the consolidated balance sheets and are depreciated over the lesser of the lease term or the useful life of the assets. Capital lease obligations are included in Short-term borrowings, current portion of long-term debt and capital lease obligations and Long-term debt and capital lease obligations, less current portion, net in the consolidated balance sheets. Generally, lease payments under capital leases are recognized as interest expense and a reduction of the capital lease obligations. Lease payments under operating leases are recognized as an expense in the consolidated statements of operations on a straight-line basis over the lease term.  See Note 13.

Impairment of Long-Lived Assets

Goodwill. Goodwill is tested for impairment annually as of March 31 and whenever events or circumstances make it more likely than not that an impairment may have occurred. Goodwill is reviewed for impairment at the reporting unit level, which is defined as operating segments or groupings of businesses one level below the operating segment level. The Company’s operating segments are the same as the reporting units used in its goodwill impairment test. Goodwill is tested for impairment by comparing the estimated fair value of a reporting unit, determined using a market approach, if market prices are available, or alternatively, a discounted cash flow model, with its carrying value. The annual evaluation of goodwill requires the use of estimates about future operating results, valuation multiples and discount rates of each reporting unit to determine their estimated fair value. Changes in these assumptions can materially affect these estimates. Once an impairment of goodwill has been recorded, it cannot be reversed. No goodwill impairment was recognized during any of the periods presented. See Note 6.

Other Long-Lived Assets. Property, plant and equipment and other intangible assets with definite lives are tested for impairment whenever events and circumstances indicate that the carrying value of an asset may not be recoverable. When an impairment test is performed and the undiscounted expected future cash flows are less than the carrying value, an impairment loss is recognized equal to an amount by which the carrying value exceeds the fair value of the asset. The factors considered by management in performing this assessment include current operating results, trends and prospects, as well as the effect of obsolescence, demand, competition and other economic factors.

Debt Issuance Costs

Costs associated with the ABL Facility are recorded as debt issuance costs, which are included in Other non-current assets in the consolidated balance sheets and are being amortized as interest expense over the contractual lives of the related agreements. Costs associated with non-revolving debt facilities are recorded as a reduction of the long-term debt, and are amortized as interest expense over the contractual lives of the related agreements. See Notes 4 and 7.

Commitments, Contingencies and Environmental Costs

Liabilities for loss contingencies arising from claims, assessments, litigation, fines, penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment and/or remediation can be reasonably estimated. Gain contingencies are not recorded until management determines it is certain that the future event will become or is realized.

Liabilities for environmental remediation costs are recognized when environmental assessments or remediation are probable and the associated costs can be reasonably estimated. Generally, the timing of these provisions coincides with the commitment to a formal plan of action or, if earlier, the divestment or closure of the relevant sites. The amount recognized reflects management’s best estimate of the expenditures expected to be required. Actual environmental expenditures that relate to current or future revenues are expensed or capitalized as appropriate. Actual expenditures that relate to an existing condition caused by past operations and that do not impact future earnings are expensed.

Ashland agreed to retain known environmental remediation liabilities and other environmental remediation liabilities for releases of hazardous materials occurring prior to March 31, 2011, and of which Ashland received notice prior to March 31, 2016. See Note 13.

Earnings or Loss per Share

Basic EPS, which excludes dilution, is computed by dividing income or loss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common shares and the proceeds from such activities, if any, were used to acquire shares of common stock at the average market price during the reporting period. During a net loss period, the assumed exercise of in-the-money stock options and unvested stock has an anti-dilutive effect and, therefore, such potential shares are excluded from the diluted EPS computation.

Per share information is based on the weighted average number of common shares outstanding during each period for the basic computation and, if dilutive, the weighted average number of potential common shares resulting from the assumed conversion of outstanding stock options, unvested stock and unvested stock units for the diluted computation. See Note 12.

Concentrations of Credit Risk

All of the Company’s financial instruments, consisting primarily of accounts and notes receivable and interest rate swaps, involve elements of credit and market risk. The most significant portion of this credit risk relates to non-performance by counterparties. To manage counterparty risk associated with financial instruments, the Company selects and monitors counterparties based on its assessment of their financial strength and on credit ratings, if available.

Foreign Currency

The reporting currency of the Company is the USD. With few exceptions, the local currency is the functional currency for the Company's foreign subsidiaries. In consolidating the results of operations, income and expense accounts are translated into USD at average exchange rates in effect during the period and asset and liability accounts are translated at period-end exchange rates. Translation gains or losses are recorded in the foreign currency translation component in Accumulated other comprehensive income (loss) in stockholders’ equity and are included in net earnings only upon sale or liquidation of the underlying foreign subsidiary or affiliated company.

Transactions undertaken in currencies other than the functional currency of the subsidiary are translated using the exchange rate in effect as of the transaction date and give rise to foreign currency transaction gains and losses, which the Company includes in Selling, general and administrative expenses in the consolidated statements of operations. Net foreign currency transaction losses from various currencies were $1.1 million, $0.6 million and $1.1 million for the fiscal years ended September 30, 2018, 2017 and 2016, respectively. Net foreign currency transaction losses were $1.6 million for the period from October 1, 2015 through June 8, 2016 for the Predecessor.

Revenue Recognition

Revenues are recognized when persuasive evidence of an arrangement exists, products are shipped and title is transferred or services are provided to customers, the sales price is fixed or determinable and collectability is reasonably assured. Revenue for product sales is recognized at the time title and risk of loss transfer to the customer, based on the terms of the sale. For products delivered under the Company’s standard shipping terms, title and risk of loss transfer when the product is delivered to the customer’s delivery site. For sales transactions designated Freight on Board shipping point, the customer assumes risk of loss and title transfers at the time of shipment. Deferred revenues may result from (i) delivery delays for products delivered under the Company’s standard shipping terms or (ii) from other arrangements with its customers. Sales are reported net of tax assessed by qualifying governmental authorities. 

The Company is generally the primary obligor in sales transactions with its customers, retains inventory risk during transit and assumes credit risk for amounts billed to its customers. Accordingly, the Company recognizes revenue primarily based on the gross amount billed to its customers. In sales transactions where the Company is not the primary obligor and does not retain inventory risk, the Company recognizes revenue on a net basis by recognizing only the commission the Company retains from such sales and including that commission in sales and operating revenues in the consolidated statements of operations. 

Consistent with industry standards, the Company may offer volume-based rebates to large customers if the customer purchases a specified volume with the Company over a specified time period. The determination of these rebates at an interim date involves management judgment. As a result, the Company’s revenues may be affected if a customer earns a rebate toward the end of a year that the Company had not expected or if its estimate of customer purchases are less than expected. The Company has the experience and access to relevant information that the Company believes are necessary to reasonably estimate the amounts of such deductions from gross revenues. The Company regularly reviews the information related to these estimates and adjusts its reserves accordingly if and when actual experience differs from previous estimates. The Company recognizes the rebate obligation as a reduction of revenue based on its estimate of the total volume of purchases from a given customer over the specified period of time. Customer rebates totaled $7.7 million, $7.8 million and $2.1 million for the fiscal years ended September 30, 2018, 2017 and 2016, respectively. Customer rebates totaled $4.0 million for the period from October 1, 2015 through June 8, 2016 for the Predecessor.  Rebates due to customers were $5.2 million and $4.8 million at September 30, 2018 and 2017, respectively.  These payables are included in Accrued expenses and other liabilities in the consolidated balance sheets. 

Supplier Rebates

Certain of the Company's vendor arrangements provide for purchase incentives based on the Company achieving a specified volume or dollar value of purchases. The Company records the incentives as a reduction of inventory costs (and related cost of sales) based on its purchases to date and its estimates of purchases for the remainder of the calendar year. The Company receives these incentives in the form of rebates that are payable only when the Company's purchases equal or exceed the relevant calendar year target. Supplier rebates totaled $8.9 million, $9.0 million and $3.1 million for the fiscal years ended September 30, 2018, 2017 and 2016, respectively. Supplier rebates totaled $6.5 million for the period from October 1, 2015 through June 8, 2016 for the Predecessor. Supplier rebates due to the Company were $4.4 million and $4.0 million at September 30, 2018 and 2017, respectively. These receivables are included in Accounts and notes receivable in the consolidated balance sheets.

Shipping and Handling

All shipping and handling amounts billed to customers are included in revenues. Costs incurred related to the shipping and handling of products are included in cost of sales.

Expense Recognition

Cost of sales include material and production costs, as well as the costs of inbound and outbound freight, purchasing and receiving, inspection, warehousing, internal transfers and all other distribution network costs. The Company's products and services are generally sold without any extended warranties. Selling, general and administrative expenses include sales and marketing costs, advertising, research and development, customer support, environmental remediation and administrative costs. Advertising and research and development costs are expensed as incurred. Advertising expenses totaled $2.3 million, $1.8 million and $0.3 million for the fiscal years ended September 30, 2018, 2017, and 2016 respectively. Advertising expenses totaled $1.3 million for the period from October 1, 2015 through June 8, 2016 for the Predecessor. There were no material research and development expenses incurred during any of the periods presented.

Income Taxes

The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the financial statements. Under this method, the Company determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. The provision for income taxes includes income taxes paid, currently payable or receivable and those deferred. 

The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of the net recorded amount, it would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.

The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) the Company determines whether it is more likely than not that the tax positions will be sustained and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount that is more than 50% likely to be realized upon ultimate settlement with the related tax authority.

The Predecessor was organized as a limited liability company and was taxed as a partnership for U.S. income tax purposes. As such, with the exception of a limited number of state and local jurisdictions, the Predecessor was not subject to U.S. income taxes. Accordingly, the members of the Predecessor reported their share of the Predecessor’s taxable income on their respective U.S. federal tax returns. The Predecessor’s sole active U.S. corporate subsidiary, Sub Holding, was subject to tax at the entity level in the U.S. The net earnings for financial statement purposes differed from taxable income reportable by the Predecessor to the members as a result of differences between the tax basis and financial reporting basis of certain assets and liabilities and other factors. The Predecessor was required to make quarterly distributions to its members to fund their tax obligations, if any, attributable to the Predecessor’s taxable income. In some jurisdictions, the Predecessor made such distributions in the form of tax payments paid directly to the taxing authority on behalf of its members. Controlled foreign corporations are subject to tax at the entity level in their respective jurisdictions. See Note 15.

Due to Related Party Pursuant to Contingent Consideration Obligations

As described in Note 3, as part of the consideration for the Business Combination, the Company entered into the TRA and agreed to pay the Deferred Cash Consideration pursuant to the Merger Agreement.  The Company’s obligation for these contingent consideration amounts was initially measured at fair value as of the Closing Date.  The Company’s contingent consideration liabilities are required to be recorded at fair value as of the end of each reporting period with any changes in fair value recorded in operating income. Changes in the estimates and inputs used in determining the fair value of the contingent consideration could have a material impact on the amounts recognized. See Note 9.

Share-Based Compensation

The Company accounts for share-based compensation expense for equity instruments granted in exchange for employee and director services.  Share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as expense over the vesting period of the equity award grant.

The Company’s PSU awards contain both market and performance-based conditions. At the grant date, market conditions are incorporated into the fair value measurement using a Monte Carlo simulation model under the assumptions that performance-based conditions are met and not met. The Company then determines the probability that performance-based conditions will be met and incorporates this into the grant date fair value of the award.

The compensation cost for the PSU awards is amortized over the vesting period on a straight-line basis, net of estimated forfeitures. Forfeiture rates are estimated based on consideration of historical forfeitures of the Company's and Predecessor’s actual forfeitures of its share-based compensation awards and a peer group of companies. See Note 10.

Recent Accounting Pronouncements Adopted as of September 30, 2018

In July 2015, the FASB issued ASU 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory. The amendments in this ASU require an entity to measure inventory at the lower of cost or net realizable value, whereas guidance previously required an assessment of market value of inventory, with different possibilities for determining market value. This ASU is effective for fiscal years beginning after December 15, 2016 and interim periods within those years and early adoption is permitted. The Company adopted this standard as of October 1, 2017, and it did not have a material effect on the Company’s financial position or results of operations.

In March 2016, the FASB issued ASU 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The updated guidance simplifies several aspects of accounting for certain aspects of share-based payment awards to employees, including the accounting for income taxes, forfeitures and statutory tax withholding requirements, as well as the classification of related matters in the statement of cash flows. This ASU is effective for annual reporting periods beginning after December 15, 2016 and interim periods within those annual periods. The Company adopted this standard as of October 1, 2017, and it did not have a material effect on the Company’s financial position or results of operations.

In May 2017, the FASB issued ASU 2017-09, Compensation - Stock Compensation (Topic 718). This ASU clarifies when changes to the terms or conditions of a share-based payment award must be accounted for as a modified award. The new guidance will reduce diversity in practice and result in fewer changes to the terms of an award being accounted for as modifications.  The amendments in this ASU will be applied prospectively to awards modified on or after the adoption date. The Company adopted this standard as of October 1, 2017, and it did not have a material effect on the Company’s financial position or results of operations.

New Accounting Pronouncements Not Yet Adopted as of September 30, 2018

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). The amendments in this ASU will supersede the revenue recognition requirements in Topic 605, Revenue Recognition and require that revenue be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB issued ASU 2015-14, which deferred the effective date of ASU 2014-09 for all entities by one year. These amendments will be effective in annual reporting periods beginning after December 15, 2017 including interim reporting periods within that reporting period. The Company has completed its assessment of the financial statement impact of the new standard, and does not expect it to have a material impact on the Company's financial position or results of operations. The Company adopted this standard on October 1, 2018 and will use the modified retrospective approach.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments (Topic 825): Recognition and Measurement of Financial Assets and Financial Liabilities. This ASU (i) requires all equity investments in unconsolidated entities other than those measured using the equity method of accounting, to be measured at fair value through earnings; (ii) when the fair value option has been elected for financial liabilities, requires that changes in fair value due to instrument specific credit risk be recognized separately in other comprehensive income and accumulated gains and losses due to these changes and will be reclassified from accumulated other comprehensive income to earnings if the liability is settled before maturity; and (iii) amends certain fair value disclosure provisions related to financial instruments carried at amortized cost. This ASU is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years and early adoption is permitted. The Company is in the process of evaluating the provisions of the ASU and assessing the potential effect on the Company’s financial position or results of operations.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). This ASU requires all leases with terms greater than 12 months, whether finance or operating, to be recorded on the balance sheet, reflecting a liability to make lease payments and a right-to-use asset representing the right to use the underlying asset for the lease term. The recognition, measurement and presentation of expenses and cash flows arising from a lease by a lessee will not significantly change from current U.S. GAAP. These amendments are effective for the reporting periods beginning after December 15, 2018 with early adoption permitted. An entity will be required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. The Company is in the process of evaluating the potential effects of this standard and believes it may have a significant impact on its consolidated financial statements due, in part, to its substantial number of operating lease obligations that will be reflected on the consolidated balance sheet upon adoption of the new guidance.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.  This ASU requires an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts.  Forward-looking information will now be used to better inform credit loss estimates.  The amendments in this ASU are effective for fiscal years beginning December 15, 2020 including interim periods within those years with early adoption permitted.  The Company is currently in the process of evaluating the provisions of this ASU and assessing the potential effect on the Company’s financial position or results of operations.

In August 2016 the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments.  This ASU will make eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The new standard is effective for fiscal years beginning after December 15, 2017. Early adoption is permitted. The new standard will require adoption on a retrospective basis unless it is impracticable to apply, in which case the Company would be required to apply the amendments prospectively as of the earliest date practicable. The Company is in the process of evaluating the provisions of this ASU but does not expect it to have a material effect on the Company’s consolidated statements of cash flows.

In August 2018 the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. This ASU modified the disclosures related to recurring and nonrecurring fair value measurements. Disclosures related to the transfer of assets between Level 1 and Level 2 hierarchies have been eliminated and various additional disclosures related to Level 3 fair value measurements have been added, modified or removed. This ASU is effective for annual periods beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted upon issuance of the standard for disclosures modified or removed with a delay of adoption of the additional disclosures until their effective date. The Company is in the process of evaluating the provisions of the ASU but does not expect it to have a material effect on the Company’s consolidated financial statements.

XML

Acquisitions

12 Months Ended

Sep. 30, 2018

Business Combinations [Abstract]

Acquisitions

Acquisitions

Merger Agreement with Univar

On September 17, 2018, Nexeo and Univar entered into the Univar Merger Agreement providing for the acquisition of Nexeo by Univar.

Subject to the terms and conditions set forth in the Univar Merger Agreement, holders of Nexeo’s common stock will receive (A) the Cash Consideration, described below, and (B) 0.305 of a share of Univar common stock (referred to as the "Stock Consideration").

The “Cash Consideration” will be $3.29 per share, subject to reduction by up to $0.41 per share based on the closing price of Univar common stock on the day prior to the closing of the proposed transaction. The Cash Consideration will be reduced on a linear basis between $3.29 per share and $2.88 per share to the extent that the closing price of Univar common stock is between $25.34 and $22.18. If the closing price of Univar common stock is $22.18 per share or lower, the Cash Consideration will be $2.88 per share. If the closing price of Univar common stock on is $25.34 per share or higher, the Cash Consideration will be $3.29 per share.

The Univar Merger Agreement and the proposed transaction were approved unanimously by the Board of Directors of both Nexeo and Univar and are subject to review by the SEC and regulatory agencies in the U.S. and other jurisdictions. The Univar Merger Agreement is also subject to a number of conditions, including, among other things and as further described in the Univar Merger Agreement: (i) the adoption by Nexeo’s stockholders of the Univar Merger Agreement, (ii) the approval by Univar’s stockholders of the issuance of the shares of Univar common stock in connection with the proposed transaction contemplated by the Univar Merger Agreement, (iii) the receipt of other required regulatory approvals, (iv) the absence of any law or governmental order prohibiting the proposed transaction, (v) the effectiveness of Univar's registration statement and the approval for listing on the NYSE of the shares of Univar common stock in connection with the proposed transaction contemplated by the Univar Merger Agreement, (vi) no material adverse effect on Nexeo's and Univar's operations having occurred since the signing of the Univar Merger Agreement and (vii) the termination of the TRA. There can be no assurance that the conditions to the completion of the proposed transaction will be satisfied or waived or that the proposed transaction will be completed. On November 16, 2018, Univar and Nexeo announced that the waiting period under the HSR Act expired.

The Univar Merger Agreement contains customary representations and warranties made by each of the Univar and Nexeo, and also contains customary pre-closing covenants, including covenants, among others, by each of Univar and Nexeo to operate its respective businesses in the ordinary course consistent with past practice and to refrain from taking certain actions without the other party’s consent during the period prior to closing.

The proposed transaction is expected to close in the first quarter of 2019. Transaction costs incurred by the Company associated with the Univar Merger Agreement were $11.3 million during the fiscal year ended September 30, 2018. Of this amount, approximately $2.8 million were recorded in Transaction Costs and $8.5 million were recorded in Selling, general and administrative expenses in the consolidated statement of operations.

Ultra Chem Acquisition

On April 3, 2017, the Company completed the Ultra Chem Acquisition for $56.7 million, net of cash acquired of $0.5 million, pursuant to the Ultra Chem Stock Purchase Agreement.  Of the purchase price, $10.7 million was initially placed in escrow. As of September 30, 2018, $9.3 million of the purchase price may remain in escrow for a period of up to five years from the closing of the Ultra Chem Acquisition and relates to indemnification obligations under the Ultra Chem Stock Purchase Agreement. The escrow amount will be released pursuant to the terms of the Ultra Chem Stock Purchase Agreement and related documentation. The Ultra Chem Acquisition was financed with approximately $58.0 million of borrowings under the ABL Facility. There is no contingent consideration related to the Ultra Chem Acquisition.

Purchase Price Allocation

The Ultra Chem Acquisition is accounted for under the acquisition method, which requires the Company to perform an allocation of the purchase consideration to the assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The excess of the purchase consideration over the estimated fair values is recorded as goodwill. The following table summarizes the Company’s allocation of the purchase consideration to assets acquired and liabilities assumed at the Ultra Chem Closing Date:

	Purchase Consideration Allocation
Accounts receivable	$	13.7
Inventory	9.1
Other current assets	2.4
Property and equipment	0.5
Customer-related intangible	24.0
Trade name	0.3
Non-compete agreements	3.9
Other non-current assets	2.5
Goodwill	28.0
Total assets acquired	84.4
Short-term borrowings	0.9
Accounts payable	12.1
Other current liabilities	4.1
Deferred tax liability — non-current	8.4
Other non-current liabilities	2.2
Total liabilities assumed	27.7
Net assets acquired	$	56.7

During the three months ended March 31, 2018, the Company completed its assessment of the fair values of the assets acquired and liabilities assumed in the Ultra Chem Acquisition. The Company recorded no material adjustments to the fair value estimates of assets and liabilities during the current period.

Transaction costs incurred by the Company associated with the Ultra Chem Acquisition were less than $0.1 million during the fiscal year ended September 30, 2018. Transaction costs incurred by the Company associated with the Ultra Chem Acquisition were $1.8 million during the fiscal year ended September 30, 2017. Of this amount, approximately $1.1 million were recorded in Transaction Costs and $0.7 million were recorded in Selling, general and administrative expenses in the consolidated statement of operations.

A summary and description of the acquired assets and assumed liabilities fair valued in conjunction with applying the acquisition method of accounting follows:

Accounts and Notes Receivable

Accounts and notes receivable consisted of receivables related to the customers of the acquired business, as well as various other miscellaneous receivables. The accounts receivable and other miscellaneous receivables were recorded at their approximate fair value based on expected collections of Ultra Chem Group. Accordingly, accounts receivable included an adjustment of $1.5 million to reduce gross receivables to their net value after consideration of expected uncollectable amounts at the Ultra Chem Closing Date.

Inventory

Inventory consisted primarily of finished products to be distributed to the acquired business’s customers. The fair value of inventory was established through application of the income approach, using estimates of selling prices and costs such as selling and marketing expenses to be incurred in order to dispose of the finished products and arriving at the future profitability expected to be generated once the inventory is sold (net realizable value). The inventory fair value step up of $1.0 million was recognized in Cost of sales and operating expenses during the fiscal year ended September 30, 2017.

Other Current Assets

Other current assets consisted primarily of prepaid expenses and did not have a fair value adjustment as part of acquisition accounting since their carrying value approximated fair value. Other current assets also include indemnification assets recorded in connection with the recognition of tax-related contingent liabilities assumed. The indemnification assets represented the reimbursement the Company would reasonably expect to receive from funds initially held in escrow pursuant to the purchase agreement if the liabilities were asserted by the relevant tax authority.

Property and Equipment

Property and equipment acquired consists primarily of leasehold improvements, computer and office equipment as well as furniture and fixtures. The purchase price allocation for property, plant and equipment was based on the carrying value of such assets as it was determined to approximate fair value.

Customer-Related Intangible

Customer relationships were valued through the application of the income approach. Under this approach, revenue, operating expenses and other costs associated with existing customers were estimated in order to derive cash flows attributable to the existing customer relationships. The resulting estimated cash flows were then discounted to present value to arrive at the fair value of existing customer relationships as of the valuation date. The value associated with customer relationships will be amortized on a straight-line basis over a ten-year period, which represents the approximate point in the projection period in which a majority of the asset’s cash flows are expected to be realized based on assumed attrition rates. The Company recognized $24.0 million for these intangible assets as part of the allocation of the purchase consideration.

Trade Name

The "Ultra Chem" trade name was valued through application of the income approach, involving the estimation of likely future sales and an estimated royalty rate reflective of the rate that a market participant would pay to use the "Ultra Chem" name. The fair value of this asset will be amortized on a straight-line basis over a two-year period, estimated based on the period in which the Company would expect a market participant to use the name prior to rebranding. The Company recognized $0.3 million for this intangible asset as part of the allocation of the purchase consideration.

Non-Compete Agreements

In connection with the Ultra Chem Acquisition, the former equityholders of the Ultra Chem Group agreed to non-compete agreements. The terms of the non-compete agreements prohibit the equityholders from competing in the chemical distribution space for three years after the Ultra Chem Closing Date. The income approach was used to value the non-compete agreements through a comparative discounted cash flow analysis based on the impact of competition absent these agreements. The Company recognized $3.9 million for this intangible asset as part of the allocation of the purchase consideration. This intangible is amortized on a straight-line basis over a three-year period.

Other Non-Current Assets

Other non-current assets acquired represented certain long-term deposits and other assets, which did not have a fair value adjustment as part of acquisition accounting since their carrying value approximated fair value. Other non-current assets also included indemnification assets recorded in connection with the recognition of tax-related contingent liabilities assumed, and the expected value of certain assets pledged as a guarantee to the Ultra Chem Group in connection with transactions with a particular customer. The indemnification assets represent the reimbursement the Company reasonably expects to receive from funds initially held in escrow pursuant to the purchase agreement if the related liabilities were asserted by the relevant tax authority.

Goodwill

Goodwill represents the excess of the total purchase price over the fair value of the underlying net assets, largely arising from synergies expected as a result of the Ultra Chem Acquisition. Goodwill is not amortized to earnings, but instead is reviewed for impairment at least annually, absent any indicators of impairment. The Company does not expect any goodwill from the Ultra Chem Acquisition to be deductible for tax purposes.

Short-Term Borrowings

Short-term borrowings included short-term borrowings of the Ultra Chem Group prior to the Ultra Chem Acquisition, which did not have a fair value adjustment as part of acquisition accounting as their carrying value approximated fair value. The balance was paid off immediately after the closing of the Ultra Chem Acquisition.

Accounts Payable

Accounts payable represented short-term obligations owed to the vendors of the acquired business, which were assumed in the Ultra Chem Acquisition. These obligations did not have a fair value adjustment as part of acquisition accounting as their carrying value approximated fair value.

Other Current Liabilities

Other current liabilities represented primarily accrued expenses, including accrued payroll, certain accrued taxes, the current portion of assumed tax-related contingent liabilities and various other liabilities arising out of the normal operations of the acquired business. The majority of these liabilities did not have a fair value adjustment as their carrying value approximated fair value.

Other Non-Current Liabilities

Other non-current liabilities represent assumed tax-related contingent liabilities, and the expected value of certain assets pledged as a guarantee to the Ultra Chem Group which would have to be returned to the third party under certain circumstances.

Deferred Taxes

Deferred tax assets and liabilities are attributable to the difference between the estimated fair values allocated to inventory, property and equipment and identified intangibles acquired for financial reporting purposes and the amounts determined for tax reporting purposes and give rise to temporary differences.  The deferred tax assets and liabilities will reverse in future periods or have reversed as the related tangible and intangible assets are amortized, acquired inventory is sold, or if goodwill is impaired.

Business Combination

On June 9, 2016, the Company consummated the Business Combination pursuant to the Merger Agreement, whereby WLRH acquired Holdings (including the portion of Holdings held by Blocker) through a series of two mergers. As a result of the transactions contemplated by the Merger Agreement, Holdings and Blocker became wholly-owned subsidiaries of WLRH.

The purchase consideration for the Business Combination was as follows:

Cash	$	424.9
Less: cash acquired	(64.3		)
Equity(1)	276.7
Founder Shares transferred to Selling Equityholders(1)	30.2
Contingent consideration - Fair value of Deferred Cash Consideration	45.4
Contingent consideration - Fair value of TRA (2)	89.8
Total purchase consideration(3)	$	802.7

⁽¹⁾ See Note 11.

⁽²⁾ During the fiscal year ended September 30, 2017, the Company recorded adjustments of $5.6 million. See below.

⁽³⁾ In addition to the total purchase consideration above, the Company assumed the outstanding indebtedness of the Predecessor, including related accrued interest through the Closing Date, totaling $774.3 million. The proceeds of the Credit Facilities were used to repay such indebtedness and accrued interest immediately following the consummation of the Business Combination.

Contingent Consideration - Deferred Cash Consideration

The contingent consideration associated with the Deferred Cash Consideration will be an amount in cash equal to the prevailing price of the Company’s common stock at the time that the Company pays such deferred cash payment multiplied by the number of Excess Shares (5,178,642 Excess Shares as of September 30, 2018).  Based on the terms of the Excess Shares, certain circumstances require the Company to pay all or a portion of the Deferred Cash Consideration to the Selling Equityholders, where such cash amount is calculated as set forth in the Merger Agreement, including (i) where the volume weighted average trading price of the Company’s common stock for any period of 20 trading days in any 30 trading day period exceeds $15.00 per share, and (ii) if any Excess Shares remain on June 30, 2021. If any Excess Shares remain on June 30, 2021, the Company must elect to either (i) within five business days of such date, pay the Selling Equityholders an amount in cash equal to the product of the number of remaining Excess Shares multiplied by the volume weighted-average trading price for the 20 trading day period immediately preceding such date or (ii) use reasonable best efforts to sell such shares to a third party in a primary offering and pay the gross proceeds thereof (less any underwriting discounts and commissions) to the Selling Equityholders. However, to the extent the number of shares issued in such offerings does not equal the full amount of Excess Shares remaining at the time of the offering, the Company’s obligations with respect to any remaining Excess Shares, including the obligation to continue to complete any necessary additional offerings, shall continue.

In order to estimate the fair value of the Deferred Cash Consideration, the Company estimates the value of the Excess Shares using a Monte Carlo simulation model. The estimated fair value of the Deferred Cash Consideration liability was $62.7 million and $35.1 million as of September 30, 2018 and September 30, 2017, respectively. See Note 9.

Upon consummation of the Univar Merger Agreement, the obligation to pay the Deferred Cash Consideration will be accelerated. The Deferred Cash Consideration will be calculated as an amount in cash equal to the Excess Shares multiplied by an amount equal to the Cash Consideration plus the implied value of the Stock Consideration based on the closing trading price of Univar's common stock on the day prior to the completion of the proposed transaction.

Contingent Consideration - TRA

Concurrent with the completion of the Business Combination, the Company incurred the liability for contingent consideration related to the TRA, which reflects amounts owed to the Selling Equityholders. This liability generally provides for the payment by the Company to the Selling Equityholders of 85% of the net cash savings, if any, in U.S. federal, state and local income taxes that the Company actually realizes (or is deemed to realize in certain circumstances) in periods after the Closing Date as a result of (i) certain increases in tax basis resulting from the Company Merger, (ii) certain tax attributes of Holdings existing prior to the Mergers, (iii) net operating losses and certain other tax attributes of Blocker available to the Company as a result of the Blocker Merger and (iv) imputed interest deemed to be paid by the Company as a result of, and additional tax basis arising from, payments the Company makes under the TRA. The Company will retain the benefit of the remaining 15% of the net cash savings, if any. The Company estimated the fair value of the TRA liability based on a discounted cash flow model which incorporates assumptions of projected taxable income, projected income tax liabilities and an estimate of tax benefits expected to be realized as a result of the Business Combination. The current undiscounted cash flows associated with the TRA liability were estimated to be approximately $131.3 million over the time period during which the tax benefits are expected to be realized, currently estimated at over 20 years. The estimated fair value of the TRA liability is $74.8 million and $105.1 million as of September 30, 2018 and September 30, 2017, respectively. See Note 9. The decrease in the liability is reflective of the provisional impact associated with the Tax Act enacted in December 2017 (see Note 15), which lowers the Company’s projected income tax liabilities, the estimate of tax benefits expected to be realized as a result of the Business Combination and the ultimate amount expected to be paid by the Company to the Selling Equityholders.

The amount and timing of any payments due under the TRA will vary depending upon a number of factors, including the amount and timing of the taxable income the Company generates in the future and the U.S. federal, state and local income tax rates then applicable. In addition, payments made under the TRA will give rise to additional tax benefits for the Company and therefore additional potential payments due under the TRA. The term of the TRA commenced upon the consummation of the Mergers and will continue until all tax benefits that are subject to the TRA have been utilized or expired, unless the Company exercises its right to terminate the TRA early. If the Company elects to terminate the TRA early, its obligations under the TRA would accelerate and it generally would be required to make an immediate payment equal to the present value of the anticipated future payments to be made by it under the TRA, calculated in accordance with certain valuation assumptions set forth in the TRA.

In connection with the Univar Merger Agreement, Nexeo and the TRA Holders entered into a TRA Termination Agreement under which the parties agreed to terminate the TRA, upon consummation of the proposed transaction. Upon termination of the TRA, a cash payment to the TRA Holders will be made in an amount equal to $60.0 million. In the event the Univar Merger Agreement is terminated, the TRA Termination Agreement will no longer be in force.

The liabilities related to the Deferred Cash Consideration and the TRA are included in Due to related party pursuant to contingent consideration obligations on the Company’s consolidated balance sheets.

Purchase Consideration Allocation

The Business Combination is accounted for under the acquisition method, with WLRH determined to be the accounting acquirer of Holdings, which requires the Company to perform an allocation of the purchase consideration to the assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The excess of the purchase consideration over the estimated fair values is recorded as goodwill. The following table summarizes the Company’s allocation of the purchase consideration to assets acquired and liabilities assumed at the Closing Date:

	Purchase Price Allocation
Accounts receivable	$	470.0
Inventory	327.9
Other current assets	26.0
Property, plant and equipment	328.2
Customer-related intangible	201.0
Trade name	21.0
Below-market leases	0.7
Other non-current assets	3.2
Deferred tax assets	1.2
Goodwill	673.4
Total assets acquired	2,052.6
Short-term borrowings and current portion of capital leases	40.6
Accounts payable	335.9
Other current liabilities	52.8
Long-term portion of capital leases	23.0
Long-term debt	767.3
Deferred tax liability	24.8
Other non-current liabilities	5.5
Total liabilities assumed	1,249.9
Net assets acquired	$	802.7

During the fiscal year ended September 30, 2017, the Company completed its assessment of the fair values of the assets acquired and liabilities assumed in the Business Combination. The Company recorded adjustments to decrease the fair value of inventory by $0.6 million, property, plant and equipment by $0.1 million, an adjustment to accounts payable of $2.1 million, an adjustment to increase the fair value of other current assets by $0.2 million, and adjustments to deferred tax liabilities of $0.4 million. Goodwill was impacted by these adjustments as well as by the $5.6 million adjustment to the fair value of the TRA described above which increased the purchase consideration.

Transaction costs incurred by the Company associated with the Business Combination were $0.9 million and $21.3 million during the fiscal years ended September 30, 2017 and 2016, respectively. The Company also incurred a total of $25.3 million of debt issuance costs related to the Credit Facilities in connection with the consummation of the Business Combination. Transaction costs incurred by the Predecessor associated with the Business Combination were $33.4 million for the period from October 1, 2015 through June 8, 2016.

A summary and description of the acquired assets and assumed liabilities fair valued in conjunction with applying the acquisition method of accounting follows:

Accounts Receivable

Accounts receivable consisted of receivables related to the customers of the acquired business, as well as various other miscellaneous receivables. The accounts receivable and other miscellaneous receivables were recorded at their approximate fair value based on expected collections of the Predecessor. Accordingly, accounts receivable included an adjustment of $4.1 million to reduce gross receivables to their net value after consideration of expected uncollectable amounts at the Closing Date.

Inventory

Inventory consisted primarily of finished products to be distributed to the acquired business’s customers. The fair value of inventory was established through application of the income approach, using estimates of selling prices and costs such as selling and marketing expenses to be incurred in order to dispose of the finished products and arriving at the future profitability that is expected to be generated once the inventory is sold (net realizable value). An inventory fair value step up of $13.8 million was recognized in income during the fiscal year ended September 30, 2016, which is included in Cost of sales and operating expenses in the consolidated statement of operations.

Other Current Assets

Other current assets consisted primarily of prepaid expenses, which did not have a fair value adjustment as part of acquisition accounting since their carrying value approximated fair value. Additionally, as a result of the Business Combination, the Company recognized $1.3 million for certain tax receivables.

Property, Plant and Equipment

Property, plant and equipment consisted primarily of: 42 owned distribution locations in the U.S., Puerto Rico and Canada; 11 leased locations in the U.S., Canada, Puerto Rico, Mexico, Europe and China (excluding third party operated warehouses); and office equipment and other similar assets used in the Predecessor's operations. The allocation of the purchase consideration for property, plant and equipment was based on the fair market value of such assets determined using the cost approach. The cost approach consisted of estimating the fixed assets’ replacement cost less all forms of depreciation. The fair value of land was determined using the comparable sales approach. The fair value adjustment to property, plant and equipment was $96.0 million.

Customer-Related Intangible

Customer relationships were valued through the application of the income approach. Under this approach, revenue, operating expenses and other costs associated with existing customers were estimated in order to derive cash flows attributable to the existing customer relationships. The resulting estimated cash flows were then discounted to present value to arrive at the fair value of existing customer relationships as of the valuation date. The value associated with customer relationships will be amortized on a straight-line basis over a 12-year period, which represents the approximate point in the projection period in which a majority of the asset’s cash flows are expected to be realized based on assumed attrition rates. The Company recognized $201.0 million for these intangible assets as part of the allocation of the purchase consideration.

Trade Name

The "Nexeo" trade name was valued through application of the income approach, involving the estimation of likely future sales and an estimated royalty rate reflective of the rate that a market participant would pay to use the Nexeo name. The fair value of this asset will be amortized on a straight-line basis over a four year period, estimated based on the period in which the Company expects a market participant would use the name prior to rebranding and the length of time the name would be expected to maintain recognition and value in the marketplace. The Company recognized $21.0 million for this intangible asset as part of the allocation of the purchase consideration.

Below-Market Leases

The Company recognized an intangible asset related to favorable lease terms of certain properties under operating leases where rental payments were determined to be less than current market rates. The intangible asset will be amortized over the remaining life of the operating leases, which ranges from one to seven years. The Company recognized $0.7 million for this intangible asset as part of the allocation of the purchase consideration.

Other Non-Current Assets

Other non-current assets acquired represented certain long-term deposits, which did not have a fair value adjustment as part of acquisition accounting since their carrying value approximated fair value.

Goodwill

Goodwill represents the excess of the total purchase consideration over the fair value of the underlying net assets acquired, largely arising from the workforce and extensive efficient distribution network that has been established by the acquired business. Of the total amount of goodwill recognized as part of the allocation of the purchase consideration above, the Company expects approximately $252.9 million to be deductible for tax purposes as of September 30, 2018.

Short-Term Borrowings and Current Portion of Capital Leases.

Short-term borrowings and current portion of capital leases includes short-term borrowings of the Company's operations in China and the current portion of capital leases, which did not have a fair value adjustment as part of acquisition accounting since their carrying value approximated fair value.

Accounts Payable

Accounts payable represented short-term obligations owed to the vendors of the acquired business, which were assumed in the Business Combination. These obligations did not have a fair value adjustment as part of acquisition accounting since their carrying value approximated fair value.

Other Current Liabilities

Other current liabilities represented primarily accrued expenses, including accrued payroll, accrued interest on long-term debt, certain accrued taxes and various other liabilities arising out of the normal operations of the acquired business. The majority of these liabilities did not have a fair value adjustment because their carrying value approximated fair value. However, no fair value was recognized for certain recorded liabilities that did not meet the definition of a liability under the acquisition method of accounting.

Long-Term Portion of Capital Leases

The long-term portion of capital leases included the non-current portion of capital leases for machinery and equipment, which did not have a fair value adjustment as part of acquisition accounting as their carrying value approximated fair value.

Long-term Debt

Long-term debt represented the outstanding principal balance at the Closing Date of the Predecessor Term Loan Facility and the Notes which did not have a fair value adjustment as part of acquisition accounting as the carrying value approximated fair value.

Deferred Taxes

Deferred tax assets and liabilities are attributable to the difference between the estimated fair values allocated to inventory, property, plant and equipment and identified intangibles acquired for financial reporting purposes and the amounts determined for tax reporting purposes and give rise to temporary differences.  The deferred tax assets and liabilities will reverse in future periods or have reversed as the related tangible and intangible assets are amortized, acquired inventory is sold, or if goodwill is impaired. Additionally, the Company’s entity structure includes several partnerships.  The amounts recorded for deferred taxes reflect the evaluation of the tax basis of each individual partner's interest in the partnerships.

Unaudited Consolidated Pro Forma Financial Information

The unaudited consolidated pro forma results presented below include the effects of the Business Combination as if it had occurred as of October 1, 2014, the beginning of the fiscal year the Business Combination was consummated, and the Ultra Chem Acquisition as if it had occurred as of October 1, 2015.  The unaudited consolidated pro forma results reflect certain adjustments related to these acquisitions, primarily reflecting a full period of Ultra Chem Group’s results of operations for each period presented, the estimated changes in fair value of the contingent consideration liability from the Business Combination, amortization expense associated with estimates for the acquired intangible assets, depreciation expense based on the new fair value of property, plant and equipment, the effects of inventory step ups from the acquisitions, transaction costs, interest expense and income taxes.

The unaudited consolidated pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the Business Combination been completed on October 1, 2014 or the Ultra Chem Acquisition on October 1, 2015.

	Fiscal Year Ended September 30,
	2018		2017		2016
Sales and operating revenues	$	4,034.2	$	3,672.2	$	3,466.3
Operating income	$	97.2	$	71.1	$	96.6
Net income from continuing operations	$	29.4	$	16.4	$	33.4
Net income	$	29.4	$	16.4	$	33.5
Basic and diluted net income per share	$	0.38	$	0.21	$	0.44
Pro forma weighted average number of common shares outstanding
Basic	76,803,187		76,752,752		76,746,168
Diluted	76,909,547		76,839,810		76,799,052

The unaudited consolidated pro forma information for the fiscal year ended September 30, 2016 above reflects the effect of recognizing the non-recurring inventory fair value step up of $1.0 million and the effect of transaction related costs of $1.8 million during that period from the Ultra Chem Acquisition.

There was no impact to the calculation of pro forma basic or diluted weighted average number of common shares outstanding as a result of the Ultra Chem Acquisition, as no shares were issued as consideration. For the fiscal year ended September 30, 2016 presented above, the pro forma weighted average number of common shares outstanding were computed assuming all shares issued as a result of the Business Combination would have been issued on October 1, 2014. There were 12,476,250 Founder Shares not included in the basic or diluted computations because market conditions are assumed to be not satisfied. Additionally, the outstanding PSU awards were not included in the computation of diluted shares outstanding because performance targets and/or market conditions are assumed not to have been met for these awards. Diluted shares outstanding also did not include 25,012,500 shares based on the exercise of 50,025,000 warrants because the warrants were out-of-the-money.

Asset Acquisitions

In December 2016, the Company acquired customer contracts and a customer list. Additionally, in connection with this transaction, the Company entered into a supply agreement and a licensing agreement granting the Company the non-exclusive use of a certain trademark. The total consideration associated with this transaction was $8.5 million, of which $5.1 million was paid at closing. Of the remaining consideration, the Company paid $1.7 million in January 2018 and the remaining $1.7 million will be paid in January 2019. The remaining consideration is included in Accrued expenses and other liabilities on the Company’s consolidated balance sheets. In connection with this transaction, the Company recognized intangible assets totaling $8.5 million which are included in Other intangible assets, net of amortization on the Company’s consolidated balance sheet. The acquired intangible assets will be fully amortized over estimated useful lives ranging between 10 and 13 years.

In April 2017, the Company acquired customer contracts, a customer list and inventory. The total consideration associated with this transaction was approximately $1.9 million, with $1.6 million paid at closing. The remaining consideration was paid in April 2018. In connection with this transaction, the Company recognized an intangible asset related to the customer list of approximately $1.1 million which is included in Other intangible assets, net of amortization on the Company’s consolidated balance sheet. The customer list will be amortized over an estimated useful life of five years.

In August 2017, the Company acquired customer contracts, a customer list and certain trademarks. As part of this transaction, the Company entered into a supply agreement. The total consideration associated with this transaction was $2.2 million, and the Company recognized intangible assets of the same amount which are included in Other intangible assets, net of amortization on the Company's consolidated balance sheet. The acquired intangible assets will be fully amortized over an estimated useful life of five years.

In February 2018, the Company acquired customer contracts and a customer list. As part of this transaction, the Company entered into a supply agreement and agreements granting the Company the non-exclusive use of certain trademarks and patents for the products covered by the supply agreement. The total consideration associated with this transaction was $9.0 million, and the Company recognized intangible assets of the same amount, which are included in Other intangible assets, net of amortization on the Company's consolidated balance sheet. The Company paid $6.0 million of the consideration during the three months ended March 31, 2018, and paid the remaining $3.0 million in April 2018. The acquired intangible assets will be fully amortized over estimated useful lives ranging between 5 and 13 years.

XML

Certain Balance Sheet Information

12 Months Ended

Sep. 30, 2018

Certain Balance Sheet Information [Abstract]

Certain Balance Sheet Information

Certain Balance Sheet Information

Cash and Cash Equivalents 

Cash and cash equivalents were $58.9 million as of September 30, 2018 and $53.9 million as of September 30, 2017. These amounts included the following:

	September 30, 2018		September 30, 2017
Cash held by foreign subsidiaries	$	52.9	$	36.8
Non-USD denominated currency held by foreign subsidiaries	$	48.8	$	31.1
Currency denominated in RMB	$	6.5	$	8.5

Non-USD denominated currency held by foreign subsidiaries was primarily in euros and CAD. While the RMB is convertible into USD, foreign exchange transactions are subject to approvals from SAFE. The Company does not anticipate any significant adverse impact to overall liquidity from potential limitations on the transfer or conversion of cash and cash equivalents.

Inventories

Inventories at September 30, 2018 and 2017 consisted of the following:

	September 30, 2018		September 30, 2017
Finished products	$	334.0	$	310.6
Supplies	4.8		4.9
Total	$	338.8	$	315.5

The Company’s inventories in the U.S. and Canada are collateral under the Credit Facilities.

Other Non-Current Assets

Other non-current assets at September 30, 2018 and 2017 consisted of the following:

	September 30, 2018		September 30, 2017
Debt issuance costs of the ABL Facility	$	3.8	$	5.1
Deposits	2.5		2.8
Interest rate swap (1)	8.0		0.3
Other	1.9		2.4
Total	$	16.2	$	10.6

⁽¹⁾ See Note 8 for additional information.

Amortization of debt issuance costs related to the ABL Facility recorded in Interest expense in the consolidated statements of operations was $1.3 million, $1.3 million and $0.4 million for the fiscal years ended September 30, 2018, 2017 and 2016, respectively.

Amortization of debt issuance costs related to the Predecessor ABL Facility recorded in interest expense was $2.1 million for the period from October 1, 2015 through June 8, 2016.

Investments and Cash Previously Held in Trust

Prior to the Business Combination, the Company held in a trust account securities which the Company had the ability and intent to hold until maturity. Held-to-maturity treasury securities were recorded at amortized cost and adjusted for the amortization of the original discount. During the fiscal year ended September 30, 2016, the Company recognized $0.5 million of amortization related to the original discount, which was recorded in Interest income in the consolidated statement of operations. As part of the Business Combination, the Company withdrew all $501.1 million of proceeds from the trust account.

XML

Property, Plant and Equipment

12 Months Ended

Sep. 30, 2018

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

Property, Plant and Equipment

Property, plant and equipment at September 30, 2018 and 2017 consisted of the following:

	September 30, 2018			September 30, 2017
Land	$	50.8		$	51.0
Plants and buildings (1)	109.7			106.5
Machinery and equipment (2)	153.4			152.8
Software and computer equipment	70.5			63.3
Construction in progress	5.4			5.0
Total	389.8			378.6
Less accumulated depreciation (3)	(104.9		)	(62.5		)
Property, plant and equipment, net	$	284.9		$	316.1

⁽¹⁾ Includes $13.7 million related to facilities acquired under capital leases for the periods ended September 30, 2018 and September 30, 2017.

⁽²⁾ Includes $26.5 million and $27.2 million, respectively, related to equipment acquired under capital leases.

⁽³⁾ Includes $7.4 million and $4.9 million, respectively, related to facilities and equipment acquired under capital leases.

Depreciation expense recognized on the property, plant and equipment described above was as follows:

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 Through June 8, 2016
Depreciation expense	$	46.8	$	48.2	$	13.6	$	27.1

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

Included in the carrying value of property, plant and equipment in the Company's consolidated balance sheets are certain closed facilities located in the U.S., which collectively have a carrying value of $1.1 million as of September 30, 2018 and 2017, respectively. The facilities do not currently meet the criteria for held-for-sale classification; accordingly, they remain classified as held and used.  

During the fourth quarter of fiscal year 2017, the Company's facilities were adversely effected by three major hurricanes. Hurricane Harvey caused extensive flooding and costly physical damage along the Texas Gulf Coast, while Puerto Rico suffered a direct hit from Hurricanes Irma and Maria. The Company has recorded an impairment charge of $1.4 million to Cost of sales and operating expenses in the Company’s consolidated income statement related to these natural disasters.

During the fourth quarter of fiscal year 2017, the Company entered into a purchase agreement to buy land currently leased at one of the Company's distribution centers. The purchase is expected to be finalized during the first half of fiscal year 2019 for approximately $10.8 million.

Facility Lease

The Company's sale of its Franklin Park facility to the Illinois Tollway Authority under an eminent domain proceeding was completed in September 2016 for $4.6 million, net of costs incurred.

As a result of the sale of this facility, the Company relocated operations to a new leased facility in Montgomery, Illinois. The Montgomery Lease has a term of 15 years, with annual payments beginning at $1.1 million per year, excluding executory costs, and annual escalations of 2.5% per year. The lease agreement includes three, five year renewal options. The Montgomery Lease is accounted for as a capital lease and began in the first quarter of fiscal year 2017 at an initial cost of $13.2 million.

During the fiscal years ended September 30, 2017 and 2016, the Company recorded a gain of $8.1 million and $0.8 million, respectively, related to capital expenditures incurred in connection with the relocation and reimbursed by the Illinois Tollway Authority, which is included in Other Income on the consolidated statements of operations.

XML

Goodwill and Other Intangibles

12 Months Ended

Sep. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangibles

Goodwill and Other Intangibles

Goodwill

The following is a progression of goodwill by reportable segment: 

	Chemicals			Plastics			Other		Total
Balance at September 30, 2016	$	331.6		$	271.1		$	63.0	$	665.7
Measurement period adjustments	2.7			1.2			0.5		4.4
Ultra Chem Acquisition	28.0			—			—		28.0
Foreign currency translation	0.5			4.4			—		4.9
Balance at September 30, 2017	$	362.8		$	276.7		$	63.5	$	703.0
Foreign currency translation	(0.4		)	(2.7		)	—		(3.1		)
Balance at September 30, 2018	$	362.4		$	274.0		$	63.5	$	699.9

Goodwill amounts by reportable segment at September 30, 2018 are based on the allocation of the purchase consideration of the Business Combination as of the Closing Date and the allocation of the purchase consideration of the Ultra Chem Acquisition as of the Ultra Chem Closing Date. See Note 3.

Goodwill Impairment Test

Goodwill is tested for impairment annually as of March 31 and whenever events or circumstances make it more likely than not that an impairment may have occurred. Goodwill is reviewed for impairment at the reporting unit level, or operating segment, for the Company. The Company performed an impairment test as of March 31 2018 and concluded that goodwill was not impaired. For purposes of the impairment testing of the Company's recognized goodwill, fair value measurements are determined using the income approach, based largely on inputs that are not observable to active markets, which would be deemed Level 3 fair value measurements as defined in Note 9. These inputs include management’s expectations about future revenue growth and profitability, working capital needs and capital expenditures. Inputs also include estimates of a market participant’s expectations for 1) a discount rate at which the cash flows should be discounted in order to determine the fair value of such expected cash flows, and 2) an estimated income tax rate. The Company also considers a market approach using the comparable company method to verify if is comparable to the income approach.

The evaluation of goodwill requires the use of estimates about future operating results of each reporting unit to determine its estimated fair value. Changes in forecasted operations can materially affect these estimates, which could materially affect the Company’s results of operations. The estimate of fair value requires significant judgment and is based on management’s fair value estimates on assumptions that are believed to be reasonable but that are unpredictable and inherently uncertain, including: estimates of future growth rates, operating margins and assumptions about the overall economic climate as well as the competitive environment for the reporting units. There can be no assurance that these estimates and assumptions made for purposes of the goodwill testing as of the time of testing will prove to be accurate. If assumptions regarding business plans, competitive environments or anticipated growth rates are not correct, the Company may be required to record goodwill impairment charges in future periods, whether in connection with future annual impairment testing, or earlier, if an indicator of an impairment is present prior to the next annual evaluation.

Other Intangible Assets

Definite-lived intangible assets at September 30, 2018 and September 30, 2017 consisted of the following: 

	September 30, 2018							September 30, 2017
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Customer-related	$	239.6	$	(44.1	)	$	195.5	$	234.6	$	(23.7	)	$	210.9
Supplier-related	3.1		(0.4		)	2.7		1.5		(0.1		)	1.4
Trade name	23.3		(12.7		)	10.6		22.3		(7.0		)	15.3
Below-market leases	0.7		(0.5		)	0.2		0.7		(0.3		)	0.4
Non-compete agreements	4.6		(2.0		)	2.6		4.2		(0.7		)	3.5
Total	$	271.3	$	(59.7	)	$	211.6	$	263.3	$	(31.8	)	$	231.5

Amortization expense recognized on the intangible assets described above was as follows:

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 Through June 8, 2016
Amortization expense	$	28.1	$	24.9	$	7.0	$	10.6

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

Expected amortization expense for the next five years is as follows:

2019	$	28.3
2020	25.9
2021	21.6
2022	21.4
2023	20.9

XML

Debt

12 Months Ended

Sep. 30, 2018

Debt Disclosure [Abstract]

Debt

Debt

Short-term borrowings outstanding and the current portion of long-term debt and capital lease obligations at September 30, 2018 and 2017 are summarized below:

	September 30, 2018		September 30, 2017
Short-term borrowings	$	38.1	$	40.8
Current portion of long-term debt and capital lease obligations	9.6		10.3
Total short-term borrowings and current portion of long term debt and capital lease obligations, net	$	47.7	$	51.1

Long-term debt outstanding at September 30, 2018 and 2017 is summarized below:

	September 30, 2018			September 30, 2017
ABL Facility	$	104.6		$	139.3
Term Loan Facility	640.4			646.9
Capital lease obligations (1)	34.0			37.5
Total long-term debt	779.0			823.7
Less: unamortized debt discount (2)	(2.3		)	(2.7		)
Less: debt issuance costs (3)	(14.7		)	(16.7		)
Less: current portion of long-term debt and capital lease obligations	(9.6		)	(10.3		)
Long-term debt and capital lease obligations, less current portion, net	$	752.4		$	794.0

⁽¹⁾  Capital lease obligations exclude executory costs and interest payments associated with the underlying leases. See “Capital Lease Obligations” below.

⁽²⁾  The unamortized debt discount is related to the Term Loan Facility and amortized to interest expense over the life of the instrument using the effective interest rate method.

⁽³⁾  See discussion below under Term Loan Facility and Debt Issuance Cost Amortization.

Short-Term Borrowings

The Company's short-term borrowings are associated with the Company's operations in China and are summarized below:    

	Facility Limit		Outstanding Borrowings Balance		Weighted Average Interest Rate on Borrowings		Outstanding LOC and Bankers' Acceptance Bills		Remaining Availability
September 30, 2018
Bank of America - China (1)	$	24.3	$	22.2	4.6	%	$	—	$	2.1
Bank of Communications - China (2)	21.8		15.9		5.4	%	5.1		0.8
Total	$	46.1	$	38.1			$	5.1	$	2.9
September 30, 2017
Bank of America - China (1)	$	24.3	$	23.8	4.3	%	$	—	$	0.5
Bank of Communications - China (2)	22.5		17.0		5.3	%	5.3		0.2
Total	$	46.8	$	40.8			$	5.3	$	0.7

⁽¹⁾  The borrowing limit of this facility is denominated in USD. This line of credit is secured by a standby letter of credit drawn on the ABL Facility covering at least 110% of the facility's borrowing limit amount. Borrowings under the line of credit are payable in full within 12 months of the date of the advance. The Company has the ability to provide additional capacity under these lines of credit, if needed.

⁽²⁾ The borrowing limit of this facility is denominated in RMB. This line of credit is secured by a standby letter of credit drawn on the ABL Facility covering at least 100% of the facility's borrowing limit amount. Borrowings under the line of credit are payable in full within 12 months of the date of the advance.

Long-Term Debt

ABL Facility

The ABL Facility provides for committed revolving credit financing including a U.S. Tranche of up to $505.0 million, a Canadian Tranche of up to the USD equivalent of $40.0 million, and a FILO Tranche up to $30.0 million. The ABL Facility matures on June 9, 2021. Provided no default or event of default, the ABL Borrowers have the option to request that the ABL Facility be increased by an aggregate amount, when included with any incremental borrowings issued under the Term Loan Facility, not to exceed $175.0 million.

The ABL Facility includes a letter of credit sub-facility, which permits up to $200.0 million of letters of credit under the U.S. Tranche (which may be denominated in USD, euros or other currencies approved by the administrative agent and the issuing bank) and up to the USD equivalent of $10.0 million of letters of credit under the Canadian Tranche (which may be denominated in CAD only). The ABL Facility also contains a FILO Tranche which can be used by any non-Canadian foreign subsidiary for loans or letters of credit up to an aggregate amount not to exceed $30.0 million.

The amount of available credit changes every month, depending on the amount of eligible receivables and inventory the ABL Borrowers have available to serve as collateral. In general, the facility is limited to the lesser of (i) the aggregate commitment or (ii) the sum of (a) 90.0% of eligible accounts receivable, as defined therein, and (b) 85.0% of the orderly liquidation value of the eligible inventory and (c) 100.0% of cash and cash equivalents held in blocked accounts, as defined, maintained by the ABL Agent, for each ABL Borrower. Available credit for the U.S. and Canadian Tranches are calculated separately, and the borrowing base components are subject to customary reserves and eligibility criteria.

Borrowings under the U.S. Tranche and the Canadian Tranche of the ABL Facility bear interest, at the ABL Borrowers’ option, at either an alternate base rate or Canadian prime rate, as applicable, plus an applicable margin (ranging from 0.25% to 0.75% pursuant to a grid based on average excess availability) or LIBOR or Canadian BA rate (as defined therein), as applicable, plus an applicable margin (ranging from 1.25% to 1.75% pursuant to a grid based on average excess availability). Loans under the FILO Tranche, within the ABL Facility, bear interest at an alternate base rate plus an applicable margin (ranging from 1.00% to 1.50% pursuant to a grid based on average excess availability) or LIBOR plus an applicable margin (ranging from 2.00% to 2.50% pursuant to a grid based on average excess availability). In addition to paying interest on outstanding principal amounts under the ABL Facility, the ABL Borrowers are required to pay a commitment fee in respect of the unutilized commitments, which commitment fee is 0.250% or 0.375% per annum and is determined based on average utilization of the ABL Facility (increasing when utilization is low and decreasing when utilization is high). The ABL Borrowers are required to pay customary letters of credit fees.

The ABL Facility requires that if the sum of (i) excess availability, as defined (for the ABL Borrowers) and (ii) the amount by which the then-current borrowing base exceeds the aggregate commitments under the ABL Facility (for the ABL Borrowers) is less than the greater of (a) $40.25 million and (b) 10.0% of the Line Cap (as defined in the ABL Facility), the ABL Borrowers shall comply with a minimum fixed charge coverage ratio of at least 1.0 to 1.0. In addition, the ABL Facility contains negative covenants that restrict Holdings and its subsidiaries, including the ABL Borrowers from, among other things, incurring additional debt, granting liens, entering into guarantees, entering into certain mergers, making certain loans and investments, disposing of assets, prepaying certain debt, declaring dividends, modifying certain material agreements or changing the business it conducts.

The ABL Facility also contains certain customary representations and warranties, affirmative covenants and events of default, including, among other things, payment defaults, breach of representations and warranties, covenant defaults, cross-defaults and cross-acceleration to certain indebtedness, certain events of bankruptcy, certain events under the Employee Retirement Income Security Act of 1974, as amended from time to time, material judgments, actual or asserted failure of any guaranty or security document supporting the ABL Facility to be in full force and effect, and change of control. If such an event of default occurs, the lenders under the ABL Facility are entitled to take various actions, including the acceleration of amounts due under the ABL Facility and all actions permitted to be taken by a secured creditor.

The weighted average interest rate on borrowings under the ABL Facility was 3.26% at September 30, 2018. The Company had the USD equivalent of $74.1 million in outstanding letters of credit under the ABL Facility at September 30, 2018. The collective credit availability under the U.S. and Canadian Tranches of the ABL Facility was the U.S. equivalent of $344.2 million at September 30, 2018. There was $5.0 million availability under the FILO Tranche at September 30, 2018.

Obligations under the ABL Facility are secured by a first priority lien on all ABL Facility first lien collateral, including eligible inventory and accounts receivable of the ABL Borrowers, and a second priority lien on all Term Loan Facility first lien collateral including outstanding equity interests of the Borrower and certain of the other subsidiaries of Holdings, in each case, subject to certain limitations; provided, that no ABL Facility first lien collateral or Term Loan Facility first lien collateral owned by the Canadian Borrower secure the obligations owing under the U.S. tranche of the ABL Facility. These accounts receivable and inventory totaled $709.4 million in the aggregate as of September 30, 2018.

As of September 30, 2018, the ABL Borrowers were in compliance with the covenants of the ABL Facility.

Term Loan Facility

The Term Loan Facility provides secured debt financing in an aggregate principal amount of up to $655.0 million and the right, at the Company's option, to request additional tranches of term loans in an aggregate principal amount, when included with any incremental borrowings issued under the ABL Facility, of up to $175.0 million, plus unlimited additional amounts such that the aggregate principal amount of indebtedness outstanding at the time of incurrence does not cause the Secured Net Leverage Ratio, calculated on a pro forma basis, to exceed 4.1 to 1.0. Availability of such additional tranches of term loans is subject to the absence of any default and, among other things, the receipt of commitments by existing or additional financial institutions. Borrowings under the Term Loan Facility bear interest at the borrower’s option at either (i) the LIBOR rate determined by reference to the costs of funds for USD deposits for the interest period relevant to such borrowing adjusted for certain additional costs, which shall be no less than 1.0%, plus an applicable margin of 4.25% or (ii) a base rate determined by reference to the highest of (a) the prime commercial lending rate published by Bank of America, N.A. as its "prime rate," (b) the federal funds effective rate plus 0.50% and (c) a one-month LIBOR rate plus 1.0%, plus an applicable margin of 3.25%. The Company is required to make scheduled quarterly payments in an aggregate annual amount equal to 1.0% of the aggregate principal amount of the initial term loans made on the Closing Date of the Mergers, with the balance due at maturity. The Term Loan Facility matures on June 9, 2023. The weighted average interest rate for the Term Loan Facility was 5.58% at September 30, 2018. The Company amortized $0.4 million and $0.5 million of debt discount to interest expense during the fiscal years ended September 30, 2018 and 2017, respectively.

On December 19, 2017, the Company completed TLB Amendment No. 2 amending the Term Loan Facility. TLB Amendment No. 2 reduced the interest rate margin applicable to outstanding term loans by 50 basis points from 3.75% to 3.25% for LIBOR loans and from 2.75% to 2.25% for base rate loans. TLB Amendment No. 2 also provides for a soft call premium equal to 1% of the amount of the term loans that are subject to certain repricing transactions occurring on or prior to twelve months from the effective date of TLB Amendment No. 2. As a result of TLB Amendment No. 2, the Company paid debt issuance costs of $0.8 million, which will be amortized throughout the remaining life of the Term Loan Facility.

Additionally, the Term Loan Facility requires the Company to make mandatory principal payments on an annual basis, if cash flows for the year, as defined in the Term Loan Facility, exceed certain levels specified in the Term Loan Facility. The Company was not required to make such mandatory principal payment for the fiscal year ended September 30, 2018. The Company generally has the right to prepay loans in whole or in-part, without incurring any penalties for early payment.

The Term Loan Facility contains a number of covenants that, among other things and subject to certain exceptions, restrict Holdings’ ability and the ability of its subsidiaries to incur additional indebtedness, pay dividends on its capital stock or redeem, repurchase or retire its capital stock or other indebtedness, make investments, loans and acquisitions, create restrictions on the payment of dividends or other amounts to the Company from its restricted subsidiaries, engage in transactions with its affiliates, sell assets, including capital stock of its subsidiaries, alter the business it conducts, consolidate or merge, incur liens. The Term Loan Facility does not require the Company to comply with any financial maintenance covenants and contains certain customary representations and warranties, affirmative covenants and provisions relating to events of default.

Obligations under the Term Loan Facility are secured by a first priority lien on all Term Loan Facility first lien collateral, including outstanding equity interests of the Borrower and certain of the other subsidiaries of Holdings, and a second priority lien on all ABL Facility first lien collateral, including accounts receivable and inventory of the loan parties under the Term Loan Facility, subject to certain limitations.

As of September 30, 2018, the Company was in compliance with the covenants of the Term Loan Facility.

Debt Issuance Cost Amortization

Amortization expense included in interest expense related to debt issuance costs of the Term Loan Facility was $2.8 million, $2.4 million and $0.7 million for the fiscal years ended September 30, 2018, 2017 and 2016, respectively.

Amortization expense included in interest expense related to debt issuance costs was $3.6 million for the period from October 1, 2015 through June 8, 2016 for the Predecessor.

Capital Lease Obligations

The capital lease obligation balance of $34.0 million as of September 30, 2018 is primarily associated with the Ryder Lease and the Montgomery Lease. The Ryder Lease obligation excludes decreasing annual interest payments ranging from $0.9 million to less than $0.1 million, for aggregate interest payments totaling $2.8 million. The Montgomery Lease obligation excludes decreasing annual interest payments ranging from $1.0 million to $0.1 million, for aggregate interest payments of $12.6 million.

Debt Obligations

The following table sets forth future principal payments on debt and capital lease obligations at September 30, 2018:

2019	$	47.7
2020	9.6
2021	114.1
2022	13.2
2023	619.7
Thereafter	12.8
Total	$	817.1

XML

Derivatives

12 Months Ended

Sep. 30, 2018

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives

Derivatives

During the three months ended March 31, 2018, the Company entered into three additional interest rate swap agreements with a combined notional amount of $300.0 million to help mitigate interest rate risk related to the variable rate Term Loan Facility. During the three months ended March 31, 2017, the Company entered into four interest rate swap agreements with a combined notional amount of $300.0 million to help mitigate interest rate risk related to the variable rate Term Loan Facility. The swap agreements expire at various dates from February 2020 through February 2023 and are accounted for as cash flow hedges. Gains or losses resulting from changes in the fair value of the swaps are recorded in other comprehensive income. Gains and losses recorded in other comprehensive income are reclassified into and recognized in income when the interest expense on the Term Loan Facility is recognized.

On June 29, 2017, the Company removed the interest rate floor component of the interest-rate swaps to align the swaps with the Term Loan Facility terms after the modification of the Term Loan Facility in March 2017 with TLB Amendment No. 1. In connection with the modification of the swaps’ terms, the Company received cash proceeds of $0.5 million. During the fiscal year ended September 30, 2017, the Company recognized approximately $0.6 million of interest expense related to ineffectiveness of the interest-rate swaps prior to June 29, 2017. The interest rate swaps continue to be accounted for as cash flow hedges and there was no material ineffectiveness related to the swaps after the modification of the terms described above.

Derivative assets and liabilities at September 30, 2018 and September 30, 2017 consisted of the following:

	Recorded to	September 30, 2018		September 30, 2017
Short-term derivative asset	Other current assets	$	2.2	$	—
Long-term derivative asset	Other non-current assets	$	8.0	$	0.3
Short-term derivative liability(1)	Accrued expenses and other liabilities	$	—	$	1.1
Long-term derivative liability	Other non-current liabilities	$	—	$	0.2
Other Comprehensive Income(2)	Accumulated other comprehensive income	$	8.1	$	—

^{(1) Short-term derivative liability for the fiscal year ended September 30, 2018 was less than $0.1 million}  

^{(2) Other Comprehensive Income for the fiscal year ended September 30, 2017 was less than $0.1 million}  

Prior to the Business Combination, the Predecessor was a party to interest rate swap agreements of varying expiration dates through March 2017, to mitigate the exposure to interest rate risk related to the variable-rate Predecessor Term Loan Facility. As a result of the Business Combination, the Predecessor Term Loan Facility was extinguished, the related swap agreements were terminated and an early termination payment penalty of $0.3 million was paid and recorded in Transaction related costs in the consolidated statement of operations.

Gains and losses (net of reclassifications into income, including any ineffective portion) related to the interest rate swaps of the Company and the Predecessor were as follows:

		Successor				Predecessor
	Recorded to	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		October 1, 2015 through June 8, 2016
Realized loss	Interest expense	$	1.2	$	2.0	$	0.3
Unrealized gain, net of tax	Other comprehensive income	$	8.1	$	—	$	0.3

The tax impact of the unrealized gains related to the interest-rate swaps was $2.8 million and less than $0.1 million for the fiscal years ended September 30, 2018 and 2017, respectively. There was no material tax impact for the Predecessor periods presented. At September 30, 2018, $2.8 million in unrealized gains were expected to be realized and recognized in income within the next twelve months.

See Note 9 for additional information on the fair value of the Company and Predecessor’s derivative instruments.

XML

Fair Value Measurements

12 Months Ended

Sep. 30, 2018

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

The accounting standard for fair value measurements establishes a framework for measuring fair value that is based on the inputs market participants use to determine the fair value of an asset or liability and establishes a fair value hierarchy to prioritize those inputs. The fair value hierarchy is as follows:

• Level 1—Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

• Level 2—Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability.

• Level 3—Prices or valuation models that require inputs that are both significant to the fair value measurement and less observable for objective sources (i.e., supported by little or no market activity).

The fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs are obtained from independent sources and can be validated by a third party, whereas unobservable inputs reflect assumptions a third party would use in pricing an asset or liability based on the best information available under the circumstances. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment, which may affect the valuation of the assets and liabilities and their placement within the fair value hierarchy levels. The Company considers active markets as those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis.

Fair value of financial instruments

The carrying values of cash and cash equivalents, accounts and notes receivable, accounts payable and short-term borrowings approximate their fair value due to the short-term maturity of those instruments.

The carrying values of borrowings outstanding under the Credit Facilities approximate fair value at September 30, 2018 and 2017 primarily due to their variable interest rate. The estimated fair value of these instruments is classified by the Company as a Level 3 measurement within the fair value hierarchy due to the varying interest rate parameters as outlined in the respective loan agreements.

Assets and Liabilities Measured at Fair Value on a Non-recurring Basis

In addition to the financial instruments that are recorded at fair value on a recurring basis, the Company records assets and liabilities at fair value on a non-recurring basis as required by U.S. GAAP. Generally, assets are recorded at fair value on a non-recurring basis as a result of impairment charges or as part of a business combination. As discussed in Note 3, during the fiscal year ended September 30, 2017, the Company recorded non-recurring fair value measurements related to the Ultra Chem Acquisition and its asset acquisitions. These fair value measurements were classified as Level 3 within the fair value hierarchy.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Contingent Consideration

The fair value of the contingent consideration related to the Deferred Cash Consideration as discussed in Note 3 was $62.7 million and $35.1 million as of September 30, 2018 and 2017, respectively. The increase in the liability was largely driven by the increase in the Company’s stock price. The measurement of the contingent consideration related to the Deferred Cash Consideration is classified by the Company as a Level 3 measurement within the fair value hierarchy. In order to estimate the fair value of the Deferred Cash Consideration, the Company estimates the value of the Excess Shares using a Monte Carlo simulation model with the market price of the Company’s common stock at each valuation date being a significant input to this model. Unobservable inputs to the valuation are the expected volatility during the applicable period as well as a marketability discount to reflect the illiquidity of the Excess Shares given their terms. An increase in the market price of the Company’s common stock has the same directional effect on the value of the liability related to the Deferred Cash Consideration. An increase in the volatility and marketability discount will lower the value of the liability related to the Deferred Cash Consideration.

The fair value of the liability for the contingent consideration related to the TRA as discussed in Note 3 was $74.8 million and $105.1 million as of September 30, 2018 and 2017, respectively. The decrease in the liability includes the impact of the Tax Act enacted in December 2017 (see Note 15), which lowers the Company's projected income tax liabilities, the estimate of tax benefits expected to be realized as a result of the Business Combination and the ultimate amount expected to be paid by the Company to the Selling Equityholders and payments made to the Selling Equityholders. The liability for the contingent consideration related to the TRA is classified by the Company as a Level 3 measurement within the fair value hierarchy. The Company estimates the fair value of the liability for the contingent consideration related to the TRA based on a discounted cash flow model which incorporates assumptions of projected taxable income, projected income tax liabilities and an estimate of tax benefits expected to be realized as a result of the Business Combination. Key inputs to the valuation are prevailing tax rates and market interest rates impacting the discount rate. A 100 basis point increase in the discount rate compared to the discount rate used at the September 30, 2018 valuation would have resulted in a decrease of approximately $0.6 million in the value of the liability for the contingent consideration related to the TRA. Additionally, this cash flow model is sensitive to changes in applicable tax rates. A 100 basis point decrease in the tax rate compared to the tax rate used at the September 30, 2018 valuation would have resulted in an increase of approximately $2.6 million in the value of the liability for the contingent consideration related to the TRA.

During the fiscal year ended September 30, 2017, the Company recorded a $5.6 million measurement period adjustment to the estimated fair value of the TRA liability as of the Closing Date, related to the assessments of the tax attributes associated with certain entities.

Changes in the fair value of the contingent consideration obligations for the fiscal years ended September 30, 2018 and 2017 were as follows:

	TRA			Deferred Cash Consideration		Total Fair Value
Contingent consideration as of September 30, 2016	$	83.4		$	35.0	$	118.4
Measurement period adjustment	5.6			—		5.6
Change in fair value of contingent consideration(1)	16.1			0.1		16.2
Contingent consideration as of September 30, 2017	$	105.1		$	35.1	$	140.2
Cash Paid to TPG	(10.2		)	—		(10.2		)
Change in fair value of contingent consideration(1)	(20.1		)	27.6		7.5
Contingent consideration as of September 30, 2018	$	74.8		$	62.7	$	137.5

⁽¹⁾ Included in Operating income in the consolidated statements of operations.

Significant changes in the estimates and inputs used in determining the fair value of the contingent consideration could have a material impact on the amounts recognized as a component of Operating income (loss) in future periods. For additional information regarding the contingent consideration obligations, see Note 3.

Interest Rate Swaps

The Company classifies interest rate swaps within Level 2. During the three months ended March 31, 2017, the Company entered into four interest rate swap agreements to help mitigate interest rate risk related to the variable-rate Term Loan Facility. On June 29, 2017, the Company removed the interest rate floor component of the interest-rate swaps to align the swaps with the Term Loan Facility terms after the modification of the Term Loan Facility in March 2017 with TLB Amendment No. 1. During the three months ended March 31, 2018, the Company entered into three additional interest rate swap agreements to help mitigate interest rate risk related to the variable rate Term Loan Facility. The agreements expire at various dates through February 2023. At September 30, 2018, the Company recorded $2.2 million in Other current assets and $8.0 million in Other non-current assets in the consolidated balance sheet related to these instruments.

Prior to the Business Combination, the Predecessor was a party to interest rate swap agreements of varying expiration dates through March 2017 to mitigate the exposure to interest rate risk related to the variable-rate Predecessor Term Loan Facility. As a result of the Business Combination, the Predecessor Term Loan Facility was extinguished, the related swap agreements were terminated and an early termination payment of $0.3 million was made and recorded during the Predecessor period of October 1, 2015 through June 8, 2016 in Transaction related costs in the consolidated statement of operations.

During the fiscal years ended September 30, 2018 and 2017, the Company did not have any transfers between Level 1, Level 2 or Level 3 fair value measurements.

XML

Share-Based Compensation and Employee Benefit Plans

12 Months Ended

Sep. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Compensation and Employee Benefit Plans

Share-Based Compensation and Employee Benefit Plans

On June 8, 2016, the Company’s stockholders approved the 2016 LTIP, with an effective date of March 30, 2016, covering approximately a ten-year period. No awards may be granted under the 2016 LTIP after March 20, 2026. The 2016 LTIP permits the grant of up to 9,000,000 shares of the Company's common stock for various types of awards to employees, directors and consultants of the Company or its subsidiaries, including incentive and non-incentive stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalents, stock awards, conversion awards and performance awards.

Vesting conditions of awards under the 2016 LTIP are determined by the Compensation Committee of the Board of Directors of the Company, including treatment upon the occurrence of a change of control of the Company. Upon a change of control, the Compensation Committee has the discretion to remove forfeiture restrictions, accelerate vesting, require recipients of awards to surrender the awards for cash consideration, cancel unvested awards without payment of consideration, cause any surviving entity to assume and continue any outstanding awards, or make other such adjustments as the Compensation Committee deems appropriate to reflect such change of control.

If any change is made to the Company’s capitalization, appropriate adjustments will be made by the Compensation Committee as to the number and price of shares awarded under the 2016 LTIP, the securities covered by such awards, the aggregate number of shares of common stock of the Company available for the issuance of awards under the 2016 LTIP and the maximum annual per person compensation limits on share-based awards under the 2016 LTIP.

Other than in connection with a change in capitalization or other transaction where an adjustment is permitted or required under the terms of the 2016 LTIP, the Compensation Committee is prohibited from making any adjustment or approving any amendment that reduces or would have the effect of reducing the exercise price of a stock option or stock appreciation right previously granted under the 2016 LTIP unless the Company’s stockholders have approved such adjustment or amendment.

In each calendar year during any part of which the 2016 LTIP is in effect, an employee may not receive awards under the plan in excess of 1,000,000 shares of common stock, or a value of greater than $12.0 million if an award is to be paid in cash or if settlement is not based on shares of common stock, in each case, multiplied by the number of full or partial calendar years in any performance period established with respect to an award, if applicable. A non-employee member of the Board may not be granted awards with a cumulative value of greater than $1.0 million during any calendar year for services rendered in their capacity as a director. This limit does not apply to grants made to a non-employee director for other reasons not related to their services as a director.

During the fiscal year ended September 30, 2018, the Company granted 193,667 PSUs to employees under the 2016 LTIP. These awards will vest on September 30, 2020, entitling the recipient to receive a certain number of shares of the Company’s common stock, based on the Company’s achievement of the performance goals included in the PSUs, which are based on a return on invested capital calculation over a three-year performance period. Depending on the calculation as of the vesting date, a recipient is entitled to receive between 0% and 200% of the initial award. The awards are accounted for as equity instruments, and the fair value of these awards was determined by the closing price of the Company's common stock on the date of grant.

During the fiscal years ended September 30, 2017 and 2016, the Company granted 212,000 and 1,557,500 PSU awards to employees, respectively, under the 2016 LTIP. The performance aspect of the PSUs vest on June 30, 2019, entitling the recipient to receive a certain number of shares of the Company's common stock, based on the Company’s achievement of the performance goals included in the PSUs. Depending on the performance of common stock during the approximate three-year performance period, a recipient of the award is entitled to receive a number of shares of common stock equal to a percentage, ranging from 0% to 200%, of the initial award granted, with a 35% total stockholder return entitling the recipient to receive 100% of the award granted. If the Company’s total stockholder return for the performance period is negative, then the number of units ultimately awarded is based on the Company’s achievement of its cumulative Adjusted EBITDA target, as defined by the PSU agreement, during the performance period. If total stockholder return is between negative 15% and 0%, a recipient is entitled to receive a number of shares of common stock between 50% and 70% of the number of PSUs granted. If the cumulative Adjusted EBITDA target is not met, or the total stockholder return is less than negative 15%, no shares of the Company’s common stock will be issued. The Company used the Monte Carlo simulation model to estimate the fair value of the PSU awards at the grant date, considering the probability of satisfying the various performance criteria. The resulting grant date fair value is recognized as expense on a straight-line basis from the grant date through the end of the performance period. The assumptions used in the Monte Carlo simulation model for PSUs included an expected stock price volatility between 35% and 40% based on a peer group of similar companies, an expected dividend yield of 0%, an expected term of two to three years, and a risk-free interest rate of between 0.9% and 1.3%.

The following table summarizes all PSU activity during the fiscal year ended September 30, 2018:

	Units		Average Grant Date Fair Value Per Unit
Unvested PSUs at September 30, 2017	1,524,000		$	8.92
Granted	193,667		7.50
Vested	—		—
Forfeited/Canceled	(22,500	)	9.13
Unvested PSUs at September 30, 2018	1,695,167		$	8.76

As of September 30, 2018, the Company may issue up to 3,390,334 shares of common stock related to the outstanding PSU awards described above under the 2016 LTIP.

In November 2017, the Company granted 415,867 shares of restricted stock to employees under the 2016 LTIP. The restricted stock awards vest equally on the anniversary of the grant date over a three-year period provided that the recipients of such grants continue their employment with the Company. The awards are accounted for as equity instruments, and the fair value of the restricted stock awards was determined by the closing price of the Company's common stock on the date of grant. During the fiscal years ended September 30, 2017 and 2016, the Company granted restricted stock awards to certain of the Company’s non-employee directors under the 2016 LTIP that vest one year from the date of grant.

During the fiscal years ended September 30, 2017 and 2016, the Company also granted 77,458 and 64,518 shares of restricted stock, respectively, to certain of the Company's non-employee directors under the 2016 LTIP. The restricted stock will vest on the anniversary of the grant date provided the director continues his services as a director of the Company. The fair value of the restricted stock was determined by the closing price of the Company's common stock on the date of grant.

The following table summarizes restricted stock activity during the fiscal year ended September 30, 2018:

	Shares of Restricted Stock		Average Grant Date Fair Value Per Unit
Restricted stock at September 30, 2017	77,458		$	8.26
Granted	415,867		7.50
Vested	(53,450	)	8.28
Forfeited/Canceled	(30,608	)	8.05
Restricted stock at September 30, 2018	409,267		$	7.50

During the fiscal year ended September 30, 2016, TPG Restricted Stock Grants were awarded with respect to 100,000 shares of Company common stock owned by TPG. These awards vest in equal amounts over a three-year period provided that the recipients of such grants continue their employment with the Company. During the fiscal year ended September 30, 2018, 27,471 shares of these awards vested and 7,163 shares were transferred to the Company (reflected as treasury stock) to satisfy the officers' and employees tax withholding obligations in connection with the vesting. During the fiscal year ended September 30, 2017, 33,297 shares of these awards vested and 9,576 shares were transferred to the Company (reflected as treasury stock) to satisfy the officers’ and employees’ tax withholding obligations in connection with the vesting, and 11,673 shares were transferred back to TPG due to forfeiture. There were 27,559 unvested shares of these awards at September 30, 2018. While these awards were not made pursuant to the 2016 LTIP, they constitute equity-based compensation and therefore will count against the 2016 LTIP's share reserve to the extent the awards vest.

During the fiscal year ended September 30, 2018, the Company granted 999,492 stock options to employees under the 2016 LTIP. The awards vest in equal amounts over a three-year period provided that the recipients of such grants continue their employment with the Company and have a ten-year contractual term. The awards are accounted for as equity instruments. The Company used the Black-Scholes Merton model to estimate the fair value of the option awards at the grant date. The resulting grant date fair value is recognized as expense on a straight-line basis over the vesting period. The assumptions used in the Black-Scholes Merton model for the options included an expected term of six years, an expected stock price volatility of 35.0% based on a peer group of similar companies, an expected dividend yield of 0% and a risk-free interest rate of 2.1%.

The following table summarizes stock option activity during the fiscal year ended September 30, 2018:

	Stock Options		Average Grant Date Fair Value Per Unit		Weighted Average Exercise Price
Stock options at September 30, 2017	—		$	—	$	—
Granted	999,492		2.84		7.42
Exercised	—		—		—
Forfeited/Canceled	(6,600	)	2.84		7.42
Stock options at September 30, 2018	992,892		$	2.84	$	7.42

The outstanding stock options as of September 30, 2018 had an aggregate intrinsic value of $4.8 million. No stock options were exercisable as of September 30, 2018.

During the fiscal year ended September 30, 2017, the Company granted certain employees a total of 28,000 RSUs that vest equally over a three-year period on the anniversary of the grant date provided the employee remains employed by the Company. The awards are accounted for as equity instruments. Upon vesting, the recipients will receive a share of common stock in the Company for each RSU awarded. The fair value of these RSUs was determined based on the closing price of the Company’s stock on the grant date.

The following table summarizes RSU award activity during the fiscal year ended September 30, 2018:

	RSUs		Average Grant Date Fair Value Per Unit
Unvested RSUs at September 30, 2017	24,500		$	7.28
Granted	—		—
Vested	(8,162	)	7.28
Forfeited/Canceled	—		—
Unvested RSUs at September 30, 2018	16,338		$	7.28

During the fiscal year ended September 30, 2017, the Company also awarded 10,500 phantom RSUs and 10,000 phantom PSUs to certain non-U.S. employees. The phantom RSUs vest equally over a three-year period on the anniversary of the grant date while the phantom PSUs vest under the same conditions as the PSU awards described above. During the fiscal year ended September 30, 2017, 3,500 of the phantom RSUs were forfeited and all of the phantom PSUs were forfeited. Upon vesting and provided the employee remains employed by the Company at that time, the awards will be settled in cash. In accordance with ASC 718, the remaining phantom RSU awards are accounted for as a liability, with the awards re-measured at the end of each reporting period based on the closing price of the Company’s common stock or using a Monte Carlo simulation model, as applicable. Compensation expense is recognized ratably on a straight-line basis over the requisite service period. An immaterial amount of compensation expense was recognized during the fiscal years ended September 30, 2018 and 2017 related to these awards.

The following table summarizes the amount of compensation expense recognized as a component of Selling, general and administrative expenses on the consolidated statements of operations by award type:

	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*
PSUs	$	4.7	$	4.5	$	1.3
Restricted Stock	$	1.2	$	0.6	$	0.1
TPG restricted stock grants	$	0.3	$	0.3	$	0.1
Stock options	$	0.8	$	—	$	—
RSUs	$	0.1	$	0.1	$	—

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

The following table summarizes unrecognized compensation expense and weighted average remaining life as of the fiscal year ended September 30, 2018 by award type:

	Unrecognized Compensation Expense		Weighted Average Remaining Life (in years)
PSUs	$	4.1	0.9
Restricted Stock	$	2.0	2.1
TPG restricted stock grants	$	0.4	0.7
Stock options	$	1.9	9.1
RSUs	$	0.1	1.1

As of September 30, 2018, there were 3,980,465 shares of the Company’s common stock available for issuance under the 2016 LTIP, assuming the PSU awards vest at their maximum target. Pursuant to the terms of the Univar Merger Agreement and upon the closing of the transactions contemplated by the Univar Merger Agreement, each outstanding award granted, including unvested awards, under the 2016 LTIP will be cancelled in exchange for the consideration set forth in the Univar Merger Agreement. Each outstanding stock option, including options out of the money, will be cancelled and converted into the right to receive the merger consideration received by the Company's stockholders in respect of each "net share" covered by such stock option. The number of "net shares" covered by each stock option is equivalent to the number of shares of the Company's common stock with a value equal to the intrinsic value of such stock option. Each outstanding share of restricted stock, including unvested shares, will be cancelled and converted into the right to receive the merger consideration received by the Company's stockholders. Each outstanding PSU award, including unvested PSU awards, will be cancelled and converted into the right to receive the merger consideration received by the Company's stockholders with respect to the number of shares of the Company's common stock subject to such PSU award (determined based on actual performance through the latest practicable date prior to the closing of the transactions contemplated by the Univar Merger Agreement). Each outstanding RSU award, including unvested RSU awards, will be cancelled and converted into the right to receive the merger consideration received by the Company's stockholders with respect to the number of shares of the Company's common stock subject to such RSU award. Each outstanding phantom RSU, including unvested phantom RSUs, will be cancelled and converted into the right to receive an amount in cash equal to the value of the merger consideration received by the Company's stockholders with respect to the number of shares of the Company's common stock subject to such phantom RSU award. The Company is restricted from granting any addition share-based compensation pursuant to a covenant contained in the Univar Merger Agreement.

Defined Contribution Plans

Qualifying employees of the Company are eligible to participate in the Company's 401(k) Plan. The 401(k) Plan is a defined contribution plan which allows employees to make tax deferred contributions as well as company contributions, designed to assist employees of the Company and its affiliates in providing for their retirement. The Company matches 100% of employee contributions up to 4.0%. The Company makes an additional contribution to the 401(k) Plan of 1.5%, 3.0%, or 4.5%, based upon years of service of one to ten years, eleven to twenty years, and over twenty-one years or more, respectively. A version of the 401(k) Plan is also available for qualifying employees of the Company in its foreign subsidiaries.

The following summarizes contributions to the plans described above:

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 through June 8, 2016
Contributions recorded as a component of cost of sales and operating expenses	$	4.2	$	4.0	$	1.3	$	2.7
Contributions recorded as a component of selling, general and administrative expenses	6.4		6.4		2.2		4.5
Total contributions	$	10.6	$	10.4	$	3.5	$	7.2

^{*The fiscal year ended September 30, 2016 includes 114 days} of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.

XML

Equity

12 Months Ended

Sep. 30, 2018

Equity [Abstract]

Equity

Equity

Common Stock

The authorized common stock of the Company consists of 300,000,000 shares. Holders of the Company’s common stock are entitled to one vote for each share of common stock. As of September 30, 2018, there were 89,747,062 shares of common stock issued and 89,727,546 shares of common stock outstanding and warrants to purchase 25,012,500 shares of common stock at a strike price of $11.50 per share. The Company has units outstanding which consist of one share of common stock and one warrant which are included in the totals above.

Prior to the completion of the Business Combination, the Company had 62,531,250 shares of common stock issued and outstanding, consisting of 50,025,000 shares originally sold as part of units issued in the Company’s IPO, consummated on June 11, 2014, and 12,506,250 shares of Founder Shares that were issued to the Sponsor prior to the IPO.

All of the 50,025,000 shares of common stock sold as part of the units in the IPO contained a redemption feature which allowed for the redemption of such shares. These redemption provisions generally required the Company to classify these shares outside of permanent equity, except for certain provisions related to ordinary liquidations involving the redemption and liquidation of all of the Company’s equity instruments that allowed the Company to classify a certain amount related to these shares as permanent equity at each reporting period. At March 31, 2016, 47,512,924 of the 50,025,000 public shares with a value of $475.2 million were classified outside of permanent equity at their redemption value.

On June 9, 2016, in connection with the completion of the Business Combination, 47,512,924 shares of common stock were reclassified into equity and 29,793,320 shares were redeemed at $10.02 per share. Additionally, the Company issued (i) 27,673,604 new shares of common stock at $10.00 per share to the Selling Equityholders as consideration, (ii) 23,492,306 new shares of common stock at a price of $10.00 per share in private placements with eligible purchasers, (iii) 3,078,578 new shares of common stock to settle the payment of an aggregate of $30.8 million in fees and disbursements outstanding and due to certain of WLRH’s advisors in connection with services and work performed by the advisors, including shares issued to pay the liability of $18.3 million for deferred underwriting fees due upon the completion of a Business Combination from the IPO and (iv) 2,240,000 new shares of common stock in exchange for 22,400,000 warrants to purchase shares of common stock privately placed to Sponsor at the time of the IPO. In connection with the completion of the Business Combination, the Sponsor (on behalf of the Company) transferred 30,000 original Founder Shares to the Company’s prior independent directors ("Director Founder Shares") in connection with services previously rendered to the Company reducing the total outstanding Founder Shares to 12,476,250. In addition, the Sponsor transferred 3,554,240 Founder Shares with a fair value of $30.2 million to the Selling Equityholders. The fair value of the Founder Shares transferred to the Company’s prior independent directors was recorded as an equity contribution and a transaction related cost in the third quarter of fiscal year 2016. The fair value of the Founder Shares transferred to the directors and the Selling Equityholders was estimated using a Monte Carlo simulation model. The 3,554,240 of Founder Shares that were transferred to the Selling Equityholders was a component of the Business Combination purchase consideration and was recorded by the Company as an equity contribution and included in the purchase consideration. See Note 3.

In connection with the consummation of the Business Combination, the Founder Shares, other than the Director Founder Shares, became subject to forfeiture on the tenth anniversary of the Closing Date unless:

• with respect to 50% of such Founder Shares, the last sale price of the Company’s common stock as quoted on NASDAQ equals or exceeds $12.50 per share (as adjusted for stock splits, dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 trading day period; and

• with respect to the remaining 50% of such Founder Shares, the last sale price of the Company’s common stock equals or exceeds $15.00 per share (as adjusted for stock splits, dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 trading day period; or

• the post-combination company completes a liquidation, merger, stock exchange or other similar transaction that results in all or substantially all of its stockholders having the right to exchange their shares of common stock for consideration in cash, securities or other property or any transaction involving a consolidation, merger, proxy contest, tender offer or similar transaction in which the post-combination company is the surviving entity which results in a change in the majority of the Company’s board of directors or management team or the Company’s post-combination stockholders immediately prior to such transaction ceasing to own a majority of the surviving entity immediately after such transaction.

The Founder Shares will not participate in dividends or other distributions with respect to the shares prior to these targets being met, whereupon the Founder Shares shall be entitled to all dividends and distributions paid on the common stock after the Business Combination as if they had been holders of record entitled to receive distributions on the applicable record date.

Warrants

As of September 30, 2018 there were 50,025,000 warrants outstanding to purchase 25,012,500 shares of common stock at an exercise price of $11.50 per share.

In the case of any reclassification, reorganization, merger or consolidation, or upon a dissolution following such sale or transfer, the holders of the warrants share thereafter have the right to purchase and receive the kind and amount of shares of stock or other securities or property (including cash) receivable upon reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holders of the warrants have received if such holders had exercised their warrants immediately prior to such event.

Preferred Stock

The authorized preferred stock of the Company consists of 1,000,000 shares. As of September 30, 2018, there were no shares of preferred stock issued and outstanding.

The Company’s second amended and restated certificate of incorporation provides that shares of preferred stock may be issued from time to time in one or more series. The Board is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The Board is able, without stockholder approval, to issue preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the Company's common stock and could have anti-takeover effects. The ability of the Board to issue preferred stock without stockholder approval could have the effect of delaying, deferring or preventing a change of control of the Company.

Treasury Stock

During the fiscal year ended September 30, 2018, 7,163 shares of common stock relating to the vesting of one third of the TPG Restricted Stock and 2,777 shares of common stock relating to RSUs were transferred to the Company to satisfy the employees' tax withholding obligations. Following the transfer, these shares were not canceled and are therefore classified as treasury stock. Total treasury stock as of September 30, 2018 is 19,516 shares.

XML

Earnings Per Share

12 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

A reconciliation of the numerators and denominators of the basic and diluted per share computation follows.

	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*
Basic:
Net income (loss)	$	29.4	$	14.4	$	(8.4	)
Weighted average number of common shares outstanding during the period	76,803,187		76,752,752		35,193,789
Net income (loss) per common share - basic	$	0.38	$	0.19	$	(0.24	)
Diluted:
Net income (loss)	$	29.4	$	14.4	$	(8.4	)
Denominator for diluted earnings per share:
Weighted average number of common shares attributable to the period	76,803,187		76,752,752		35,193,789
Incremental common shares attributable to outstanding dilutive options and unvested restricted shares	106,360		87,058		—
Denominator for diluted earnings per common share	76,909,547		76,839,810		35,193,789
Net income (loss) per common share - diluted	$	0.38	$	0.19	$	(0.24	)

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

Dilutive computations during the current fiscal year contain additional incremental common shares which are attributable to the outstanding unvested restricted stock awards issued to directors and employees, restricted stock units awarded to employees and unvested outstanding stock options awarded to employees. For the fiscal years ended September 30, 2018, 2017 and 2016, there were 12,476,250 Founder Shares excluded from the basic and diluted computations because such shares were subject to forfeiture, and PSU awards, which were not included in the computation of diluted shares outstanding because performance targets and/or market conditions were not yet met for these awards. Diluted shares outstanding also did not include 25,012,500 shares of common stock issuable on the exercise of 50,025,000 warrants because the warrants were out-of-the-money for the fiscal years ended September 30, 2018, 2017 and 2016. There were no stock options outstanding as of September 30, 2017 and 2016. As of September 30, 2016, the shares of unvested restricted stock awards issued to directors were not included in the diluted share calculation as their impact on the Company's net loss would have been antidilutive. There were no restricted stock units outstanding as of September 30, 2016.

The calculation for weighted average number of common shares reflects shares outstanding over the reporting period based on the actual number of days the shares of common stock were outstanding. A large number of shares were issued in connection with the Business Combination on the Closing Date and the weighted average common shares outstanding only incorporates these shares from that date through September 30, 2016, or 114 days.

XML

Commitments, Contingencies and Litigation

12 Months Ended

Sep. 30, 2018

Commitments and Contingencies Disclosure [Abstract]

Commitments, Contingencies and Litigation

Commitments, Contingencies and Litigation

Operating Leases

The Company is a lessee of office buildings, transportation equipment, warehouses and storage facilities, other equipment, facilities and properties under operating lease agreements that expire at various dates. Rent expense (including rentals under short-term leases) was $25.9 million, $25.0 million and $6.9 million for the fiscal years ended September 30, 2018, 2017 and 2016, respectively, and $17.1 million for the period from October 1, 2015 through June 8, 2016 for the Predecessor.

Future minimum non-cancellable rental payments as of September 30, 2018 are as follows:

2019	$	14.1
2020	8.9
2021	7.1
2022	5.2
2023	2.8
Thereafter	0.3
Total	$	38.4

Capital Leases

The Company leases certain equipment and facilities under capital lease agreements. As of September 30, 2018, future minimum lease payments under capital leases were as follows:

2019	$	7.6
2020	7.2
2021	7.1
2022	10.4
2023	6.9
Thereafter	25.4
Total minimum capital lease payments	64.6
Less amount representing executory costs	(15.1		)
Less amount representing interest	(15.5		)
Present value of net minimum capital lease payments	$	34.0

Environmental Remediation

Due to the nature of its business, the Company is subject to various laws and regulations pertaining to the environment and to the sale, handling, transportation and disposal of chemicals and hazardous materials. These laws pertain to air and water, the management of solid and hazardous wastes, transportation and human health and safety.

On March 31, 2011, the Predecessor purchased certain assets of the global distribution business (the "Distribution Business") from Ashland (the "Ashland Distribution Acquisition"), evidenced by the ADA Purchase Agreement.  In the ADA Purchase Agreement, Ashland agreed to retain all known environmental remediation liabilities ("the Retained Specified Remediation Liabilities") and other environmental remediation liabilities unknown at the closing of the Ashland Distribution Acquisition related to the Distribution Business for which Ashland received notice prior to the fifth anniversary of the closing (the "Other Retained Remediation Liabilities") (collectively, the "Retained Remediation Liabilities").  Ashland’s liability for the Retained Remediation Liabilities is not subject to any claim thresholds or deductibles other than expenses the Predecessor incurs arising out of the Other Retained Remediation Liabilities. Had the Predecessor incurred expenses arising out of the Other Retained Remediation Liabilities, Ashland’s indemnification obligation would have been subject to an individual claim threshold of $0.2 million and an aggregate claim deductible of $5.0 million.  Ashland’s indemnification obligation under the ADA Purchase Agreement as described above terminated as of March 31, 2016, other than for Retained Remediation Liabilities.

In July 2014, Ashland filed a lawsuit numbered Ashland Inc. v. Nexeo Solutions, LLC, Case No. N14C-07-243 JTV CCLD, in the Superior Court for the State of Delaware in and for New Castle County.  In the suit, Ashland seeks a declaration that, pursuant to the ADA Purchase Agreement, Solutions was obligated to indemnify Ashland for losses Ashland incurred pertaining to the Other Retained Remediation Liabilities, up to the amount of the aggregate $5.0 million deductible applicable to expenses incurred by Solutions, whether or not Solutions incurred any expenses or obtained any indemnity from Ashland.  Ashland further alleged that Solutions breached duties related to the ADA Purchase Agreement by not having so indemnified Ashland for amounts Ashland incurred for Other Retained Remediation Liabilities, and on that basis sought unspecified compensatory damages, costs and attorney’s fees.  On June 21, 2017, the Company's Motion for Summary Judgment for this lawsuit was granted. Ashland appealed the ruling on July 20, 2017. On January 31, 2018, the Delaware Supreme Court affirmed the lower court's grant of the Company's Motion for Summary Judgment. Ashland did not request a rehearing of the ruling. Therefore, the judgment in the Company's favor is final and this matter is closed. The Company does not currently have any environmental or remediation reserves for matters covered under the ADA Purchase Agreement.

The Company’s reserves will be subject to numerous uncertainties that affect its ability to accurately estimate its costs, or its share of costs if multiple parties are responsible. These uncertainties involve the legal, regulatory and enforcement parameters governing environmental assessment and remediation, the nature and extent of contamination, the extent of required remediation efforts, the choice of remediation methodology, availability of insurance coverage and, in the case of sites with multiple responsible parties, the number and financial strength of other potentially responsible parties.

Other Legal Proceedings

The Company is subject to various claims and legal proceedings covering a wide range of matters that arise in the ordinary course of its business activities, including product liability claims.  Management believes that any liability that may ultimately result from the resolution of these matters will not have a material adverse effect on the financial condition or results of operations of the Company.

Other Contingencies

In June 2014, the Predecessor self-disclosed to the DTSC that an inventory of its Fairfield facility had revealed potential violations of the RCRA and the California Health and Safety Code. Although no formal proceeding has been initiated, the Company expects the DTSC to seek payment of fines or other penalties for non-compliance. The Company does not expect the amount of any such fine or other penalty to have a material adverse effect on its business, financial position or results of operations.

XML

Related Party Transactions

12 Months Ended

Sep. 30, 2018

Related Party Transactions [Abstract]

Related Party Transactions

Related Party Transactions

On February 28, 2018, the Company entered into a Transportation Logistics Management Services Agreement with Transplace Texas, LP (“Transplace”), pursuant to which Transplace, a portfolio company of TPG and affiliate of the Company, agreed to provide certain transportation logistics management services to the Company over a minimum period of three years. The agreement was entered into on arms’ length terms following a competitive bid process. The Company subsequently signed an addendum to this agreement whereby Transplace will provide additional services for certain foreign operations. The estimated annual fee for services to be performed by Transplace is $1.4 million.

The table below summarizes activity recorded during the respective periods for related party transactions:

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 Through June 8, 2016
Sales to related entities:
TPG portfolio entities	$	4.5	$	3.1	$	1.7	$	3.1
Entities related to members of the Board of Directors	$	1.4	$	0.1	$	—	$	—
Purchases from related entities:
TPG portfolio entities	$	0.5	$	—	$	—	$	—
Entities related to members of the Board of Directors	$	13.1	$	1.7	$	—	$	—
Amounts included in Selling, general and administrative expenses
Management fees to TPG	$	—	$	—	$	—	$	2.1
Consulting fees to TPG	$	—	$	—	$	0.1	$	0.4
Amounts included in Transaction related costs
Fee paid in connection with the Business Combination	$	—	$	—	$	—	$	9.9

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

	September 30, 2018		September 30, 2017
Accounts receivable from related entities:
TPG portfolio entities	$	1.0	$	0.7
Entities related to members of the Board of Directors	$	0.2	$	—
Accounts payable to related entities:
TPG portfolio entities	$	0.5	$	—
Entities related to members of the Board of Directors	$	0.6	$	0.1

Contingent Consideration Obligations Pursuant to the TRA and the Merger Agreement

Subsequent to the Business Combination, TPG beneficially owns approximately 35% of the Company’s common stock, including Founder Shares, and is considered a related party of the Company. In connection with the Business Combination, TPG became a party to the TRA and obtained the right to receive the Deferred Cash Consideration pursuant to the Merger Agreement. The fair value of these contingent consideration liabilities was as follows:

	September 30, 2018		September 30, 2017
Due to related party pursuant to contingent consideration obligations:
Current liability	$	14.7	$	12.5
Non-current liability	122.8		127.7
Total fair value	$	137.5	$	140.2

During the fiscal year ended September 30, 2018 the Company paid $10.2 million to TPG related to the TRA. See Note 9.

Predecessor - Other Agreements with TPG

The Predecessor entered into agreements with TPG, including a management services agreement pursuant to which the Predecessor paid TPG management fees and also consulting fees for services provided. The fees incurred in connection with this agreement were recorded in Selling, general and administrative expenses in the consolidated statements of operations.

As a result of the Business Combination on the Closing Date, TPG and the Predecessor terminated the management services agreement and their rights and obligations thereunder. Pursuant to the management services agreement, the Predecessor paid TPG a success fee of $9.9 million relating to the closing of the Business Combination determined in accordance with the terms of the management services agreement.  This fee was recorded in Transaction related costs in the consolidated statement of operations.

FPA Subscription Agreement

On May 23, 2016, the Company entered into a Subscription Agreement (the "FPA Subscription Agreement") with Sponsor and First Pacific Advisors, LLC ("FPA"), on behalf of certain clients pursuant to which FPA agreed to purchase 18,260,000 shares of common stock on a private placement basis in connection with the Business Combination.

Sponsor Subscription Agreement

On June 6, 2016, the Company entered into a Subscription Agreement with Sponsor, pursuant to which Sponsor agreed to purchase 1,000,000 shares of common stock on a private placement basis for $10.00 per share in connection with the Business Combination. Wilbur L. Ross, Jr. was the manager of Sponsor and a former Chairman of the Board of Nexeo Solutions, Inc.

PWPI and PWIMF Commitment Agreements

On June 6, 2016, the Company entered into a Commitment Agreement with Sponsor and Park West Investors Master Fund, Ltd. ("PWIMF") and a second Commitment Agreement with Sponsor and Park West Partners International, Ltd. ("PWPI") (such agreements collectively, the "PW Commitment Agreements"), pursuant to which PWIMF and PWPI agreed to purchase from redeeming stockholders and withdraw from redemption an aggregate of 3,000,000 public shares of common stock.

FPA Commitment Agreement

On June 6, 2016, the Company entered into a Commitment Agreement (the "FPA Commitment Agreement") with Sponsor and FPA, pursuant to which FPA agreed not to redeem 2,094,727 public shares of common stock then owned by FPA in connection with the closing of the Business Combination.

Sponsor Convertible Notes and Promissory Note

On March 31, 2016, the Company issued the March 2016 promissory note to Sponsor pursuant to which the Company could borrow up to $0.75 million. The March 2016 promissory note was interest bearing at 5% per annum and was due and payable on the first to occur of (1) the consummation of Business Combination or (2) June 11, 2016 (or such later date as would have been approved by the Company’s stockholders by amendment of the Company’s charter to complete the Business Combination). Sponsor loaned the Company $0.2 million to cover expenses related to daily operations. In connection with the consummation of the Business Combination, the March 2016 promissory note balance of $0.2 million, including unpaid interest, was paid in full.

On January 5, 2016, the Company issued a convertible promissory note, referred to as the "January 2016 convertible note" to Sponsor pursuant to which the Company borrowed $0.4 million from Sponsor for operating expenses. The January 2016 convertible note was interest bearing at 5% per annum and was due and payable on June 11, 2016. At the option of Sponsor, any amounts outstanding under the January 2016 convertible note could have been converted into warrants to purchase shares of common stock at a conversion price of $0.50 per warrant. Each warrant would have entitled Sponsor to purchase one-half of one share of common stock at an exercise price of $5.75 per half share ($11.50 per whole share). Each warrant would have contained other terms identical to the terms contained in the private placement warrants previously issued to Sponsor. Through March 31, 2016, the Company incurred an insignificant amount of interest expense which, under the terms of the January 2016 convertible note, was added to the principal amount. In connection with the consummation of the Business Combination, the January 2016 convertible note balance of $0.4 million, including unpaid interest, was paid in full.

On March 26, 2015, the Company issued a convertible promissory note, referred to as the "March 2015 convertible note," to Sponsor pursuant to which, on April 16, 2015, the Company borrowed $0.3 million from Sponsor for operating expenses. The March 2015 convertible note was interest bearing at 5% per annum and was due and payable on June 11, 2016. At the option of Sponsor, any amounts outstanding under the March 2015 convertible note could have been converted into warrants to purchase shares of common stock at a conversion price of $0.60 per warrant. Each warrant would have entitled Sponsor to purchase one-half of one share of common stock at an exercise price of $5.75 per half share ($11.50 per whole share). Each such warrant would have contained other terms identical to the terms contained in the private placement warrants previously issued to Sponsor. Through March 31, 2016, the Company incurred $14,000 of interest expense which under the terms of the March 2015 convertible note was added to the principal amount. In connection with the consummation of the Business Combination, the March 2015 convertible note balance of $0.3 million, including unpaid interest, was paid in full.

Predecessor - Letter Agreement for Chairman’s Services

On January 16, 2012, the Predecessor and Dan F. Smith, a member of the Predecessor Board of Directors, entered into a Letter Agreement for Chairman’s Services (together with subsequent extensions, the "Letter Agreement"). In connection with the closing of the Business Combination, the parties agreed to terminate the Letter Agreement and their rights and obligations thereunder.  The termination of the Letter Agreement entitled Mr. Smith to a fee of $0.2 million in cash, which is included in Transaction related costs on the Company’s consolidated statement of operations.

Predecessor - Consulting Services Agreement

The Predecessor had a strategic consulting services agreement with Steven B. Schwarzwaelder, a member of the board of directors of the Predecessor, under which it paid an annual fee of $0.175 million. The Predecessor recorded $0.1 million from October 1, 2015 through June 8, 2016 related to this agreement. This fee was recorded in Selling, general and administrative expenses in the consolidated statements of operations. As a result of the Business Combination, the parties terminated the consulting services agreement and their rights and obligations thereunder.

XML

Income Taxes

12 Months Ended

Sep. 30, 2018

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

The Company provides for income taxes and the related accounts under the asset and liability method. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates expected to be in effect during the year in which the basis differences reverse. The Company has not recognized deferred taxes for temporary outside basis differences of $94.3 million as of September 30, 2018, related to investments in foreign subsidiaries that management considers to be permanent in duration. It is not practicable to estimate the amount of the unrecognized deferred income tax liabilities at this time due to the complexities associated with its hypothetical calculation.

The Company and its two active U.S. corporate subsidiaries, Blocker and Sub Holding, were both incorporated in the U.S. and as such are subject to U.S. income taxes. The Company and Blocker will file a consolidated U.S. Federal income tax return and both will file various state returns. Sub Holding will file a separate U.S. Federal income tax return and various state tax returns. The Company’s controlled foreign corporations are subject to taxation at the entity level in each of their respective jurisdictions.

Holdings is organized as a limited liability company and is taxed as a partnership for U.S. income tax purposes. With the exception of a limited number of state and local jurisdictions, Holdings is not subject to U.S. income taxes. Accordingly, Blocker and the Selling Equityholders (other than the holders of equity interests in Blocker) will report their share of Holdings’ taxable income earned prior to the Closing Date on their respective U.S. federal tax returns. Holdings and its subsidiaries made no tax distributions to, or on behalf of, the Selling Equityholders during the fiscal year ended September 30, 2016.

For all periods, the Company computed the provision for income taxes based on the actual year-to-date effective tax rate by applying the discrete method.  Use of the annual effective tax rate, which relies on accurate projections by legal entity of income earned and taxed in foreign jurisdictions, as well as accurate projections by legal entity of permanent and temporary differences, was not considered a reliable estimate for purposes of calculating year-to-date income tax expense.

The Tax Act significantly revises future U.S. corporate income taxes by, among other things, lowering U.S. corporate income tax rates and implementing a modified territorial tax system. Because the Company has a September 30 fiscal year end, the lower corporate income tax rate will be phased in, resulting in a U.S. statutory federal rate of approximately 24.5% for the Company's fiscal year ending September 30, 2018 and 21.0% for subsequent fiscal years. The Tax Act also provided for certain transition impacts. As part of the transition to the new modified territorial tax system, the Tax Act imposes a one-time repatriation tax on deemed repatriation of historical earnings of foreign subsidiaries. The Company did not have an impact from the repatriation tax charge.

For the twelve months ended September 30, 2018, the impact of the Tax Act resulted in a net benefit of approximately $4.5 million, related solely to the remeasurement of the Company's net deferred tax liabilities at the lower enacted corporate tax rates.

For financial reporting purposes, income (loss) before income taxes includes the following components:

	Successor							Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*			October 1, 2015 Through June 8, 2016
U.S.	$	24.8	$	7.9	$	(9.1	)	$	(19.6	)
Foreign	21.3		17.0		1.9			9.9
Income (loss) before income taxes	$	46.1	$	24.9	$	(7.2	)	$	(9.7	)

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

A summary of income tax expense (benefit) is as follows:

	Successor									Predecessor
	Fiscal Year Ended September 30, 2018			Fiscal Year Ended September 30, 2017			Fiscal Year Ended September 30, 2016*			October 1, 2015 Through June 8, 2016
Current tax expense (benefit):
U.S. - Federal	$	9.5		$	1.3		$	0.5		$	—
U.S. - State	2.8			0.5			(0.2		)	(0.1		)
Foreign	11.3			6.5			2.0			3.2
Total current tax expense	23.6			8.3			2.3			3.1
Deferred tax expense (benefit):
U.S. - Federal	(4.7		)	4.6			(0.8		)	0.4
U.S. - State	0.1			0.2			0.4			0.1
Foreign	(2.3		)	(2.6		)	(0.7		)	0.6
Total deferred tax expense (benefit)	(6.9		)	2.2			(1.1		)	1.1
Total income tax expense	$	16.7		$	10.5		$	1.2		$	4.2

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

Reconciliation of income taxes at the U.S. statutory rate and income tax expense (benefit):

	Successor									Predecessor
	Fiscal Year Ended September 30, 2018*			Fiscal Year Ended September 30, 2017**			Fiscal Year Ended September 30, 2016***			October 1, 2015 Through June 8, 2016
U.S. statutory rate	21.0		%	34.0		%	34.0		%	0.0		%
Pretax income (loss) at statutory rate	$	9.7		$	8.5		$	(2.5	)	$	—
State income taxes	2.1			0.9			0.2			—
Statutory rate differential	1.4			(1.4		)	(0.2		)	2.5
FIN 48 expense (benefit)	2.3			(0.5		)	—			0.1
Non-U.S. tax credit	(2.0		)	—			—			—
Withholding and other taxes	0.5			0.5			—			0.3
Tax impact of tax reform	(4.5		)	—			—			—
Transaction costs	0.9			—			5.0			—
Contingent liability	0.8			2.4			(1.6		)	—
Other permanent differences	0.3			0.3			0.3			0.6
Statutory tax rate changes and differences	0.9			—			(0.2		)	(0.1		)
True-up to prior year taxes	2.6			(0.3		)	—			0.2
Nondeductible stewardship costs	1.1			—			—			—
Valuation allowance	0.6			0.1			0.2			0.6
Income tax expense	$	16.7		$	10.5		$	1.2		$	4.2
Effective tax rate	36.2		%	42.2		%	(16.7		)%	(43.3		)%

^{*Due to the Company's fiscal year ending on September 30, 2018, the phased in rate of 24.5% was used in calculating the U.S. federal taxes presented in the reconciliation for the fiscal year ended September 30, 2018.} 

^{**For comparability, the presentation of balances at September 30, 2017 were adjusted to align to current year presentation.} 

^{***The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

The principal temporary differences included in deferred income taxes reported on the September 30, 2018 and 2017 balance sheets were:

	September 30, 2018			September 30, 2017
Deferred Tax Assets
Foreign operating losses	$	5.5		$	6.3
Federal and state operating losses	15.5			27.6
Non-U.S. tax credit (1)	1.9			—
Unrealized gains/losses	0.3			0.2
Fixed assets and intangibles	1.1			0.9
Compensation and other accruals	4.0			2.4
Other items	0.8			0.9
Valuation allowance	(3.6		)	(3.1		)
Total deferred tax assets	$	25.5		$	35.2
Deferred Tax Liabilities
Fixed assets and intangibles	$	23.2		$	23.8
Compensation and other accruals	0.2			0.2
Investment in partnerships	27.1			43.2
Other items	3.4			0.6
Total deferred tax liabilities	$	53.9		$	67.8

⁽¹⁾  Related to the European tax uncertainty recorded in the current period.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

At September 30, 2018, the Company had foreign loss carryforwards of $23.4 million and U.S. federal loss carryforwards of $59.5 million. In those countries in which net operating losses are subject to an expiration period, the Company's loss carryforwards, if not utilized, will expire at various dates from 2018 through 2038. Based on historical performance, the Company believes that it is more likely than not that taxable income in future years will allow the Company to utilize the carryforwards that have not had a valuation allowance placed against them.

At September 30, 2018 and September 30, 2017, the valuation allowance was $3.6 million and $3.1 million, respectively, primarily relating to operations in Asia. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based upon management’s expectations at September 30, 2018, management believes it is more likely than not that it will realize the majority of its deferred tax assets.

Uncertain Tax Positions

U.S. GAAP prescribes a recognition threshold and measurement attribute for the accounting and financial statement disclosure of tax positions taken or expected to be taken in a tax return. The evaluation of a tax position is a two-step process.  The first step requires the Company to determine whether it is more likely than not that a tax position will be sustained upon examination based on the technical merits of the position.  The second step requires the Company to recognize in the financial statements each tax position that meets the more likely than not criteria, measured as the amount of benefit that has a greater than 50% likelihood of being realized. Differences between the amount of tax benefits taken or expected to be taken in the income tax returns and the amount of tax benefits recognized in the financial statements represent the Company’s unrecognized income tax benefits, which are recorded as a liability, with the long-term portion included in Other non-current liabilities and the current portion included in Accrued expenses and other liabilities on the Company’s consolidated balance sheets.

During the fiscal year ended September 30, 2018, the Company added income tax related uncertainties primarily related to the Company's operations in Europe. The reserve of approximately $2.2 million is inclusive of interest and penalties.

During the fiscal year ended September 30, 2017, the Company added income tax-related uncertainties associated with the purchase of Ultra Chem. The initial reserve of $1.3 million, inclusive of interest and penalties, was added in connection with these uncertainties. Accordingly, the Company also recognized indemnification assets related to certain of these income tax-related uncertainties. The indemnification assets were initially included in Other current assets and other non-current assets in the consolidated balance sheets, representing the reimbursement the Company reasonably expected to receive from funds held in escrow pursuant to the purchase agreement.

A reconciliation of the beginning and ending amount of unrecognized tax benefits is shown below:

	September 30, 2018			September 30, 2017
Balance at beginning of period	$	1.2		$	0.9
Increases related to positions taken on items from prior years	2.3			0.1
Decreases related to positions taken on items from prior years	(0.2		)	—
Unrecognized tax benefits assumed related to acquisitions	—			0.8
Lapse of statute of limitations	(0.2		)	(0.6		)
Balance at end of period	$	3.1		$	1.2

The Company recognizes interest and penalties related to uncertain tax positions, if any, as a component of income tax expense in the consolidated statements of operations. The amount of interest and penalties recognized was $0.9 million during fiscal years ending September 30, 2018 and 2017 and $0.2 million during fiscal year ended September 30, 2016. At September 30, 2018, September 30, 2017 and September 30, 2016, there was $4.0 million, $1.8 million and $1.2 million, respectively, related to uncertain tax positions.

The total amount of the unrecognized tax benefits that would affect the Company's effective tax rate, if recognized, is $3.1 million as of September 30, 2018. The Company does not expect a significant change in the unrecognized tax benefits during the next twelve months.

The Company or one of its subsidiaries files income tax returns in the U.S. and various state and foreign jurisdictions. Within the U.S., the Company is subject to federal and state income tax examination by tax authorities for periods after December 2013. With respect to countries outside of the U.S., with certain exceptions, the Company’s foreign subsidiaries are subject to income tax audits for years after 2013.

XML

Segment and Geographic Data

12 Months Ended

Sep. 30, 2018

Segment Reporting [Abstract]

Segment and Geographic Data

Segment and Geographic Data

The Company operates through three lines of business, or operating segments: Chemicals, Plastics and Environmental Services, which market to different sets of customers operating in an array of industries, with various end markets and customer segments within those industries. For segment presentation and disclosure purposes, the Chemicals and Plastics lines of business constitute separate reportable segments, while the Environmental Services line of business, which does not meet the materiality threshold for separate disclosure, is included in an "Other" segment.

Each line of business represents unique products and suppliers, and each line of business focuses on specific end markets within its industry based on a variety of factors, including supplier or customer opportunities, expected growth and prevailing economic conditions. Across the Chemicals and Plastics lines of business there are numerous industry segments, end markets and sub markets that the Company may choose to focus on. These end markets may change from year to year depending on the underlying market economics, supplier focus, expected profitability and the Company’s strategic agenda.

The Chemicals, Plastics and Environmental Services lines of business compete with national, regional and local companies throughout North America. Additionally, the Chemicals and Plastics lines of business compete with other distribution companies in Asia. The Plastics line of business also competes with other distribution companies in EMEA. Competition within each line of business is based primarily on the diversity of the product portfolio, service offerings, reliability of services and supply, technical support, price and delivery capabilities. The accounting policies used to account for transactions in each of the lines of business are the same as those used to account for transactions at the corporate level.

The Chemicals and Plastics lines of business are distribution businesses, while the Environmental Services line of business provides hazardous and non-hazardous waste collection, recovery, recycling and disposal services.

A brief description of each segment follows:

Chemicals. The Chemicals line of business distributes specialty and industrial chemicals, additives and solvents to industrial users via railcars, barges, bulk tanker trucks and as packaged goods in trucks. The Company’s chemical products are distributed in approximately 50 countries worldwide, primarily in North America and Asia. In connection with the distribution of chemicals products, the Company provides value-added services such as custom blending, packaging and re-packaging, private-label manufacturing and product testing in the form of chemical analysis, product performance analysis and product development. While the Chemicals line of business serves multiple end markets, the key end markets within the industrial space are household, industrial and institutional, performance coatings (including architectural coatings, adhesives, sealants and elastomers), lubricants, oil and gas and personal care.

Plastics. The Plastics line of business distributes a broad product line consisting of commodity polymer products and prime engineering resins to plastics processors engaged in blow molding, extrusion, injection molding and rotation molding via railcars, bulk trucks, truckload boxes and mixed truckloads, or less-than-truckload quantities. The Company's plastics products are distributed in more than 60 countries worldwide, primarily in North America, EMEA and Asia. The Plastics line of business serves a broad cross section of industrial segments, including key automotive and healthcare end markets.

Other. The Environmental Services line of business, in connection with certain waste disposal service companies, provides customers with comprehensive on-site and off-site hazardous and non-hazardous waste collection, transportation, recovery, disposal arrangement and recycling services in North America, primarily in the U.S. These environmental services are offered through the Company’s network of distribution facilities used as transfer facilities and through a staff of dedicated on-site waste professionals. The Environmental Services line of business serves multiple end markets such as aerospace and defense, automotive, chemical manufacturing, industrial manufacturing and oil and gas.

The Chief Executive Officer is the Chief Operating Decision Maker. The Chief Operating Decision Maker reviews operating results in order to make decisions, assess performance and allocate resources to each line of business. In order to maintain the focus on line of business performance, certain expenses are excluded from the line of business results utilized by the Company’s Chief Operating Decision Maker in evaluating line of business performance. These expenses include depreciation and amortization, selling, general and administrative expense and corporate items including transaction related costs, interest and income tax expense. These items are separately delineated to reconcile to reported net income. Intersegment revenues were insignificant.

No single customer accounted for more than 10.0% of revenues for any line of business for each of the fiscal years reported. In each of the past three fiscal years, polypropylene, a product offering in the Company’s Plastics line of business, was the only product that accounted for over 10.0% of the Company's consolidated net revenue. Polypropylene accounted for 15.9%, 15.5% and 17.6% during the fiscal years ended September 30, 2018, 2017 and 2016, respectively, of total consolidated net revenue. Polypropylene accounted for 17.7% for the period from October 1, 2015 through June 8, 2016 of Predecessor total consolidated net revenue. Two suppliers accounted for 11.6% and 9.6%, respectively, of the consolidated purchases during the fiscal year ended September 30, 2018, 12.1% and 9.9%, respectively, for the fiscal year ended September 30, 2017, and 11.9% and 10.4%, respectively for the fiscal year ended September 30, 2016. Two suppliers accounted for 12.0% and 9.8%, respectively, for the period from October 1, 2015 through June 8, 2016 for the Predecessor consolidated purchases.

Certain assets are aggregated at the line of business level. The assets attributable to the Company’s lines of business, that are reviewed by the Chief Operating Decision Maker, consist of trade accounts receivable, inventories, goodwill and any specific assets that are otherwise directly associated with a line of business. The Company’s inventory of packaging materials and containers, as well as property, plant and equipment, are generally not allocated to a line of business and are included in unallocated assets.

Summarized financial information relating to the Company’s lines of business is as follows:

	Successor									Predecessor
	Fiscal Year Ended September 30, 2018			Fiscal Year Ended September 30, 2017			Fiscal Year Ended September 30, 2016*			October 1, 2015 through June 8, 2016
Sales and operating revenues
Chemicals	$	1,904.5		$	1,667.2		$	478.1		$	1,066.4
Plastics	1,980.0			1,841.7			546.7			1,192.2
Other	149.7			128.0			40.9			81.5
Total sales and operating revenues	$	4,034.2		$	3,636.9		$	1,065.7		$	2,340.1
Gross profit
Chemicals	248.0			205.6			55.7			136.2
Plastics	186.4			167.2			43.6			117.6
Other	25.7			25.6			9.1			18.1
Total gross profit	460.1			398.4			108.4			271.9
Selling, general and administrative expenses	352.6			312.9			91.7			208.9
Transaction related costs	2.8			1.9			21.3			33.4
Change in fair value of contingent consideration obligations	7.5			16.2			(11.2		)	—
Operating income	97.2			67.4			6.6			29.6
Other income, net	1.0			8.3			0.5			2.9
Interest income (expense)
Interest income	0.5			0.3			0.8			0.1
Interest expense	(52.6		)	(51.1		)	(15.1		)	(42.3		)
Net income (loss) from continuing operations before income taxes	$	46.1		$	24.9		$	(7.2	)	$	(9.7	)

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

	September 30, 2018		September 30, 2017
IDENTIFIABLE ASSETS
Chemicals	$	826.2	$	793.6
Plastics	758.2		762.7
Other	95.7		91.0
Total identifiable assets by reportable segment	1,680.1		1,647.3
Unallocated assets	563.5		606.2
Total assets	$	2,243.6	$	2,253.5

Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale, are presented below:

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 through June 8, 2016
U.S.	$	2,959.9	$	2,682.2	$	808.2	$	1,779.4
Canada	189.9		171.6		46.5		102.4
Other North America	132.8		87.2		18.4		35.4
Total North America Operations	3,282.6		2,941.0		873.1		1,917.2
EMEA	539.7		481.7		130.6		291.9
Asia	211.9		214.2		62.0		131.0
Total	$	4,034.2	$	3,636.9	$	1,065.7	$	2,340.1

 

^{*The fiscal year ended September 30, 2016 includes 114 days} of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.

XML

Unaudited Quarterly Information

12 Months Ended

Sep. 30, 2018

Quarterly Financial Information Disclosure [Abstract]

Unaudited Quarterly Information

Unaudited Quarterly Information

The following tables contain selected unaudited statement of operations information for each quarter of the fiscal years ended September 30, 2018 and 2017. All numbers are in millions except for per share amounts.

	Fiscal Year Ended September 30, 2018
	First Quarter		Second Quarter		Third Quarter		Fourth Quarter
Sales and operating revenues	$	929.6	$	1,041.0	$	1,046.4	$	1,017.2
Gross profit	$	106.9	$	115.7	$	120.2	$	117.3
Net income (loss)	$	26.5	$	0.4	$	17.5	$	(15.0	)
Income (loss) per share:(1)
Basic	$	0.35	$	0.01	$	0.23	$	(0.20	)
Diluted	$	0.34	$	0.01	$	0.23	$	(0.20	)
Weighted average number of common shares outstanding
Basic	76,793,518		76,795,742		76,797,414		76,825,850
Diluted	76,857,244		76,961,218		76,983,350		76,825,850

⁽¹⁾ Per share amounts for the quarter and full year have been computed separately. The sum of the quarterly amounts may not equal the annual amounts presented because of differences in the average shares outstanding during each period.

	Fiscal Year Ended September 30, 2017
	First Quarter			Second Quarter			Third Quarter		Fourth Quarter
Sales and operating revenues	$	794.8		$	917.7		$	942.7	$	981.7
Gross profit	$	84.4		$	102.2		$	102.7	$	109.1
Net income (loss)	$	(8.3	)	$	(1.1	)	$	10.2	$	13.6
Income (loss) per share:(1)
Basic	$	(0.11	)	$	(0.01	)	$	0.13	$	0.18
Diluted	$	(0.11	)	$	(0.01	)	$	0.13	$	0.18
Weighted average number of common shares outstanding
Basic	76,746,168			76,746,168			76,743,853		76,774,578
Diluted	76,746,168			76,746,168			76,828,868		76,852,267

⁽¹⁾ Per share amounts for the quarter and full year have been computed separately. The sum of the quarterly amounts may not equal the annual amounts presented because of differences in the average shares outstanding during each period.

XML

Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Sep. 30, 2018

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

Schedule II - Valuation and Qualifying Accounts

Nexeo Solutions, Inc. and Subsidiaries

Schedule II—Valuation and Qualifying Accounts

(in millions)	Balance Beginning of Period		Charged to  Costs and  Expenses			Charged to Other Accounts				Deductions				Balance End of Period
Fiscal Year Ended September 30, 2018
Allowance for doubtful accounts	$	2.2	$	1.9		$	—			$	0.1		(1)	$	4.2
Reserve for sales returns and allowances	1.4		—			0.2			(2)	—				1.6
Fiscal Year Ended September 30, 2017
Allowance for doubtful accounts	$	1.4	$	(0.2	)	$	1.7			$	(0.7	)	(1)	$	2.2
Reserve for sales returns and allowances	1.5		—			(0.1		)	(2)	—				1.4
Fiscal Year Ended September 30, 2016
Allowance for doubtful accounts	$	—	$	0.3		$	1.3			$	(0.2	)	(1)	$	1.4
Reserve for sales returns and allowances	—		—			1.5			(2)	—				1.5
October 1, 2015 through June 8, 2016 (Predecessor)
Allowance for doubtful accounts	$	3.8	$	1.2		$	—			$	(0.9	)	(1)	$	4.1
Reserve for sales returns and allowances	1.6		—			(0.1		)	(2)	—				1.5

⁽¹⁾  Accounts written off during the year, net of recoveries and foreign exchange impact.

⁽²⁾ 

Amounts represent estimates for expected sales returns.

XML

Significant Accounting Policies and Recent Accounting Pronouncements (Policies)

12 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Principles of Consolidation

Principles of Consolidation

The accompanying consolidated financial statements include all the accounts of the Company and all wholly-owned subsidiaries in which it maintains control. Significant intercompany transactions and balances have been eliminated in consolidation.

Use of Estimates, Risks, and Uncertainties

Use of Estimates, Risks, and Uncertainties

The preparation of consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosures of contingent assets and liabilities. Significant items that are subject to such estimates and assumptions include:

•the fair value of assets acquired and liabilities assumed in a business combination;

•the assessment of recoverability of long lived assets, including property and equipment, goodwill

and intangible assets, income taxes, reserves and environmental remediation;

•the estimated useful lives of intangible and depreciable assets;

•the grant date fair value of equity-based awards;

•the recognition, measurement and valuation of current and deferred income taxes;

•the recognition and measurement of contingent consideration related to the TRA liability; and

•the recognition and measurement of contingent consideration related to the Deferred Cash Consideration.

Although management bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, actual results could differ significantly from the estimates under different assumptions or conditions.

The Company's financial instruments exposed to concentration of credit risk consist primarily of cash and cash equivalents. Although the Company deposits cash with multiple banks, these deposits, including those held in foreign branches of global banks, may exceed the amount of insurance provided on such deposits. These deposits may generally be redeemed upon demand and bear minimal risks.

No single customer accounted for more than 10% of revenues for any line of business, or on a consolidated basis, and no individual customer represented greater than 5.0% of the outstanding accounts receivable balance for each of the periods reported. The Company had two suppliers that each accounted for approximately 11.6% and 9.6% of consolidated purchases during the fiscal year ended September 30, 2018, 12.1% and 9.9% for the fiscal year ended September 30, 2017 and 11.9% and 10.4% for the fiscal year ended September 30, 2016. For the period from October 1, 2015 through June 8, 2016, these two suppliers accounted for approximately 12.0% and 9.8% of consolidated purchases for the Predecessor.

Cash and Cash Equivalents

Cash and Cash EquivalentsAll highly liquid temporary investments with original maturities of three months or less are considered to be cash equivalents. See Note 4.

Accounts and Notes Receivable and Allowance for Doubtful Accounts

Accounts and Notes Receivable and Allowance for Doubtful Accounts

Accounts receivable are recorded net of discounts and allowance for doubtful accounts. The Company performs ongoing credit evaluations of its customers and generally does not require collateral from its customers. The Company’s accounts receivable in the U.S. and Canada are collateral under the Credit Facilities.

The Company records an allowance for doubtful accounts as a best estimate of the amount of probable credit losses for accounts receivable. On a recurring basis, the Company reviews this allowance and considers factors such as customer credit, past transaction history with the customer and changes in customer payment terms when determining whether the collection of a receivable is reasonably assured. Past due balances over 90 days and over a specified amount are reviewed individually for collectability. Receivables are charged off against the allowance for doubtful accounts when it is probable a receivable will not be recovered. The allowance for doubtful accounts was $4.2 million and $2.2 million at September 30, 2018 and 2017, respectively. Bad debt expense, net of recoveries is a component of Selling, general and administrative expenses in the consolidated statements of operations. For the fiscal year ended September 30, 2018 net bad debt expense was $1.9 million and for the fiscal year ended September 30, 2017 net bad debt recovery was $0.2 million. For the fiscal year ended September 30, 2016 net bad debt expense was $0.3 million. Net bad debt expense for the Predecessor period from October 1, 2015 through June 8, 2016 was $1.2 million.

Certain customers of the Company's operations in China are allowed to remit payment during a period of time ranging from 30 days up to nine months. These notes receivables, which are supported by banknotes issued by large banks in China on behalf of these customers, are included in Accounts and Notes Receivable on the Company's consolidated balance sheets and totaled $8.6 million and $8.3 million at September 30, 2018 and 2017, respectively.

Inventories

Inventories

Inventories are carried at the lower of cost or net realizable value using the weighted average cost method. The Company’s inventories in the U.S. and Canada are collateral under the Credit Facilities. See Note 4.

Goodwill and Intangibles

Goodwill and Intangibles

The Company had goodwill of $699.9 million and $703.0 million at September 30, 2018 and 2017, respectively, associated with the Business Combination and asset acquisitions. The purchase consideration of an acquisition is allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values at the date of acquisition. The estimated fair values are determined after review and consideration of relevant information including discounted cash flows, quoted market prices and estimates made by management. To the extent that the purchase consideration exceeds the fair value of the net identifiable tangible and intangible assets acquired, such excess is allocated to goodwill. See Notes 3 and 6.

The Company had other intangible assets, net of amortization, of $211.6 million and $231.5 million at September 30, 2018 and 2017, respectively. These intangible assets, which are amortized on a straight-line basis over their estimated useful lives, consist of customer relationships, supplier relationships, trade names, below-market leases and non-compete agreements. See Notes 3 and 6. The range of estimated useful lives used to amortize these intangible assets is as follows:

	Estimated Useful Lives (years)
Customer-related	5-13
Supplier-related	6-10
Trade name	2-10
Below-market leases	1-7
Non-compete agreements	3-10

Property, Plant and Equipment

Property, Plant and Equipment

Property, plant and equipment includes plants, buildings, machinery, equipment, software and computer equipment. Property, plant and equipment acquired or constructed in the normal course of business are initially recorded at cost. Property and equipment acquired in business combinations and asset acquisitions are initially recorded at their estimated fair value. Property, plant and equipment are depreciated by the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the shorter of their economic useful life or their lease term. The range of useful lives used to depreciate property, plant and equipment is as follows:

	Estimated Useful Lives (years)
Plants and buildings	5-35
Machinery and equipment	2-30
Software and computer equipment	3-10

Repairs and maintenance expenditures that do not extend the useful life of the asset are charged to expense as incurred. Major expenditures for replacements and significant improvements that increase asset values or extend useful lives are capitalized. The carrying amounts of assets that are sold or retired and the related accumulated depreciation are removed from the accounts in the year of disposal and any resulting gain or loss is reflected in the consolidated statements of operations. See Note 5.

Leases

Leases

The Company leases certain property, plant and equipment in the ordinary course of business. The leases are classified as either capital leases or operating leases. Assets under capital leases are included in Property, plant and equipment, net in the consolidated balance sheets and are depreciated over the lesser of the lease term or the useful life of the assets. Capital lease obligations are included in Short-term borrowings, current portion of long-term debt and capital lease obligations and Long-term debt and capital lease obligations, less current portion, net in the consolidated balance sheets. Generally, lease payments under capital leases are recognized as interest expense and a reduction of the capital lease obligations. Lease payments under operating leases are recognized as an expense in the consolidated statements of operations on a straight-line basis over the lease term.  See Note 13.

Impairment of Long-lived Assets and Other Long Lived Assets

Impairment of Long-Lived Assets

Goodwill. Goodwill is tested for impairment annually as of March 31 and whenever events or circumstances make it more likely than not that an impairment may have occurred. Goodwill is reviewed for impairment at the reporting unit level, which is defined as operating segments or groupings of businesses one level below the operating segment level. The Company’s operating segments are the same as the reporting units used in its goodwill impairment test. Goodwill is tested for impairment by comparing the estimated fair value of a reporting unit, determined using a market approach, if market prices are available, or alternatively, a discounted cash flow model, with its carrying value. The annual evaluation of goodwill requires the use of estimates about future operating results, valuation multiples and discount rates of each reporting unit to determine their estimated fair value. Changes in these assumptions can materially affect these estimates. Once an impairment of goodwill has been recorded, it cannot be reversed. No goodwill impairment was recognized during any of the periods presented. See Note 6.

Other Long-Lived Assets. Property, plant and equipment and other intangible assets with definite lives are tested for impairment whenever events and circumstances indicate that the carrying value of an asset may not be recoverable. When an impairment test is performed and the undiscounted expected future cash flows are less than the carrying value, an impairment loss is recognized equal to an amount by which the carrying value exceeds the fair value of the asset. The factors considered by management in performing this assessment include current operating results, trends and prospects, as well as the effect of obsolescence, demand, competition and other economic factors.

Debt Issuance Costs

Debt Issuance CostsCosts associated with the ABL Facility are recorded as debt issuance costs, which are included in Other non-current assets in the consolidated balance sheets and are being amortized as interest expense over the contractual lives of the related agreements. Costs associated with non-revolving debt facilities are recorded as a reduction of the long-term debt, and are amortized as interest expense over the contractual lives of the related agreements. See Notes 4 and 7.

Commitments, Contingencies, and Environmental Costs

Commitments, Contingencies and Environmental Costs

Liabilities for loss contingencies arising from claims, assessments, litigation, fines, penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment and/or remediation can be reasonably estimated. Gain contingencies are not recorded until management determines it is certain that the future event will become or is realized.

Liabilities for environmental remediation costs are recognized when environmental assessments or remediation are probable and the associated costs can be reasonably estimated. Generally, the timing of these provisions coincides with the commitment to a formal plan of action or, if earlier, the divestment or closure of the relevant sites. The amount recognized reflects management’s best estimate of the expenditures expected to be required. Actual environmental expenditures that relate to current or future revenues are expensed or capitalized as appropriate. Actual expenditures that relate to an existing condition caused by past operations and that do not impact future earnings are expensed.

Ashland agreed to retain known environmental remediation liabilities and other environmental remediation liabilities for releases of hazardous materials occurring prior to March 31, 2011, and of which Ashland received notice prior to March 31, 2016. See Note 13.

Earnings or Loss per Share

Earnings or Loss per Share

Basic EPS, which excludes dilution, is computed by dividing income or loss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common shares and the proceeds from such activities, if any, were used to acquire shares of common stock at the average market price during the reporting period. During a net loss period, the assumed exercise of in-the-money stock options and unvested stock has an anti-dilutive effect and, therefore, such potential shares are excluded from the diluted EPS computation.

Per share information is based on the weighted average number of common shares outstanding during each period for the basic computation and, if dilutive, the weighted average number of potential common shares resulting from the assumed conversion of outstanding stock options, unvested stock and unvested stock units for the diluted computation. See Note 12.

Concentrations of Credit Risk

Concentrations of Credit Risk

All of the Company’s financial instruments, consisting primarily of accounts and notes receivable and interest rate swaps, involve elements of credit and market risk. The most significant portion of this credit risk relates to non-performance by counterparties. To manage counterparty risk associated with financial instruments, the Company selects and monitors counterparties based on its assessment of their financial strength and on credit ratings, if available.

Foreign Currency

Foreign Currency

The reporting currency of the Company is the USD. With few exceptions, the local currency is the functional currency for the Company's foreign subsidiaries. In consolidating the results of operations, income and expense accounts are translated into USD at average exchange rates in effect during the period and asset and liability accounts are translated at period-end exchange rates. Translation gains or losses are recorded in the foreign currency translation component in Accumulated other comprehensive income (loss) in stockholders’ equity and are included in net earnings only upon sale or liquidation of the underlying foreign subsidiary or affiliated company.

Transactions undertaken in currencies other than the functional currency of the subsidiary are translated using the exchange rate in effect as of the transaction date and give rise to foreign currency transaction gains and losses, which the Company includes in Selling, general and administrative expenses in the consolidated statements of operations. Net foreign currency transaction losses from various currencies were $1.1 million, $0.6 million and $1.1 million for the fiscal years ended September 30, 2018, 2017 and 2016, respectively. Net foreign currency transaction losses were $1.6 million for the period from October 1, 2015 through June 8, 2016 for the Predecessor.

Revenue Recognition

Revenue Recognition

Revenues are recognized when persuasive evidence of an arrangement exists, products are shipped and title is transferred or services are provided to customers, the sales price is fixed or determinable and collectability is reasonably assured. Revenue for product sales is recognized at the time title and risk of loss transfer to the customer, based on the terms of the sale. For products delivered under the Company’s standard shipping terms, title and risk of loss transfer when the product is delivered to the customer’s delivery site. For sales transactions designated Freight on Board shipping point, the customer assumes risk of loss and title transfers at the time of shipment. Deferred revenues may result from (i) delivery delays for products delivered under the Company’s standard shipping terms or (ii) from other arrangements with its customers. Sales are reported net of tax assessed by qualifying governmental authorities. 

The Company is generally the primary obligor in sales transactions with its customers, retains inventory risk during transit and assumes credit risk for amounts billed to its customers. Accordingly, the Company recognizes revenue primarily based on the gross amount billed to its customers. In sales transactions where the Company is not the primary obligor and does not retain inventory risk, the Company recognizes revenue on a net basis by recognizing only the commission the Company retains from such sales and including that commission in sales and operating revenues in the consolidated statements of operations. 

Consistent with industry standards, the Company may offer volume-based rebates to large customers if the customer purchases a specified volume with the Company over a specified time period. The determination of these rebates at an interim date involves management judgment. As a result, the Company’s revenues may be affected if a customer earns a rebate toward the end of a year that the Company had not expected or if its estimate of customer purchases are less than expected. The Company has the experience and access to relevant information that the Company believes are necessary to reasonably estimate the amounts of such deductions from gross revenues. The Company regularly reviews the information related to these estimates and adjusts its reserves accordingly if and when actual experience differs from previous estimates. The Company recognizes the rebate obligation as a reduction of revenue based on its estimate of the total volume of purchases from a given customer over the specified period of time. Customer rebates totaled $7.7 million, $7.8 million and $2.1 million for the fiscal years ended September 30, 2018, 2017 and 2016, respectively. Customer rebates totaled $4.0 million for the period from October 1, 2015 through June 8, 2016 for the Predecessor.  Rebates due to customers were $5.2 million and $4.8 million at September 30, 2018 and 2017, respectively.  These payables are included in Accrued expenses and other liabilities in the consolidated balance sheets. 

Supplier Rebates

Supplier RebatesCertain of the Company's vendor arrangements provide for purchase incentives based on the Company achieving a specified volume or dollar value of purchases. The Company records the incentives as a reduction of inventory costs (and related cost of sales) based on its purchases to date and its estimates of purchases for the remainder of the calendar year. The Company receives these incentives in the form of rebates that are payable only when the Company's purchases equal or exceed the relevant calendar year target. Supplier rebates totaled $8.9 million, $9.0 million and $3.1 million for the fiscal years ended September 30, 2018, 2017 and 2016, respectively. Supplier rebates totaled $6.5 million for the period from October 1, 2015 through June 8, 2016 for the Predecessor. Supplier rebates due to the Company were $4.4 million and $4.0 million at September 30, 2018 and 2017, respectively. These receivables are included in Accounts and notes receivable in the consolidated balance sheets.

Shipping and Handling

Shipping and HandlingAll shipping and handling amounts billed to customers are included in revenues. Costs incurred related to the shipping and handling of products are included in cost of sales.

Expense Recognition

Expense RecognitionCost of sales include material and production costs, as well as the costs of inbound and outbound freight, purchasing and receiving, inspection, warehousing, internal transfers and all other distribution network costs. The Company's products and services are generally sold without any extended warranties. Selling, general and administrative expenses include sales and marketing costs, advertising, research and development, customer support, environmental remediation and administrative costs. Advertising and research and development costs are expensed as incurred. Advertising expenses totaled $2.3 million, $1.8 million and $0.3 million for the fiscal years ended September 30, 2018, 2017, and 2016 respectively. Advertising expenses totaled $1.3 million for the period from October 1, 2015 through June 8, 2016 for the Predecessor. There were no material research and development expenses incurred during any of the periods presented.

Income Taxes

Income Taxes

The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the financial statements. Under this method, the Company determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. The provision for income taxes includes income taxes paid, currently payable or receivable and those deferred. 

The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of the net recorded amount, it would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.

The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) the Company determines whether it is more likely than not that the tax positions will be sustained and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount that is more than 50% likely to be realized upon ultimate settlement with the related tax authority.

The Predecessor was organized as a limited liability company and was taxed as a partnership for U.S. income tax purposes. As such, with the exception of a limited number of state and local jurisdictions, the Predecessor was not subject to U.S. income taxes. Accordingly, the members of the Predecessor reported their share of the Predecessor’s taxable income on their respective U.S. federal tax returns. The Predecessor’s sole active U.S. corporate subsidiary, Sub Holding, was subject to tax at the entity level in the U.S. The net earnings for financial statement purposes differed from taxable income reportable by the Predecessor to the members as a result of differences between the tax basis and financial reporting basis of certain assets and liabilities and other factors. The Predecessor was required to make quarterly distributions to its members to fund their tax obligations, if any, attributable to the Predecessor’s taxable income. In some jurisdictions, the Predecessor made such distributions in the form of tax payments paid directly to the taxing authority on behalf of its members. Controlled foreign corporations are subject to tax at the entity level in their respective jurisdictions. See Note 15.

Due to Related Party Pursuant to Contingent Consideration Obligations

Due to Related Party Pursuant to Contingent Consideration Obligations

As described in Note 3, as part of the consideration for the Business Combination, the Company entered into the TRA and agreed to pay the Deferred Cash Consideration pursuant to the Merger Agreement.  The Company’s obligation for these contingent consideration amounts was initially measured at fair value as of the Closing Date.  The Company’s contingent consideration liabilities are required to be recorded at fair value as of the end of each reporting period with any changes in fair value recorded in operating income. Changes in the estimates and inputs used in determining the fair value of the contingent consideration could have a material impact on the amounts recognized. See Note 9.

Share-Based Compensation

Share-Based Compensation

The Company accounts for share-based compensation expense for equity instruments granted in exchange for employee and director services.  Share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as expense over the vesting period of the equity award grant.

The Company’s PSU awards contain both market and performance-based conditions. At the grant date, market conditions are incorporated into the fair value measurement using a Monte Carlo simulation model under the assumptions that performance-based conditions are met and not met. The Company then determines the probability that performance-based conditions will be met and incorporates this into the grant date fair value of the award.

The compensation cost for the PSU awards is amortized over the vesting period on a straight-line basis, net of estimated forfeitures. Forfeiture rates are estimated based on consideration of historical forfeitures of the Company's and Predecessor’s actual forfeitures of its share-based compensation awards and a peer group of companies. See Note 10.

Recent Accounting Pronouncements

Recent Accounting Pronouncements Adopted as of September 30, 2018

In July 2015, the FASB issued ASU 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory. The amendments in this ASU require an entity to measure inventory at the lower of cost or net realizable value, whereas guidance previously required an assessment of market value of inventory, with different possibilities for determining market value. This ASU is effective for fiscal years beginning after December 15, 2016 and interim periods within those years and early adoption is permitted. The Company adopted this standard as of October 1, 2017, and it did not have a material effect on the Company’s financial position or results of operations.

In March 2016, the FASB issued ASU 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The updated guidance simplifies several aspects of accounting for certain aspects of share-based payment awards to employees, including the accounting for income taxes, forfeitures and statutory tax withholding requirements, as well as the classification of related matters in the statement of cash flows. This ASU is effective for annual reporting periods beginning after December 15, 2016 and interim periods within those annual periods. The Company adopted this standard as of October 1, 2017, and it did not have a material effect on the Company’s financial position or results of operations.

In May 2017, the FASB issued ASU 2017-09, Compensation - Stock Compensation (Topic 718). This ASU clarifies when changes to the terms or conditions of a share-based payment award must be accounted for as a modified award. The new guidance will reduce diversity in practice and result in fewer changes to the terms of an award being accounted for as modifications.  The amendments in this ASU will be applied prospectively to awards modified on or after the adoption date. The Company adopted this standard as of October 1, 2017, and it did not have a material effect on the Company’s financial position or results of operations.

New Accounting Pronouncements Not Yet Adopted as of September 30, 2018

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). The amendments in this ASU will supersede the revenue recognition requirements in Topic 605, Revenue Recognition and require that revenue be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB issued ASU 2015-14, which deferred the effective date of ASU 2014-09 for all entities by one year. These amendments will be effective in annual reporting periods beginning after December 15, 2017 including interim reporting periods within that reporting period. The Company has completed its assessment of the financial statement impact of the new standard, and does not expect it to have a material impact on the Company's financial position or results of operations. The Company adopted this standard on October 1, 2018 and will use the modified retrospective approach.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments (Topic 825): Recognition and Measurement of Financial Assets and Financial Liabilities. This ASU (i) requires all equity investments in unconsolidated entities other than those measured using the equity method of accounting, to be measured at fair value through earnings; (ii) when the fair value option has been elected for financial liabilities, requires that changes in fair value due to instrument specific credit risk be recognized separately in other comprehensive income and accumulated gains and losses due to these changes and will be reclassified from accumulated other comprehensive income to earnings if the liability is settled before maturity; and (iii) amends certain fair value disclosure provisions related to financial instruments carried at amortized cost. This ASU is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years and early adoption is permitted. The Company is in the process of evaluating the provisions of the ASU and assessing the potential effect on the Company’s financial position or results of operations.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). This ASU requires all leases with terms greater than 12 months, whether finance or operating, to be recorded on the balance sheet, reflecting a liability to make lease payments and a right-to-use asset representing the right to use the underlying asset for the lease term. The recognition, measurement and presentation of expenses and cash flows arising from a lease by a lessee will not significantly change from current U.S. GAAP. These amendments are effective for the reporting periods beginning after December 15, 2018 with early adoption permitted. An entity will be required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. The Company is in the process of evaluating the potential effects of this standard and believes it may have a significant impact on its consolidated financial statements due, in part, to its substantial number of operating lease obligations that will be reflected on the consolidated balance sheet upon adoption of the new guidance.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.  This ASU requires an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts.  Forward-looking information will now be used to better inform credit loss estimates.  The amendments in this ASU are effective for fiscal years beginning December 15, 2020 including interim periods within those years with early adoption permitted.  The Company is currently in the process of evaluating the provisions of this ASU and assessing the potential effect on the Company’s financial position or results of operations.

In August 2016 the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments.  This ASU will make eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The new standard is effective for fiscal years beginning after December 15, 2017. Early adoption is permitted. The new standard will require adoption on a retrospective basis unless it is impracticable to apply, in which case the Company would be required to apply the amendments prospectively as of the earliest date practicable. The Company is in the process of evaluating the provisions of this ASU but does not expect it to have a material effect on the Company’s consolidated statements of cash flows.

In August 2018 the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. This ASU modified the disclosures related to recurring and nonrecurring fair value measurements. Disclosures related to the transfer of assets between Level 1 and Level 2 hierarchies have been eliminated and various additional disclosures related to Level 3 fair value measurements have been added, modified or removed. This ASU is effective for annual periods beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted upon issuance of the standard for disclosures modified or removed with a delay of adoption of the additional disclosures until their effective date. The Company is in the process of evaluating the provisions of the ASU but does not expect it to have a material effect on the Company’s consolidated financial statements.

XML

Significant Accounting Policies and Recent Accounting Pronouncements (Tables)

12 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Intangible Assets Estimated Useful Lives

The range of estimated useful lives used to amortize these intangible assets is as follows:

	Estimated Useful Lives (years)
Customer-related	5-13
Supplier-related	6-10
Trade name	2-10
Below-market leases	1-7
Non-compete agreements	3-10

Property, Plant and Equipment Estimated Useful Lives

The range of useful lives used to depreciate property, plant and equipment is as follows:

	Estimated Useful Lives (years)
Plants and buildings	5-35
Machinery and equipment	2-30
Software and computer equipment	3-10

Property, plant and equipment at September 30, 2018 and 2017 consisted of the following:

	September 30, 2018			September 30, 2017
Land	$	50.8		$	51.0
Plants and buildings (1)	109.7			106.5
Machinery and equipment (2)	153.4			152.8
Software and computer equipment	70.5			63.3
Construction in progress	5.4			5.0
Total	389.8			378.6
Less accumulated depreciation (3)	(104.9		)	(62.5		)
Property, plant and equipment, net	$	284.9		$	316.1

⁽¹⁾ Includes $13.7 million related to facilities acquired under capital leases for the periods ended September 30, 2018 and September 30, 2017.

⁽²⁾ Includes $26.5 million and $27.2 million, respectively, related to equipment acquired under capital leases.

⁽³⁾ Includes $7.4 million and $4.9 million, respectively, related to facilities and equipment acquired under capital leases.

Depreciation expense recognized on the property, plant and equipment described above was as follows:

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 Through June 8, 2016
Depreciation expense	$	46.8	$	48.2	$	13.6	$	27.1

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

XML

Acquisitions (Tables)

12 Months Ended

Sep. 30, 2018

Business Acquisition [Line Items]

Schedule of Business Acquisitions, by Acquisition

The purchase consideration for the Business Combination was as follows:

Cash	$	424.9
Less: cash acquired	(64.3		)
Equity(1)	276.7
Founder Shares transferred to Selling Equityholders(1)	30.2
Contingent consideration - Fair value of Deferred Cash Consideration	45.4
Contingent consideration - Fair value of TRA (2)	89.8
Total purchase consideration(3)	$	802.7

⁽¹⁾ See Note 11.

⁽²⁾ During the fiscal year ended September 30, 2017, the Company recorded adjustments of $5.6 million. See below.

⁽³⁾ In addition to the total purchase consideration above, the Company assumed the outstanding indebtedness of the Predecessor, including related accrued interest through the Closing Date, totaling $774.3 million. The proceeds of the Credit Facilities were used to repay such indebtedness and accrued interest immediately following the consummation of the Business Combination.

Schedule of Unaudited Consolidated Pro Form Financial Information

The unaudited consolidated pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the Business Combination been completed on October 1, 2014 or the Ultra Chem Acquisition on October 1, 2015.

	Fiscal Year Ended September 30,
	2018		2017		2016
Sales and operating revenues	$	4,034.2	$	3,672.2	$	3,466.3
Operating income	$	97.2	$	71.1	$	96.6
Net income from continuing operations	$	29.4	$	16.4	$	33.4
Net income	$	29.4	$	16.4	$	33.5
Basic and diluted net income per share	$	0.38	$	0.21	$	0.44
Pro forma weighted average number of common shares outstanding
Basic	76,803,187		76,752,752		76,746,168
Diluted	76,909,547		76,839,810		76,799,052

Ultra Chem

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The following table summarizes the Company’s allocation of the purchase consideration to assets acquired and liabilities assumed at the Ultra Chem Closing Date:

	Purchase Consideration Allocation
Accounts receivable	$	13.7
Inventory	9.1
Other current assets	2.4
Property and equipment	0.5
Customer-related intangible	24.0
Trade name	0.3
Non-compete agreements	3.9
Other non-current assets	2.5
Goodwill	28.0
Total assets acquired	84.4
Short-term borrowings	0.9
Accounts payable	12.1
Other current liabilities	4.1
Deferred tax liability — non-current	8.4
Other non-current liabilities	2.2
Total liabilities assumed	27.7
Net assets acquired	$	56.7

Nexeo Solutions Inc.

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The following table summarizes the Company’s allocation of the purchase consideration to assets acquired and liabilities assumed at the Closing Date:

	Purchase Price Allocation
Accounts receivable	$	470.0
Inventory	327.9
Other current assets	26.0
Property, plant and equipment	328.2
Customer-related intangible	201.0
Trade name	21.0
Below-market leases	0.7
Other non-current assets	3.2
Deferred tax assets	1.2
Goodwill	673.4
Total assets acquired	2,052.6
Short-term borrowings and current portion of capital leases	40.6
Accounts payable	335.9
Other current liabilities	52.8
Long-term portion of capital leases	23.0
Long-term debt	767.3
Deferred tax liability	24.8
Other non-current liabilities	5.5
Total liabilities assumed	1,249.9
Net assets acquired	$	802.7

XML

Certain Balance Sheet Information (Tables)

12 Months Ended

Sep. 30, 2018

Certain Balance Sheet Information [Abstract]

Schedule of Cash and Cash Equivalents

These amounts included the following:

	September 30, 2018		September 30, 2017
Cash held by foreign subsidiaries	$	52.9	$	36.8
Non-USD denominated currency held by foreign subsidiaries	$	48.8	$	31.1
Currency denominated in RMB	$	6.5	$	8.5

Summary of Inventories

Inventories at September 30, 2018 and 2017 consisted of the following:

	September 30, 2018		September 30, 2017
Finished products	$	334.0	$	310.6
Supplies	4.8		4.9
Total	$	338.8	$	315.5

Schedule of Other Non-Current Assets

Other non-current assets at September 30, 2018 and 2017 consisted of the following:

	September 30, 2018		September 30, 2017
Debt issuance costs of the ABL Facility	$	3.8	$	5.1
Deposits	2.5		2.8
Interest rate swap (1)	8.0		0.3
Other	1.9		2.4
Total	$	16.2	$	10.6

⁽¹⁾ See Note 8 for additional information.

XML

Property, Plant and Equipment (Tables)

12 Months Ended

Sep. 30, 2018

Property, Plant and Equipment [Abstract]

Summary of Property, Plant and Equipment

The range of useful lives used to depreciate property, plant and equipment is as follows:

	Estimated Useful Lives (years)
Plants and buildings	5-35
Machinery and equipment	2-30
Software and computer equipment	3-10

Property, plant and equipment at September 30, 2018 and 2017 consisted of the following:

	September 30, 2018			September 30, 2017
Land	$	50.8		$	51.0
Plants and buildings (1)	109.7			106.5
Machinery and equipment (2)	153.4			152.8
Software and computer equipment	70.5			63.3
Construction in progress	5.4			5.0
Total	389.8			378.6
Less accumulated depreciation (3)	(104.9		)	(62.5		)
Property, plant and equipment, net	$	284.9		$	316.1

⁽¹⁾ Includes $13.7 million related to facilities acquired under capital leases for the periods ended September 30, 2018 and September 30, 2017.

⁽²⁾ Includes $26.5 million and $27.2 million, respectively, related to equipment acquired under capital leases.

⁽³⁾ Includes $7.4 million and $4.9 million, respectively, related to facilities and equipment acquired under capital leases.

Depreciation expense recognized on the property, plant and equipment described above was as follows:

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 Through June 8, 2016
Depreciation expense	$	46.8	$	48.2	$	13.6	$	27.1

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

XML

Goodwill and Other Intangibles (Tables)

12 Months Ended

Sep. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Progression of Goodwill by Reportable Segment

The following is a progression of goodwill by reportable segment: 

	Chemicals			Plastics			Other		Total
Balance at September 30, 2016	$	331.6		$	271.1		$	63.0	$	665.7
Measurement period adjustments	2.7			1.2			0.5		4.4
Ultra Chem Acquisition	28.0			—			—		28.0
Foreign currency translation	0.5			4.4			—		4.9
Balance at September 30, 2017	$	362.8		$	276.7		$	63.5	$	703.0
Foreign currency translation	(0.4		)	(2.7		)	—		(3.1		)
Balance at September 30, 2018	$	362.4		$	274.0		$	63.5	$	699.9

Schedule of Definite-Lived Intangible Assets

Definite-lived intangible assets at September 30, 2018 and September 30, 2017 consisted of the following: 

	September 30, 2018							September 30, 2017
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Customer-related	$	239.6	$	(44.1	)	$	195.5	$	234.6	$	(23.7	)	$	210.9
Supplier-related	3.1		(0.4		)	2.7		1.5		(0.1		)	1.4
Trade name	23.3		(12.7		)	10.6		22.3		(7.0		)	15.3
Below-market leases	0.7		(0.5		)	0.2		0.7		(0.3		)	0.4
Non-compete agreements	4.6		(2.0		)	2.6		4.2		(0.7		)	3.5
Total	$	271.3	$	(59.7	)	$	211.6	$	263.3	$	(31.8	)	$	231.5

Amortization Expense Recognized on Intangible Assets

Amortization expense recognized on the intangible assets described above was as follows:

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 Through June 8, 2016
Amortization expense	$	28.1	$	24.9	$	7.0	$	10.6

^{*The fiscal year ended September 30, 2016 includes 114 days} of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.Expected amortization expense for the next five years is as follows:

2019	$	28.3
2020	25.9
2021	21.6
2022	21.4
2023	20.9

XML

Debt (Tables)

12 Months Ended

Sep. 30, 2018

Debt Disclosure [Abstract]

Summary of Short-Term Borrowings Outstanding and Current Portion of Long-Term Debt and Capital Lease Obligations

Short-term borrowings outstanding and the current portion of long-term debt and capital lease obligations at September 30, 2018 and 2017 are summarized below:

	September 30, 2018		September 30, 2017
Short-term borrowings	$	38.1	$	40.8
Current portion of long-term debt and capital lease obligations	9.6		10.3
Total short-term borrowings and current portion of long term debt and capital lease obligations, net	$	47.7	$	51.1

Sumary of Long-Term Debt Outstanding

Long-term debt outstanding at September 30, 2018 and 2017 is summarized below:

	September 30, 2018			September 30, 2017
ABL Facility	$	104.6		$	139.3
Term Loan Facility	640.4			646.9
Capital lease obligations (1)	34.0			37.5
Total long-term debt	779.0			823.7
Less: unamortized debt discount (2)	(2.3		)	(2.7		)
Less: debt issuance costs (3)	(14.7		)	(16.7		)
Less: current portion of long-term debt and capital lease obligations	(9.6		)	(10.3		)
Long-term debt and capital lease obligations, less current portion, net	$	752.4		$	794.0

⁽¹⁾  Capital lease obligations exclude executory costs and interest payments associated with the underlying leases. See “Capital Lease Obligations” below.

⁽²⁾  The unamortized debt discount is related to the Term Loan Facility and amortized to interest expense over the life of the instrument using the effective interest rate method.

⁽³⁾  See discussion below under Term Loan Facility and Debt Issuance Cost Amortization.

Short-Term Borrowings Associated with Operations in China

The Company's short-term borrowings are associated with the Company's operations in China and are summarized below:    

	Facility Limit		Outstanding Borrowings Balance		Weighted Average Interest Rate on Borrowings		Outstanding LOC and Bankers' Acceptance Bills		Remaining Availability
September 30, 2018
Bank of America - China (1)	$	24.3	$	22.2	4.6	%	$	—	$	2.1
Bank of Communications - China (2)	21.8		15.9		5.4	%	5.1		0.8
Total	$	46.1	$	38.1			$	5.1	$	2.9
September 30, 2017
Bank of America - China (1)	$	24.3	$	23.8	4.3	%	$	—	$	0.5
Bank of Communications - China (2)	22.5		17.0		5.3	%	5.3		0.2
Total	$	46.8	$	40.8			$	5.3	$	0.7

⁽¹⁾  The borrowing limit of this facility is denominated in USD. This line of credit is secured by a standby letter of credit drawn on the ABL Facility covering at least 110% of the facility's borrowing limit amount. Borrowings under the line of credit are payable in full within 12 months of the date of the advance. The Company has the ability to provide additional capacity under these lines of credit, if needed.

⁽²⁾

The borrowing limit of this facility is denominated in RMB. This line of credit is secured by a standby letter of credit drawn on the ABL Facility covering at least 100% of the facility's borrowing limit amount. Borrowings under the line of credit are payable in full within 12 months of the date of the advance.

Schedule of Maturities of Future Principal Payments on Debt and Capital Lease Obligations

The following table sets forth future principal payments on debt and capital lease obligations at September 30, 2018:

2019	$	47.7
2020	9.6
2021	114.1
2022	13.2
2023	619.7
Thereafter	12.8
Total	$	817.1

XML

Derivatives (Tables)

12 Months Ended

Sep. 30, 2018

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Summary of Derivative Assets and Liabilities

Derivative assets and liabilities at September 30, 2018 and September 30, 2017 consisted of the following:

	Recorded to	September 30, 2018		September 30, 2017
Short-term derivative asset	Other current assets	$	2.2	$	—
Long-term derivative asset	Other non-current assets	$	8.0	$	0.3
Short-term derivative liability(1)	Accrued expenses and other liabilities	$	—	$	1.1
Long-term derivative liability	Other non-current liabilities	$	—	$	0.2
Other Comprehensive Income(2)	Accumulated other comprehensive income	$	8.1	$	—

^{(1) Short-term derivative liability for the fiscal year ended September 30, 2018 was less than $0.1 million}  

^{(2) Other Comprehensive Income for the fiscal year ended September 30, 2017 was less than $0.1 million}

Summary of Gains and Losses (Net of Reclassifications Into Income, Including any Ineffective Portion)

Gains and losses (net of reclassifications into income, including any ineffective portion) related to the interest rate swaps of the Company and the Predecessor were as follows:

		Successor				Predecessor
	Recorded to	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		October 1, 2015 through June 8, 2016
Realized loss	Interest expense	$	1.2	$	2.0	$	0.3
Unrealized gain, net of tax	Other comprehensive income	$	8.1	$	—	$	0.3

XML

Fair Value Measurements (Tables)

12 Months Ended

Sep. 30, 2018

Fair Value Disclosures [Abstract]

Schedule of Changes in Fair Value of Contingent Consideration

Changes in the fair value of the contingent consideration obligations for the fiscal years ended September 30, 2018 and 2017 were as follows:

	TRA			Deferred Cash Consideration		Total Fair Value
Contingent consideration as of September 30, 2016	$	83.4		$	35.0	$	118.4
Measurement period adjustment	5.6			—		5.6
Change in fair value of contingent consideration(1)	16.1			0.1		16.2
Contingent consideration as of September 30, 2017	$	105.1		$	35.1	$	140.2
Cash Paid to TPG	(10.2		)	—		(10.2		)
Change in fair value of contingent consideration(1)	(20.1		)	27.6		7.5
Contingent consideration as of September 30, 2018	$	74.8		$	62.7	$	137.5

⁽¹⁾ Included in Operating income in the consolidated statements of operations.

XML

Share-Based Compensation and Employee Benefit Plans (Tables)

12 Months Ended

Sep. 30, 2018

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of Non-Vested Equity Plan Units

The following table summarizes restricted stock activity during the fiscal year ended September 30, 2018:

	Shares of Restricted Stock		Average Grant Date Fair Value Per Unit
Restricted stock at September 30, 2017	77,458		$	8.26
Granted	415,867		7.50
Vested	(53,450	)	8.28
Forfeited/Canceled	(30,608	)	8.05
Restricted stock at September 30, 2018	409,267		$	7.50

Schedule of Stock Option Activity

The following table summarizes stock option activity during the fiscal year ended September 30, 2018:

	Stock Options		Average Grant Date Fair Value Per Unit		Weighted Average Exercise Price
Stock options at September 30, 2017	—		$	—	$	—
Granted	999,492		2.84		7.42
Exercised	—		—		—
Forfeited/Canceled	(6,600	)	2.84		7.42
Stock options at September 30, 2018	992,892		$	2.84	$	7.42

Schedule of Compensation Expense by Award

The following table summarizes the amount of compensation expense recognized as a component of Selling, general and administrative expenses on the consolidated statements of operations by award type:

	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*
PSUs	$	4.7	$	4.5	$	1.3
Restricted Stock	$	1.2	$	0.6	$	0.1
TPG restricted stock grants	$	0.3	$	0.3	$	0.1
Stock options	$	0.8	$	—	$	—
RSUs	$	0.1	$	0.1	$	—

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

Schedule of Compensation Expense and Weighted Average Remaining Life

The following table summarizes unrecognized compensation expense and weighted average remaining life as of the fiscal year ended September 30, 2018 by award type:

	Unrecognized Compensation Expense		Weighted Average Remaining Life (in years)
PSUs	$	4.1	0.9
Restricted Stock	$	2.0	2.1
TPG restricted stock grants	$	0.4	0.7
Stock options	$	1.9	9.1
RSUs	$	0.1	1.1

Schedule of Retirement Plan Contributions

The following summarizes contributions to the plans described above:

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 through June 8, 2016
Contributions recorded as a component of cost of sales and operating expenses	$	4.2	$	4.0	$	1.3	$	2.7
Contributions recorded as a component of selling, general and administrative expenses	6.4		6.4		2.2		4.5
Total contributions	$	10.6	$	10.4	$	3.5	$	7.2

^{*The fiscal year ended September 30, 2016 includes 114 days} of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.

Restricted Stock Units (RSUs)

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Share-based Compensation Activity

The following table summarizes RSU award activity during the fiscal year ended September 30, 2018:

	RSUs		Average Grant Date Fair Value Per Unit
Unvested RSUs at September 30, 2017	24,500		$	7.28
Granted	—		—
Vested	(8,162	)	7.28
Forfeited/Canceled	—		—
Unvested RSUs at September 30, 2018	16,338		$	7.28

PSUs

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Share-based Compensation Activity

The following table summarizes all PSU activity during the fiscal year ended September 30, 2018:

	Units		Average Grant Date Fair Value Per Unit
Unvested PSUs at September 30, 2017	1,524,000		$	8.92
Granted	193,667		7.50
Vested	—		—
Forfeited/Canceled	(22,500	)	9.13
Unvested PSUs at September 30, 2018	1,695,167		$	8.76

XML

Earnings Per Share (Tables)

12 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

Reconciliation of Basic and Diluted Earnings Per Share

A reconciliation of the numerators and denominators of the basic and diluted per share computation follows.

	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*
Basic:
Net income (loss)	$	29.4	$	14.4	$	(8.4	)
Weighted average number of common shares outstanding during the period	76,803,187		76,752,752		35,193,789
Net income (loss) per common share - basic	$	0.38	$	0.19	$	(0.24	)
Diluted:
Net income (loss)	$	29.4	$	14.4	$	(8.4	)
Denominator for diluted earnings per share:
Weighted average number of common shares attributable to the period	76,803,187		76,752,752		35,193,789
Incremental common shares attributable to outstanding dilutive options and unvested restricted shares	106,360		87,058		—
Denominator for diluted earnings per common share	76,909,547		76,839,810		35,193,789
Net income (loss) per common share - diluted	$	0.38	$	0.19	$	(0.24	)

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

XML

Commitments, Contingencies and Litigation (Tables)

12 Months Ended

Sep. 30, 2018

Commitments and Contingencies Disclosure [Abstract]

Schedule of Future Minimum Non-Cancellable Rental Payments

Future minimum non-cancellable rental payments as of September 30, 2018 are as follows:

2019	$	14.1
2020	8.9
2021	7.1
2022	5.2
2023	2.8
Thereafter	0.3
Total	$	38.4

Schedule of Future Minimum Lease Payments Under Capital Leases

The Company leases certain equipment and facilities under capital lease agreements. As of September 30, 2018, future minimum lease payments under capital leases were as follows:

2019	$	7.6
2020	7.2
2021	7.1
2022	10.4
2023	6.9
Thereafter	25.4
Total minimum capital lease payments	64.6
Less amount representing executory costs	(15.1		)
Less amount representing interest	(15.5		)
Present value of net minimum capital lease payments	$	34.0

XML

Related Party Transactions (Tables)

12 Months Ended

Sep. 30, 2018

Related Party Transactions [Abstract]

Schedule of Activity with Related Parties

The fair value of these contingent consideration liabilities was as follows:

	September 30, 2018		September 30, 2017
Due to related party pursuant to contingent consideration obligations:
Current liability	$	14.7	$	12.5
Non-current liability	122.8		127.7
Total fair value	$	137.5	$	140.2

The table below summarizes activity recorded during the respective periods for related party transactions:

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 Through June 8, 2016
Sales to related entities:
TPG portfolio entities	$	4.5	$	3.1	$	1.7	$	3.1
Entities related to members of the Board of Directors	$	1.4	$	0.1	$	—	$	—
Purchases from related entities:
TPG portfolio entities	$	0.5	$	—	$	—	$	—
Entities related to members of the Board of Directors	$	13.1	$	1.7	$	—	$	—
Amounts included in Selling, general and administrative expenses
Management fees to TPG	$	—	$	—	$	—	$	2.1
Consulting fees to TPG	$	—	$	—	$	0.1	$	0.4
Amounts included in Transaction related costs
Fee paid in connection with the Business Combination	$	—	$	—	$	—	$	9.9

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

	September 30, 2018		September 30, 2017
Accounts receivable from related entities:
TPG portfolio entities	$	1.0	$	0.7
Entities related to members of the Board of Directors	$	0.2	$	—
Accounts payable to related entities:
TPG portfolio entities	$	0.5	$	—
Entities related to members of the Board of Directors	$	0.6	$	0.1

XML

Incomes Taxes (Tables)

12 Months Ended

Sep. 30, 2018

Income Tax Disclosure [Abstract]

Schedule of Income (Loss) before Income Taxes

For financial reporting purposes, income (loss) before income taxes includes the following components:

	Successor							Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*			October 1, 2015 Through June 8, 2016
U.S.	$	24.8	$	7.9	$	(9.1	)	$	(19.6	)
Foreign	21.3		17.0		1.9			9.9
Income (loss) before income taxes	$	46.1	$	24.9	$	(7.2	)	$	(9.7	)

Schedule of Provision for Income Taxes

A summary of income tax expense (benefit) is as follows:

	Successor									Predecessor
	Fiscal Year Ended September 30, 2018			Fiscal Year Ended September 30, 2017			Fiscal Year Ended September 30, 2016*			October 1, 2015 Through June 8, 2016
Current tax expense (benefit):
U.S. - Federal	$	9.5		$	1.3		$	0.5		$	—
U.S. - State	2.8			0.5			(0.2		)	(0.1		)
Foreign	11.3			6.5			2.0			3.2
Total current tax expense	23.6			8.3			2.3			3.1
Deferred tax expense (benefit):
U.S. - Federal	(4.7		)	4.6			(0.8		)	0.4
U.S. - State	0.1			0.2			0.4			0.1
Foreign	(2.3		)	(2.6		)	(0.7		)	0.6
Total deferred tax expense (benefit)	(6.9		)	2.2			(1.1		)	1.1
Total income tax expense	$	16.7		$	10.5		$	1.2		$	4.2

^{*The fiscal year ended September 30, 2016 includes 114 days} of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.

Schedule of Effective Income Tax Rate Reconciliation

Reconciliation of income taxes at the U.S. statutory rate and income tax expense (benefit):

	Successor									Predecessor
	Fiscal Year Ended September 30, 2018*			Fiscal Year Ended September 30, 2017**			Fiscal Year Ended September 30, 2016***			October 1, 2015 Through June 8, 2016
U.S. statutory rate	21.0		%	34.0		%	34.0		%	0.0		%
Pretax income (loss) at statutory rate	$	9.7		$	8.5		$	(2.5	)	$	—
State income taxes	2.1			0.9			0.2			—
Statutory rate differential	1.4			(1.4		)	(0.2		)	2.5
FIN 48 expense (benefit)	2.3			(0.5		)	—			0.1
Non-U.S. tax credit	(2.0		)	—			—			—
Withholding and other taxes	0.5			0.5			—			0.3
Tax impact of tax reform	(4.5		)	—			—			—
Transaction costs	0.9			—			5.0			—
Contingent liability	0.8			2.4			(1.6		)	—
Other permanent differences	0.3			0.3			0.3			0.6
Statutory tax rate changes and differences	0.9			—			(0.2		)	(0.1		)
True-up to prior year taxes	2.6			(0.3		)	—			0.2
Nondeductible stewardship costs	1.1			—			—			—
Valuation allowance	0.6			0.1			0.2			0.6
Income tax expense	$	16.7		$	10.5		$	1.2		$	4.2
Effective tax rate	36.2		%	42.2		%	(16.7		)%	(43.3		)%

^{*Due to the Company's fiscal year ending on September 30, 2018, the phased in rate of 24.5% was used in calculating the U.S. federal taxes presented in the reconciliation for the fiscal year ended September 30, 2018.} 

^{**For comparability, the presentation of balances at September 30, 2017 were adjusted to align to current year presentation.} 

^{***The fiscal year ended September 30, 2016 includes 114 days} of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.

Schedule of Deferred Tax Assets and Liabilities

The principal temporary differences included in deferred income taxes reported on the September 30, 2018 and 2017 balance sheets were:

	September 30, 2018			September 30, 2017
Deferred Tax Assets
Foreign operating losses	$	5.5		$	6.3
Federal and state operating losses	15.5			27.6
Non-U.S. tax credit (1)	1.9			—
Unrealized gains/losses	0.3			0.2
Fixed assets and intangibles	1.1			0.9
Compensation and other accruals	4.0			2.4
Other items	0.8			0.9
Valuation allowance	(3.6		)	(3.1		)
Total deferred tax assets	$	25.5		$	35.2
Deferred Tax Liabilities
Fixed assets and intangibles	$	23.2		$	23.8
Compensation and other accruals	0.2			0.2
Investment in partnerships	27.1			43.2
Other items	3.4			0.6
Total deferred tax liabilities	$	53.9		$	67.8

⁽¹⁾  Related to the European tax uncertainty recorded in the current period.

Schedule of Unrecognized Tax Benefits Roll Forward

A reconciliation of the beginning and ending amount of unrecognized tax benefits is shown below:

	September 30, 2018			September 30, 2017
Balance at beginning of period	$	1.2		$	0.9
Increases related to positions taken on items from prior years	2.3			0.1
Decreases related to positions taken on items from prior years	(0.2		)	—
Unrecognized tax benefits assumed related to acquisitions	—			0.8
Lapse of statute of limitations	(0.2		)	(0.6		)
Balance at end of period	$	3.1		$	1.2

XML

Segment and Geographic Data (Tables)

12 Months Ended

Sep. 30, 2018

Segment Reporting [Abstract]

Summary of Financial Information

Summarized financial information relating to the Company’s lines of business is as follows:

	Successor									Predecessor
	Fiscal Year Ended September 30, 2018			Fiscal Year Ended September 30, 2017			Fiscal Year Ended September 30, 2016*			October 1, 2015 through June 8, 2016
Sales and operating revenues
Chemicals	$	1,904.5		$	1,667.2		$	478.1		$	1,066.4
Plastics	1,980.0			1,841.7			546.7			1,192.2
Other	149.7			128.0			40.9			81.5
Total sales and operating revenues	$	4,034.2		$	3,636.9		$	1,065.7		$	2,340.1
Gross profit
Chemicals	248.0			205.6			55.7			136.2
Plastics	186.4			167.2			43.6			117.6
Other	25.7			25.6			9.1			18.1
Total gross profit	460.1			398.4			108.4			271.9
Selling, general and administrative expenses	352.6			312.9			91.7			208.9
Transaction related costs	2.8			1.9			21.3			33.4
Change in fair value of contingent consideration obligations	7.5			16.2			(11.2		)	—
Operating income	97.2			67.4			6.6			29.6
Other income, net	1.0			8.3			0.5			2.9
Interest income (expense)
Interest income	0.5			0.3			0.8			0.1
Interest expense	(52.6		)	(51.1		)	(15.1		)	(42.3		)
Net income (loss) from continuing operations before income taxes	$	46.1		$	24.9		$	(7.2	)	$	(9.7	)

^{*The fiscal year ended September 30, 2016 includes 114 days of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.} 

	September 30, 2018		September 30, 2017
IDENTIFIABLE ASSETS
Chemicals	$	826.2	$	793.6
Plastics	758.2		762.7
Other	95.7		91.0
Total identifiable assets by reportable segment	1,680.1		1,647.3
Unallocated assets	563.5		606.2
Total assets	$	2,243.6	$	2,253.5

Schedule of Revenues by Geographic Location, Based on Jurisdiction of Subsidiary Entity

Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale, are presented below:

	Successor						Predecessor
	Fiscal Year Ended September 30, 2018		Fiscal Year Ended September 30, 2017		Fiscal Year Ended September 30, 2016*		October 1, 2015 through June 8, 2016
U.S.	$	2,959.9	$	2,682.2	$	808.2	$	1,779.4
Canada	189.9		171.6		46.5		102.4
Other North America	132.8		87.2		18.4		35.4
Total North America Operations	3,282.6		2,941.0		873.1		1,917.2
EMEA	539.7		481.7		130.6		291.9
Asia	211.9		214.2		62.0		131.0
Total	$	4,034.2	$	3,636.9	$	1,065.7	$	2,340.1

 

^{*The fiscal year ended September 30, 2016 includes 114 days} of the acquired business’ operating activities as a result of the consummation of the Business Combination on June 9, 2016.

XML

Unaudited Quarterly Information (Tables)

12 Months Ended

Sep. 30, 2018

Quarterly Financial Information Disclosure [Abstract]

Unaudited Statement of Operations Information

The following tables contain selected unaudited statement of operations information for each quarter of the fiscal years ended September 30, 2018 and 2017. All numbers are in millions except for per share amounts.

	Fiscal Year Ended September 30, 2018
	First Quarter		Second Quarter		Third Quarter		Fourth Quarter
Sales and operating revenues	$	929.6	$	1,041.0	$	1,046.4	$	1,017.2
Gross profit	$	106.9	$	115.7	$	120.2	$	117.3
Net income (loss)	$	26.5	$	0.4	$	17.5	$	(15.0	)
Income (loss) per share:(1)
Basic	$	0.35	$	0.01	$	0.23	$	(0.20	)
Diluted	$	0.34	$	0.01	$	0.23	$	(0.20	)
Weighted average number of common shares outstanding
Basic	76,793,518		76,795,742		76,797,414		76,825,850
Diluted	76,857,244		76,961,218		76,983,350		76,825,850

⁽¹⁾ Per share amounts for the quarter and full year have been computed separately. The sum of the quarterly amounts may not equal the annual amounts presented because of differences in the average shares outstanding during each period.

	Fiscal Year Ended September 30, 2017
	First Quarter			Second Quarter			Third Quarter		Fourth Quarter
Sales and operating revenues	$	794.8		$	917.7		$	942.7	$	981.7
Gross profit	$	84.4		$	102.2		$	102.7	$	109.1
Net income (loss)	$	(8.3	)	$	(1.1	)	$	10.2	$	13.6
Income (loss) per share:(1)
Basic	$	(0.11	)	$	(0.01	)	$	0.13	$	0.18
Diluted	$	(0.11	)	$	(0.01	)	$	0.13	$	0.18
Weighted average number of common shares outstanding
Basic	76,746,168			76,746,168			76,743,853		76,774,578
Diluted	76,746,168			76,746,168			76,828,868		76,852,267

⁽¹⁾ Per share amounts for the quarter and full year have been computed separately. The sum of the quarterly amounts may not equal the annual amounts presented because of differences in the average shares outstanding during each period.

XML

Basis of Presentation and Nature of Operations - Narrative (Details) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Jun. 30, 2014	Sep. 30, 2018
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Cash proceeds from initial public offering	$ 500.0
Revenue
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Out-of-period adjustment		$ 0.4
Gross Profit
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Out-of-period adjustment		0.9
Net Income
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Out-of-period adjustment		$ (2.0)

XML

Significant Accounting Policies and Recent Accounting Pronouncements - Narrative (Details)	4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2016 USD ($)	Jun. 08, 2016 USD ($)	Sep. 30, 2018 USD ($)	Sep. 30, 2017 USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Number of supplier representing company's purchases			2
Threshold period past due for review of collectability			90 days
Allowance for doubtful accounts			$ 4,200,000	$ 2,200,000
Bad debt expense, net of recoveries	$ 300,000		1,900,000	(200,000)
Accounts and notes receivable, net			607,800,000	597,400,000
Goodwill	665,700,000		699,900,000	703,000,000.0
Other intangible assets, net of amortization			211,600,000	231,500,000
Goodwill impairment	0		0	0
Customer rebates	2,100,000		7,700,000	7,800,000
Suppliers rebates	3,100,000		8,900,000	9,000,000.0
Advertising expenses	$ 300,000		2,300,000	1,800,000
Predecessor
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Bad debt expense, net of recoveries		$ 1,200,000
Goodwill impairment		0
Customer rebates		4,000,000.0
Suppliers rebates		6,500,000
Advertising expenses		$ 1,300,000
Accrued expenses and other liabilities
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Rebates due to customers			5,200,000	4,800,000
Accounts and notes receivable
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Supplier rebates due to company			4,400,000	4,000,000.0
Certain customers of operations in China
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accounts and notes receivable, net			$ 8,600,000	$ 8,300,000
Certain customers of operations in China | Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Threshold period for customers to remit payment			30 days
Certain customers of operations in China | Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Threshold period for customers to remit payment			9 months
Purchases | Supplier One | Supplier Concentration Risk
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk, percentage	11.90%		11.60%	12.10%
Purchases | Supplier One | Supplier Concentration Risk | Predecessor
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk, percentage		12.00%
Purchases | Supplier Two | Supplier Concentration Risk
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk, percentage	10.40%		9.60%	9.90%
Purchases | Supplier Two | Supplier Concentration Risk | Predecessor
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk, percentage		9.80%
Selling, General and Administrative Expenses
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net foreign currency transaction losses	$ 1,100,000		$ 1,100,000	$ 600,000
Selling, General and Administrative Expenses | Predecessor
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net foreign currency transaction losses		$ 1,600,000

XML

Significant Accounting Policies and Recent Accounting Pronouncements - Schedule for Intangible Assets Estimated Useful Lives (Details)	12 Months Ended
	Sep. 30, 2018
Customer-related | Minimum
Other intangibles
Estimated Useful Lives (years)	5 years
Customer-related | Maximum
Other intangibles
Estimated Useful Lives (years)	13 years
Supplier-related | Minimum
Other intangibles
Estimated Useful Lives (years)	6 years
Supplier-related | Maximum
Other intangibles
Estimated Useful Lives (years)	10 years
Trade name | Minimum
Other intangibles
Estimated Useful Lives (years)	2 years
Trade name | Maximum
Other intangibles
Estimated Useful Lives (years)	10 years
Below-market leases | Minimum
Other intangibles
Estimated Useful Lives (years)	1 year
Below-market leases | Maximum
Other intangibles
Estimated Useful Lives (years)	7 years
Non-compete agreements | Minimum
Other intangibles
Estimated Useful Lives (years)	3 years
Non-compete agreements | Maximum
Other intangibles
Estimated Useful Lives (years)	10 years

XML

Significant Accounting Policies and Recent Accounting Pronouncements - Schedule for Property, Plant, and Equipment Estimated Useful Lives (Details)	12 Months Ended
	Sep. 30, 2018
Plants and buildings | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives (years)	5 years
Plants and buildings | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives (years)	35 years
Machinery and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives (years)	2 years
Machinery and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives (years)	30 years
Software and computer equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives (years)	3 years
Software and computer equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives (years)	10 years

XML

Acquisitions - Narrative (Details)					1 Months Ended						3 Months Ended	4 Months Ended	8 Months Ended	12 Months Ended
	Jan. 01, 2019 USD ($)	Sep. 17, 2018 USD ($) shares	Apr. 03, 2017 USD ($)	Jun. 09, 2016 USD ($) location merger $ / shares	Apr. 30, 2018 USD ($)	Feb. 28, 2018 USD ($)	Jan. 31, 2018 USD ($)	Aug. 31, 2017 USD ($)	Apr. 30, 2017 USD ($)	Dec. 31, 2016 USD ($)	Mar. 31, 2018 USD ($)	Sep. 30, 2016 USD ($) shares	Jun. 08, 2016 USD ($)	Sep. 30, 2018 USD ($) shares	Sep. 30, 2017 USD ($) shares
Business Acquisition [Line Items]
Reduction per share based on closing price of Univar common stock		$ 0.41
Cash paid for business acquisition												$ 360,600,000		$ 11,000,000.0	$ 65,600,000
Borrowings used for acquisition														817,100,000
Contingent Consideration- fair value of deferred cash												$ 118,400,000		$ 137,500,000	$ 140,200,000
Debt issuance cost				$ 18,300,000
Warrants outstanding (in shares) | shares												50,025,000		50,025,000	50,025,000
Total consideration									$ 1,900,000
Payment at closing									1,600,000
Founders Shares
Business Acquisition [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares) | shares												12,476,250		12,476,250	12,476,250
Warrant
Business Acquisition [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares) | shares												25,012,500		25,012,500	25,012,500
Trade names | Minimum
Business Acquisition [Line Items]
Estimated Useful Lives (years)														2 years
Trade names | Maximum
Business Acquisition [Line Items]
Estimated Useful Lives (years)														10 years
Below-market leases | Minimum
Business Acquisition [Line Items]
Estimated Useful Lives (years)														1 year
Below-market leases | Maximum
Business Acquisition [Line Items]
Estimated Useful Lives (years)														7 years
Non-compete agreements | Minimum
Business Acquisition [Line Items]
Estimated Useful Lives (years)														3 years
Non-compete agreements | Maximum
Business Acquisition [Line Items]
Estimated Useful Lives (years)														10 years
Customer lists
Business Acquisition [Line Items]
Intangible assets acquired									$ 1,100,000
Predecessor
Business Acquisition [Line Items]
Cash paid for business acquisition													$ 0
Univar Merger
Business Acquisition [Line Items]
Transaction costs														$ 11,300,000
TRA Termination Agreement cash payment		60,000,000.0
Univar Merger | Minimum
Business Acquisition [Line Items]
Cash consideration per share		2.88
Cash consideration basis-Univar common stock closing price		22.18
Univar Merger | Maximum
Business Acquisition [Line Items]
Cash consideration per share		3.29
Cash consideration basis-Univar common stock closing price		$ 25.34
Univar Merger | Transaction related costs
Business Acquisition [Line Items]
Transaction costs														2,800,000
Univar Merger | Selling, General and Administrative Expenses
Business Acquisition [Line Items]
Transaction costs														8,500,000
Ultra Chem
Business Acquisition [Line Items]
Cash paid for business acquisition			$ 56,700,000
Cash acquired from acquisition			500,000
Indemnification obligations held in escrow			$ 10,700,000											9,300,000
Maximum holding period in escrow			5 years
Contingent consideration			$ 0
Transaction costs														$ 100,000	$ 1,800,000
Reduction in gross receivables acquired			$ (1,500,000)
Ultra Chem | Customer-related intangible
Business Acquisition [Line Items]
Intangible asset, amortization period (years)			10 years
Definite-lived intangible assets			$ 24,000,000.0
Ultra Chem | Trade names
Business Acquisition [Line Items]
Intangible asset, amortization period (years)			2 years
Definite-lived intangible assets			$ 300,000
Ultra Chem | Non-compete agreements
Business Acquisition [Line Items]
Intangible asset, amortization period (years)			3 years
Definite-lived intangible assets			$ 3,900,000
Ultra Chem | Transaction Costs
Business Acquisition [Line Items]
Transaction costs															1,100,000
Ultra Chem | Selling, General and Administrative Expenses
Business Acquisition [Line Items]
Transaction costs															700,000
Ultra Chem | Cost of sales and operating expenses
Business Acquisition [Line Items]
Inventory fair value step up															1,000,000.0
Ultra Chem | ABL Facility
Business Acquisition [Line Items]
Borrowings used for acquisition			$ 58,000,000.0
Nexeo Solutions Inc.
Business Acquisition [Line Items]
Transaction costs												$ 21,300,000			900,000
Inventory fair value step up												13,800,000
Number of mergers | merger				2
Excess shares (in shares) | shares														5,178,642
Number of days for election with excess share provision				5 days
Payment by the company to selling equityholders of percentage of net cash tax savings				85.00%
Percentage of net cash tax savings retained by the company				15.00%
Contingent consideration - current undiscounted cash flows of TRA liability				$ 89,800,000										$ 131,300,000
Expected benefit period of TRA (years)														20 years
Contingent consideration - fair value of TRA														$ 74,800,000	105,100,000
Increase (decrease) in inventory															(600,000)
Decrease in property, plant and equipment															100,000
Decrease in accounts payable															2,100,000
Increase in other current assets															200,000
Increase in deferred tax liabilities															400,000
Measurement period adjusment															5,600,000
Debt issuance cost				25,300,000
Accounts receivable fair value adjustment				(4,100,000)
Fair value adjustments to tax receivables				$ 1,300,000
Number of owned distribution locations | location				42
Number of leased locations | location				11
Decrease in fair value of property, plant and equipment				$ (96,000,000.0)
Expected tax deductible goodwill amount														252,900,000
Total consideration				802,700,000
Payment at closing				$ 424,900,000
Nexeo Solutions Inc. | Selling Equityholders
Business Acquisition [Line Items]
Number of trading days to meet condition				20 days
Number of consecutive trading days				30 days
Share price (USD per share) | $ / shares				$ 15.00
Nexeo Solutions Inc. | Customer-related intangible
Business Acquisition [Line Items]
Intangible asset, amortization period (years)				12 years
Definite-lived intangible assets				$ 201,000,000.0
Nexeo Solutions Inc. | Trade names
Business Acquisition [Line Items]
Intangible asset, amortization period (years)				4 years
Definite-lived intangible assets				$ 21,000,000.0
Nexeo Solutions Inc. | Below-market leases
Business Acquisition [Line Items]
Definite-lived intangible assets				$ 700,000
Nexeo Solutions Inc. | Below-market leases | Minimum
Business Acquisition [Line Items]
Remaining life of operating lease (years)				1 year
Nexeo Solutions Inc. | Below-market leases | Maximum
Business Acquisition [Line Items]
Remaining life of operating lease (years)				7 years
Nexeo Solutions Inc. | Predecessor
Business Acquisition [Line Items]
Transaction costs													$ 33,400,000
Other intangible assets
Business Acquisition [Line Items]
Total consideration						$ 9,000,000.0		$ 2,200,000		$ 8,500,000
Payment for intangible assets					$ 3,000,000.0		$ 1,700,000			5,100,000	$ 6,000,000.0
Recognized intangible assets										$ 8,500,000
Estimated Useful Lives (years)								5 years	5 years
Other intangible assets | Minimum
Business Acquisition [Line Items]
Estimated Useful Lives (years)						5 years				10 years
Other intangible assets | Maximum
Business Acquisition [Line Items]
Estimated Useful Lives (years)						13 years				13 years
Other intangible assets | Scenario, Forecast
Business Acquisition [Line Items]
Payment for intangible assets	$ 1,700,000
Univar common stock
Business Acquisition [Line Items]
Number of Univar common stock holders of Nexeo stock will receive | shares		0.305
Deferred Cash Consideration
Business Acquisition [Line Items]
Contingent Consideration- fair value of deferred cash												$ 35,000,000.0		$ 62,700,000	$ 35,100,000

XML

Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Millions	Sep. 30, 2018	Sep. 30, 2017	Apr. 03, 2017	Sep. 30, 2016
Business Acquisition [Line Items]
Goodwill	$ 699.9	$ 703.0		$ 665.7
Ultra Chem
Business Acquisition [Line Items]
Accounts receivable			$ 13.7
Inventory			9.1
Other current assets			2.4
Property and equipment			0.5
Other non-current assets			2.5
Goodwill			28.0
Total assets acquired			84.4
Short-term borrowings			0.9
Accounts payable			12.1
Other current liabilities			4.1
Deferred tax liability-non-current			8.4
Other non-current liabilities			2.2
Total liabilities assumed			27.7
Net assets acquired			56.7
Ultra Chem | Customer-related intangible
Business Acquisition [Line Items]
Definite-lived intangible assets			24.0
Ultra Chem | Trade name
Business Acquisition [Line Items]
Definite-lived intangible assets			0.3
Ultra Chem | Non-compete agreements
Business Acquisition [Line Items]
Definite-lived intangible assets			$ 3.9

XML

Acquisitions - Purchase Consideration (Details) - USD ($) $ in Millions		1 Months Ended	12 Months Ended
	Jun. 09, 2016	Apr. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Business Acquisition [Line Items]
Cash		$ 1.6
Total purchase consideration		$ 1.9
Nexeo Solutions Inc.
Business Acquisition [Line Items]
Cash	$ 424.9
Less: cash acquired	(64.3)
Equity	276.7
Founder Shares transferred to Selling Equityholders	30.2
Contingent consideration - fair value of deferred cash consideration	45.4		$ 62.7	$ 35.1
Contingent consideration - fair value of TRA	89.8		$ 131.3
Total purchase consideration	802.7
Measurement period adjusment				$ 5.6
Assumed liabilities	$ 774.3

XML

Acquisitions - Purchase Price Allocation (Details) - USD ($) $ in Millions	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2016	Jun. 09, 2016
Business Acquisition [Line Items]
Goodwill	$ 699.9	$ 703.0	$ 665.7
Nexeo Solutions Inc.
Business Acquisition [Line Items]
Accounts receivable				$ 470.0
Inventory				327.9
Other current assets				26.0
Property, plant and equipment				328.2
Other non-current assets				3.2
Deferred tax assets				1.2
Goodwill				673.4
Total assets acquired				2,052.6
Short-term borrowings and current portion of capital leases				40.6
Accounts payable				335.9
Other current liabilities				52.8
Long-term portion of capital leases				23.0
Long-term debt				767.3
Deferred tax liability				24.8
Other non-current liabilities				5.5
Total liabilities assumed				1,249.9
Net assets acquired				802.7
Nexeo Solutions Inc. | Customer-related intangible
Business Acquisition [Line Items]
Definite-lived intangible assets				201.0
Nexeo Solutions Inc. | Trade name
Business Acquisition [Line Items]
Definite-lived intangible assets				21.0
Nexeo Solutions Inc. | Below-market leases
Business Acquisition [Line Items]
Definite-lived intangible assets				$ 0.7

XML

Acquisitions - Pro Forma Operating Results (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2016
Business Combinations [Abstract]
Sales and operating revenues	$ 4,034.2	$ 3,672.2	$ 3,466.3
Operating income	97.2	71.1	96.6
Net income from continuing operations	29.4	16.4	33.4
Net income	$ 29.4	$ 16.4	$ 33.5
Basic and diluted net income per share (USD per share)	$ 0.38	$ 0.21	$ 0.44
Pro forma weighted average number of common shares outstanding
Basic (in shares)	76,803,187	76,752,752	76,746,168
Diluted (in shares)	76,909,547	76,839,810	76,799,052

XML

Certain Balance Sheet Information - Cash and Cash Equivalents (Details) - USD ($) $ in Millions	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2016	Jun. 08, 2016
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	$ 58.9	$ 53.9	$ 47.5	$ 0.2
China | Currency denominated in RMB
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	6.5	8.5
Subsidiaries | Foreign subsidiaries
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	52.9	36.8
Subsidiaries | Foreign subsidiaries | Non-USD denominated currency held by foreign subsidiaries
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	$ 48.8	$ 31.1

XML

Certain Balance Sheet Information - Inventories (Details) - USD ($) $ in Millions	Sep. 30, 2018	Sep. 30, 2017
Summary of Inventories
Finished products	$ 334.0	$ 310.6
Supplies	4.8	4.9
Total	$ 338.8	$ 315.5

XML

Certain Balance Sheet Information - Other Non-Current Assets (Details) - USD ($) $ in Millions	Sep. 30, 2018	Sep. 30, 2017
Other Non-current Assets [Line Items]
Debt issuance costs of the ABL Facility	$ 3.8	$ 5.1
Deposits	2.5	2.8
Interest rate swap	8.0	0.3
Other	1.9	2.4
Total	$ 16.2	$ 10.6

XML

Certain Balance Sheet Information - Narrative (Details) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2015
Line of Credit Facility [Line Items]
Cash and cash equivalents	$ 47.5	$ 0.2	$ 58.9	$ 53.9
Proceeds withdrawn from trust account	501.1		0.0	0.0
Term Loan Facility
Line of Credit Facility [Line Items]
Amortization of debt issuance costs	0.7		2.8	2.4
Predecessor
Line of Credit Facility [Line Items]
Cash and cash equivalents		64.3			$ 127.7
Proceeds withdrawn from trust account		0.0
Predecessor | ABL Facility
Line of Credit Facility [Line Items]
Amortization of debt issuance costs		2.1
Predecessor | Term Loan Facility
Line of Credit Facility [Line Items]
Amortization of debt issuance costs		$ 3.6
Interest expense | ABL Facility
Line of Credit Facility [Line Items]
Amortization of debt issuance costs	0.4		$ 1.3	$ 1.3
Interest income
Line of Credit Facility [Line Items]
Amortization of debt discount	$ 0.5

XML

Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Millions	Sep. 30, 2018	Sep. 30, 2017
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 389.8	$ 378.6
Less accumulated depreciation	(104.9)	(62.5)
Property, plant and equipment, net	284.9	316.1
Facilities and equipment acquired under capital lease, accumulated depreciation	7.4	4.9
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	50.8	51.0
Plants and buildings
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	109.7	106.5
Facilities and equipment acquired under capital leases	13.7	13.7
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	153.4	152.8
Facilities and equipment acquired under capital leases	26.5	27.2
Software and computer equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	70.5	63.3
Construction in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 5.4	$ 5.0

XML

Property, Plant and Equipment - Depreciation Expense (Details) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 13.6		$ 46.8	$ 48.2
Period acquiree is included in operations	114 days
Predecessor
Property, Plant and Equipment [Line Items]
Depreciation expense		$ 27.1

XML

Property, Plant and Equipment - Narrative (Details) $ in Millions	1 Months Ended	3 Months Ended		4 Months Ended	12 Months Ended
	Sep. 30, 2016 USD ($)	Sep. 30, 2017 USD ($)	Dec. 31, 2016 USD ($) lease_renewal_option	Sep. 30, 2016 USD ($)	Sep. 30, 2018 USD ($)	Sep. 30, 2017 USD ($)
Property, Plant and Equipment [Line Items]
Property, plant and equipment, net		$ 316.1			$ 284.9	$ 316.1
Land under purchase options, not recorded		10.8				10.8
Proceeds from the disposal of closed US facility	$ 4.6			$ 4.7	3.4	0.6
Capital lease obligations				0.2	0.3	15.3
Gain on sale of facility				(0.2)	0.5	(0.2)
Montgomery Lease
Property, Plant and Equipment [Line Items]
Capital leases, term			15 years
Number of lease renewal options | lease_renewal_option			3
Operating lease renewal term			5 years
Capital lease obligations			$ 13.2
Gain on sale of facility				$ 0.8		8.1
U.S. | Closed facilities
Property, Plant and Equipment [Line Items]
Property, plant and equipment, net		1.1			$ 1.1	$ 1.1
Capital lease obligations | Montgomery Lease
Property, Plant and Equipment [Line Items]
Minimum annual payments			$ 1.1
Annual rent escalation percentage			2.50%
Cost of sales and operating expenses
Property, Plant and Equipment [Line Items]
Impairment of property and equipment due to natural disasters		$ 1.4

XML

Goodwill and Other Intangibles - Schedule of Goodwill by Reportable Segments (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Goodwill
Balance at September 30, 2016	$ 703.0	$ 665.7
Measurement period adjustments		4.4
Ultra Chem Acquisition		28.0
Foreign currency translation	(3.1)	4.9
Balance at September 30, 2018	699.9	703.0
Chemicals
Goodwill
Balance at September 30, 2016	362.8	331.6
Measurement period adjustments		2.7
Ultra Chem Acquisition		28.0
Foreign currency translation	(0.4)	0.5
Balance at September 30, 2018	362.4	362.8
Plastics
Goodwill
Balance at September 30, 2016	276.7	271.1
Measurement period adjustments		1.2
Ultra Chem Acquisition		0.0
Foreign currency translation	(2.7)	4.4
Balance at September 30, 2018	274.0	276.7
Other
Goodwill
Balance at September 30, 2016	63.5	63.0
Measurement period adjustments		0.5
Ultra Chem Acquisition		0.0
Foreign currency translation	0.0	0.0
Balance at September 30, 2018	$ 63.5	$ 63.5

XML

Goodwill and Other Intangibles - Definite Lived Intangible Assets (Details) - USD ($) $ in Millions	Sep. 30, 2018	Sep. 30, 2017
Other intangibles
Gross Carrying Amount	$ 271.3	$ 263.3
Accumulated Amortization	(59.7)	(31.8)
Net Carrying Amount	211.6	231.5
Customer-related
Other intangibles
Gross Carrying Amount	239.6	234.6
Accumulated Amortization	(44.1)	(23.7)
Net Carrying Amount	195.5	210.9
Supplier-related
Other intangibles
Gross Carrying Amount	3.1	1.5
Accumulated Amortization	(0.4)	(0.1)
Net Carrying Amount	2.7	1.4
Trade name
Other intangibles
Gross Carrying Amount	23.3	22.3
Accumulated Amortization	(12.7)	(7.0)
Net Carrying Amount	10.6	15.3
Below-market leases
Other intangibles
Gross Carrying Amount	0.7	0.7
Accumulated Amortization	(0.5)	(0.3)
Net Carrying Amount	0.2	0.4
Non-compete agreements
Other intangibles
Gross Carrying Amount	4.6	4.2
Accumulated Amortization	(2.0)	(0.7)
Net Carrying Amount	$ 2.6	$ 3.5

XML

Goodwill and Other Intangibles - Amortization Expense (Details) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017
Definite-Lived Intangible Assets
Amortization expense	$ 7.0		$ 28.1	$ 24.9
Period acquiree is included in operations	114 days
Expected amortization expense, year ending 2019			28.3
Expected amortization expense, year ending 2020			25.9
Expected amortization expense, year ending 2021			21.6
Expected amortization expense, year ending 2022			21.4
Expected amortization expense, year ending 2023			$ 20.9
Predecessor
Definite-Lived Intangible Assets
Amortization expense		$ 10.6

XML

Goodwill and Other Intangibles -Narrative (Details) - USD ($)	4 Months Ended	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2018	Sep. 30, 2017
Goodwill [Line Items]
Goodwill impairment	$ 0	$ 0	$ 0

XML

Debt - Summary of Short-Term Debt (Details) - USD ($) $ in Millions	Sep. 30, 2018	Sep. 30, 2017
Debt Disclosure [Abstract]
Short-term borrowings	$ 38.1	$ 40.8
Current portion of long-term debt and capital lease obligations	9.6	10.3
Total short-term borrowings and current portion of long term debt and capital lease obligations, net	$ 47.7	$ 51.1

XML

Debt - Long-Term Debt Outstanding (Details) - USD ($) $ in Millions	Sep. 30, 2018	Sep. 30, 2017
Long-term debt
Total long-term debt	$ 779.0	$ 823.7
Less: unamortized debt discount	(2.3)	(2.7)
Less: debt issuance costs	(14.7)	(16.7)
Less: current portion of long-term debt and capital lease obligations	(9.6)	(10.3)
Long-term debt and capital lease obligations, less current portion, net	752.4	794.0
Capital lease obligations
Long-term debt
Total long-term debt	34.0	37.5
ABL Facility
Long-term debt
Total long-term debt	104.6	139.3
Term Loan Facility
Long-term debt
Total long-term debt	$ 640.4	$ 646.9

XML

Debt - Short-term Borrowings Associated with Operations in China (Details) - USD ($)	Sep. 30, 2018	Sep. 30, 2017
Debt Instrument [Line Items]
Facility Limit	$ 46,100,000	$ 46,800,000
Outstanding Borrowings Balance	38,100,000	40,800,000
Remaining Availability	2,900,000	700,000
Outstanding LOC and Bankers’ Acceptance Bills
Debt Instrument [Line Items]
Outstanding LOC and Bankers' Acceptance Bills	5,100,000	5,300,000
Bank of America - China
Debt Instrument [Line Items]
Facility Limit	24,300,000	24,300,000
Outstanding Borrowings Balance	$ 22,200,000	$ 23,800,000
Weighted Average Interest Rate on Borrowings	4.60%	4.30%
Remaining Availability	$ 2,100,000	$ 500,000
Bank of America - China | ABL Facility
Debt Instrument [Line Items]
Line of credit facility collateral coverage (at least)	110.00%
Bank of America - China | Outstanding LOC and Bankers’ Acceptance Bills
Debt Instrument [Line Items]
Outstanding LOC and Bankers' Acceptance Bills	$ 0	0
Bank of Communications - China
Debt Instrument [Line Items]
Facility Limit	21,800,000	22,500,000
Outstanding Borrowings Balance	$ 15,900,000	$ 17,000,000.0
Weighted Average Interest Rate on Borrowings	5.40%	5.30%
Remaining Availability	$ 800,000	$ 200,000
Bank of Communications - China | ABL Facility
Debt Instrument [Line Items]
Line of credit facility collateral coverage (at least)	100.00%
Bank of Communications - China | Outstanding LOC and Bankers’ Acceptance Bills
Debt Instrument [Line Items]
Outstanding LOC and Bankers' Acceptance Bills	$ 5,100,000	$ 5,300,000

XML

Debt - Long-Term Debt Narrative (Details)			4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 19, 2017 USD ($)	Dec. 18, 2017	Sep. 30, 2016 USD ($)	Jun. 08, 2016 USD ($)	Sep. 30, 2018 USD ($)	Sep. 30, 2017 USD ($)	Jun. 09, 2016
Long-term debt
Line of credit facility, maximum borrowing capacity					$ 46,100,000	$ 46,800,000
Remaining availability					2,900,000	700,000
Debt issuances costs incurred			$ 25,300,000		800,000	1,300,000
Long-term debt					779,000,000.0	823,700,000
Annual interest payments					15,500,000
Montgomery Lease
Long-term debt
Capital lease, aggregate future interest payments					12,600,000
Ryder | Ryder Lease
Long-term debt
Capital lease, aggregate future interest payments					2,800,000
Predecessor
Long-term debt
Debt issuances costs incurred				$ 0
Minimum | Montgomery Lease
Long-term debt
Annual interest payments					100,000
Minimum | Ryder | Ryder Lease
Long-term debt
Annual interest payments					100,000
Maximum | Montgomery Lease
Long-term debt
Annual interest payments					1,000,000.0
Maximum | Ryder | Ryder Lease
Long-term debt
Annual interest payments					900,000
Capital lease obligations
Long-term debt
Long-term debt					$ 34,000,000.0	37,500,000
ABL Facility
Long-term debt
Eligible accounts receivable for monthly credit					90.00%
Percentage of orderly liquidation of eligible inventory for monthly credit					85.00%
Cash and cash equivalents held in blocked accounts					100.00%
Line of credit facility excess availability (greater of)					$ 40,250,000
Line of credit facility, capacity					10.00%
Weighted average interest rate					3.26%
Outstanding letters of credit					$ 74,100,000
Amount as collateral to the banking institution					709,400,000
Long-term debt					$ 104,600,000	139,300,000
ABL Facility | Predecessor
Long-term debt
Amortization of debt issuance costs				2,100,000
ABL Facility | Minimum
Long-term debt
Basis spread					0.25%
Line of credit facility, commitment fee					0.25%
Fixed charge coverage ratio (at least)					1.0
ABL Facility | Maximum
Long-term debt
Basis spread					0.75%
Line of credit facility, commitment fee					0.375%
ABL Facility | LIBOR or Canadian BA Rate | Minimum
Long-term debt
Basis spread					1.25%
ABL Facility | LIBOR or Canadian BA Rate | Maximum
Long-term debt
Basis spread					1.75%
ABL Facility | US Tranche
Long-term debt
Line of credit facility, maximum borrowing capacity					$ 505,000,000.0
ABL Facility | Canadian Tranche
Long-term debt
Line of credit facility, maximum borrowing capacity					40,000,000.0
ABL Facility | FILO Tranche
Long-term debt
Line of credit facility, maximum borrowing capacity					30,000,000.0
Remaining availability					$ 5,000,000.0
ABL Facility | FILO Tranche | Alternate base rate | Minimum
Long-term debt
Basis spread					1.00%
ABL Facility | FILO Tranche | Alternate base rate | Maximum
Long-term debt
Basis spread					1.50%
ABL Facility | FILO Tranche | LIBOR | Minimum
Long-term debt
Basis spread					2.00%
ABL Facility | FILO Tranche | LIBOR | Maximum
Long-term debt
Basis spread					2.50%
ABL Facility | U.S. and Canadian Tranches
Long-term debt
Remaining availability					$ 344,200,000
Term Loan Facility
Long-term debt
Line of credit facility, maximum borrowing capacity					655,000,000.0
Line of credit facility, increase in maximum borrowing capacity					$ 175,000,000.0
Basis spread					4.25%
Secured net leverage ratio of available amount (to exceed)					4.1
Weighted average interest rate for term loan facility					5.58%		1.00%
Percentage of aggregate annual amount to be paid every quarter					1.00%
Amortization of debt discount					$ 400,000	500,000
Amortization of debt issuance costs			$ 700,000		2,800,000	2,400,000
Long-term debt					$ 640,400,000	$ 646,900,000
Term Loan Facility | Predecessor
Long-term debt
Amortization of debt issuance costs				$ 3,600,000
Term Loan Facility | LIBOR
Long-term debt
Basis spread					1.00%
Term Loan Facility | Federal Funds Effective Rate
Long-term debt
Basis spread					0.50%
Term Loan Facility | One Month London Interbank Offered Rate
Long-term debt
Basis spread					3.25%
Term Loan Facility | TLB Amendment No. 2
Long-term debt
Debt issuances costs incurred	$ 800,000
Letter of Credit | US Tranche
Long-term debt
Line of credit facility, maximum borrowing capacity					$ 200,000,000.0
Letter of Credit | Canadian Tranche
Long-term debt
Line of credit facility, maximum borrowing capacity					$ 10,000,000.0
Secured Debt | Term Loan Facility | Alternate base rate
Long-term debt
Basis spread		2.75%
Secured Debt | Term Loan Facility | LIBOR
Long-term debt
Basis spread		3.75%
Secured Debt | Term Loan Facility | TLB Amendment No. 2
Long-term debt
Decrease in basis spread	0.50%
Prepayment premium, percentage	1.00%
Secured Debt | Term Loan Facility | TLB Amendment No. 2 | Alternate base rate
Long-term debt
Basis spread	2.25%
Secured Debt | Term Loan Facility | TLB Amendment No. 2 | LIBOR
Long-term debt
Basis spread	3.25%

XML

Debt - Future Principal Payment Obligations (Details) $ in Millions	Sep. 30, 2018 USD ($)
Debt Disclosure [Abstract]
2019	$ 47.7
2020	9.6
2021	114.1
2022	13.2
2023	619.7
Thereafter	12.8
Total	$ 817.1

XML

Derivatives - Narrative (Details)		8 Months Ended	12 Months Ended
	Jun. 29, 2017 USD ($)	Jun. 08, 2016 USD ($)	Sep. 30, 2018 USD ($)	Sep. 30, 2017 USD ($)	Mar. 31, 2018 USD ($) interest_rate_swap	Mar. 31, 2017 USD ($) interest_rate_swap
Derivative Instruments, Gain (Loss) [Line Items]
Cash proceeds from modification of interest rate swaps	$ 500,000
Interest expense related to ineffectiveness				$ (600,000)
Tax impact of unrealized gains			$ (2,800,000)
Interest rate swap | Cash flow hedging
Derivative Instruments, Gain (Loss) [Line Items]
Number of new swaps entered into to manage interest rate exposure | interest_rate_swap					3	4
Combined notional amount					$ 300,000,000.0	$ 300,000,000.0
Tax impact of unrealized gains			2,800,000	$ 100,000
Unrealized gain expected to be realized and recognized in income within the next twelve months			$ 2,800,000
Transaction related costs
Derivative Instruments, Gain (Loss) [Line Items]
Early termination penalty on swap agreement		$ 300,000

XML

Derivatives - Summary of Derivative Assets and Liabilities (Details) - Cash flow hedging - Interest rate swap - USD ($) $ in Millions	Sep. 30, 2018	Sep. 30, 2017
Accumulated other comprehensive income
Derivatives, Fair Value [Line Items]
Accumulated other comprehensive income	$ 8.1	$ 0.0
Level 2 | Other current assets
Derivatives, Fair Value [Line Items]
Derivative asset	2.2	0.0
Level 2 | Other non-current assets
Derivatives, Fair Value [Line Items]
Derivative asset	8.0	0.3
Level 2 | Accrued expenses and other liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	0.0	1.1
Level 2 | Other non-current liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	0.0	0.2
Maximum | Level 2 | Accrued expenses and other liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	$ 0.1
Maximum | Level 2 | Accumulated other comprehensive income
Derivatives, Fair Value [Line Items]
Accumulated other comprehensive income		$ 0.1

XML

Derivatives - Gain (Loss) on Interest Rate Swaps (Details) - USD ($) $ in Millions		4 Months Ended	8 Months Ended	12 Months Ended
		Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017
Derivative [Line Items]
Unrealized gain (loss) on interest rate swaps, net of tax	[1]	$ 0.0		$ (8.1)	$ 0.0
Cash flow hedging | Designated as hedging instrument | Interest rate swap | Other comprehensive income
Derivative [Line Items]
Unrealized gain (loss) on interest rate swaps, net of tax				(8.1)	0.0
Cash flow hedging | Designated as hedging instrument | Interest rate swap | Interest expense
Derivative [Line Items]
Unrealized gain (loss) on interest rate swaps, net of tax				$ 1.2	$ 2.0
Predecessor
Derivative [Line Items]
Unrealized gain (loss) on interest rate swaps, net of tax	[1]		$ (0.3)
Predecessor | Cash flow hedging | Designated as hedging instrument | Interest rate swap | Other comprehensive income
Derivative [Line Items]
Unrealized gain (loss) on interest rate swaps, net of tax			(0.3)
Predecessor | Cash flow hedging | Designated as hedging instrument | Interest rate swap | Interest expense
Derivative [Line Items]
Unrealized gain (loss) on interest rate swaps, net of tax			$ 0.3

[1] Tax impact of the unrealized gains related to the interest-rate swaps was ^{$2.8 million for the fiscal year ended September 30, 2018 and immaterial for the}  fiscal years ended September 30, 2017 and 2016 and for the period from October 1, 2015 through June 8, 2016, for the Predecessor.

XML

Fair Value Measurements - Narrative (Details) $ in Millions		8 Months Ended	12 Months Ended
	Jun. 09, 2016 USD ($)	Jun. 08, 2016 USD ($)	Sep. 30, 2018 USD ($)	Sep. 30, 2017 USD ($)	Mar. 31, 2018 interest_rate_swap	Mar. 31, 2017 interest_rate_swap
TRA
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Discount rate, fair value of liability contingent consideration adjustment			$ 0.6
Tax rate, fair value of liability contingent consideration adjustment			2.6
Measurement period adjustment				$ 5.6
Nexeo Solutions Inc.
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Contingent consideration - fair value of deferred cash consideration	$ 45.4		62.7	35.1
Contingent consideration - fair value of TRA			74.8	105.1
Cash flow hedging | Interest rate swap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Number of new swaps entered into to manage interest rate exposure | interest_rate_swap					3	4
Cash flow hedging | Level 2 | Interest rate swap | Other current assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Derivative asset			2.2	0.0
Cash flow hedging | Level 2 | Interest rate swap | Other non-current assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Derivative asset			$ 8.0	$ 0.3
Transaction related costs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Early termination penalty on swap agreement		$ 0.3

XML

Fair Value Measurements - Changes in Fair Value of Contingent Consideration (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Contingent consideration as of September 30, 2016	$ 140.2	$ 118.4
Measurement period adjustment		5.6
Cash paid to TPG related to TRA	(10.2)
Change in fair value of contingent consideration	7.5	16.2
Contingent consideration as of September 30, 2018	137.5	140.2
TRA
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Contingent consideration as of September 30, 2016	105.1	83.4
Measurement period adjustment		5.6
Cash paid to TPG related to TRA	(10.2)
Change in fair value of contingent consideration	(20.1)	16.1
Contingent consideration as of September 30, 2018	74.8	105.1
Deferred Cash Consideration
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Contingent consideration as of September 30, 2016	35.1	35.0
Measurement period adjustment		0.0
Cash paid to TPG related to TRA	0.0
Change in fair value of contingent consideration	27.6	0.1
Contingent consideration as of September 30, 2018	$ 62.7	$ 35.1

XML

Share-Based Compensation and Employee Benefit Plans - Narrative (Details) - USD ($)		1 Months Ended	4 Months Ended	12 Months Ended
	Jun. 08, 2016	Nov. 30, 2017	Sep. 30, 2016	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2016
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)				193,667
Vested (in shares)				0
Outstanding RSUs (in shares)				1,695,167	1,524,000
Forfeited/Canceled (in shares)				(22,500)
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)				415,867
Vested (in shares)				(53,450)
Shares associated with employee tax withholding for vesting of certain equity awards (in shares)				7,163
Outstanding RSUs (in shares)				409,267	77,458
Forfeited/Canceled (in shares)				(30,608)
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate intrinsic value				$ 4,800,000
Exercisable stock options				0
Granted (in shares)				999,492
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)				0
Vested (in shares)				(8,162)
Outstanding RSUs (in shares)			0	16,338	24,500	0
Forfeited/Canceled (in shares)				0
Restricted Stock Units (RSUs) | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance period				3 years
Phantom Restricted Stock Unit (RSU)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards issued to certain non-U.S. employees (in shares)					10,500
Forfeited/Canceled (in shares)					(3,500)
Phantom Restricted Stock Unit (RSU) | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance period				3 years
Phantom Performance Share Unit (PSU)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards issued to certain non-U.S. employees (in shares)					10,000
2016 LTIP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Effective period of plan	10 years
Number of shares available for grant (up to)	9,000,000
Maximum number of shares per calendar year employees are allowed to receive (in shares)				1,000,000
Maximum value of award employee may receive per calendar year				$ 12,000,000.0
Shares available for issuance (in shares)				3,980,465
2016 LTIP | Non-Employee Board Member
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum value of award employee may receive per calendar year				$ 1,000,000.0
2016 LTIP | PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
PSU's granted (in shares)					212,000	1,557,500
Stockholder return					35.00%
Entitled percentage of common shares to recipient with a 35% stockholder return					100.00%
Minimum stockholder return for awards to be awarded					(15.00%)
Expected dividend yield				0.00%
Additional shares authorized to be issued (up to) (in shares)				3,390,334
Granted (in shares)				193,667
2016 LTIP | PSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Entitled percentage of common shares to recipient				0.00%	0.00%
Volatility rate				35.00%
Risk-free interest rate				0.90%
Expected term				2 years
2016 LTIP | PSUs | Minimum | Negative 15 to 0 Return
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Entitled percentage of common shares to recipient					50.00%
Stockholder return					(15.00%)
2016 LTIP | PSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance period				3 years	3 years
Entitled percentage of common shares to recipient				200.00%	200.00%
Volatility rate				40.00%
Risk-free interest rate				1.30%
Expected term				3 years
2016 LTIP | PSUs | Maximum | Negative 15 to 0 Return
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Entitled percentage of common shares to recipient					70.00%
Stockholder return					0.00%
2016 LTIP | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)		415,867
2016 LTIP | Restricted Stock | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance period		3 years
2016 LTIP | Restricted Stock | Non-Employee Board Member
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)			64,518		77,458
2016 LTIP | Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected stock price volatility				35.00%
Expected dividend yield				0.00%
Risk-free interest rate				2.10%
Expected term				6 years
Granted (in shares)				999,492
2016 LTIP | Employee Stock Option | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				3 years
Contractual term				10 years
2016 LTIP | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)					28,000
TPG
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of restricted stock			100,000
Forfeited/Canceled (in shares)					(11,673)
TPG | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested (in shares)				(27,471)	(33,297)
Outstanding RSUs (in shares)				27,559
TPG | Restricted Stock | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			3 years
Treasury Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares associated with employee tax withholding for vesting of certain equity awards (in shares)				9,940	9,576
Treasury Stock | TPG
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares associated with employee tax withholding for vesting of certain equity awards (in shares)					9,576

XML

Share-Based Compensation and Employee Benefit Plans - PSU Activity (Details) - PSUs	12 Months Ended
	Sep. 30, 2018 $ / shares shares
Units
Outstanding at the beginning of the period (in shares) | shares	1,524,000
Granted (in shares) | shares	193,667
Vested (in shares) | shares	0
Forfeited/Canceled (in shares) | shares	(22,500)
Outstanding at the end of the period (in shares) | shares	1,695,167
Average Grant Date Fair Value Per Unit
Outstanding at the beginning of the period (in USD per share) | $ / shares	$ 8.92
Granted (in USD per share) | $ / shares	7.50
Vested (in USD per share) | $ / shares	0
Forfeited/Canceled (in USD per share) | $ / shares	9.13
Outstanding at the end of the period (in USD per share) | $ / shares	$ 8.76

XML

Share-Based Compensation and Employee Benefit Plans - Restricted Stock Activity (Details) - Restricted Stock	12 Months Ended
	Sep. 30, 2018 $ / shares shares
Units
Outstanding at the beginning of the period (in shares) | shares	77,458
Granted (in shares) | shares	415,867
Vested (in shares) | shares	(53,450)
Forfeited/Canceled (in shares) | shares	(30,608)
Outstanding at the end of the period (in shares) | shares	409,267
Average Grant Date Fair Value Per Unit
Outstanding at the beginning of the period (in USD per share) | $ / shares	$ 8.26
Granted (in USD per share) | $ / shares	7.50
Vested (in USD per share) | $ / shares	8.28
Forfeited/Canceled (in USD per share) | $ / shares	8.05
Outstanding at the end of the period (in USD per share) | $ / shares	$ 7.50

XML

Share-Based Compensation and Employee Benefit Plans - Stock Options Activity (Details) - Employee Stock Option	12 Months Ended
	Sep. 30, 2018 $ / shares shares
Units
Outstanding at the beginning of the period (in shares) | shares	0
Granted (in shares) | shares	999,492
Exercised (in shares) | shares	0
Forfeited/Canceled (in shares) | shares	(6,600)
Outstanding at the end of the period (in shares) | shares	992,892
Average Grant Date Fair Value Per Unit
Granted (in USD per share)	$ 2.84
Forfeited/Canceled (in USD per share)	2.84
Outstanding at the end of the period (in USD per share)	2.84
Weighted Average Exercise Price
Outstanding at the beginning of the period (in USD per share)	0
Granted (in USD per share)	7.42
Exercised (in USD per share)	0
Forfeited/Canceled (in USD per share)	7.42
Outstanding at the end of the period (in USD per share)	$ 7.42

XML

Share-Based Compensation and Employee Benefit Plans - Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) - $ / shares	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Units
Outstanding at the beginning of the period (in shares)	24,500	0
Granted (in shares)	0
Vested (in shares)	(8,162)
Forfeited/Canceled (in shares)	0
Outstanding at the end of the period (in shares)	16,338	24,500
Average Grant Date Fair Value Per Unit
Outstanding at the beginning of the period (in USD per share)	$ 7.28
Granted (in USD per share)	0
Vested (in USD per share)	7.28
Forfeited/Canceled (in USD per share)	0
Outstanding at the end of the period (in USD per share)	$ 7.28	$ 7.28

XML

Share-Based Compensation and Employee Benefit Plans - Schedule of Compensation Expense (Details) - Selling, General and Administrative Expenses - USD ($) $ in Millions	4 Months Ended	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2018	Sep. 30, 2017
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 1.3	$ 4.7	$ 4.5
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	0.1	1.2	0.6
Restricted Stock | TPG
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	0.1	0.3	0.3
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	0.0	0.8	0.0
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 0.0	$ 0.1	$ 0.1

XML

Share-Based Compensation and Employee Benefit Plans - Unrecognized Compensation Cost and Weighted Average Remaining Life (Details) $ in Millions	12 Months Ended
	Sep. 30, 2018 USD ($)
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 4.1
Weighted Average Remaining Life (in years)	10 months 24 days
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 2.0
Weighted Average Remaining Life (in years)	2 years 1 month 6 days
Restricted Stock | TPG
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 0.4
Weighted Average Remaining Life (in years)	8 months 12 days
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 1.9
Weighted Average Remaining Life (in years)	9 years 1 month 6 days
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 0.1
Weighted Average Remaining Life (in years)	1 year 1 month 6 days

XML

Share-Based Compensation and Employee Benefit Plans - Defined Contribution Plans Narrative (Details)	12 Months Ended
	Sep. 30, 2018
Defined Contribution Plan Disclosure [Line Items]
Company matching contribution of employee contributions up to 4% (as a percent)	100.00%
Portion of employee contribution eligible for company match, percentage of pay	4.00%
Service of one to 10 years
Defined Contribution Plan Disclosure [Line Items]
Company contribution percentage based on years of service	1.50%
Service of 11 to 20 years
Defined Contribution Plan Disclosure [Line Items]
Company contribution percentage based on years of service	3.00%
Service Period over Twenty One Years
Defined Contribution Plan Disclosure [Line Items]
Company contribution percentage based on years of service	4.50%
Minimum | Service of one to 10 years
Defined Contribution Plan Disclosure [Line Items]
Service period	1 year
Minimum | Service of 11 to 20 years
Defined Contribution Plan Disclosure [Line Items]
Service period	11 years
Minimum | Service Period over Twenty One Years
Defined Contribution Plan Disclosure [Line Items]
Service period	21 years
Maximum | Service of one to 10 years
Defined Contribution Plan Disclosure [Line Items]
Service period	10 years
Maximum | Service of 11 to 20 years
Defined Contribution Plan Disclosure [Line Items]
Service period	20 years

XML

Share-Based Compensation and Employee Benefit Plans - Cost of Defined Contribution Plan (Details) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017
Defined Benefit Plan Disclosure [Line Items]
Contributions	$ 3.5		$ 10.6	$ 10.4
Period acquiree is included in operations	114 days
Contributions recorded as a component of cost of sales and operating expenses
Defined Benefit Plan Disclosure [Line Items]
Contributions	$ 1.3		4.2	4.0
Contributions recorded as a component of selling, general and administrative expenses
Defined Benefit Plan Disclosure [Line Items]
Contributions	$ 2.2		$ 6.4	$ 6.4
Predecessor
Defined Benefit Plan Disclosure [Line Items]
Contributions		$ 7.2
Predecessor | Contributions recorded as a component of cost of sales and operating expenses
Defined Benefit Plan Disclosure [Line Items]
Contributions		2.7
Predecessor | Contributions recorded as a component of selling, general and administrative expenses
Defined Benefit Plan Disclosure [Line Items]
Contributions		$ 4.5

XML

Equity - Common Stock (Details) - USD ($) $ / shares in Units, $ in Millions	Jun. 09, 2016	Jun. 11, 2014	Sep. 30, 2018	Sep. 30, 2017	Mar. 31, 2016
Class of Stock [Line Items]
Common stock, shares authorized (in shares)			300,000,000	300,000,000
Common stock, shares issued (in shares)		62,531,250	89,747,062	89,353,641
Common stock, shares outstanding (in shares)		62,531,250	89,727,546	89,344,065
Warrants to purchase shares of common stock (in shares)			25,012,500
Strike price (USD per share)			$ 11.50
Common stock outstanding, unit (in shares)			1
Warrant, unit (in shares)			1
Temporary equity, shares outstanding (in shares)					47,512,924
Temporary equity value					$ 475.2
Stock redeemed (in shares)	29,793,320
Temporary equity, redemption price (USD per share)	$ 10.02
New shares issued (in shares)	2,240,000
Shares issued for deferred underwriting fees	$ 18.3
Warrants called (in shares)	22,400,000
Selling Equityholders
Class of Stock [Line Items]
New shares issued (in shares)	27,673,604
Shares issued (USD per share)	$ 10.00
Shares in lieu of payment (in shares)	3,078,578
Shares issued for advisory services	$ 30.8
Founders Shares
Class of Stock [Line Items]
Shares issued (in shares)	12,476,250	12,506,250
Shares transferred to Selling Equityholders (in shares)	3,554,240
Founder Shares transferred to Selling Equityholders	$ 30.2
Percentage of shares subject to condition one	50.00%
Sale price equals or exceeds, condition one (USD per share)	$ 12.50
Number of trading days to meet condition one	20 days
Number of consecutive trading days condition one	30 days
Number of trading days to meet condition two	20 days
Number of consecutive trading days condition two	30 days
Percentage of shares subject to condition two	50.00%
Sale price equals or exceeds, condition two (USD per share)	$ 15.00
Directors Founders Shares
Class of Stock [Line Items]
Shares in lieu of payment (in shares)	30,000
IPO
Class of Stock [Line Items]
Number of IPO shares (in shares)		50,025,000
Private Placement
Class of Stock [Line Items]
Shares issued (USD per share)	$ 10.00
Private Placement | Selling Equityholders
Class of Stock [Line Items]
New shares issued (in shares)	23,492,306

XML

Equity - Warrants (Details) - $ / shares	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2016
Class of Stock [Line Items]
Warrants outstanding (in shares)	50,025,000	50,025,000	50,025,000
Warrants to purchase shares of common stock (in shares)	25,012,500
Exercise price (USD per share)	$ 11.50

XML

Equity - Preferred Stock (Details) - shares	Sep. 30, 2018	Sep. 30, 2017
Equity [Abstract]
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0

XML

Equity - Treasury Stock (Details) - shares	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2016
Class of Stock [Line Items]
Treasury stock, shares acquired (in shares)	7,163
Treasury Stock
Class of Stock [Line Items]
Shares, Issued	19,516	9,576	0
Restricted Stock
Class of Stock [Line Items]
Treasury stock, shares acquired (in shares)	2,777

XML

Earnings Per Share - Schedule of Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								4 Months Ended	12 Months Ended
	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Sep. 30, 2018	Sep. 30, 2017
Basic:
Net income (loss)									$ (8.4)	$ 29.4	$ 14.4
Weighted average number of common shares outstanding, basic (in shares)	76,825,850	76,797,414	76,795,742	76,793,518	76,774,578	76,743,853	76,746,168	76,746,168	35,193,789	76,803,187	76,752,752
Net income (loss) per common share - basic (USD per share)	$ (0.20)	$ 0.23	$ 0.01	$ 0.35	$ 0.18	$ 0.13	$ (0.01)	$ (0.11)	$ (0.24)	$ 0.38	$ 0.19
Diluted:
Net income (loss)									$ (8.4)	$ 29.4	$ 14.4
Denominator for diluted earnings per share:
Weighted average number of common shares outstanding, basic (in shares)	76,825,850	76,797,414	76,795,742	76,793,518	76,774,578	76,743,853	76,746,168	76,746,168	35,193,789	76,803,187	76,752,752
Incremental common shares attributable to outstanding dilutive options and unvested restricted shares (in shares)									0	106,360	87,058
Denominator for diluted earnings per common share (in shares)	76,825,850	76,983,350	76,961,218	76,857,244	76,852,267	76,828,868	76,746,168	76,746,168	35,193,789	76,909,547	76,839,810
Net income (loss) per common share - diluted (USD per share)	$ (0.20)	$ 0.23	$ 0.01	$ 0.34	$ 0.18	$ 0.13	$ (0.01)	$ (0.11)	$ (0.24)	$ 0.38	$ 0.19
Period acquiree is included in operations									114 days

XML

Earnings Per Share - Narrative (Details) - shares	4 Months Ended	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2018	Sep. 30, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Warrants exercised (in shares)	50,025,000	50,025,000	50,025,000
Incorporation period of shares related to business combination	114 days
Restricted Stock Units (RSUs)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Outstanding RSUs (in shares)	0	16,338	24,500
Founders Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	12,476,250	12,476,250	12,476,250
Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	25,012,500	25,012,500	25,012,500

XML

Commitments, Contingencies and Litigation - Non-Cancellable Rental Payments (Details) $ in Millions	Sep. 30, 2018 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2019	$ 14.1
2020	8.9
2021	7.1
2022	5.2
2023	2.8
Thereafter	0.3
Total	$ 38.4

XML

Commitments, Contingencies and Litigation - Future Minimum Lease Payments Under Capital Leases (Details) $ in Millions	Sep. 30, 2018 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2019	$ 7.6
2020	7.2
2021	7.1
2022	10.4
2023	6.9
Thereafter	25.4
Total minimum capital lease payments	64.6
Less amount representing executory costs	(15.1)
Less amount representing interest	(15.5)
Present value of net minimum capital lease payments	$ 34.0

XML

Commitments, Contingencies and Litigation - Narrative (Details) - USD ($) $ in Millions		4 Months Ended	8 Months Ended	12 Months Ended
	Mar. 31, 2011	Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017
Environmental Remediation
Rent expense for operating leases		$ 6.9		$ 25.9	$ 25.0
Ashland | Other Retained Remediation Liabilities
Environmental Remediation
Remediation indemnification obligation resulting from breach of any representation, warranty or covenant individual claim threshold	$ 0.2
Remediation indemnification obligation resulting from breach of any representation, warranty or covenant aggregate claim deductible	$ 5.0
Predecessor
Environmental Remediation
Rent expense for operating leases			$ 17.1

XML

Related Party Transactions - Narrative (Details) - USD ($)								4 Months Ended	8 Months Ended	12 Months Ended
	Feb. 28, 2018	Jun. 09, 2016	Jun. 06, 2016	May 23, 2016	Mar. 31, 2016	Jan. 05, 2016	Mar. 26, 2015	Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017	Mar. 31, 2016
Related Party Transaction [Line Items]
Repayments of debt								$ 0		$ 10,200,000	$ 0
Exercise price (USD per share)										$ 11.50
TPG portfolio entities
Related Party Transaction [Line Items]
Purchases from related entities								0		$ 500,000	0
Ownership interest by related party		35.00%
Fee paid in connection with the Business Combination								0		0	0
Entities related to members of the Board of Directors
Related Party Transaction [Line Items]
Purchases from related entities								$ 0		13,100,000	$ 1,700,000
Sponsor
Related Party Transaction [Line Items]
Promissory note, maximum borrowing amount					$ 750,000							$ 750,000
Promissory note interest rate (percentage)					5.00%
Current accounts payable related to daily operations					$ 200,000							200,000
Repayments of debt		$ 200,000
Predecessor
Related Party Transaction [Line Items]
Repayments of debt									$ 0
Predecessor | TPG portfolio entities
Related Party Transaction [Line Items]
Purchases from related entities									0
Fee paid in connection with the Business Combination		9,900,000							9,900,000
Predecessor | Entities related to members of the Board of Directors
Related Party Transaction [Line Items]
Purchases from related entities									0
Transportation Logistics Services Agrmt | TPG portfolio entities
Related Party Transaction [Line Items]
Related Party Transaction, Service Agreement, Period	3 years
Purchases from related entities										1,400,000
FPA Subscription Agreement | Private Placement
Related Party Transaction [Line Items]
Number of IPO shares (in shares)				18,260,000
Sponsor Subscription Agreement | Private Placement
Related Party Transaction [Line Items]
Number of IPO shares (in shares)			1,000,000
Sale of Stock, Price Per Share			$ 10.00
PWPI and PWIMF Commitment Agreements
Related Party Transaction [Line Items]
Stock Repurchased During Period, Shares			3,000,000
FPA Commitment Agreement
Related Party Transaction [Line Items]
Agreement For Shares Not To Redeem, Shares			2,094,727
January 2016 Convertible Note | Sponsor
Related Party Transaction [Line Items]
Promissory note interest rate (percentage)						5.00%
Current accounts payable related to daily operations						$ 400,000
Repayments of debt		400,000
Conversion price (USD per warrant)						$ 0.50
Class of warrant, exercise price of warrants for half share						5.75
Exercise price (USD per share)						$ 11.50
March 2015 Convertible Note | Sponsor
Related Party Transaction [Line Items]
Promissory note interest rate (percentage)							5.00%
Current accounts payable related to daily operations							$ 300,000
Repayments of debt		300,000
Conversion price (USD per warrant)							$ 0.60
Class of warrant, exercise price of warrants for half share							5.75
Exercise price (USD per share)							$ 11.50
Related party interest expense												$ 14,000
Letter Agreement for Chairman’s Services
Related Party Transaction [Line Items]
Letter termination fee		$ 200,000
Consulting Services Agreement | Predecessor | Entities related to members of the Board of Directors
Related Party Transaction [Line Items]
Purchases from related entities									100,000
Consulting services annual fee									$ 175,000
TRA | TPG portfolio entities
Related Party Transaction [Line Items]
Repayments of debt										$ 10,200,000

XML

Related Party Transactions - Schedule of Agreements with Related Parties (Details) - USD ($) $ in Millions		4 Months Ended	8 Months Ended	12 Months Ended
	Jun. 09, 2016	Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017
Related Party Transaction [Line Items]
Due to Related Parties, Current				$ 14.7	$ 12.5
Period acquiree is included in operations		114 days
TPG portfolio entities
Related Party Transaction [Line Items]
Due from Related Parties, Current				1.0	0.7
Due to Related Parties, Current				0.5	0.0
Sales to related entities:
Sales to related entities		$ 1.7		4.5	3.1
Purchases from related entities:
Purchases from related entities		0.0		0.5	0.0
Amounts included in Selling, general and administrative expenses
Management fees to TPG		0.0		0.0	0.0
Consulting fees to TPG		0.1		0.0	0.0
Amounts included in Transaction related costs
Fee paid in connection with the Business Combination		0.0		0.0	0.0
Entities related to members of the Board of Directors
Related Party Transaction [Line Items]
Due from Related Parties, Current				0.2	0.0
Due to Related Parties, Current				0.6	0.1
Sales to related entities:
Sales to related entities		0.0		1.4	0.1
Purchases from related entities:
Purchases from related entities		$ 0.0		$ 13.1	$ 1.7
Predecessor | TPG portfolio entities
Sales to related entities:
Sales to related entities			$ 3.1
Purchases from related entities:
Purchases from related entities			0.0
Amounts included in Selling, general and administrative expenses
Management fees to TPG			2.1
Consulting fees to TPG			0.4
Amounts included in Transaction related costs
Fee paid in connection with the Business Combination	$ 9.9		9.9
Predecessor | Entities related to members of the Board of Directors
Sales to related entities:
Sales to related entities			0.0
Purchases from related entities:
Purchases from related entities			$ 0.0

XML

Related Party Transactions - Contingent Consideration Obligations (Details) - USD ($) $ in Millions	Sep. 30, 2018	Sep. 30, 2017
Related Party Transactions [Abstract]
Due to Related Parties, Current	$ 14.7	$ 12.5
Due to related party pursuant to contingent consideration obligations, non-current	122.8	127.7
Total fair value	$ 137.5	$ 140.2

XML

Income Taxes - Income (Loss) Before Income Taxes (Details) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017
Income (Loss) Before Income Taxes [Line Items]
U.S.	$ (9.1)		$ 24.8	$ 7.9
Foreign	1.9		21.3	17.0
Net income (loss) from continuing operations before income taxes	$ (7.2)		$ 46.1	$ 24.9
Period acquiree is included in operations	114 days
Predecessor
Income (Loss) Before Income Taxes [Line Items]
U.S.		$ (19.6)
Foreign		9.9
Net income (loss) from continuing operations before income taxes		$ (9.7)

XML

Income Taxes - Provision for Income Taxes (Details) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017
Current tax expense (benefit):
U.S. - Federal	$ 0.5		$ 9.5	$ 1.3
U.S. - State	(0.2)		2.8	0.5
Foreign	2.0		11.3	6.5
Total current tax expense	2.3		23.6	8.3
Deferred tax expense (benefit):
U.S. - Federal	(0.8)		(4.7)	4.6
U.S. - State	0.4		0.1	0.2
Foreign	(0.7)		(2.3)	(2.6)
Total deferred tax expense (benefit)	(1.1)		(6.9)	2.2
Income tax expense	$ 1.2		$ 16.7	$ 10.5
Period acquiree is included in operations	114 days
Predecessor
Current tax expense (benefit):
U.S. - Federal		$ 0.0
U.S. - State		(0.1)
Foreign		3.2
Total current tax expense		3.1
Deferred tax expense (benefit):
U.S. - Federal		0.4
U.S. - State		0.1
Foreign		0.6
Total deferred tax expense (benefit)		1.1
Income tax expense		$ 4.2

XML

Income Taxes - Effective Tax Rate Reconciliation (Details) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017
Income tax expense (benefit), continuing operations
Pretax income (loss) at statutory rate	$ (2.5)		$ 9.7	$ 8.5
State income taxes	0.2		2.1	0.9
Statutory rate differential	(0.2)		1.4	(1.4)
FIN 48 expense (benefit)	0.0		2.3	(0.5)
Non-U.S. tax credit	0.0		(2.0)	0.0
Withholding and other taxes	0.0		0.5	0.5
Tax impact of tax reform	0.0		(4.5)	0.0
Transaction costs	5.0		0.9	0.0
Contingent liability	(1.6)		0.8	2.4
Other permanent differences	0.3		0.3	0.3
Statutory tax rate changes and differences	(0.2)		0.9	0.0
True-up to prior year taxes	0.0		2.6	(0.3)
Nondeductible stewardship costs	0.0		1.1	0.0
Valuation allowance	0.2		0.6	0.1
Income tax expense	$ 1.2		$ 16.7	$ 10.5
Effective tax rate	(16.70%)		36.20%	42.20%
U.S. statutory federal rate			24.50%
Period acquiree is included in operations	114 days
Predecessor
Income tax expense (benefit), continuing operations
Pretax income (loss) at statutory rate		$ 0.0
State income taxes		0.0
Statutory rate differential		2.5
FIN 48 expense (benefit)		0.1
Non-U.S. tax credit		0.0
Withholding and other taxes		0.3
Tax impact of tax reform		0.0
Transaction costs		0.0
Contingent liability		0.0
Other permanent differences		0.6
Statutory tax rate changes and differences		(0.1)
True-up to prior year taxes		0.2
Nondeductible stewardship costs		0.0
Valuation allowance		0.6
Income tax expense		$ 4.2
Effective tax rate		(43.30%)

XML

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2018	Sep. 30, 2017
Deferred Tax Assets
Foreign operating losses	$ 5.5	$ 6.3
Federal and state operating losses	15.5	27.6
Non-U.S. tax credit	1.9	0.0
Unrealized gains/losses	0.3	0.2
Fixed assets and intangibles	1.1	0.9
Compensation and other accruals	4.0	2.4
Other items	0.8	0.9
Valuation allowance	(3.6)	(3.1)
Total deferred tax assets	25.5	35.2
Deferred Tax Liabilities
Fixed assets and intangibles	23.2	23.8
Compensation and other accruals	0.2	0.2
Investment in partnerships	27.1	43.2
Other items	3.4	0.6
Total deferred tax liabilities	$ 53.9	$ 67.8

XML

Income Taxes - Unrecognized Tax Benefits Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at beginning of period	$ 1.2	$ 0.9
Increases related to positions taken on items from prior years	2.3	0.1
Decreases related to positions taken on items from prior years	(0.2)	0.0
Unrecognized tax benefits assumed related to acquisitions	0.0	0.8
Lapse of statute of limitations	(0.2)	(0.6)
Balance at end of period	$ 3.1	$ 1.2

XML

Income Taxes - Narrative (Details)	4 Months Ended	12 Months Ended
	Sep. 30, 2016 USD ($)	Sep. 30, 2018 USD ($) subsidiary	Sep. 30, 2017 USD ($)
Operating Loss Carryforwards [Line Items]
Earnings reinvested related to foreign subsidiaries		$ 94,300,000
Number of active subsidiaries | subsidiary		2
Tax distributions made to LLC	$ 0
U.S. statutory federal rate		24.50%
Impact from tax act, net benefit		$ 4,500,000
Valuation allowance		3,600,000	$ 3,100,000
Unrecognized tax benefits assumed related to acquisitions		0	800,000
Uncertain tax positions, related accrued interest and penalties	200,000	900,000	900,000
Unrecognized tax benefits	1,200,000	4,000,000.0	1,800,000
Uncertain tax position less the interest and penalties	$ 900,000	3,100,000	1,200,000
Foreign
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards		23,400,000
U.S.
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards		59,500,000
Ultra Chem
Operating Loss Carryforwards [Line Items]
Unrecognized tax benefits assumed related to acquisitions			$ 1,300,000
Europe
Operating Loss Carryforwards [Line Items]
Unrecognized tax benefits		$ 2,200,000

XML

Segment and Geographic Data - Narrative (Details)	4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018 segment country	Sep. 30, 2017
Segment and Geographic Data
Number of operating segments | segment			3
Chemicals
Segment and Geographic Data
Number of countries products are sold in			50
Plastics | Minimum
Segment and Geographic Data
Number of countries products are sold in			60
Polypropylene Product | Revenue | Plastics
Segment and Geographic Data
Concentration risk, percentage	17.60%		15.90%	15.50%
Predecessor | Polypropylene Product | Revenue | Plastics
Segment and Geographic Data
Concentration risk, percentage		17.70%
Supplier One | Supplier Concentration Risk | Purchases
Segment and Geographic Data
Concentration risk, percentage	11.90%		11.60%	12.10%
Supplier One | Supplier Concentration Risk | Predecessor | Purchases
Segment and Geographic Data
Concentration risk, percentage		12.00%
Supplier Two | Supplier Concentration Risk | Purchases
Segment and Geographic Data
Concentration risk, percentage	10.40%		9.60%	9.90%
Supplier Two | Supplier Concentration Risk | Predecessor | Purchases
Segment and Geographic Data
Concentration risk, percentage		9.80%

XML

Segment and Geographic Data - Summarized Financial Information (Details) - USD ($) $ in Millions	3 Months Ended								4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017
Summarized financial information
Sales and operating revenues	$ 1,017.2	$ 1,046.4	$ 1,041.0	$ 929.6	$ 981.7	$ 942.7	$ 917.7	$ 794.8	$ 1,065.7		$ 4,034.2	$ 3,636.9
Gross profit	117.3	$ 120.2	$ 115.7	$ 106.9	109.1	$ 102.7	$ 102.2	$ 84.4	108.4		460.1	398.4
Selling, general and administrative expenses									91.7		352.6	312.9
Transaction related costs									21.3		2.8	1.9
Change in fair value of contingent consideration obligations									(11.2)		7.5	16.2
Operating income									6.6		97.2	67.4
Other income, net									0.5		1.0	8.3
Interest income (expense)
Interest income									0.8		0.5	0.3
Interest expense									(15.1)		(52.6)	(51.1)
Net income (loss) from continuing operations before income taxes									$ (7.2)		46.1	24.9
Period acquiree is included in operations									114 days
Segment assets
Assets	2,243.6				2,253.5						2,243.6	2,253.5
Operating Segments
Segment assets
Assets	1,680.1				1,647.3						1,680.1	1,647.3
Unallocated assets
Segment assets
Assets	563.5				606.2						563.5	606.2
Chemicals | Operating Segments
Summarized financial information
Sales and operating revenues									$ 478.1		1,904.5	1,667.2
Gross profit									55.7		248.0	205.6
Segment assets
Assets	826.2				793.6						826.2	793.6
Plastics | Operating Segments
Summarized financial information
Sales and operating revenues									546.7		1,980.0	1,841.7
Gross profit									43.6		186.4	167.2
Segment assets
Assets	758.2				762.7						758.2	762.7
Other | Operating Segments
Summarized financial information
Sales and operating revenues									40.9		149.7	128.0
Gross profit									$ 9.1		25.7	25.6
Segment assets
Assets	$ 95.7				$ 91.0						$ 95.7	$ 91.0
Predecessor
Summarized financial information
Sales and operating revenues										$ 2,340.1
Gross profit										271.9
Selling, general and administrative expenses										208.9
Transaction related costs										33.4
Change in fair value of contingent consideration obligations										0.0
Operating income										29.6
Other income, net										2.9
Interest income (expense)
Interest income										0.1
Interest expense										(42.3)
Net income (loss) from continuing operations before income taxes										(9.7)
Predecessor | Chemicals | Operating Segments
Summarized financial information
Sales and operating revenues										1,066.4
Gross profit										136.2
Predecessor | Plastics | Operating Segments
Summarized financial information
Sales and operating revenues										1,192.2
Gross profit										117.6
Predecessor | Other | Operating Segments
Summarized financial information
Sales and operating revenues										81.5
Gross profit										$ 18.1

XML

Segment and Geographic Data - Revenues by Geographic Location (Details) - USD ($) $ in Millions	3 Months Ended								4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017
Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale
Sales and operating revenues	$ 1,017.2	$ 1,046.4	$ 1,041.0	$ 929.6	$ 981.7	$ 942.7	$ 917.7	$ 794.8	$ 1,065.7		$ 4,034.2	$ 3,636.9
Period acquiree is included in operations									114 days
U.S.
Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale
Sales and operating revenues									$ 808.2		2,959.9	2,682.2
Canada
Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale
Sales and operating revenues									46.5		189.9	171.6
Other North America
Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale
Sales and operating revenues									18.4		132.8	87.2
Total North America Operations
Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale
Sales and operating revenues									873.1		3,282.6	2,941.0
EMEA
Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale
Sales and operating revenues									130.6		539.7	481.7
Asia
Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale
Sales and operating revenues									$ 62.0		$ 211.9	$ 214.2
Predecessor
Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale
Sales and operating revenues										$ 2,340.1
Predecessor | U.S.
Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale
Sales and operating revenues										1,779.4
Predecessor | Canada
Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale
Sales and operating revenues										102.4
Predecessor | Other North America
Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale
Sales and operating revenues										35.4
Predecessor | Total North America Operations
Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale
Sales and operating revenues										1,917.2
Predecessor | EMEA
Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale
Sales and operating revenues										291.9
Predecessor | Asia
Revenues by geographic location, based on the jurisdiction of the subsidiary entity receiving revenue credit for the sale
Sales and operating revenues										$ 131.0

XML

Unaudited Quarterly Information (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								4 Months Ended	12 Months Ended
	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Sep. 30, 2018	Sep. 30, 2017
Condensed Income Statements, Captions [Line Items]
Sales and operating revenues	$ 1,017.2	$ 1,046.4	$ 1,041.0	$ 929.6	$ 981.7	$ 942.7	$ 917.7	$ 794.8	$ 1,065.7	$ 4,034.2	$ 3,636.9
Gross profit	117.3	120.2	115.7	106.9	109.1	102.7	102.2	84.4	108.4	460.1	398.4
Net income (loss)	$ (15.0)	$ 17.5	$ 0.4	$ 26.5	$ 13.6	$ 10.2	$ (1.1)	$ (8.3)	$ (8.4)	$ 29.4	$ 14.4
Net income (loss) per common share - basic (USD per share)	$ (0.20)	$ 0.23	$ 0.01	$ 0.35	$ 0.18	$ 0.13	$ (0.01)	$ (0.11)	$ (0.24)	$ 0.38	$ 0.19
Net income (loss) per common share - diluted (USD per share)	$ (0.20)	$ 0.23	$ 0.01	$ 0.34	$ 0.18	$ 0.13	$ (0.01)	$ (0.11)	$ (0.24)	$ 0.38	$ 0.19
Weighted average number of common shares outstanding, basic (in shares)	76,825,850	76,797,414	76,795,742	76,793,518	76,774,578	76,743,853	76,746,168	76,746,168	35,193,789	76,803,187	76,752,752
Weighted average number of common shares outstanding, diluted (in shares)	76,825,850	76,983,350	76,961,218	76,857,244	76,852,267	76,828,868	76,746,168	76,746,168	35,193,789	76,909,547	76,839,810

XML

Schedule II - Valuation and Qualifying Accounts (Details) - USD ($) $ in Millions		4 Months Ended	8 Months Ended	12 Months Ended
		Sep. 30, 2016	Jun. 08, 2016	Sep. 30, 2018	Sep. 30, 2017
Allowance for Doubtful Accounts
Movement in Valuation Allowances and Reserves
Balance Beginning of Period		$ 0.0		$ 2.2	$ 1.4
Charged to Costs and Expenses		0.3		1.9	(0.2)
Charged to Other Accounts		1.3		0.0	1.7
Deductions	[1]	(0.2)		0.1	(0.7)
Balance End of Period		1.4		4.2	2.2
Reserve for sales returns and allowances
Movement in Valuation Allowances and Reserves
Balance Beginning of Period		0.0		1.4	1.5
Charged to Costs and Expenses		0.0		0.0	0.0
Charged to Other Accounts	[2]	1.5		0.2	(0.1)
Deductions		0.0		0.0	0.0
Balance End of Period		$ 1.5		$ 1.6	$ 1.4
Predecessor | Allowance for Doubtful Accounts
Movement in Valuation Allowances and Reserves
Balance Beginning of Period			$ 3.8
Charged to Costs and Expenses			1.2
Charged to Other Accounts			0.0
Deductions	[1]		(0.9)
Balance End of Period			4.1
Predecessor | Reserve for sales returns and allowances
Movement in Valuation Allowances and Reserves
Balance Beginning of Period			1.6
Charged to Costs and Expenses			0.0
Charged to Other Accounts	[2]		(0.1)
Deductions			0.0
Balance End of Period			$ 1.5

[1] Accounts written off during the year, net of recoveries and foreign exchange impact.

[2] Amounts represent estimates for expected sales returns.